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ABSTRACT 
CHAPTER I: 
SYNTHESIS OF HALOGENATED NAPHTHOLS 
Substituted naphthalenes are common structural motifs present in many biologically active compounds 
and pharmaceuticals. The first chapter of this Ph.D. thesis describes the development of a novel ring-
opening reaction for the synthesis of halogenated naphthols. The efficient and practical procedure enabled 
the preparation of a library of polysubstituted 1-naphthols in three steps from commercially available 
indanones via oxidation, cyclopropanation and an electrocyclic ring opening. This operationally simple 
method does not require any additives or transition metal catalysts and can be performed under an air 
atmosphere. The reaction mechanism is assumed to proceed through a thermally induced disrotatory 
2π-electrocyclic ring opening of the cyclopropanated indanone followed by a chloride migration to 
preferentially afford the para-chloro substituted 1-naphthols. The developed method was successfully 
applied to the total synthesis of chartarin, a potent anticancer natural product. The synthesis revealed the 
remarkable potential of this method for the construction of highly substituted, sterically hindered biaryl 
compounds. 
 
In addition, our synthetic efforts towards applying this method for the synthesis of fluorinated naphthols 
are illustrated. Various methods for the preparation of fluorinated cyclopropane-indanones were 
examined; however, a general method could not be developed. The development of one successful 
approach is described, which afforded an exemplary fluorinated 1-naphthol. However, all attempts to 
generalize this methodology were met with failure. 
 
VIII 
 
CHAPTER II: 
STUDIES TOWARDS THE TOTAL SYNTHESIS OF JERANTININE E 
The second chapter of this thesis describes our efforts towards the total synthesis of jerantinine E, an 
Aspidosperma alkaloid which was isolated in 2008 from the Malayan plant Tabernaemontana corymbosa. The 
pentacyclic 6,5,6,6,5-ring system of jerantinine E exhibits three contiguous stereogenic centers and a 
highly oxygenated tetrahydrocarbazolone core. The synthetic route towards an advanced intermediate in 
the synthesis of jerantinine E features a β-C–H bromination reaction, a palladium-catalyzed amination and 
an oxidative indole formation. The installation of the secondary amine building block, which contains all 
carbon atoms of the D and E rings of jerantinine E, was enabled by the incorporation of an ally ester. A 
palladium-catalyzed decarboxylative allylation reaction of the ester was envisioned to set the first 
quaternary stereocenter. 
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1 Introduction 
1.1 Synthesis of Polyfunctionalized Naphthalenes 
Substituted naphthalenes are important structural motifs that can be found in many biologically active 
compounds or pharmaceuticals. They are common building blocks in natural product synthesis and 
various naphthalene-containing natural products have been reported to date, including elsamicin A (I.1),1 
the atropisomers michellamines A–C (I.2)2 and lactonamycin (I.3) (Figure 1).3 
 
Figure 1. Natural products containing variously substituted naphthalene motifs. 
Traditionally, polysubstituted naphthalenes were prepared by conventional methods, such as electrophilic 
or nucleophilic aromatic substitution reactions. However, these methods often rely on a stepwise 
functionalization from readily available naphthalene precursors and can be rather inefficient due to low 
stereochemical control. In recent years, several methods based on annulation, cyclization or ring 
expansion reactions were developed. 
1.1.1 Preparation of Polysubstituted Naphthalenes from Naphthalene Precursors 
1.1.1.1 Electrophilic Aromatic Substitution 
For several decades, the electrophilic aromatic substitution was widely used to functionalize aromatic 
compounds. In general, polycyclic aromatic hydrocarbons like naphthalene, anthracene, and phenanthrene 
are more reactive than benzene and can undergo a variety of electrophilic aromatic substitution reactions. 
This can be explained by the preservation of more of the initial resonance stabilization in fused ring 
systems like naphthalenes, resulting in a lower localization energy for the formation of the cationic 
intermediate. The calculated localization energies for benzene, naphthalene, and anthracene are 36.3, 15.4, 
and 8.3 kcal/mol, respectively.4 
Under kinetically controlled reaction conditions, the electrophilic attack occurs in the α-position of the 
naphthalene (I.6) due to a better stabilization of the cationic intermediate I.5. The cationic intermediate 
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benefits from an allylic and benzylic stabilization whereas the attack at the β-position provides only a 
benzylic carbocation. However, the β-substituted naphthalene can be obtained under thermodynamic 
conditions. For example, the sulfonation of naphthalene under kinetic conditions (80 °C) provided 
predominantly naphthalene-1-sulfonic acid (I.4), whereas the reaction at elevated temperature gave the 
more stable thermodynamic product naphthalene-2-sulfonic acid (I.8) (Scheme 1).5 
 
Scheme 1. Sulfonation of naphthalene (I.6) under kinetic and thermodynamic conditions. 
Since its discovery, the Friedel–Crafts acylation6 was frequently applied in the synthesis of functionalized 
aromatic compounds. Recently, Ospina et al. reported the synthesis of 2-hydroxy-8-(4-
hydroxyphenyl)-1H-phenalen-1-one (I.13) using a Friedel–Crafts acylation/Michael addition cascade. The 
reaction of 2-methoxynaphthalene (I.9) with acryloyl chloride (I.10) in the presence of aluminum chloride 
followed by an acidic workup afforded 9-methoxy-2,3-dihydro-1H-phenalen-1-one (I.11). Subsequent 
dehydrogenation with 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) provided I.12 in 40% yield over two 
steps (Scheme 2).7 
 
Scheme 2. Synthesis of 2-hydroxy-8(4-hydroxyphenyl)-1H-phenalen-1-one (I.13) using a Friedel–Crafts acylation/Michael 
addition reaction. 
1.1.1.2 Nucleophilic Aromatic Substitution 
The increased reactivity of naphthalenes as compared to benzenes in electrophilic aromatic substitution 
reactions also holds true for nucleophilic aromatic substitutions. This can be explained with a greater 
stabilization of the generated negative charge. This effect was further demonstrated by the 10–100 times 
faster reaction of 1-chloro-2,4-dinitronaphthalene with common nucleophiles as compared to the 
reactions of 1-chloro-2,4-dinitrobenzene.8 
In 2012, the group of Montier described the nucleophilic aromatic substitution of 1- and 2-naphthoic 
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acids I.14 and I.16. The substitution reaction of an ortho-fluoro or ortho-methoxy substituent with a variety 
of organolithium species or Grignard reagents proceeded in good yield (Scheme 3).9 A similar reaction 
with other electron-withdrawing groups was also reported by Miyano.10 
 
Scheme 3. Nucleophilic aromatic substitution of unprotected 1- and 2-naphthoic acids. 
1.1.1.3 Directed Metalation 
The directed metalation of arenes in the presence of an appropriate directing metalation group (DMG) by 
organolithium reagents is an important method for the regioselective functionalization of arenes. One can 
distinguish between directed ortho-metalation (DoM) of arenes, directed remote metalation (DreM) of 
polyarenes, peri-metalation of naphthalenes, metalation of metal‐complexed arenes (mainly chromium 
complexes) and heteroatom-promoted lateral metalation (Figure 2).11 Ortho-metalation is favored if the 
DMG is F, Cl, CF3, OCF3 or CONR2. Peri-lithiation is predominant in naphthalenes having a DMG 
which can coordinate to the base and does not acidify, and thereby activate, the ortho-position, including 
OLi, NLi2, NLiMe, NMe2, and CH2NMe2.12 
 
Figure 2. Different types of directed metalation of arenes. 
Besides ortho-lithiation, directed magnesiation of naphthalenes with magnesium bases was reported by the 
group of Knochel. The metalation of ethyl 1-naphthoate (I.18) was achieved with magnesium bis(2,2,6,6-
tetramethylpiperamide) (Mg(TMP)2) complexed with two equivalents of lithium chloride 
((TMP)2Mg·2 LiCl). The resulting magnesiated intermediate I.19 reacted with electrophiles to furnish I.20 
(Scheme 4) or was used in cross-coupling reactions.13 
 
Scheme 4. Directed ortho-magnesiation of naphthalenes with (TMP)2Mg·2 LiCl and their reaction with electrophiles. 
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1.1.1.4 C–H Activation 
In recent years, there has been vast progress in the development of site-selective metal-catalyzed C–H 
functionalization of arenes. Generally, the selectivity arises from directing groups,14 the use of tethered 
coupling partners15 or the inherent reactivity of heteroarene substrates.16 However, the site-selective 
functionalization of unactivated arenes, such as naphthalene, remains challenging.  
A catalyst-controlled site-selective arylation of naphthalene was reported by Sanford. While the arylation 
of naphthalene (I.6) with diaryl iodonium salts in the presence of sodium tetrachloropalladate(II) 
(Na2PdCl4) furnished the α-arylated naphthalenes I.21, the change to sodium tetrachloroplatinate(II) 
(Na2PtCl4) resulted in the formation of the corresponding β-isomer I.22 (Scheme 5).17 In a similar 
procedure for the preparation of α-arylated naphthalenes, palladium on charcoal (Pd/C) was successfully 
utilized as the catalyst.18  
 
Scheme 5. Site-selective arylation of naphthalenes by Sanford. 
1.1.2 De novo Approaches Towards Naphthalenes 
In contrast to the aromatic substitution reactions for the synthesis of functionalized naphthalenes, the 
synthesis from functionalized non-aromatic precursors can circumvent problems concerning the 
regiochemistry. In the following chapters, several methods for the preparation of naphthalenes are 
described. However, only selected examples are presented due to the number of reported methods. 
1.1.2.1 Pericyclic Reactions 
1.1.2.1.1 [4+2] Cycloaddition Reactions 
For several decades, vinyl ketene acetals, like the Danishefsky diene19 or Brassad’s diene (I.24),20 have 
served as dienes in Diels–Alder cycloaddition reactions. The reaction of these dienes with quinones can 
generate functionalized naphthalenes after aromatization. This method was utilized in the synthesis of 
iso-kidamycin by Martin (I.29). In addition, the authors employed an intramolecular benzyne Diels–Alder 
reaction to generate an anthracene motif after removal of the silicon tether (Scheme 6).21 
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Scheme 6. The Diels–Alder reaction of I.24 with I.23 and an intramolecular benzyne Diels–Alder reaction in the total synthesis 
of iso-kidamycin (I.29). 
Several reviews cover the generation and the application of ortho-quinodimethanes in organic synthesis.22 
The group of Danishefsky employed the ortho-quinodimethane Diels–Alder reaction in the synthesis of 
(±)-rishilide B (I.35). Ring opening of a substituted benzocyclobutane I.30 generated the ortho-
quinodimethane I.31 which reacted in a Diels–Alder reaction with quinone I.32 to furnish I.34 after 
aromatization (Scheme 7).23 
 
Scheme 7. ortho-Quinodimethane Diels–Alder reaction in the synthesis of (±)-rishilide B (I.35). TSE = 2-(trimethylsilyl)-ethyl. 
In 2002, the group of Yamamoto reported a AuCl3-catalyzed formal [4+2] benzannulation of o-alkynyl-
benzaldehydes I.36 with alkynes I.39. The mechanistic proposal involved a nucleophilic attack of the 
carbonyl oxygen to the gold-activated alkyne to form an intermediate auric ate complex I.38 followed by 
an intramolecular [4+2] cycloaddition with alkyne I.39. Regeneration of the catalyst resulted in formation 
of naphthalene I.42 (Scheme 8). 24 A copper-catalyzed variant of this reaction was reported as well.25 
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Scheme 8. Mechanism of the AuCl3-catalyzed formal [4+2] benzannulation of o-alkynylbenzaldehydes I.36 with alkynes I.39. 
1.1.2.1.2 6π-Electrocyclization Reactions 
The construction of naphthalenes via 6π-electrocyclizations was illustrated by a method reported by He et 
al.26 In an initial Blaise reaction, 2-alkynylbenzonitriles I.43 reacted with the organozinc compound 
derived from α-bromoester I.44 to give intermediate I.45. The following 6π-electrocyclization furnished 
ethyl 1-amino-2-naphthoates I.46 in good yields (Scheme 9A). If the R2 substituent is a hydroxymethylene 
group (CH2OH), lactonization was observed. This reaction was employed for the synthesis of the naturally 
occurring arylnaphthalene lactones chinensin (I.50) and taiwanin C (I.51) (Scheme 9B). 
 
Scheme 9. A) Naphthalene synthesis via Blaise reaction followed by 6π-electrocyclization. B) Application in the total syntheses of 
chinensin (I.50) and taiwanin C (I.51). 
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The synthesis of fluorinated naphthols can be achieved through a base induced 6π-electrocyclization of 
C2-allylated (trifluoromethyl)phenols I.52, which are derived from (trifluoromethyl)phenols via allylation 
and subsequent Claisen rearrangement. Treatment of I.52 with potassium tert-butoxide (KOt-Bu) in 
dimethylsulfoxide (DMSO) at 120 °C formed the thermodynamically favored isomer I.53. Subsequent 
deprotonation and elimination of a fluoride anion generated the intermediate I.54. A 6π-electrocyclization 
furnishes I.55, which rearomatized under concomitant loss of a second fluoride anion to provide naphthol 
I.56 (Scheme 10).27 
 
Scheme 10. 6π-Electrocyclization of C2-allylated (trifluoromethyl)phenols I.52 to provide fluorinated naphthols I.56. 
1.1.2.1.3 Ring-Expansion Reactions 
Rearrangement of Cyclobutenones 
Several methods are known to prepare naphthalenes from cyclobutenones.28 A 4π-electrocyclic ring 
opening results in the formation of a vinyl ketene intermediate, which cyclizes in a 6π-electrocyclization to 
give the corresponding naphthols.29 Two examples, developed by the group of Schmidt30 and Moore,31 are 
depicted in Scheme 11.  
 
Scheme 11. Synthesis of naphthalenes from cyclobutenones via 4π-electrocyclic ring opening followed by 6π-electrocyclization.  
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The group of Suzuki reported a method for the preparation of naphthalenes via a similar thermal 
4π-electrocyclic ring opening of benzocyclobutenones followed by a 6π-electrocyclization (Scheme 12).32 
The corresponding benzocyclobutenones were prepared by the [2+2] cycloaddition of benzynes and 
ketene silyl acetals.33 However, the same starting material I.65 could be converted into isomeric naphthols 
I.71 in a two-step process, involving two consecutive ring enlargements. Ring expansion of the alkenyl 
benzocyclobutene I.65 by a halonium ion furnished indanone I.69. The second ring expansion proceeds 
via a SmI2-promoted intramolecular Barbier-type reaction followed by a Grob fragmentation of the 
cyclopropanol intermediate I.70 with concomitant loss of ROSmI2.34 
 
Scheme 12. Synthesis of isomeric naphthalenes I.68 and I.71 from alkenyl benzocyclobutene I.65. 
Rearrangement of Cyclopropanes 
In addition to the rearrangement of cyclobutanes, various methods for the rearrangement of 
cyclopropanes have been reported. Tanabe et al. described the synthesis of halogenated naphthalenes 
from substituted gem-dichloro cyclopropanes I.72. In the first step, two different acid-catalyzed bond 
cleavages could occur, depending on the stability of the resulting carbocation. A subsequent 
intramolecular Friedel–Crafts reaction and aromatization with concomitant elimination of hydrogen 
chloride afforded the corresponding naphthalenes I.75 or I.77 (Scheme 13).35 
 
Scheme 13. Rearrangement of cyclopropanes I.72 to give halogenated naphthalenes I.75 and I.77. 
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Another reaction in this category is the synthesis of fluorinated 1-naphthols I.83 from commercially 
available indanones I.78 and (bromomethyl)trimethylsilane (TMSCH2Br), catalyzed by 
tetrabutylammonium bromide (TBAB). At the outset, the silyl enol ether I.79 was formed in the presence 
of bromotrimetylsilane (TMSBr), which was generated from TMSCF2Br and TBAB, and subsequently 
cyclopropanated with difluorocarbene. A fluoride-induced desilylation induced a ring 
opening/aromatization sequence to provide ortho-fluorinated naphthols I.83 (Scheme 14).36 
 
Scheme 14. Synthesis of fluorinated 1-naphthols I.83 from indanones I.78. 
In 2008, Glass et al. reported a ring-opening reaction of cyclopropylcarbinol I.84 to provide 
functionalized naphthalenes.37 I.84 could be prepared from indenones by treatment with commercially 
available trimethylsilyldiazomethane in the presence of Pd(OAc)2 followed by nucleophilic addition of 
Grignard reagents or organolithium species. A beneficial feature of this methodology was the possibility to 
synthesize tetra-ortho-substituted biaryl compounds I.87 (Scheme 15).38 The advantage of this method is 
that the formation of the key C–C bond was achieved through a simple nucleophilic addition. 
 
Scheme 15. Synthesis of tetra-ortho-substituted biaryl compounds I.87 via ring opening of cyclopropyl carbinols I.84. 
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1.1.2.2 Transition Metal-Catalyzed Reaction 
1.1.2.2.1 Dötz Reaction 
The Dötz reaction, a thermal [3+2+1]-benzannulation reaction of alkynes with α,β-unsaturated Fisher 
carbine complexes, was discovered in 197539 and is widely used in organic chemistry and natural product 
synthesis.40 The mechanism commences with the rate-determining reverse dissociation of carbon 
monoxide from the initial pentacarbonyl carbine complex I.88 to form the coordinatively unsaturated 
tetracarbonyl carbene complex I.89 (Scheme 16). Coordination of the alkyne I.90 to the 16-electron 
complex and insertion into the metal-carbon bond furnishes the (η1:η3)-vinylcarbene complex I.92. Carbon 
monoxide insertion to form a η4-vinylketene I.93 and subsequent electrocyclic ring closure gives 
η4-cyclohexadienone I.94. The final tautomerization led to the formation of phenol I.95. 
 
Scheme 16. Mechanism of the Dötz reaction. 
The naphthol intermediate I.98 in the synthesis of (−)-juglomycin A (I.99) was derived via a Dötz 
benzannulation reaction of Fischer carbene I.96 with alkyne I.97 in 51% yield. The same intermediate was 
utilized in the synthesis of (+)-kalafungin (I.100) and (+)-frenolicin B (I.101) (Scheme 17).41 
 
Scheme 17. Total synthesis of (−)-juglomycin A (I.99), (+)-kalafungin (I.100) and (+)-frenolicin B (I.101) via Dötz reaction. 
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1.1.2.2.2 [2+2+2] Cyclization Reactions 
The application of a palladium(0)-catalyzed [2+2+2] cyclization for the preparation of functionalized 
naphthalenes was reported in the synthesis of the natural arylnaphthalene lignans taiwanin C (I.51) and 
taiwanin E (I.105).42 Generation of a benzyne intermediate from I.102 with cesium fluoride followed by a 
cyclotrimerization reaction with I.103 furnished arylnaphthalene I.104 (Scheme 18). 
 
Scheme 18. A [2+2+2] cyclization reaction in the synthesis of taiwanin E (I.105). 
1.1.2.2.3 Ring-closing Metathesis Reactions 
The ring-closing metathesis (RCM) is a versatile method to construct small- and medium-sized cyclic 
compounds and was also reported for the synthesis of naphthols. With suitable RCM precursors I.105, the 
RCM reaction with Grubbs I catalyst and concomitant elimination of water smoothly provided the 
corresponding functionalized naphthalenes I.107 in good yields (Scheme 19).43  
 
Scheme 19. RCM approach for the synthesis of functionalized naphthalenes. 
1.1.2.3 Radical Reactions 
The Bergman cyclization44 is a thermal or photochemical cycloaromatization of enediynes in the presence 
of a hydrogen radical donor and allows the construction of substituted arenes. In the Bergman cyclization, 
an enediyne I.108 cyclizes to form a 1,4-benzenediyl diradical I.109, which reacts with a hydrogen radical 
donor like 1,4-cyclohexadiene (CHD) to give the corresponding arenes I.110 (Scheme 20A).45 In a related 
radical cyclization, the Myers–Saito cyclization, allenyl enynes I.111 were cyclized to the corresponding 
arenes I.113 (Scheme 20B). The advantage of this reaction is a much lower reaction temperature.46 
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Scheme 20. Mechanism of A) the Bergman cyclization and B) the Myers–Saito cyclization; (CHD = 1,4-cyclohexadiene). 
The use of the Bergman cyclization for the synthesis of fused ring systems was reported in 1996. Alkenes 
tethered to the enediyene unit were synthesized. The cycloaromatized diradical I.115 then underwent 
further 5-exo-trig cyclizations to form additional saturated rings (Scheme 21).47 
 
Scheme 21. Bergman cyclization for the synthesis of fused ring systems (CHD = 1,4-cyclohexadiene). 
In an example reported by Finn,48 a ruthenium catalyst was used to generate ruthenium-allene precursor 
I.118, which could be cyclized under relatively low temperatures. The proceeding cyclization can be 
regarded as a Myers–Saito cyclization that gives rise to a metal-centered radical in naphthalene I.119. A 
subsequent 5-exo-trig cyclization gave the fused naphthalene I.121 (Scheme 22). 
 
Scheme 22. Myers–Saito cyclization of ruthenium allene I.118 to give fused naphthalene I.121. 
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1.1.2.4 Annulation Reactions 
1.1.2.4.1 Hauser–Kraus Annulation 
The annulation reaction of 3-substituted phthalides with Michael acceptors was developed by Hauser49 
and Kraus.50 There are two mechanisms reported in the literature.51 In the originally proposed mechanism, 
the generated anion I.123 of phthalide I.122 underwent a Michael reaction with enone I.124 followed by 
an intramolecular Dieckmann cyclization. Elimination of the C3-substituent and final tautomerization 
resulted in the formation of the naphthoquinol I.128 (Scheme 23A). Alternatively, the reaction could 
proceed via a concerted [4+2] cycloaddition of the ortho-quinodimethane intermediate I.128 (Scheme 23B). 
 
Scheme 23. Mechanism of the Hauser–Kraus annulation via A) Michael addition and Dieckmann cyclization or B) Diels–Alder 
reaction. 
The Hauser–Kraus reaction was applied in several total syntheses. For example, the reaction was 
successfully applied to the total synthesis of (±)-7-con-O-methylnogarol (I.133) by Hauser.52 Cyano-
phthalide I.130, prepared in 15 steps from commercially available 2,5-dimethoxyacetophenone, was 
treated with lithium N,N-diisopropylamide (LDA) in the presence of hexamethylphosphoramide (HMPA) 
and the generated anion reacted with tetrahydronaphthalenone I.131 to give hydroquinone I.132 in 65% 
yield (Scheme 24). A further 14 step sequence completed the total synthesis of I.133. 
Introduction 
15 
 
 
Scheme 24. Total synthesis of (±)-7-con-O-methylnogarol (I.133) via Hauser–Kraus reaction. 
In the synthesis of chartreusin (I.137) and its analogues by Hertweck, the protected polycyclic aromatic 
aglycon (I.136) could be rapidly assembled by a Hauser–Kraus annulation of coumarin I.134 and phthalide 
I.135 (Scheme 25). The aglycon was successfully glycosylated using cultures of a ∆chaABC mutant.53 
 
Scheme 25. Synthesis of chartreusin (I.137) via Hauser–Kraus reaction. 
In 2011, Mal et al. reported a benzannulation reaction that is related to the Hauser–Kraus reaction, leading 
to C2-substituted 1-naphthols. Similar to the Hauser–Kraus reaction, the mechanism commences with a 
Michael addition of the deprotonated phthalide I.139 to the Michael acceptor I.140 followed by a 
Dieckmann condensation. As a consequence of the missing C3-leaving group, an intramolecular 
nucleophilic attack of the alkoxy anion occurred to form in carbonate I.144 after fragmentation. The 
elimination of the carbonate as CO2 and MeO− resulted in the formation the C2-substituted 1-naphthol 
I.145 (Scheme 26A). This reaction was employed in the total synthesis of arnottin I (I.148) 
(Scheme 26B).54 
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Scheme 26. A) Benzannulation reaction for the synthesis of C2-substituted 1-naphthols. B) Synthesis of arnottin I (I.148). 
1.1.2.4.2 Staunton–Weinreb Annulation 
The Staunton–Weinreb annulation was discovered independently by Staunton55 and Weinreb56 and is a 
stepwise naphthol synthesis involving a Michael addition followed by a Dieckmann condensation and 
subsequent aromatization (Scheme 27). A variety of o-toluates and α,β-unsaturated esters or ketones could 
be employed. However, the reaction generally required an ether group ortho to the ester functionality in 
order to stabilize the generated anion. The annulation reaction was used in the total synthesis of 
(S)-semiviriditoxin (I.158) to prepare the tricyclic core I.157 in 36% yield.57  
 
Scheme 27. Mechanism of the Staunton–Weinreb annulation and its application in the synthesis of (S)-semiviriditoxin (I.158). 
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1.2 Synthesis and Applications of Fluorinated Compounds 
1.2.1 Properties of Fluorine 
The application of organofluorine compounds include materials, pharmaceuticals, medical applications, 
agrochemicals and fine chemicals. The incorporation of fluorine can have a tremedous influence on 
chemical and physical properties of compounds, such as acidity, lipophilicity, boiling points and 
conformation.  
Fluorine has the highest electronegativity in the periodic table. Commonly, fluorine replaces hydrogen in 
organic molecules although the van der Waals radius of fluorine and the C–F bond length are more 
comparable to the van der Waals radius of oxygen and the C–O bond (Table 1). The C–F bond is the 
strongest bond in organic chemistry. It is highly polarized and has more ionic than covalent character, 
leading to strong dipoles.58 The fluorine substitution strengthens adjacent C–C single bonds, but weakens 
allylic C=C double bonds. Organofluorine substituents are poorly polarizable, thereby influencing 
intermolecular interactions.59 
Table 1. Electronegativity, van der Waals radius, bond dissociation energy and bond length of selected atoms and bonds in 
organic chemistry.  
Atom Pauling's 
electronegativity χP60 
van der Waals 
radius [Å]61 
Bond dissociation energy    
CH3–X [kcal mol-1]62 
Bond length  
C–X [Å]63 
H 2.20 1.20 105 1.09 
F 3.98 1.47 115 1.35 
Cl 3.16 1.74 84 1.79 
Br 2.96 1.85 72 1.97 
I 2.66 1.98 57 2.16 
C 2.55 1.70 90 1.51 
N 3.04 1.55 85 1.47 
O 3.44 1.52 92 1.43 
 
In most cases, fluorination increases the lipophilicity of a molecule. A quantitative measurement for the 
lipophilicity is the Hansch–Leo hydrophobic parameter (π). It is derived from octanol–water partition 
coefficients (πX = log(PX/PH) (octanol–water)) and higher π-values indicate a higher lipophilicity.64 As 
depicted in Table 2, fluorination can increase the lipophilicity up to two orders of magnitude on partition 
coefficients. Aromatic fluorination, per-/polyfluorination and fluorination adjacent to atoms with π-bonds 
can increase the lipophilicity, whereas monofluorination or trifluorination of saturated alkyl groups 
decreases the lipophilicity (Table 3). A reason for the decline is the relatively polar character of 
monofluoro- and trifluoromethylalkanes. In the presence of heteroatoms in the molecule, the lipophilicity 
is only decreased when the fluorination is more than three C–C bonds remote from the heteroatom (in 
the case of terminal trifluoromethyl groups).64 
Introduction 
18 
 
Table 2. Hydrophobic parameters πX of functional groups.        Table 3. Hydrophobic parameters πX of alkanes and alcohols.  
 πXa) X = H πX X = F   πXa) X = H πX X = F 
CX3 0.56 0.88  CH3CHX2 1.81 0.75 
OCX3 −0.02 1.04  CH3(CH2)3CH2X 3.11 2.33 
SCX3 0.61 1.44  CX3CH2OH −0.32 0.36 
CX3C(O) 0.02 0.55  CX3(CH2)2OH 0.34 0.39 
CX3C(O)NH −1.27 0.08  CX3(CH2)3OH 0.88 0.90 
CX3SO2 −1.63 0.55  CX3(CH2)4OH 1.19 1.15 
a) πX = log(PX/PH) (octanol–H2O)           a) πX = log(PX/PH) (octanol–H2O) 
Due to its high electronegativity, fluorine incorporation has a remarkable effect on the acidity of 
functional groups and can induce pKa shifts of several orders of magnitude. For instance, a strong effect 
on the dissociation constants of simple carboxylic acids is perceivable.65 In general, fluorination increases 
hydrogen bond and Brønsted acidity and decreases hydrogen bond and Brønsted basicities (Table 4).64 
Table 4. Comparison of pKa values of selected (fluorinated) acids and bases.64  
acid pKa X= H pKa X= F base pKBH+ X= H pK BH+ X= F 
CX3CO2H 4.76 0.52 CX3CH2NH2 10.7 5.9 
C6X5CO2H 4.21 1.75 C6X5NH2 4.6 −0.36 
CX3CH2OH 15.9 12.4    
(CX3)2CHOH 16.1 9.3    
(CX3)3COH 19.0 5.4    
C6X5OH 10.0 5.5    
 
The C–H acidity is, in most cases, enhanced by α-fluorination. An exception is the decrease of the C–H 
acidity when the geometry of the generated conjugated carbanion is almost planar due to the greater lone-
pair repulsion. However, the effect of fluorination is less intense than the effect of other halogenations. β-
Fluorination always increases the C–H acidity through inductive and hyperconjugative resonance 
stabilization.64 Some examples are shown in Table 5. 
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Table 5. C–H acidities of selected (fluorinated) molecules.64 
compound pKa 
CH4 68-70 
CF3H 30.5 
CCl3H 24.4 
CBr3H 22.7 
CH3CO2CH3 28.2 
CH2FCO2CH3 21 
C6H5C(O)CH2C(O)C6H5 10.7 
C6H5C(O)CHFC(O)C6H5 8.5 
 
Furthermore, fluorination has a major influence on the conformation of organic molecules. For instance, 
n-butane preferentially adapts the anti conformation whereas 1,2-difluoroethane prefers the gauche 
conformation (Scheme 28A).66 The gauche rotamer has a lower energy than the anti rotamer by 2.4–3.4 
kJ/mol67 and is stabilized by hyperconjugation of the C–H σ-orbital donating into the C–F σ*-orbital 
(Scheme 28B).68 
 
Scheme 28. A) Conformation of 1,2-difluoroethane. B) Stabilization of the gauche conformer by hyperconjugation. 
Another example of this influence is the different conformations of methoxyphenol and 
trifluoromethoxyphenol. In the preferred conformation, the methoxy group lies in the plane of the phenyl 
ring, which is explained by the possible conjugation of the sp2-hybridized p-orbital with the aromatic π-
system. Due to steric and stereoelectronic effects, the trifluoromethoxy group is orientated orthogonal to 
the plane of the aromatic ring. The orientation of the C–F bonds antiperiplanar to the lone pairs of the 
sp3-hybridized oxygen account for an anomeric conjugation of the nO and the σ*C–F bonds. This results in 
longer C–F bonds, thereby reducing the conjugation of oxygen and the aromatic π-system.59 
1.2.2 Natural Occurance of Organofluorine Compounds 
Fluorine in the form of fluoride minerals is the thirteenth most abundant element and most abundant 
halogen in the Earth’s crust.69 Nevertheless, only few a fluorine containing natural products are known. 
Toxic fluoroacetate (I.159) is the most common organofluorine compound (Scheme 29A).70 The first 
known natural fluorinating enzyme 5’-fluoro-5’-deoxyadenosine synthase (5’-FDAS), isolated from 
Streptomyces cattleya in 2003, is supposed to dehydrate solvated fluoride in the active site and thereby 
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increasing the nucleophilicity of fluoride.69 5’–FDAS is involved in the biosynthesis of fluoroacetate 
(I.159) and 4-fluorothreonine (I.161), catalyzing the reaction between S-adenosyl-L-methionine (SAM, 
I.165) and a fluoride ion to generate 5’-fluoro-5’-deoxyadenosine (5’-FDA, I.166) (Scheme 29B).71 
 
Scheme 29. A) Selected naturally-occurring organofluorine compounds. B) Proposed biosynthesis of fluoroacetate (I.159) and 
4-fluorothreonine (I.161). 
1.2.3 Synthesis of Fluorinated Compounds 
1.2.3.1 Nucleophilic and Electrophilic Fluorination Reagents 
Organofluorine compounds have a variety of applications and many methods for fluorination have been 
developed in recent years. Traditional methods often require harsh conditions and are often unselective 
and functional group intolerant. This problem derives from the high reactivity of most fluorine sources. 
On industrial scale, fluorination of simple molecules is well elaborated and a variety of nucleophilic and 
electrophilic fluorination reagents are commercially available.  
Today, all fluorination reagents are derived from fluorite (CaF2, fluorspar). Approximately half of all CaF2 
is employed to reduce melting points and increase the viscosity of metals in iron and steel manufacturing. 
The remaining CaF2 is used to produce anhydrous hydrogen fluoride (HF), which is the starting point for 
the preparation of all other fluorination reagents (Scheme 30).72  
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Scheme 30. Preparation of fluorination reagents from fluroite (CaF2). 
In general, one distinguishes between nucleophilic and electrophilic fluorination reagents. Common 
nucleophilic fluorination reagents besides fluoride salts (KF, CsF, AgF, [R4N]F), triethylamine 
trihydrofluoride (Et3N∙3HF) and hydrogen fluoride pyridine (HF∙py) are depicted in Figure 3. 
 
Figure 3. Common nucleophilic fluorination reagents.73  
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Besides the nucleophilic reagents, there are various electrophilic fluorination reagents known.74 Some 
examples include SelectFluor (I.168),75 N-fluoropyridinium-2-sulfonates (I.183),76 N-fluoro-2,4,6-
trimethylpyridinium tetrafluoroborate (I.184)77 and N-fluorosulfonimides such as N-fluoro-o-benzenedi-
sulfonimide (NFOBS, I.185) and N-fluorobenzenesulfonimide (NFSI, I.170) (Figure 4A).78 Additionally, a 
number of chiral N-fluorosulfonimides are known, including (+)-N-fluoro-2,10-camphorsultam (I.186), 
N-fluoro-2,10-(3,3-dichlorocamphorsultam (I.187), (R)-CMIT-F (N-Fluoro-3-cyclohexyl-3-methyl-2,3-
dihydrobenzo[1,2-d]isothiazole 1,1-dioxide, I.188) and 2-fluoro-14-methyl-11-(methylethyl)-spiro[4H-
benzo[e]-1,2-thiazine-3,2′-cyclohexane]-1,1-dione (I.189) (Figure 4B).79 
 
Figure 4. A) Common electrophilic fluorination reagents. B) Chiral N-fluorosulfonimides for enantioselective fluorination.  
1.2.3.2 Fluorination of Arenes 
Aromatic fluorination is a fundamental challenge. The electrophilic fluorination of arenes, in particular, is 
ambitious because the rate-determining step – the formation of the halocyclohexadienyl cation – is 
hindered by the electronegativity of fluorine.80  
Early examples of the fluorination of arenes were reported by Wallach in 1888 and by Balz and Schiemann 
in 1927.81 They developed a method for the nucleophilic fluorination of arenes via thermal decomposition 
of aryl diazonium tetrafluoroborate salts or aryl triazines in the presence of hydrogen fluoride 
(Scheme 31).  
 
Scheme 31. Balz–Schiemann and Wallach reactions for the preparation of fluorinated arenes. 
The displacement of chlorine substituents with fluorine in electron-poor arenes was achieved at high 
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temperatures with anhydrous potassium fluoride (the Halex process).82 A more practical method was 
established by employing anhydrous tetrabutylammonium fluoride (TBAF) in DMSO or 
tetramethylammonium fluoride (TMAF) in N,N-dimethylformaide (DMF) at room temperature. Various 
(hetero)aromatic fluorides were prepared with this methods.83 
The group of Knochel describes a synthesis of fluorinated arenes starting from the corresponding aryl 
bromides I.193.84 Insertion of magnesium into the C–Br bond by using either i-propylmagnesium chloride 
lithium chloride (i-PrMgCl∙LiCl) or magnesium together with lithium chloride (LiCl), followed by 
fluorination with NFSI (I.170) in CH2Cl2/perfluorodecaline at 23 °C furnished fluorinated benzenes and 
pyridines (Scheme 32). Using this method, fluorinated derivatives of important classes of heterocycles 
were prepared, including an isoquinoline, a pyrrole, a benzo[b]thiophene, thiophenes, and a furan. 
 
Scheme 32. Preparation and fluorination of Grignard reagents. 
The synthesis of fluorinated arenes via deoxyfluorination of phenols was reported by Ritter. The reaction 
of phenol with PhenoFluor (I.182) in the presence of cesium carbonate (Cs2CO3) in toluene at 80–110 °C 
smoothly furnished the corresponding fluorides in high yields (Scheme 33A). The reaction tolerates 
functional groups such as nitro groups, esters, α,β-unsaturated esters, ketones, amides, amines, protected 
alcohols and halogens. Furthermore, flurorinated indoles, carbazoles, pyridines and quinolones could be 
prepared. By using this method, the fluorination of complex molecules like estrone, zearalenone and 
quinine was achieved.73k A more stable variant of PhenoFluor (I.182) is PhenoFluorMix (I.197), consisting 
of cesium fluoride (CsF) and N,N’-1,3-bis(2,6-diisopropylphenyl)-2-chloroimidazolium chloride, which is 
not air- and moisture-sensitive and can be stored under an air atmosphere (Scheme 33B).85 
 
Scheme 33. A) Deoxyfluorination of phenols with PhenoFluor (I.182). B) Moisture stable PhenoFluorMix (I.197). 
In addition, a couple of palladium-catalyzed methods for the fluorination of arenes exist. In 2009, 
Buchwald disclosed a methodology for the synthesis of fluorinated arenes and heteroarenes from the 
corresponding aryl triflates I.198. With CsF in the presence of a palladium(0) catalyst and t-BuBrettPhos, 
various fluorinated arenes were prepared in good yield (Scheme 34A). An additional method was 
developed by the group of Ritter. Trifluoroborate salts I.199 were successfully employed in cross-coupling 
reactions with SelectFluor (I.168) as fluoride source (Scheme 34B).86 
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Scheme 34. Palladium catalyzed fluorination of A) triflates by Buchwald and B) trifluoroborates by Ritter. (terpy = 2,6-bis(2-
pyridyl)pyridine. 
More examples of arene fluorination are described in rewiews by Gouverneur and Ritter.87 
1.2.3.3 Csp3–F Bond Formation 
A common way to introduce aliphatic fluorides is the deoxyfluorination of an alcohol I.200 or a 
ketone I.202, which are replaced by one or two fluorides respectively. Additionally, carboxylic acids 
(I.208) can be converted to acid fluorides I.204 or trifluoromethyl groups (Scheme 35). Two of the most 
commonly employed reagents for deoxyfluorination reactions are DAST (I.171) and Deoxofluor (I.172). 
Deoxofluor is more stable than DAST, which can decomposes explosively at temperatures above 90 °C.88 
The same reactivity is observed with XtalFluor-E (I.175) and XtalFluor-M (I.176) in combination with 
1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) or triethylamine trihydrofluoride (Et3N∙3HF), except for the 
formation of trifluoromethyl groups from acid fluorides. XtalFluor-E (I.175) and XtalFluor-M (I.176) are 
more stable than DAST (I.171) and Deoxofluor (I.172) and do not generate free hydrofluoric acid.73e 
 
Scheme 35. Conversion of A) alcohols, B) ketons and C) carboxylic acids into A) mono-fluorinated, B) geminal difluorinated 
products and C) carboxylic acid fluorides or trifluoromethyl groups by DAST (I.171) or Deoxofluor (I.172). 
Several procedures for the enantioselective α-fluorination of ketones and aldehydes have been described. 
The catalytic enantioselective fluorination of β-ketoesters was achieved with SelectFluor (I.168) in the 
presence of a chiral titanium complex ([TiCl2(1-naphthyl-TADDOLato)(MeCN)2], I.210) (Scheme 36A).89 
Furthermore, α-fluorination can be catalyzed by cinchona alkaloids. For example, acid chlorides I.215 can 
be activated by benzoylquinidine (I.212) and nickel or palladium catalysts to give a dually activated 
intermediate I.213, which can be fluorinated by NFSI (I.170). The resulting amide I.215 can be converted 
to the corresponding carboxylic acid, ester, amide or peptide depending on the nucleophile used to 
quench the reaction (Scheme 36B).90 Comparable methods for the enantioselective α-fluorination of 
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ketones or aldehydes with SelectFluor (I.169) or NFSI (I.171) catalyzed by cinchona alcaloids were 
reported by the groups of Shibata and MacMillan.91 In addition, the group of Toste applied phase transfer 
catalysts (PTCs) for enantioselective α-fluorination and could also realize a dearomatising ortho-
fluorination of phenols.92  
 
Scheme 36. A) Titanium-catalyzed enantioselective α-fluorination of β-ketoesters. B) Benzoylquinidine and metal-catalyzed 
enantioselective α-fluorination of acid chlorides followed by nucleophilic quenching. 
In addition, the enantioselective α-fluorination with Selectfluor (I.168) or NFSI (I.170) can be catalyzed by 
the proline-derived Jørgensen catalysts like I.223 or the imidazolidin-4-one-derived MacMillan 
catalysts I.224 as disclosed by Jørgensen and MacMillan (Scheme 37).93 
 
Scheme 37. A) Catalytic cycle for the proline-catalyzed α-fluorination. B) Catalysts for the enantioselective α-fluorination. 
Another method to introduce fluorine substituents is the fluorodesilylation of linear or cyclic 
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allylsilanes I.225. The reaction occurs via an SN2’ mechanism where the addition of the fluorinating 
reagent SelectFluor (I.168) occurs anti with respect to the silane, furnishing the allylic fluoride. Using 
achiral substrates, cinchona alkaloids can be employed to induce enantioselectivity (Scheme 38.A).94 In 
addition, the fluorodesilylation can be applied to prepare vinyl fluorides I.228 from the corresponding 
vinyl silanes I.227 (Scheme 38.B).95 
 
Scheme 38. A) Fluorodesilylation of linear or cyclic allyl silanes with SelectFluor. B) Fluorodesilylation of vinyl silanes. 
Allylic fluorides can also be obtained by metal-catalyzed nucleophilic fluorination. SN2-type attack of 
fluoride on an electrophilic palladium(II)-allyl intermediate I.231 furnishes allylic fluorides I.233 with an 
overall retention of configuration (Scheme 39).96 
 
Scheme 39. Mechanism of the metal-catalyzed nucleophilic allylic fluorination.  
In 2015, Aggarwal reported the enantioselective electrophilic fluorination of alkyl boronic esters.97 The 
intermediate boronate complex (I.235) was generated by treatment of a secondary boronic acid I.234 with 
phenyl lithium. A solvent switch to acetonitrile (MeCN) followed by the addition of 
SelectFluor II (I.237)75 enabled the preparation of the corresponding secondary fluorides I.236 
(Scheme 40). Stryrene was crucial as an additive for the reaction as it is believed to act as a radical trap that 
prevents radical propagation, thereby suppressing racemization. 
 
Scheme 40. Enantioselective electrophilic fluorination of alkyl boronic esters. 
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A last example for the synthesis of alkyl fluorides is a decarboxylative fluorination process via alkyl 
radicals, generated from the corresponding primary, secondary or tertiary carboxylic acids. This reaction 
can be achieved by employing xenon difluoride (XeF2), SelectFluor/AgNO3 or 
SelectFluor/Ir[dF(CF3)ppy]2(dtbbpy)PF6 (Scheme 41).98 
 
Scheme 41. Conditions for the decarboxylative fluorination reaction. 
1.2.4 Applications of Organofluorine Compounds 
Organofluorine compounds are widely used in pharmaceuticals and agrochemicals, and many of the 
leading blockbuster pharmaceuticals contain fluorine.99 5-Fluorouracil is one of the first fluorinated 
anticancer drugs synthesized in 1957. 5-Fluoro-deoxyuridine monophosphate, its pharmacologically active 
metabolite, inhibits the thymidylate synthase in the synthesis of thymidine.100 
The absorption and distribution of drugs are predominantly controlled by the balance of lipophilicity and 
hydrophilicity and the ionization state of the molecule. An increased lipophilicity from fluorine 
substitution can result in a more advantageous partitioning between the less polar receptor site and the 
aqueous solution.59 The incorporation of fluorine can lead to higher selectivity, potency and better 
absorption, distribution, metabolism and excretion (ADME) properties.101  
The metabolic stability, a determining factor for the bioavailability (% of the dose reaching the circulatory 
system) of a drug, can be enhanced by blocking the labile metabolic site with fluorine. Oxidation by 
cytochrome P450 monooxygenases in the liver, decreasing the lipophilicity of compounds, is thereby 
prohibited.102 This strategy is illustrated by the development of the cholesterol absorption inhibitor 
SCH 58235 (Ezetimibe, I.241) from SCH 48461 (I.240) (Figure 5). Aromatic fluorination to hamper 
undesired metabolism led to a 50 fold increased potency (ED50 = 0.4 mg/kg/day) compared to 
SCH 48461 (ED50 = 2.2 mg/kg/day).103 
 
Figure 5. Design of the cholesterol absorption inhibitor SCH 58235 (Ezetimibe, I.241) from SCH 48461 (I.240). 
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The use of bioisosteric replacements in lead optimization is prevalent.104 Bioisosterism is the capacity to 
interchange atoms or functional groups with similar sizes or shapes without a significant change in the 
biological behavior, such as binding affinity.59 A fluorovinyl group (C=CHF) is an isoster of the peptide 
bond, mimicking the planarity and the size of the functional group. This strategy is highlighted in the 
development of the DPP IV inhibitor 2-(2-amino-1-fluoro-propylidene)-cyclopentanecarbonitriles (I.242, 
Scheme 42A). The replacement of the amide bond in the original inhibitor I.243 resulted in the 
suppression of the undesired cyclization of the free N-terminal amino group with the reactive site of the 
inhibitor (Scheme 42B).105 
 
Scheme 42. A) DPP IV inhibitor 2-(2-amino-1-fluoro-propylidene)-cyclopentanecarbonitriles I.242a and I.242b. B) Undesired 
cyclization of I.244. 
A second example for a bioisosteric replacement is the optimization of the cathepsin K inhibitor 
odanacatib (I.246). The original inhibitors I.245 suffers from low potency, amide hydrolysis and leucine 
hydroxylation followed by lactonization. The poor potency could be circumvented by the replacement of 
the C=O group with an isosteric C-CF3 fragment.106 The basicity of the NH-fragment is thereby 
minimized to maintain the hydrogen bond capability of an amide, which is required for the activity.107 
Additionally, the reduced amine basicity affects the membrane permeability.59 This substitution resulted in 
a 10–20-fold higher potency. Fluorination of the iso-butyl group and introduction of a cyclopropyl 
fragment suppressed the hydroxylation and subsequent lactonization (Figure 6).108 
 
Figure 6. Optimization of cathepsin K inhibitors leading to odanacatib (I.250). 
The adjustment in pKa value by fluorination was successfully applied in the optimization of methotrexate 
(I.247, Figure 7), used against various types of cancers and rheumatoid arthritis. Continued treatment with 
methotrexate revealed disadvantageous effects including gastrointestinal toxicity, stomatitis, hematologic 
toxicity, hepatotoxicity, and pulmonary toxicity. The decrease of the toxicity of methotrexate could be 
achieved by a monofluorination at the γ-carboxylic acid group. The resulting increased acidity prevents the 
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formation of polyglutamates. These metabolites are responsible for a prolonged retention within the cells, 
which is related to the adverse effects in the treatment with methotrexate.109 
 
Figure 7. Structure of methotrexate (I.247) and γ-fluroromethotrexate (I.248). 
Fluorinated compounds can also be used as anesthetic drugs, agrochemicals and as radiopharmaceutical 
for positron emission tomography (PET).102,110 Fluorine substitution can be applied in biochemical and 
binding assays to evaluate the strength of intermolecular interactions by 19F Nuclear Magnetic Resonance 
(19F NMR) spectroscopy.111 In material chemistry, the development of fluoropolymers like 
polytetrafluoroethylene (Teflon) at DuPont by Roy Plunkett in 1938 opened up the presumably largest 
commercial application of organofluorine compounds. With properties like high thermal and oxidative 
stability, low dielectric constant, low moisture absorption, low flammability, low surface energy, excellent 
biocompatibility, marked gas permeability and excellent resistance to most chemicals, they are widely used 
as thermoplastics, elastomers, coatings, fluids and membranes.70 
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2 Results and Discussion 
2.1 Rapid Access to Orthogonally Functionalized Naphthalenes: Application 
to the Total Synthesis of the Anticancer Agent Chartarin 
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Rapid Access to Orthogonally Functionalized Naphthalenes: Appli-
cation to the Total Synthesis of the Anticancer Agent Chartarin
Teresa A. Unzner, Adriana S. Grossmann, and Thomas Magauer*
Abstract: We report the synthesis of orthogonally functional-
ized naphthalenes from simple, commercially available inda-
nones in four steps. The developed method proceeds through
a two-step process that features a thermally induced fragmen-
tation of a cyclopropane indanone with simultaneous 1,2-
chloride shift. Migration of the chloride substituent occurs in
a regioselective manner to preferentially afford the para-
chloronaphthol substitution pattern. The obtained naphthols
are versatile building blocks that can be selectively modified
and used for the efficient construction of biologically active
molecules. This has enabled the total synthesis of the potent
anticancer natural product chartarin through a highly con-
vergent retrosynthetic bond disconnection.
Substituted naphthalenes are common substructural units in
many biologically active molecules.[1,2] These include the
antiproliferative natural products chartarin (1), the aglycon of
chartreusin (2) and elsamicin,[3] justicidin A (3),[4] furomollu-
gin (4)[5] and drugs such as the dopamine antagonist
nafadotride (5)[6] and the nonsteroidal anti-inflammatory
drug naproxene (Figure 1a).[7] Traditional strategies for the
functionalization of this structural motif hinge on a stepwise
approach, that is the electrophilic aromatic substitution of
partially substituted naphthalene building blocks.[8] Owing to
the inherent low substrate selectivity and the complex
substitution pattern found in many natural products, stepwise
functionalization from readily available naphthalene precur-
sors is rather inefficient and thus inapplicable for polyfunc-
tionalized molecules. In recent years, methods based on
annelation,[2,9] cycloaddition[10] or ring expansion[11] reactions
have emerged as possible alternatives to access the bicyclic
aromatic system. However, these concepts often require the
use of expensive catalysts, involve relatively harsh reaction
conditions with inherent lack of functional group compati-
bility or are dependent on multistep sequences to access the
substrates. As a consequence, their application in the syn-
thesis of more complex molecules has remained rather
restricted.
As part of our ongoing program to develop practical and
scalable methods for the synthesis of polysubstituted, highly
functionalized arenes and heteroarenes,[12] we designed
a strategy that would allow us to address the current
limitations in a highly efficient manner (Figure 1b). After
considering various options, we identified indanone-cyclo-
propane A, readily accessible from a plethora of commer-
cially available, inexpensive indanones via oxidation and
cyclopropanation,[13] as the ideal substrate. The envisaged
thermally induced disrotatory 2p-electrocyclic ring opening[14]
of A was expected to be operationally simple on large-scale
without requiring additional promoters and requires tempo-
rary carbon-halogen bond cleavage. This step produces the
benzylallyl cation B. Regioselective attack by the chloride
anion at the benzylic position affords enone C that should
spontaneously isomerize to the orthogonally functionalized
naphthol D. By virtue of the orthogonal functionalization
present in D, rapid access to selectively modified products
would be possible.
Figure 1. a) Occurrence of naphthalene pharmacophores and b) syn-
thetic design.
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At the outset, we were curious if conditions that were
previously developed in our group for the preparation of
methyl 3-hydroxybenzoates[12a] could be adapted to this novel
substrate class. After a short evaluation of possible reaction
conditions, we were pleased to see that the envisaged ring-
opening/1,2-migration could be successfully promoted for
a panel of compounds upon heating a 0.5m solution of our
substrates in sulfolane at 190 8C (Table 1).
At this temperature, the reaction went cleanly to full
conversion within less than 30 minutes in most cases.
Removal of sulfolane could be best accomplished by repeat-
edly washing an ethereal (diethyl ether; tert-butyl methyl
ether) product solution with water. We then investigated the
scope of this transformation by varying the substitution
pattern of our substrates and evaluated the observed regio-
selectivity.[15] For the majority of substrates, moderate to high
yields were obtained with a strong preference for the
formation of the para-chloronaphthol substitution pattern.
The choice of substituents along the ring junction enabled us
to fully direct the migration of the chloride to either the para-
(compound 9) or the ortho-position (compound 12). Within
this context it is interesting to note that the observed lower
yield for 12 might be a result of the inherent substrate
preference for the para-position. While steric hindrance was
expected to affect the regioselectivity to a minor extent, a low
degree of delocalization that results in the predominance of
the highly stabilized mesomeric resonance structure B might
account for this observation.
Having established a robust platform for the synthesis of
several polyfunctionalized naphthalenes, we evaluated differ-
ent strategies to further increase the chloride attack at the
para-position. As illustrated in Scheme 1a, site-selective
lithiation of the ring opening precursor 20 followed by
quenching with trimethylsilyl chloride[16] afforded 21, which,
upon exposure to the standard reaction conditions, was
smoothly opened to afford 6a in excellent yields (93%).
This transformation is viewed to proceed via 22, which
undergoes a spontaneous Brook rearrangement at elevated
temperatures.[17] The developed transformation was not only
limited to bicyclic ring systems, but could also be realized for
bicyclo[3.1.0]hex-3-en-2-one substrates as shown in Sche-
me 1b.
Having synthesized a library of polysubstituted naphtha-
lenes, we wanted to evaluate the selective modification of our
products by taking advantage of the orthogonal reactivity of
the hydroxy, chloro and ester substituents. We found out that
allyl ether 26 could be converted to tricycle 31 via an
unprecedented cascade cyclization (Scheme 2). This sequence
is initiated by thermal Claisen rearrangement of 26 to 27,
which then reacts in a subsequent Cope rearrangement to the
thermally unstable chloride 28. Elimination of hydrogen
Table 1: Evaluation of substituents in the electrocyclic ring opening to
give orthogonally functionalized naphthalenes.[a]
[a] Yield of the isolated product.
Scheme 1. a) Directed chlorine migration with concomitant carbon-
silicon cleavage and b) ring opening of bicyclo[3.1.0]hex-3-en-2-ones to
give chlorinated benzoates.
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chloride generates a para-quinone methide structure 29 and
its tautomeric form 30, respectively. Termination of the
sequence could be facilitated by capture of residual water to
give a benzylic alcohol that undergoes an acid catalyzed (p-
TsOH·H2O) lactonization to afford 31. Since formation of 31
was also observed under anhydrous conditions, a competing
pathway that involves direct attack of the ester might be also
operative. The realization of this one-pot cyclization method
gives rapid access to annulated naphthalene lactones, an
important structural motif that is also part of dioscorealide B
(32).[18]
An additional remarkable feature of the developed ring-
expansion reaction is the possibility to design powerful
retrosynthetic bond disconnections for the construction of
highly substituted, sterically hindered biaryl compounds. The
first application of this strategy could be realized in the
convergent total synthesis of the potent anticancer natural
product chartarin (1).[3b] We began our synthesis with the
coupling of indanone 33, derived from commercially available
7-methoxy-1-indanone in one synthetic operation, to the
known para-quinone 34 (Scheme 3).[19] For the conjugate
addition of 33 to 34, we relied on a previously reported
protocol by Jørgensen.[20] Thus, in the presence of catalytic
amounts of hydroquinidine (20 mol%), immediate consump-
tion of the equimolar mixture of reactants occurred. Trapping
of the formed hydroquinone as its bis-pivalate ester prevented
oxidation to the quinone, and subsequent addition of
trifluoroacetic acid promoted decarboxylation of the tert-
butyl ester to afford the 2-arylated indanone 35 in good
overall yield on gram scale. Next, oxidation of 36 to the
indenone could be accomplished using Stahls palladium-
catalyzed aerobic dehydrogenation conditions.[21] In order to
overcome the low reactivity of the 2-substituted indenone in
the following cyclopropanation reaction, we had to modify
the standard reaction conditions. Replacement of lithium
hexamethyldisilazane (LHMDS) by its potassium derivative
KHMDS in the presence of 18-crown-6 allowed us to improve
the initial low yield of 36 to 75%. Sequential treatment of 36
with methanolic potassium carbonate and then triflic anhy-
dride provided 37. Having prepared sufficient amounts of the
crucial intermediate (1.6 g), we turned our attention to the
key-step of the synthesis. Heating a solution of triflate 37 in
sulfolane at 200 8C for 15 min induced the desired ring
opening reaction and led to clean conversion to the biaryl
intermediate 38 (75%, 1.2 g). For the installation of the
methyl group, a site-selective coupling of the triflate had to be
developed. Careful experimentation revealed that, upon
exposure of 38 to an excess of dimethyl zinc in the presence
of Pd(dppf)Cl2 at 95 8C for 1 h, the chloride was left unreacted
and exclusive insertion at the triflate occurred.[22]
Lactone formation with loss of the biaryl axis was
promoted upon hydrolysis of the remaining pivalate
Scheme 2. One-pot functionalization of naphthyl allyl ether 26 through
sequential Claisen–Cope lactonization. Reagents and conditions:
a) allylBr, K2CO3, acetone, 89%, b) sulfolane, p-TsOH·H2O, 190 8C,
15 min, 40%. p-Ts=para-toluenesulfonyl.
Scheme 3. Application of the ring opening protocol to the total syn-
thesis of chartarin (1). Reagents and conditions: a) 33 (1 equiv), 34
(1 equiv), HQ (20 mol%), CH2Cl2, 20 8C; NEt3, PivCl, 23 8C, 70%;
b) TFA, CH2Cl2, 23 8C, 89%; c) Pd(TFA)2 (20 mol%), 4,5-diazafluoren-
9-one (20 mol%), O2 (1 atm), DMSO, 80 8C, 67%, 24% 35 ;
d) KHMDS, MDCA, 18-crown-6 (10 mol%), THF, 78 to 23 8C, 75%;
e) K2CO3, MeOH, 23 8C, 74%; f) Tf2O, NEt3, CH2Cl2, 78 8C to 23 8C,
98%; g) sulfolane, 200 8C, 15 min, 75%; h) Pd(dppf)Cl2, Me2Zn, 1,4-
dioxane, 95 8C, 83%; i) NaOH, CH2Cl2, MeOH, 23 8C; p-TsOH·H2O,
toluene, 80 8C, 98%; j) Pd(CH3CN)2Cl2 (5 mol%), SPhos (8 mol%),
KB(OMe)4, 1,4-dioxane, 90 8C, 87%; k) pyridine·HCl, 195 8C, 69%.
dppf=1,1’-bis(diphenylphosphino)ferrocene, HQ=hydroquinidine,
KHMDS=potassium hexamethyldisilazane, MDCA=methyl dichloroa-
cetate, Piv=pivaloyl, Tf= trifluoromethanesulfonyl, TFA= trifluoroace-
tic acid.
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(NaOH, MeOH) and acid catalyzed (p-TsOH·H2O) ring
closure at elevated temperature (toluene, 80 8C) gave 39.
Substitution of the chloride with a hydroxyl group was
initially investigated with a model substrate that was lacking
the methoxy substituent (see Supporting Information for
further details). To our surprise, this seemingly trivial
coupling reaction was not successful under a variety of
reaction conditions[23] and, in most cases, only dehalogenation
of the starting material was observed. Fortunately, when
a solution of the more electron rich naphthalene 39 in 1,4-
dioxane (0.05m) was exposed to potassium tetramethoxybo-
rate in the presence of bis(acetonitrile)dichloropalladium(II)
(5 mol%) and SPhos (8 mol%) at 90 8C for 3 h, efficient
incorporation of the desired methoxy group occurred
(87%).[24] For the completion of the synthesis, simultaneous
removal of both methyl substituents was accomplished by
treatment of 39 with pyridine hydrochloride at elevated
temperature (195 8C) for 16 h. Chartarin (1) crystallized from
methanol as a yellow-brownish powder whose spectroscopic
data (1H and 13C NMR, mp, HRMS) were in full agreement
with those reported for the naturally occurring substance.[3b,25]
In conclusion, we have developed an efficient and
practical ring opening/1,2-migration transformation for the
synthesis of orthogonally functionalized naphthalenes. The
reaction is operationally simple, does not require any
additives, occurs in a regioselective manner with a strong
preference for the para-chloronaphthol substitution pattern
and enables novel, powerful retrosynthetic bond disconnec-
tions. A translation of this method to natural product
synthesis was realized for the preparation of the potent
anticancer agent chartarin (1). The developed route can be
conducted on gram scale, provides efficient access to the
highly substituted, polycyclic carbon framework and enables
rapid diversification by standard transformations. Further
applications of this concept in the synthesis of complex
naphthalene containing molecules are currently underway in
our laboratories.
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2.2  Synthesis of Fluorinated Naphthols 
The selective synthesis of fluorinated naphthols from non-halogenated precursors is a demanding 
challenge. In recent years, many new processes for the introduction of fluorine atoms into aromatic 
molecules have been developed. However, established strategies often require the use of expensive 
transition metals or harsh conditions. The reactions often lack regiocontrol or rely on multistep sequences. 
As part of our ring-expansion strategy for the synthesis of halogenated phenols and naphthols, we 
envisioned to the application of the method for the preparation of fluorinated naphthols (Scheme 43). 
 
Scheme 43. Synthesis of fluorinated naphthols from cyclopropanated indanones.  
2.2.1 Cyclopropanation of Indenones 
The first goal for the development of a protocol for the synthesis of fluorinated naphthols was the 
preparation of the fluorinated cyclopropane. Few methods are known to produce such cyclopropanes, 112 
and they have not been applied to indenones. At the beginning of this project, we envisioned to apply the 
conditions used previously for the synthesis of chlorinated cyclopropanes, replacing the common methyl 
dichloroacetate (MDCA) with commercially available fluorinated derivatives: ethyl chlorofluoroacetate 
(I.252), ethyl bromofluoroacetate (I.253) and ethyl dibromofluoroacetate (I.254). The examined 
conditions for the cyclopropanation of indenones are summarized in Table 6. 
Initially, following the standard procedure for the synthesis of the cyclopropane derivatives, 5-methoxy-
indenone, prepared via bromination and elimination from 5-methoxy-indanone, was reacted with lithium 
bis(trimethylsilyl)amide (LHMDS) and ethyl chlorofluoroacetate (I.252), but the desired product could not 
be obtained (Table 6, entry 1). Surprisingly, a 1,2-addition occurred to give I.255 in only 6% yield. This 
transformation was not observed when methyl dichloroacetate was used. Additionally, the indenone 
polymerized under the reaction conditions which accounted for the low yield. For further studies, we 
employed 2,3-diphenyl-indenone due to higher stability and commercially availability. When 2,3-diphenyl-
indenone was used, the 1,2-addition product I.256 was obtained in excellent yield (89%) (Table 6, entry 2). 
With HMPA as additive,113 the desired cyclopropane I.257 could be obtained for the first time in 11% 
yield (Table 6, entry 3). Employing an excess of reagent and base, the yield could be improved to 29% 
(Table 6, entry 4). The influence of other additives which could promote the 1,4-addition was briefly 
investigated next. While no product formation was observed with copper iodide (CuI, Table 6, entry 5),114 
the use of to zinc bromide (ZnBr2, Table 6, entry 6) or lithium chloride (LiCl, Table 6, entry 7) afforded 
only traces of the 1,2-adduct.  
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Table 6. Examined conditions for the cyclopropanation of indenones with I.256, I.257 and I.258. 
 
entry R1 nucleophile reagents additive solvent, temperature result 
1 5-OMe I.252 LHMDS - THF, −78 °C to 23 °C I.255 (6%) 
2 2,3-Ph I.252 LHMDS - THF, −78 °C to 23 °C I.256 (89%) 
3 2,3-Ph I.252 LHMDS HMPA THF, −78 °C to 23 °C I.257 (11%) 
4b) 2,3-Ph I.252 LHMDS HMPA THF, −78 °C to 23 °C I.257 (29%) 
5 2,3-Ph I.252 LHMDS CuI THF, −78 °C to 23 °C starting material 
6 2,3-Ph I.252 LHMDS ZnBr2 THF, −78 °C to 23 °C traces of I.256 
7 2,3-Ph I.252 LDA LiCl THF, −78 °C to 23 °C traces of I.256 
8 2,3-Ph I.252 LDA LiCl, HMPA THF, −78 °C to 23 °C I.257 (24%) 
9 2,3-Ph I.252 KHMDS 18-crown-6 THF, −78 °C to 23 °C decomposition 
10 2,3-Ph I.252 NaH - THF, 23 °C complex mixture 
11 2,3-Ph I.252 NaH - DMF, 23 °C to 50 °C starting material 
12 2,3-Ph I.252 Cs2CO3 - DMF, 23 °C to 50 °C starting material 
13 2,3-Ph I.252 TMPZnCl∙LiCl - THF, 0 °C to 23 °C starting material 
14b) 5-OMe I.252 LHMDS HMPA THF, −78 °C to 23 °C polymerization of 
the indenone 
15 5-F I.253 LHMDS - THF, −78 °C to 23 °C -c) 
16d) 5-OMe I.254 1) Zn 
2) DBU 
TESCl 
- 
MeCN, 23 °C 
DMF, 23 °C 
complex mixture 
17e) H I.254 1) Zn TESCl MeCN, 23 °C complex mixture 
18f) 2,3-Ph I.254 Zn LiCl THF, DMSO, 0 °C Traces of 1,4-adduct 
19f) H I.254 Zn LiCl THF, DMSO, 0 °C polymerization of 
the indenone 
a) The reactions were performed using 1.1 equivalents of reagent. b) 3 Equivalents of reagent A were used. c) No conversion was 
observed and the starting material decomposed over time. d) The reactions were performed using Zn (2.0 equiv), TESCl (2.2 
equiv) and reagent I.254 (2.5 equiv). e) The reactions were performed using Zn (6.0 equiv), TESCl (6.6 equiv) and reagent I.254 
(7.5 equiv). f) The reactions were performed using Zn (3.0 equiv), LiCl (3.0 equiv) and reagent I.254 (2.0 equiv).  
Additionally, employing LDA as base together with HMPA and LiCl also did not improve the reaction 
outcome and the general problem of low conversion remained (Table 6, entry 8). Furthermore, extensive 
screening using other bases failed to provide the desired cyclopropane in good yield. We either observed 
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decomposition of the substrate (KHMDS/18-crown-6, Table 6, entry 9), the formation of a complex 
product mixture (NaH in THF, Table 6, entry 10) or no consumption of the starting material (NaH in 
DMF, Cs2CO3, TMPZnCl∙LiCl, Table 6, entries 11–13). When the optimized conditions (LHMDS (3 
equiv.), HMPA (3 equiv.), THF, −78 °C to 23 °C) were applied to 5-methoxy-indanone, only 
polymerization of the indenone was observed under the reaction conditions (Table 6, entry 14). 
Furthermore, the use of ethyl bromofluoroacetate (I.253) as nucleophile was also met with failure 
(Table 6, entry 15). 
As a conclusion, the attempt to adapt the developed conditions for the chloro-cyclopropanation or 
modification thereof for the synthesis of fluoro-cyclopropanes was not effective. Although no protocol 
for the synthesis of fluorocyclopropanated indanones is reported in the literature, a couple of different 
methods have been described for the preparation of fluoro-cyclopropanes. In 2002, Nakazato et al. 
reported a method for the cyclopropanation of cyclopentenone.115 This procedure involved the reaction 
of zinc, activated by triethylsilyl chloride (TESCl), with ethyl dibromofluoroacetate (I.254) to form the 
corresponding zinc enolate, which attacks cyclopentenone to form the 1,4-adduct. Closure of the 
3-membered ring was achieved by using DBU. With 5-methoxyindenone or unsubstituted indenone, the 
reaction of the zinc enolate resulted in a complex and inseparable mixture of the 1,4-adduct and cyclized 
product in low yields (Table 6, entries 16–17). The attempt to close the cyclopropane ring resulted in the 
exo-elimination product. When the reaction was conducted with the more stable 2,3-diphenyl-indenone in 
a mixture of tetrahydrofuran (THF) and DMSO with LiCl to activate the zinc, only traces of the 
corresponding 1,4-adduct were obtained (Table 6, entry 18). Furthermore, the unsubstituted indenone 
polymerized under these conditions (Table 6, entry 19) and the use of degassed THF or the addition of 
hydroquinone did not prevent this side reaction. 
So far, no general method for the synthesis of fluorinated cyclopropanes using the commercially available 
halogenated acetates could be established. Therefore, we focused on the synthesis of different 
nucleophiles. A search in the literature revealed a method for the cyclopropanation by the group of 
Pannecoucke.112e They describe the cyclopropanation of linear enones using 1,4-diazabicyclo[2.2.2]octane 
(DABCO) salt I.259 and cesium carbonate (Cs2CO3). I.259 was prepared from ethyl bromofluoroacetate 
(I.253) by converting it to the morpholine amide I.258 followed by reaction with DABCO (Scheme 44A).  
 
Scheme 44. Synthesis of cyclopropanation reagents DABCO salt I.259, sulfone I.261a and sulfone I.261b. 
Results and Discussion 
39 
 
In addition, two new cyclopropanation reagents containing a fluorine substituent were synthesized 
(Scheme 44B). Addition of a sulfide I.260 to ethyl bromofluoroacetate (I.253) gave the corresponding 
thioether which was oxidized using meta-chloroperbenzoic acid (m-CPBA) to give sulfone I.261a in 22% 
yield and sulfone I.261b in 58% yield.116 
With these three new cyclopropanation reagents in hand, we set out to examine conditions for the 
cyclopropanation of indenones. The applied conditions are depicted in Table 7. 
Table 7. Examined conditions for the cyclopropanation of indenones with I.259, I.261a or I.261b. 
 
entry R nucleophile base additive solvent, temperature result 
1 H I.259 Cs2CO3 - 1,4-dioxane, 50 °C starting material 
2 2,3-Ph I.259 Cs2CO3 - 1,4-dioxane, 50 °C starting material 
3 2,3-Ph I.259 Cs2CO3 - MeCN, 80 °C starting material 
4 2,3-Ph I.259 Cs2CO3 BF3∙OEt2 MeCN, 80 °C starting material 
5 H I.261a hydroquinidine - 1,4-dioxane, 23 °C -a) 
6 2,3-Ph I.261a hydroquinidine - 1,4-dioxane, 23 °C starting material 
7 2,3-Ph I.261a NaH - toluene, 0 °C to 23 °C decomposition 
8 H I.261b NaH  THF, 0 °C to 23 °C decomposition 
9 H I.261b LHMDS HMPA THF, 0 °C to 23 °C I.262 (7%) 
a) No conversion was observed and the starting material decomposed over time. 
First, the reaction with the DABCO salt I.259 was screened. Unfortunately, a combination of I.259 with 
Cs2CO3 did not react with unsubstituted indenone or 2,3-diphenyl-indenone in 1,4-dioxane at 50 °C or 
MeCN at 80 °C. The addition of boron trifluoride etherate to activate the enone did not improve the 
reaction (Table 7, entries 1–4). When sulfone I.261a was used as cyclopropanation reagent together with 
hydroquinidine as base, no reaction was detected with the unsubstituted indenone and 2,3-diphenyl-
indenone (Table 7, entries 5–6). Switching to sodium hydride (NaH) as base resulted in the decomposition 
of the starting material (Table 7, entry 7). The same result was observed with sulfone I.261b (Table 7, 
entry 8). Finally, the 1,4-adduct I.262 was observed in 7% yield when unsubstituted indenone was treated 
with sulfone I.261b, LHMDS as base and HMPA as additive. Unfortunately, the yield of this reaction 
could not be improved and the attempt to prepare the cyclopropane with DBU resulted in the formation 
of the exo-double bond. 
Given the difficulties associated with the 1,4-addition of nucleophiles to indenones, we decided to increase 
the reactivity of the enone system by the introduction of an electron-withdrawing group at the C2-position 
of the indenone. The corresponding α-ester was prepared with NaH and dimethyl carbonate in THF at 
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50 °C or NaH and Boc-imidazol in THF at 70 °C and the introduction of a phenylselenide moiety was 
achieved using phenylselenyl chloride and pyridine in dichloromethane (CH2Cl2) at 0 °C (Scheme 45).  
 
Scheme 45. Synthesis of α-selenides I.264, I.268 and I.269. 
The C2-substituted indenones were prepared from the corresponding α-selenides I.264, I.268 and I.269 
via oxidative elimination. The applied conditions for the cyclopropanation are shown in Table 8. 
Table 8. Conditions for the cyclopropanation of C2-substituted indenones. 
 
entry substrate nucleophile reagent additive solvent, temperature result 
1 I.270 I.252 LHMDS - THF, −78 °C to 23°C decomposition 
2 I.270 I.254 Zn TESCl MeCN, −20 °C to 23 °C decomposition 
3 I.270 I.261a LHMDS HMPA THF, −78 °C to 23°C decomposition 
4 I.270 I.261b LHMDS HMPA THF, −78 °C to 23°C decomposition 
5 I.271 I.259 Cs2CO3 - 1,4-dioxane, 50 °C 
 
6 I.272 I.259 Cs2CO3 - 1,4-dioxane, 50 °C 
 
7 I.272 I.276 Cs2CO3 - 1,4-dioxane, 50 °C decomposition 
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At the outset, the cyclopropanation of I.270 was investigated with various previously described 
nucleophiles. Unfortunately, the employment of ethyl chlorofluoroacetate (I.252), ethyl 
dibromofluoroacetate (I.254), sulfone I.261a and sulfone I.261b resulted only in decomposition of the 
starting material (Table 8, entries 1–4). When the reaction was investigated with the DABCO salt I.259 
and Cs2CO3 the corresponding cyclopropanes I.277 and I.278 were obtained in 15% and 21 % yield 
respectively (Table 8, entries 5–6). Interestingly, the use of a similar triethylamine salt I.276 again led to 
decomposition of the starting material (Table 8, entry 7). 
2.2.2 Halogen Exchange Reactions 
The aim to establish a general strategy for the synthesis of fluorinated cyclopropanes was not achieved by 
the cyclopropanation of indenones with an appropriate fluoride-containing nucleophile. Therefore, we 
revised our strategy and attempted a halogen exchange reaction for the introduction of the fluoride 
substituent (Scheme 46). This would allow us to utilize the previously described chlorinated cyclopropanes 
which could be synthesized efficiently from the corresponding indanones.  
 
Scheme 46. Envisioned synthesis of fluorinated cyclopropanes via a halogen exchange reaction. 
Zhang et al.112f reported a chlorine–fluorine exchange reaction on cyclopropyl derivatives. Upon exposure 
to potassium bifluoride (KHF2) in DMSO at 120 °C, the fluorinated cyclopropane I.282 could be 
generated efficiently (Scheme 47A). Adopting this process, cyclopropane I.279 was treated with KHF2, 
but in our hand, aromatization occurred and the chlorinated naphthol I.283 was obtained (Scheme 47B). 
The reason for this reaction pathway might be the fused ring system of I.279. This structural feature 
prevents the formation of a cyclopropene intermediate, which was postulated in the reported mechanism. 
 
Scheme 47. A) Chlorine–fluorine exchange on cyclopropanes. B) Attempted chlorine–fluorine exchange on cyclopropanated 
indanones. 
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In addition to the fluorination of the chloro-cyclopropane, the corresponding brominated substrate was 
also investigated. We supposed that the bromide is a better leaving group than the chloride and therefore, 
milder conditions could be employed. Thus, bromo-cyclopropane I.284 was exposed to silver 
tetrafluoroborate (AgBF4) in trifluoroethanol or diethyl ether (Et2O), but no conversion was observed and 
only the starting material could be recovered (Scheme 48).  
 
Scheme 48. Attempted bromine–fluorine exchange. 
In 2016, Nishikata et al. reported a method for the selective formation of tertiary fluorides from 
α-bromoamides.117 They could efficiently convert various α-bromoamides into the corresponding 
fluorides with CsF catalyzed by copper bromide (CuBr) and N,N,N’,N’’,N’’-pentamethyldiethylene-
triamine (PMDETA) in THF at 80 °C. To employ this methodology, amide I.286 was prepared from 
I.284 in 44% yield in two steps via saponification with potassium carbonate (K2CO3) followed by an 
amide coupling with 3,4-dimethoxyaniline in the presence of N,N’-dicyclohexylcarbodiimide (DCC) and 
4-(dimethylamino)-pyridine (DMAP) (Scheme 49A). In our hand, the fluorination reaction of I.286 
resulted in decomposition of the starting material, presumably due to the fused cyclopropane structure. 
Additionally, we treated ethyl ester I.284 with the same conditions, but only the starting material and 
traces of the dehalogenated naphthol were observed.  
Finally, we tried to employ a decarboxylative fluorination, which was reported to smoothly furnish 
aliphatic fluorides by the treatment of carboxylic acids with SelectFluor (I.168) and a catalytic amount of 
silver nitrate (AgNO3).98b Applying these conditions to our system, no conversion was observed at 23 °C 
and decomposition occurred at 55 °C (Scheme 49B).  
 
Scheme 49. Attempts for the introduction of a fluoride substituent. PMDETA = N,N,N',N'',N''-pentamethyldiethylenetriamine. 
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The observation of the aromatization during the attempted halogen exchange led to the idea of 
performing the halogen exchange during the aromatization reaction. Therefore, various fluoride sources, 
reported for halogen exchange reactions, were investigated. The results for the one-pot halogen 
exchange/aromatization reaction are summarized in Table 9. 
Table 9. Examined conditions for the one pot halogen exchange/aromatization reaction. 
 
entry fluoride source Additive conditions result 
1 AgF - sulfolane, 190 °C I.283a) 
2 AgF - sulfolane, 140 °C decomposition 
3 TBAF - sulfolane, 140 °C decomposition 
4 KF Ph4PBr DMSO, 170 °C decomposition 
5 KF Ph4PBr sulfolane, 170 °C I.291a) 
6 KF Ph4PBr, 1-fluoro-4-nitrobenzene sulfolane, 170 °C I.292 (62%) 
7 - Ph4PBr, 1-fluoro-4-nitrobenzene sulfolane, 170 °C decomposition 
8 KF Ph4PBr, nitrobenzene sulfolane, 170 °C I.283, I.289, I.291a) 
a) The reaction was monitored by thin layer chromatography (TLC). 
Thus, silver fluoride (AgF) was added and the reaction mixture was heated to 190 °C in sulfolane for 
30 min. The analysis of the product showed that the chloro-naphthol I.283 was obtained and no traces of 
the fluoro-naphthol I.290 were observed (Table 9, entry 1). A slow reaction rate for the introduction of 
fluoride and a fast reaction rate for the aromatization might be the reason. To investigate this assumption, 
the reaction was performed at 140 °C with a prolonged reaction time to decelerate the aromatization 
reaction (Table 9, entry 2). But only decomposition was observed. The same result was obtained with 
TBAF as fluoride source (Table 9, entry 3).  
In the literature, potassium fluoride (KF) in combination with the phase-transfer catalyst 
tetraphenylphosphonium bromide (Ph4PBr) is reported to convert aromatic halides into aromatic fluorides 
(the so-called halex reaction).118 Following this reported procedure, a mixture of cyclopropane I.279, KF 
and Ph4PBr in DMSO was heated to 170 °C for 2 h, but only decomposition was observed (Table 9, 
entry 4). Switching the solvent to sulfolane resulted in the formation of the dehalogenated product I.291 
(Table 9, entry 5). The addition of a radical scavenger (e.g. 1-fluoro-4-nitrobenzene to inhibit the 
dehalogenation did not provide the desired fluorinated naphthol. Instead a nucleophilic aromatic 
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substitution occurred to give I.292 in 62% yield (Table 9, entry 6). A control experiment with 
Ph4PBr/1-fluoro-4-nitrobenzene (Table 9, entry 7) showed that KF induces the nucleophilic aromatic 
substitution. Using nitrobenzene as radical scavenger to prevent the substitution reaction was not 
successful and only the chlorinated naphthol I.283, as well as the ortho-chloro-naphthol I.289 and the 
dehalogenated naphthol I.291 were obtained (Table 9, entry 8).  
To check whether the halex reaction would work for our substrates, the reported conditions were used for 
the conversion of chloro-naphthol I.283 to fluoro-naphthol I.290. Using KF and Ph4PBr in DMSO led to 
decomposition, and performing the reaction in sulfolane afforded only the dehalogenated product 
(Scheme 50). 
 
Scheme 50. Halex reaction of chloro-naphthol I.283. 
2.2.3 Direct Fluorination of Cyclopropanes 
As a result of the difficulties in developing a synthesis of fluorinated cyclopropanes through direct 
cyclopropanation or a chloride–fluoride exchange reaction, we aimed for the electrophilic fluorination of 
cyclopropyl anions (Scheme 51). 
 
Scheme 51. Envisioned fluorination of mono-substituted cyclopropanated indanones.  
The non-halogenated cyclopropane I.293 was prepared from 1-indanone (I.263) in three steps. First, 
benzylic bromination was achieved using N-bromosuccinimide (NBS) and 2,2’-azobis(2-
methylpropionitrile) (AIBN) in benzene at 80 °C. Elimination with NEt3 in CH2Cl2 afforded the enone 
I.295, which was treated with LHMDS and sulfonium salt I.296 (prepared in 1 step from ethyl 
bromoacetate in 72% yield) as cyclopropanation agent119 to afford I.293 in 31% yield over three steps. 
Unfortunately, the fluorination could not be accomplished using LDA and NFSI as fluorinating reagent 
(Scheme 52). Presumably, the concomitant generation of a carbanion at the α-position of the ketone led to 
decomposition of the starting material.  
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Scheme 52. Cyclopropanation of 1-indanone (I.263) with sulfonium salt I.296 and attempted fluorination of I.293. 
To block this position, we introduced a trimethylsilyl (TMS) group at the α-position of the ketone. This 
remarkable reaction was achieved by a slow addition of LDA to a premixed solution of I.293 and an 
excess of TMSCl in THF at −78 °C and I.297 was obtained in 30% yield (Scheme 53). The generated 
anion is supposed to be very unstable because ring strain prevents the resonance stabilization. Therefore, 
it is essential to directly trap the anion with an excess of the electrophile. Finally, fluorination was 
successful employing LDA and NFSI at −15 °C in THF. However, the product I.298 was obtained in 
moderate yield and could not be purified using flash column chromatography. Nevertheless, I.298 was 
subjected to fragmentation conditions (190 °C, sulfolane). The cyclopropane did not open to form a 
six-membered ring, however, the formation of an exo-double bond was observed. The structure of I.299 
was unambiguously confirmed by single-crystal X-ray diffraction. 
 
Scheme 53. Synthesis and fragmentation of fluoro derivative I.298.  
We speculated that the TMS group directed the undesired bond cleavage which led to the formation of 
I.299. Therefore, substrate I.302 was synthesized, bearing a methyl substituent at the α-position. Starting 
from 2-methyl-1-indanone (I.300), α-bromination was conducted with copper(II) bromide120 and 
subsequent elimination with DBU121 gave indenone I.301. The cyclopropanation was accomplished using 
sulfonium salt I.296. Thereby, cyclopropane I.302 was obtained 50% yield in 3 steps (Scheme 54). 
 
Scheme 54. Synthesis of methyl substituted cyclopropane I.302.  
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Substrate I.302 was used to investigate the fluorination at the α-position next to the ester. The conditions 
are summarized in Table 10. 
Table 10. Examined fluorination of I.302. 
 
entry base conditions result 
1 LDA THF, −78 °C to 23 °C decomposition 
2 LDAa) THF, −100 °C to 23 °C decomposition 
3 TMPZnCl∙LiCl THF, 0 °C to 23 °C starting material 
a) LDA was added dropwise to a mixture of NFSI (I.170) and substrate (I.302). 
Neither the deprotonation of I.302 with LDA and subsequent treatment with NFSI (I.170) nor the 
reverse addition of LDA to a mixture of NFSI (I.170) and I.302 (Table 10, entries 1–2) led to product 
formation. Instead, decomposition of the starting material occurred. Using TMPZnCl∙LiCl as base, no 
conversion was observed and the starting material could be recovered (Table 10, entry 3). Additionally, the 
electrophilic fluorination was investigated under flow conditions,122 but no improvement was achieved.  
2.2.4 Rhodium-Catalyzed Cyclopropanations 
A common way to synthesis cyclopropanes is the rhodium-catalyzed cyclopropanation of simple double 
bonds. However, indenone substrates are rare.37,38,123 Therefore, we planned to cyclopropanate 
indene (I.304) and its derivatives, which should be oxidized at the benzylic position thereafter 
(Scheme 55).  
 
Scheme 55. Envisioned Rh-catalyzed cyclopropanation of indene (I.304) with ethyl diazofluoroacetate (I.305). 
The first key target for the aimed synthesis of fluorinated cyclopropanes was the preparation of ethyl 
diazofluoroacetate (I.305). Ethyl diazofluoroacetate (I.305) has never been synthesized, although the 
chlorinated and brominated variants are known. The group of Hansen described the synthesis of ethyl 
diazochloroacetate and ethyl diazobromoacetate from commercially available ethyl fluoroacetate (I.307), 
though the fluorination has not been reported.124 In accordance to their preparation, we envisioned the 
preparation of ethyl diazofluoroacetate by deprotonation of ethyl diazoacetate with an appropriate base 
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and subsequent trapping of the generated anion by an electrophilic fluorinating reagent. But in our hand, 
analysis of the crude reaction mixture revealed that no product was formed in the reaction of I.307 with 
DBU and NFSI (I.170) in dichloromethane or with DABCO and SelectFluor (I.168) (Scheme 56). 
 
Scheme 56. Attempted synthesis of ethyl diazofluoroacetate (I.305). 
Further efforts focused on the preparation of I.305 from different fluoroacetates through introduction of 
the diazo moiety. Thus, the reaction of ethyl bromofluoroacetate (I.253) and N,N-ditosylhydrazine 
(TsNHNHTs) was briefly investigated. Due to the supposed instability of I.305, the rhodium-catalyzed 
cyclopropanation was pursued directly afterwards. The tested conditions are summarized in Table 11. 
Table 11. Conditions for the synthesis of diazo compound I.305 and their use in the rhodium catalyzed cyclopropanation. 
 
entry base solvent work-up result 
1 DBU THF aqueous traces of I.306 
2 DBU THF filtration no product 
3a) DBU  THF-d8 - traces of I.305 visible in the 1H NMR spectrum 
4 DBU toluene - no product 
5 DBU CH2Cl2 - no product 
6 DBU CH2Cl2 aqueous no product 
7 DBU MeCN filtration no product 
8 TMG THF filtration no product 
9 NaH THF - decomposition of I.253 
a) NMR experiment; TMG = 1,1,3,3-tetramethylguanidine 
The reaction of ethyl bromofluoroacetate (I.253) with N,N-ditosylhydrazine and DBU followed by an 
aqueous workup and subsequent cyclopropanation of 1-H-indene with bis[rhodium(α,α,α′,α′-tetramethyl-
1,3-benzenedipropionic acid)] (Rh2(esp)2) gave only traces of I.306 (Table 11, entry 1). We assumed that 
I.305 might not tolerate an aqueous workup. Therefore, the crude reaction mixture was filtered through a 
celite plug before its use in the cyclopropanation reaction, but the desired product was not obtained 
(Table 11, entry 2). To further investigate this reaction, the experiment was conducted in deuterated THF 
and was monitored by 1H NMR spectroscopy (Table 11, entry 3). The NMR analysis showed the 
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formation of the desired diazo compound as minor product together with two other unidentified 
products. To improve the reaction outcome, different solvents like toluene, CH2Cl2 and MeCN, were 
tested, but no cyclopropane formation was observed (Table 11, entries 4–7). Changing the base to 1,1,3,3-
tetramethylguanidine (TMG) or NaH did not improve the reaction (Table 11, entries 8–9).  
Due to these disappointing results, we choose to use a two-step procedure for the diazo formation, 
addition of N,N-ditosylhydrazine followed by base-induced diazo formation. But the addition reaction 
with Cs2CO3 in DMF at 23 °C did not furnish the addition product I.308. Instead, after nitrogen 
elimination,125 the tosyl anion could attack acetate I.253 to give adduct I.309. Similar results were obtained 
with K2CO3 or DBU as bases (Scheme 57).  
 
Scheme 57. Addition reaction N,N-ditosylhydrazine to I.253.  
We then set out to examine various diazo-transfer reagents to achieve the synthesis of I.305 from ethyl 
fluoroacetate (I.310). The examined conditions are shown in Table 12. 
Table 12. Reaction of ethyl fluoroacetate (I.310) with diazo transfer reagents.  
 
entry R-N3 base solvents result 
1 Tf-N3 pyridine MeCN, CH2Cl2, 0 °C no product 
2 
 
DBU MeCN, 23 °C no product 
3 
 
DBU MeCN, 23 °C no product 
4 
 
DBU MeCN, 23 °C 6% conversion 
 
Different azides were tested in the diazo transfer reactions. First, triflic azide (Tf-N3) was reacted with 
ethyl fluoroacetate (I.310) in the presence of pyridine in MeCN at 23 °C, but no product was observed by 
1H NMR spectroscopy (Table 12, entry 1). The same result was obtained when 
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4-acetamidobenzenesulfonyl azide (p-ABSA, I.311) or 2,4,6-triisopropylbenzenesulfonyl azide (I.312) 
together with DBU were used (Table 12, entries 2–3). When I.310 was treated with 
4-dodecylbenzenesulfonyl azide (I.312) as diazo transfer reagent in the presence of DBU in MeCN at 
23 °C, 6% conversion was observed (Table 12, entry 4). All attempts to further optimize this reaction were 
successful. 
In a final attempt, ethyl 2-fluoroacetoacetate (I.314) was treated with p-ABSA and DBU in MeCN to give 
I.305. Subsequent reaction with indene and catalytic amounts of Rh2(esp)2 did not furnish the desired 
product (Scheme 58). Presumably, the formation of ethyl diazofluoroacetate (I.305) was not successful. 
 
Scheme 58. Diazo-transfer reaction with p-ABSA and attempted cyclopropanation of indene (I.308). 
2.2.5 Cyclic sulfate Approach 
In 1988, Sharpless reported a cyclopropanation reaction of a cyclic sulfate with dimethyl malonate and 
NaH.126 With the cyclic sulfate acting as a double leaving group, the cyclopropanation with 
ethylfluoroacetate (I.310) should give rise to the fluorinated cyclopropane I.294 (Scheme 59). 
Dihydroxylation of indenone I.295, derived from bromo-indanone I.315 through elimination, with 
catalytic amounts of osmium tetroxide (OsO4) and 4-methylmorpholine N-oxide (NMO) as oxidant 
provided diol I.316 in 13% yield, which could not be purified using flash column chromatography or 
recrystallization methods. The reaction to form the cyclic sulfite I.317 with either thionyl chloride (SOCl2) 
and triethylamine or SOCl2 and a catalytic amount of DMF did not take place. Under basic conditions, 
deprotonation at the α-position can occur which could induce the cleavage of the sulfate to give an 
α-substituted enone.  
 
Scheme 59. Attempted synthesis of the cyclic sulfate I.318 and planned cyclopropanation with I.310.  
Results and Discussion 
50 
 
To prevent the observed side reaction, the α-position of the indenone should be substituted for further 
studies. 2-Methyl-1-indanone (I.300) was quantitatively α-brominated using CuBr2 in a mixture of 
chloroform (CHCl3) and ethyl acetate (EtOAc) at 70 °C (Scheme 60).120 Subsequent elimination with 
DBU and dihydroxylation with OsO4 and NMO furnished diol I.320 in 58% yield. Treatment of I.320 
with SOCl2 and NEt3 in CH2Cl2 at 0 °C followed by oxidation of the intermediate sulfite by 
ruthenium(III) chloride (RuCl3) and sodium periodate (NaIO4) in MeCN/H2O at 23 °C resulted in the 
formation of cyclic sulfate I.1 However, the cyclic sulfate could not be transformed into cyclopropane 
I.302 by using LHMDS or NaH and ethyl fluoroacetate (I.310) under various conditions.  
 
Scheme 60. Synthesis of cyclic sulfate I.321 and tested cyclopropanation. 
2.2.6 Diels–Alder Approach 
The synthesis of fluorinated cyclopropanes of cyclopentanone is literature known.115 To benefit from this 
fact, we aimed to introduce the benzene ring of the desired fluorocyclopropanated indanones through a 
Diels–Alder/aromatization sequence. Following the literature known procedure, the Michael addition of 
the generated zinc enolate of ethyl dibromofluoroacetate (I.254) to 2-cyclopentene-1-one (I.322) 
furnished I.323 in 49% yield (Scheme 61.). Ring closure to provide the cyclopropane ring was performed 
in excellent yield with DBU. A Saegusa–Ito reaction gave the fused cyclopentenone I.325, which set the 
stage for the key cycloaddition reaction. 
 
Scheme 61. Preparation of cyclopentenone I.325 as precursor for the Diels–Alder/aromatization sequence. 
With I.325 in hand, we tested the cycloaddition reaction with two different dienes. The reaction of I.326 
and I.325 in CH2Cl2 at 23 °C, in the presence of aluminum chloride (AlCl3) as Lewis acid or in toluene at 
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110 °C did not led to product formation (Scheme 62.A). Next, the Danishefsky diene (I.327) together 
with I.325 was heated to 110 °C in toluene. The reaction furnished the addition product I.328 as well as 
two isomeric enones I.329 and I.330 after elimination of methanol as inseparable mixture in 70% yield 
(Scheme 62.B). Yet, the aromatization with camphorsulfonic acid (CSA) in toluene at 110 °C or with 
pyridinium p-toluenesulfonate (PPTS) in CH2Cl2 at 23 °C did not proceed.  
 
Scheme 62. Diels–Alder reactions for the synthesis of fluorocyclopropanated indanones. 
2.2.7 Ring Opening–Aromatization Reaction 
With some fluorocyclopropanated indanones in hand, the stage was set to investigate the ring-
expansion/aromatization reaction for the synthesis of fluorinated 1-naphthols. The diphenyl substituted 
cyclopropane I.257 was subjected to the conditions for the ring-expansion reaction (sulfolane, 190 °C) 
and a rearranged product was obtained in 72% yield (Scheme 63). The structure of the formed product 
could not be unambiguously determined by 2D NMR spectroscopy. However, the 13C peaks of the 
cyclopropyl moiety disappeared and the mass spectroscopy revealed the same mass for the product as for 
the starting material.127  
 
Scheme 63. Ring opening–aromatization reaction of the fluoride substituted cyclopropane I.27. 
Encouraged by this promising result, the ring-expansion reaction was examined with cyclopropane I.277 
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having the morpholine ester. Indeed, heating I.277 to 190 °C in sulfolane provided naphthol I.336 
although the tert-butyl ester was cleaved under these conditions (Scheme 64). On a 0.016 mmol scale, 
naphthol I.332 was obtained in 43% yield. To examine whether the yield of the reaction is superior 
without the tert-butyl ester, we treated I.277 with trifluoroacetic acid (TFA) in CH2Cl2 at 23 °C to cleave 
the ester, but only decomposition occurred under the reaction conditions.  
 
Scheme 64. Ring-expansion reaction of I.277. 
Finally, the ring-expansion reaction of the cyclopentene derivative I.325 to give fluorinated phenols was 
investigated. The tested conditions are summarized in Table 13. 
Table 13. Examined conditions for the ring-expansion reaction of I.325. 
 
entry temperature time result 
1 190 °C 30 min decomposition 
2 120 °C 3 h starting material 
3 140 °C 3 h starting material 
4 160 °C 2 h starting material 
5 170 °C 2 h starting material 
6 170 °C 8 h decomposition 
 
Under the standard ring-expansion conditions only decomposition was observed (Table 13, entry 1). This 
result was surprising because the corresponding chlorinated substrate smoothly fragmented to furnish the 
two isomeric phenols in 60% yield.128 Conducting the reaction at lower temperatures (120 °C to 170 °C), 
no conversion could be detected and the starting material was recovered (Table 13, entries 2–5) and at 
longer reaction times, decomposition occurred again (Table 13, entry 6). 
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3 Conclusion and Further Directions 
Chapter one of this thesis details the development of an efficient and practical ring opening reaction for 
the synthesis of halogenated 1-naphthols. The procedure enabled the preparation of a variety of 
polysubstituted 1-naphthols from cyclopropanated indanones. The reaction is supposed to proceed 
through a thermally-induced disrotatory 2π-electrocyclic ring opening of the cyclopropanated indanone 
followed by a chloride migration, preferentially in the para-position (Scheme 65). The cyclopropanated 
indanones could be readily obtained from commercially available, inexpensive indanones via Wohl–
Ziegler bromination, base-induced elimination followed by cyclopropanation with LHMDS and methyl 
dichloroacetate (MDCA). It should be noted that the generated indanones are unstable and tend to 
polymerize. The operationally simple method did not require any additives or transition metal catalysts 
and could be performed in a flask open to air atmosphere. Various functional groups, including alkyl, 
ether, halogen substituents as well as protected alcohols and thioethers, were tolerated. The use of 
bromocyclopropanated indanones was also possible and the corresponding bromonaphthols were 
obtained by using modified reaction conditions (DMSO, 120 °C). Furthermore, the ring opening/1,2-
migration reaction was successfully adapted for the synthesis of chlorinated phenols from 
bicyclo[3.1.0]hex-3-en-2-ones. 
 
Scheme 65. Mechanism of the ring opening reaction. 
The applicability of the prepared orthogonally functionalized 1-naphthols was highlighted by the 
development of an unprecedented cascade reaction, involving a Claisen–Cope rearrangement followed by 
elimination of hydrogen chloride and lactone formation, to give access to annulated naphthalene lactones, 
the structural motif of dioscorealide B (Scheme 66).  
 
Scheme 66. Cascade reaction to give annulated naphthalene lactones. 
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Additionally, the ring opening reaction was successfully implemented in the total synthesis of chartarin, 
the aglycon of elsamicin A and B and chartreusin. The construction of a highly substituted, sterically 
hindered biaryl bond was thereby achieved. Upon heating to 200°C in sulfolane, the ring opening reaction 
smoothly furnished the desired sterically hindered biaryl intermediate. A sequence of standard 
transformations accomplished the synthesis of chartarin in 11 steps overall (Scheme 67).  
 
Scheme 67. Synthesis of chartarin.  
In addition to the synthesis of chlorinated 1-naphthols, we planned to extend this method to the synthesis 
of fluorinated naphthols. The first challenge for the development of a synthesis of fluorinated naphthols 
was the preparation of a fluorocyclopropanated indanone. Different methods for the preparation of this 
key intermediate were examined, including the cyclopropanation of indenones, a halogen exchange 
reaction, the fluorination of non-halogenated cyclopropanes, a rhodium-catalyzed cyclopropanation 
followed by benzylic oxidation and the construction of the aromatic ring by a Diels–Alder reaction 
(Scheme 68). However, a general method could not be developed. 
 
Scheme 68. Overview of examined methods for the preparation of the key fluorocyclopropanated indanone. 
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A representative fluorinated cyclopropane could be prepared from indanone I.266 by introduction of an 
α-phenylselenyl substituent, followed by oxidative elimination and cyclopropanation with the DABCO salt 
I.259. The prepared substrate was successfully subjected to the standard reaction conditions, giving rise to 
the fluorinated 1-naphthol I.332 (Scheme 69). 
 
Scheme 69. Synthesis of fluorinated naphthol I.332. 
Future studies will be directed at the development of a general procedure for the preparation of 
fluorocyclopropanated indanones with DABCO salt I.259. Moreover, the Diels–Alder reaction could be 
examined employing different dienes. Ultimately, a general method for the synthesis fluorinated 1-
naphthols would allow its implementation in the development of fluorinated compounds as 
pharmaceuticals. 
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4 Introduction 
4.1 Monoterpenoid Indole Alkaloids 
Alkaloids are a diverse class of natural products which exhibit a variety of biological activities. Due to their 
structural diversity, a general definition of alkaloids is difficult. In general, they are described as cyclic, 
nitrogen-containing compounds of plant or animal origin, prominent examples being morphine (II.1), 
quinine (II.2), nicotine (II.3) or caffeine (II.4) (Figure 8). Commonly, members of the alkaloid family are 
classified according to their nitrogen-containing core structure or according to their biological origin.  
 
Figure 8. Structures of the alkaloids morphine (II.1), quinine (II.2), nicotine (II.3) and caffeine (II.4). 
With their fascinating structural complexity and their interesting bioactivity, monoterpenoid indole 
alkaloids are of high interest for natural product synthesis and medical applications. Monoterpenoid indole 
alkaloids biosynthetically originate from a secologanin-derived C9 or C10 terpene unit which is condensed 
to a tryptamine.129 The secoiridiol secologanin (II.12) itself is a natural product synthesized from 
geraniol (II.5) (Scheme 70). However, the biosynthetic pathway has not been fully elucidated. Starting 
from geraniol (II.5), iridotrial (II.8) is synthesized through a four-step sequence. A geraniol-10-
hydroxylase (G10H) catalyzed allylic hydroxylation followed by an oxidation provides 10-oxogeraniol 
(II.7). Subsequent monoterpene cyclase (MTC) catalyzed cyclization and oxidation gives iridotrial (II.8).  
 
Scheme 70. Biosynthesis of secologanin (II.12) from geraniol (II.5). 
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II.8 is further oxidized and glycosylated to generate 7-deoxyloganic acid (II.10), which is esterified and 
hydroxylated. Finally, oxidative cleavage of loganin (II.11) by the secologanin synthase (SLS), presumably 
through a radical process, results in the formation of secologanin (II.12).130 
In the first step of the monoterpenoid indole alkaloid biosynthesis, the enzyme strictosidine synthase 
catalyzes a stereoselective Pictet–Spengler condensation between tryptamine (II.13) and 
secologanin (II.12) to generate the tetrahydro-β-carboline structure, producing strictosidine (II.14). The 
hydrolysis of the glycoside function leads to an opening of the hemiacetal to generate an aldehyde, which 
reacts with the secondary amine to form a Schiff base. Subsequent isomerization of the exo double bond 
gives 4,21-dehydrogeissoschizine (II.15).131 4,21-Dehydrogeissoschizine (II.15), having the Corynanthe-type 
skeleton, is the biosynthetic precursor of Aspidosperma and Iboga alkaloids. Rearrangement of the 
secologanin unit furnished strychnine-related alkaloids like preakuammicine (II.16). However, the 
operational mechanism remains unknown. Ring opening and reduction furnishes stemmadenine (II.18), 
which rearranges to give, hypothetically, the acrylic ester dehydrosecodine (II.20). II.20 is believed to 
react in a Diels–Alder reaction to give either the Aspidosperma-type skeletons as in tabersonine (II.21) or 
the Iboga-type skeletons (catharanthine, II.22) (Scheme 71A). 
 
Scheme 71. A) Proposed biosynthetic pathway of Corynanthe, Aspidosperma and Iboga alkaloids. B) Secologanin skeleton; the circle 
indicates the missing carbon atoms in the alkaloids which contain the C9 fragment instead of C10. 
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In general, the subfamilies of the monoterpenoid indole alkaloid family are classified by the different 
carbon skeleton of the terpenoid units derived from secologanin II.12 (Scheme 71B).130a,132 
4.2 The Aspidosperma Subclass 
The Aspidosperma alkaloid class of natural products consists of more than 250 members which exhibit 
potent biological activities. Many of them have been synthesized so far,133 including the archetypical 
members (−)-aspidospermine (II.23),134 (+)-aspidospermidine (II.24)135 and (+)-tabersonine (II.21)136 
(Figure 9A) as well as more complex compounds like (−)-aspidophytine (II.25),137 (+)-aspidofractinine 
(II.26),138 (−)-subincanadine A (II.27)139 and (−)-conophylline (II.28) (Figure 9B).140 
 
Figure 9. Selected examples of Aspidosperma alkaloids.  
4.3 Jerantinine E 
In 2008, seven new Aspidosperma alkaloids, jerantinine A–G (Figure 10), were isolated from leaf extracts of 
the Malayan plant Tabernaemontana corymbosa.141 They possess a pentacyclic 6,5,6,6,5-ring system including a 
highly oxygenated tetrahydrocarbazolone core. Its complex structure and oxygenated indole core make 
jerantinine E (II.33) a challenging target molecule for total synthesis. 
 
Figure 10. Structures of the Aspidosperma alkaloids jerantinine A–G. 
Introduction 
60 
 
Jerantinine E (II.33), structurally related to vincadifformine, displays cytotoxicity against vincristine-
sensitive (IC50 = 2.55 μM) and vincristine-resistant (IC50 = 2.03 μM) epidermoid carcinoma cell lines.141 
Additionally, jerantinine E (II.33) exhibits cytotoxic effects against breast and lung cancer cell lines. The 
cell growth of moderately invasive and highly invasive breast cancer cell lines (MCF-7 and MDA-MB-231) 
from breast ductal carcinoma were inhibited with the same efficiency (IC50 = 4.4–6.0 μM). In lung cancer 
cell lines, the highest cytotoxicity was reported for the human adenocarcinoma cell line (A549) from 
alveolar ephithelial cells (IC50 = 4.2 and 1.0 μM after 24 and 72 h).142 Furthermore, a cell migratory assay 
and an impedance study revealed that the activity of jerantinine E (II.33) relies on inhibition of the tubulin 
polymerization, thereby disrupting the microtubule network. An IC50 value of 0.45 μM showed that 
(−)-jerantinine E (II.33) is even more active than the known microtubule skeleton disruptor colchicine.  
In 2013, the first total synthesis of jerantinine E (II.33) was reported by Waser and was realized in 
17 steps with an overall yield of 16% starting from commercially available δ-valerolactam (II.36).142 The 
synthesis included a highly stereoselective formal homo-Nazarov cyclization of (II.37), which was 
developed by the Waser group,143 furnishing the cis-diastereomer (II.38) in 85% yield with high C3 
regioselectivity (Scheme 72). The final selective demethylation was achieved by a ceric ammonium nitrate 
(CAN) oxidation followed by in situ reduction with sodium dithionite to give jerantinine E (II.33).  
 
Scheme 72. Synthesis of jerantinine E (II.33) by Waser.  
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5 Results and Discussion 
5.1 Development of a β-C–H Bromination Approach Towards the Synthesis 
of Jerantinine E 
 
 
 
 
Reprinted with permission from T. Huber,† T. A. Preuhs,† C. K. G. Gerlinger, J. Org. Chem. 2017, 82, 
7410–7419. Copyright © 2017 American Chemical Society. 
 
 
† These authors contributed equally to this work. 
 
 
Results and Discussion 
Development of a β‑C−H Bromination Approach toward the
Synthesis of Jerantinine E
Tatjana Huber,†,∥ Teresa A. Preuhs,†,∥ Christa K. G. Gerlinger,‡ and Thomas Magauer*,†,§
†Department of Chemistry and Pharmacy, Ludwig-Maximilians-University, 81377 Munich, Germany
‡Faculty of Chemistry, University of Konstanz, 78457 Konstanz, Germany
§Institute of Organic Chemistry and Center for Molecular Biosciences, University of Innsbruck, 6020 Innsbruck, Austria
*S Supporting Information
ABSTRACT: The development of an asymmetric and highly convergent three-component synthesis of the functionalized ABC
ring system of the Aspidosperma alkaloid jerantinine E is reported. The presented synthetic strategy relies on our recently
developed method for the one-pot β-C−H bromination of enones, which allows for rapid construction of the tricyclic
tetrahydrocarbazolone core via a palladium-catalyzed amination and oxidative indole formation. Moreover, a secondary amine
building block that contains all carbon atoms of the D and E ring of the natural product could be installed in three additional
steps.
■ INTRODUCTION
Monoterpenoid indole alkaloids have been attractive targets for
synthetic chemists for several decades, and many of their
unique skeletons have been synthesized in the past.1 In addition
to their daunting structural complexity, a variety of biological
activities and medicinal applications have been reported,
including anticancer (e.g., jerantinine E, vinblastine, brucine)2
and insecticidal (e.g., aspidophytine)3 activities (Figure 1A).
The Aspidosperma alkaloid subfamily consists of more than 250
different members and biosynthetically originates from the
condensation of tryptamine with a rearranged secologanin-
derived C9 or C10 terpene unit.
4 The secondary metabolites
jerantinine A−G (Figure 1B) were isolated in 2008 from leaf
extracts of the Malayan plant Tabernaemontana corymbosa and
exhibit cytotoxic effects against vincristine-sensitive and
vincristine-resistant epidermoid carcinoma cell lines (IC50 =
0.68−2.55 μM).2a In 2013, Waser reported the first synthesis of
the Aspidosperma alkaloid jerantinine E (1) in 17 steps5 and
disclosed its antiproliferative activity against several human-
derived breast and lung cancer cell lines (IC50 = 1.0−6.0 μM)
mediated by inhibition of tubulin polymerization.
In the course of our studies toward novel methods for the
site-selective functionalization of α,β-unsaturated compounds,6
we identified several monoterpenoid indole alkaloids that could
be retrosynthetically traced back to a β-halogenated enone.
Despite significant advances made in the functionalization of
α,β-unsaturated compounds in recent years,7 only two
examples for the direct β-halogenation of enones are known.8
The syntheses of Aspidosperma alkaloids by Desmael̈e9 and
Qiu10 both require multistep sequences relying on prefunction-
alized vinylogous thioesters for the preparation of the crucial β-
enaminone subunit common to several Aspidosperma alkaloids
(Scheme 1A). We could circumvent these rather inefficient
transformations by our two-step sequence starting from simple
enones (Scheme 1B). Herein, we describe a convergent
synthesis of the ABC ring system of the oxygenated indole
alkaloid jerantinine E (1) employing our recently developed
protocol for the one-pot β-C−H bromination of enones.6
■ RESULTS AND DISCUSSION
Our retrosynthetic analysis of 1 was guided by the proposed
use of β-bromo enone 11 (Figure 1B) as a general entry to
polycyclic indole alkaloids. Identification of this subunit in
jerantinine E (1) inspired the strategy illustrated in Scheme 2A.
In our analysis, tetracycle 12 would arise from the sequential
diastereoselective alkylation of the tetrahydrocarbazolone 13
with iodide 14 and ethyl iodide. For the construction of the D-
ring of 1, we envisioned a sequence that would be initiated by
the reduction of the ketone and subsequent acid-mediated
elimination of the alcohol followed by in situ addition of the
free amine to the resultant vinylogous iminium ion 19 (Scheme
2B).11 The tetrahydrocarbazolone 13 was traced back to 3,4-
dimethoxyaniline (15) and β-bromo enone 16 which in turn
could be accessed via β-C−H bromination of the parent enone.
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In an initial attempt to synthesize jerantinine E (1), we
targeted racemic intermediate 12. The synthesis started with
our previously reported preparation of tetrahydrocarbazolone
rac-13, prepared in three steps from enone 21 utilizing a β-C−
H bromination, a palladium-catalyzed amination with 3,4-
dimethoxyaniline (15), and oxidative indole formation
(Scheme 3).6 Finally, tetrahydrocarbazolone rac-13 was Boc-
protected to give 22 in a good yield (88%). To examine the
introduction of secondary amine 14, we performed first
alkylation with 1-chloro-3-iodopropane as a model electrophile.
Treatment of 22 with lithium bis(trimethylsilyl)amide
(LHMDS) and an excess of 1-chloro-3-iodopropane followed
by nucleophilic displacement of the chloride provided azide 23.
Unfortunately, alkylation of 23 by treatment with LHMDS and
ethyl iodide did not give the desired product. Instead, the
elimination of the benzyl ether to give alkene 24 was
observed,12 which was prone to aromatization upon exposure
to traces of acid.
Since 23 underwent undesired elimination under basic
alkylation conditions, we contemplated exchange of the
CH2OBn moiety for a protected hydroxy group in the γ-
position of the enone. Our revised retrosynthetic analysis
featured the synthesis of a modified, asymmetric tetrahydro-
carbazolone core structure which could be constructed from
3,4-dimethoxyaniline (15), secondary amine building block 14,
and enantiopure β-bromo enone 27 (Scheme 4). The
stereocenter of the latter component was planned to direct
the sequential introduction of the side chains and enable the
asymmetric total synthesis of jerantinine E (1).
We began our endeavor with the synthesis of known chiral
alcohol 29, itself derived from 1,4-cyclohexanedione mono-
ethylene acetal (28) in four steps.13 Protection of 29 as its para-
methoxybenzyl ether (PMB) using Dudley’s reagent II (2-(4-
methoxybenzyloxy)-4-methylquinoline)14 furnished 30. Enone
30 was then subjected to our conditions for one-pot β-C−H
bromination, which includes (1) umpolung of the enone by
hydrazone formation with tert-butyl carbazate (tert-butoxy-
carbonyl hydrazide), (2) selective β-C−H bromination with N-
bromosuccinimide (NBS) followed by addition of triethylamine
to isomerize the allyl bromide, and (3) hydrolysis of the
hydrazone moiety, to afford 27 in 57% yield on a 340 mg scale
(Scheme 5). Palladium-catalyzed amination with 3,4-dimethox-
yaniline (15) employing Buchwald’s SPhos second generation
precatalyst15 followed by an oxidative indole formation16 using
palladium acetate and copper acetate furnished 32. It is
noteworthy that careful monitoring of the C−H activation
reaction proved to be crucial to avoid overoxidation and
subsequent hydrolysis of the PMB ether with extended reaction
times. Benzyl protection of the tetrahydrocarbazolone 32
provided 33,17 whose structure could be validated by single-
crystal X-ray diffraction.18
Having developed a short and efficient synthesis of key
intermediate 33, the stage was set for the installation of the
quaternary stereocenter as the crucial handle to construct the
DE ring system of jerantinine E (1). However, in sharp contrast
to the results obtained for the alkylation of 22, direct alkylation
of 33 with ethyl iodide was not feasible under a variety of
conditions. The use of LHMDS, LDA, or LDA/HMPA only led
Figure 1. (A) Naturally occurring indole alkaloids and (B) structures of jerantinines A−G.
Scheme 1. Methods for the Preparation of Functionalized β-
Enaminones for the Synthesis of Aspidosperma Alkaloids
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to recovered starting material. The exact influence of the
substituent at the γ-position of the ketone and the protecting
groups (Bn and PMB) on the alkylation is unclear.
To overcome this poor reactivity, we investigated the
acylation of 33. Surprisingly, exposure of 33 to LHMDS and
Mander’s reagent19 (methyl cyanoformate) at −78 °C followed
by alkylation with sodium hydride and ethyl iodide proceeded
cleanly and furnished 34 in good yields (Scheme 6). Next, we
attempted to convert 34 to 35 by means of a decarboxylation
using lithium chloride in aqueous dimethylformamide and
subsequent reaction using acrylonitrile as a reactive model
electrophile. Although traces of the decarboxylated product
were observed, we were unable to detect any of the conjugate
addition product.
Based on the successful alkylation of the β-keto ester with
ethyl iodide, we decided to investigate the alkylation of 33
using iodide 14. Thus, the Boc-protected amine building block
14 was synthesized as illustrated in Scheme 7A. Alkylation of
commercially available tert-butyl N-allylcarbamate (36) with
literature known iodide 37 under standard conditions (NaH,
DMF) afforded 38 in good yield (80%).20 Hydroboration of 38
with 9-borabicyclo[3.3.1]nonane (9-BBN) followed by oxida-
tive workup using aqueous hydrogen peroxide furnished
alcohol 39. The latter was then transformed into iodide 14,
employing Appel’s conditions (I2, PPh3, imH). With iodide 14
and tricyclic key intermediate 33 in hand, we were poised to
examine the challenging fragment coupling. Acylation of 33
followed by reaction of the β-keto ester with sodium hydride
and iodide 14 furnished the quaternary stereocenter in 40 in
good yield (Scheme 7B). Thus, the introduction of the
secondary amine building block could be accomplished in an
efficient manner. The methyl ester of 40 could then be
Scheme 2. (A) Initial Retrosynthetic Analysis of Jerantinine E (1) and (B) Envisioned Cascade Reaction for the Construction of
the D-Ring
Scheme 3. Synthesis of Tetrahydrocarbazolone 22 and
Alkylation with a Model Electrophile
Scheme 4. Revised Retrosynthetic Analysis of Jerantinine E
(1)
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transformed to the ethyl group of the natural product at a later
stage of the synthesis.
For the construction of the D-ring of 1 (see Scheme 1B), we
first tried to selectively reduce 40 using sodium borohydride
(Scheme 8A). Since these conditions turned out to be
ineffective and no conversion was observed, we opted for
more forcing conditions. As direct reduction of 40 with lithium
aluminum hydride could not be considered due to concomitant
reduction of the Boc protecting group, 40 was treated with 4 M
hydrochloric acid in 1,4-dioxane to remove the Boc protecting
group (Scheme 8B). Unfortunately under these conditions,
deprotection of the Boc group and elimination of the PMB
ether occurred, giving compound 42 as the major product.
Exposure of the crude reaction mixture to lithium aluminum
hydride followed by treatment with either 1 M aqueous
hydrochloric acid or Rochelle’s salt did not afford any
detectable amounts of tetracycle 43. Attempts to remove the
Boc group under basic conditions (K2CO3, DMSO/H2O, 65
°C; DIBAL-H, CH2Cl2, 23 °C) without affecting the PMB
Scheme 5. Synthesis of Tetrahydrocarbazolone 33
Scheme 6. Attempted Formation of the Quaternary
Stereocenter
Scheme 7. (A) Preparation of the Boc-Protected Amine
Building Block 14 and (B) Introduction of the Quaternary
Stereocenter
Scheme 8. Attempted Closure of the D-Ring of Jerantinine E
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group were unsuccessful, and only complex product mixtures
were obtained.
In order to avoid these undesired pathways in the
functionalization of 40, we decided to replace the methyl
with an allyl ester and set the quaternary stereocenter in a
subsequent diastereoselective palladium-catalyzed decarboxyla-
tive allylation reaction.21 The obtained allyl group could then
be converted to the ethyl group in three additional steps.22 We
anticipated that the stereochemical outcome of the allylation
step could be controlled by the stereocenter at C16. To obtain
the desired stereochemistry in the decarboxylative allylation
reaction, we prepared ent-33 according to the route described
above.23
For the incorporation of the allyl ester, we examined the
conditions shown in Table 1. Initially, the acylation reaction of
ent-33 with sodium hydride (1.1 equiv) and commercially
available allyl chloroformate (1.2 equiv) at −78 °C resulted in
no product formation. Surprisingly, treatment of ent-33 with
lithium diisopropylamide (LDA, 1.2 equiv) and allyl chlor-
oformate (1.2 equiv) resulted in the formation of the diacylated
product 45 (entry 2). Extensive screening using a variety of
lithium amide bases and allyl chloroformate or allyl 1H-
imidazole-1-carboxylate failed to provide β-keto ester 44, and
only formation of the diacylated product was observed (entries
3−7). Based on our previous findings that acylation of 44
works best with methyl cyanoformate, we investigated the use
of allyl cyanoformate. This modification resulted in the
formation of β-keto ester 44 for the first time (entry 8, 42%).
Further optimization of the reaction conditions by variation of
lithium amide bases and solvents revealed that the use of
LHMDS (1.5 equiv) in the presence of hexamethylphos-
phoramide (HMPA, 2 equiv) is crucial to reproducibly obtain
44 in good yield (70%).
Finally, treatment of 44 with LHMDS, HMPA, and iodide 14
resulted in the smooth formation of β-keto ester 46 (Scheme
9). Other alkylation conditions explored (Cs2CO3, MeCN;
NaH, DMF; KHMDS, THF) were inferior. Unfortunately,
initial attempts to induce the palladium-catalyzed decarbox-
ylative allylation reaction (Pd(PPh3)4 or Pd2(dba)3, (S)-t-Bu-
PHOX)24 only resulted in decarboxylation without incorpo-
ration of the allyl group. A more exhaustive screen of ligands is
currently underway in our laboratories and should ultimately
allow us to complete the total synthesis of jerantinine E.
■ CONCLUSION
We have reported a synthetic route toward the total synthesis
of the Aspidosperma alkaloid jerantinine E (1). The presented
strategies rely on an efficient one-pot β-C−H bromination
protocol to provide the C-ring subunit of the target structure. A
palladium-catalyzed amination reaction was used to further
functionalize the β-bromo enones and oxidative indole
formation enabled formation of the tricyclic ABC tetrahydro-
carbazolone fragment of jerantinine E (1). Our initial strategy
to construct the functionalized tricyclic key intermediate of the
natural product was hampered by the base-mediated elimi-
nation of the benzyl ether at C16 of the C-ring. Starting from a
γ-hydroxylated enone instead, we were able to prepare highly
functionalized precursor 46. The overall sequence to the
functionalized tetrahydrocarbazolone core of 1 proceeds in 11
linear steps from commercially available ketone 28 and the
secondary amine component 14. The latter contains all carbon
atoms of the D and E rings of the natural product. The
presented strategy is amenable to rapid modification to give a
variety of tetrahydrocarbazolone structural motifs.
■ EXPERIMENTAL SECTION
General Methods. All reactions were performed in oven-dried or
flame-dried glassware fitted with rubber septa under a positive pressure
of argon unless otherwise stated. Tetrahydrofuran (THF) and diethyl
ether (Et2O) were distilled from benzophenone and sodium prior to
use. Dichloromethane (CH2Cl2), triethylamine (NEt3), and N,N-
diisopropylamine (DIPA) were distilled from CaH2 prior to use.
Commercially available N-bromosuccinimide (NBS) was purified by
recrystallization from water.25 All other reagents and solvents were
purchased from commercial suppliers and were used without further
purification. The reactions were magnetically stirred and monitored by
NMR spectroscopy or analytical thin-layer chromatography (TLC).
The TLC plates were visualized by exposure to ultraviolet light (UV,
254 nm) and exposure to either an aqueous solution of ceric
ammoniummolybdate (CAM) or an aqueous solution of potassium
permanganate (KMnO4) followed by heating with a heat gun.
1H
NMR and 13C NMR spectra were measured in CDCl3 or CD2Cl2.
Proton chemical shifts are expressed in parts per million (δ scale) and
Table 1. Screen of Conditions for the Acylation of ent-33a
entry base X product: yieldb
1c NaH Cl −
2 LDA Cl 45: 24%
3 LHMDS Cl 45d
4 LiTMP Cl 45d
5 LTBTA Cl 45d
6 LDA im 45d
7 LHMDS im 45d
8 LDA CN 44: 42%
9 LHMDS CN 44: 62%
10e LHMDS, HMPA CN 44: 70%
aAll reactions were performed on a 0.02 mmol scale in THF (c = 0.02
M) with 1.1−1.2 equiv of base and 1.2 equiv of electrophile. bYields of
isolated products. cThe reaction was performed at 0 °C. dThe
reactions were monitored by 1H NMR spectroscopy. The yields were
not determined. e2 equiv of HMPA were used as additive. LiTMP =
lithium 2,2,6,6-tetramethylpiperidide, LTBTA = lithium tert-butyltrityl-
amide, im = 1-imidazoyl.
Scheme 9. Successful Alkylation with Building Block 14
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are calibrated using residual undeuterated solvent as an internal
reference. Additionally to 1H and 13C NMR measurements, 2D NMR
techniques such as homonuclear correlation spectroscopy (COSY),
heteronuclear single quantum coherence (HSQC), and heteronuclear
multiple bond coherence (HMBC) were used to assist signal
assignment. Infrared (IR) spectra were recorded on an FT-IR
spectrometer. IR data are reported in frequency of absorption
(cm−1). High resolution mass spectra (HRMS) were obtained by
electrospray ionization (ESI) or electron ionization (EI) using a sector
field mass spectrometer. Melting points (Mp’s) were determined on a
B-450 melting point apparatus from BÜCHI Labortechnik AG.
Optical rotations were recorded on a PerkinElmer 241 or Anton Paar
MCP 200 polarimeter with a sodium lamp and are reported as follows:
[α]D
T[°C] (c [g/100 mL], solvent). X-ray structural analyses were
performed on a diffractometer using Mo Kα radiation (λ = 0.71073 Å,
graphite monochromator).
Preparation of Azide 19. N-Boc-tetrahydrocarbazolone 22. To
a solution of tetrahydrocarbazolone rac-136 (80 mg, 0.22 mmol, 1
equiv) in tetrahydrofuran (2.74 mL) was added sodium hydride (13
mg, 0.3 mmol, 1.5 equiv, 60% dispersion in mineral oil) at 0 °C. After
30 min, di-tert-butyl dicarbonate (72 mg, 0.3 mmol, 1.5 equiv) was
added and the solution was allowed to warm to 23 °C. After 1.5 h, the
solution was diluted with saturated aqueous ammonium chloride
solution (10 mL) and diethyl ether (10 mL). The layers were
separated, and the aqueous layer was extracted with diethyl ether (3 ×
10 mL). The combined organic layers were washed with saturated
aqueous sodium chloride solution (10 mL), and the washed solution
was dried over sodium sulfate. The dried solution was filtered, and the
filtrate was concentrated. The crude product was purified by flash
column chromatography on silica gel (40% ethyl acetate in hexanes) to
afford 22 as a white solid (90 mg, 88%). TLC (25% ethyl acetate in
hexane): Rf = 0.38 (UV, CAM).
1H NMR (400 MHz, CDCl3) δ 7.78
(s, 1H), 7.71 (s, 1H), 7.34−7.24 (m, 5H), 4.60 (d, J = 12.1 Hz, 1H),
4.50 (d, J = 12.1 Hz, 1H), 4.09−4.02 (m, 1H), 3.97 (s, 3H), 3.94 (s,
3H), 3.78 (dd, J = 9.2, 3.8 Hz, 1H), 3.62 (app t, J = 9.1 Hz, 1H), 2.72
(ddd, J = 17.4, 14.4, 5.2 Hz, 1H), 2.52−2.42 (m, 2H), 2.33−2.22 (m,
1H), 1.67 (s, 9H). 13C NMR (100 MHz, CDCl3) δ 196.0, 149.7,
149.4, 147.9, 147.6, 138.1, 130.3, 128.5, 127.9, 127.9, 118.6, 117.9,
102.9, 99.3, 85.5, 73.2, 69.4, 56.3, 56.2, 34.8, 33.9, 28.2, 25.4. IR
(Diamond-ATR, neat) vm̃ax: 2937, 1736, 1660, 1550, 1493, 1475, 1453,
1369, 1307, 1251, 1209, 1134 cm−1. HR-MS (EI): calcd for
(C27H31O6N)
+: 465.2146; found, 465.2150.
Azide 23. N-Boc-tetrahydrocarbazolone 22 (12 mg, 0.026 mmol, 1
equiv) was dissolved in tetrahydrofuran (0.3 mL) and 1-chloro-3-
iodopropane (21.1 mg, 0.10 mmol, 4.00 equiv) was added. The
solution was cooled to 0 °C, and a solution of lithium bis(trimethyl-
silyl)amide (1 M in tetrahydrofuran, 36 μL, 0.036 mmol, 1.40 equiv)
was added dropwise over 6 min. After 2 h, the reaction mixture was
allowed to warm to 23 °C. After 1 h, the reaction mixture was diluted
with diethyl ether (5 mL), one drop of acetic acid was added, and the
resulting suspension was filtered through a fritted glass funnel (Por. 4).
The filter cake was rinsed with diethyl ether (10 mL). The filtrate was
concentrated, and the crude product was purified by flash column
chromatography on silica gel (20% ethyl acetate in hexanes) to afford
the chloride as a colorless oil (8.8 mg, dr = 5:1). No separation of the
two diastereomers could be achieved, and the diastereomeric mixture
was used for the next step.
The chloride was dissolved in N,N-dimethylformamide (0.16 mL),
and sodium azide (5.3 mg, 0.08 mmol, 5.00 equiv) was added. The
reaction mixture was stirred at 50 °C for 2 h, and then the temperature
was increased to 75 °C. After 5 h, heating was ceased and the reaction
mixture was diluted with water (5 mL) and ethyl acetate (5 mL). The
layers were separated, and the aqueous layer was extracted with ethyl
acetate (3 × 10 mL). The combined organic layers were washed with
saturated aqueous sodium chloride solution (10 mL), the washed
solution was dried over sodium sulfate, and the dried solution was
filtered. The filtrate was concentrated. The crude product was purified
by flash column chromatography on silica gel (25% ethyl acetate in
hexanes) to afford 23 as a yellow oil (7.5 mg, 53% over 2 steps, dr =
5:1). The major diastereomer could be separated by flash column
chromatography. TLC (25% ethyl acetate in hexanes): Rf = 0.48 (UV,
CAM). 1H NMR (400 MHz, CDCl3) δ 7.78 (s, 1H), 7.70 (s, 1H),
7.37−7.25 (m, 5H), 4.63 (d, J = 12.2 Hz, 1H), 4.48 (d, J = 12.2 Hz,
1H), 4.09−4.04 (m, 1H), 3.96 (s, 3H), 3.94 (s, 3H), 3.80 (dd, J = 9.1,
3.9 Hz, 1H), 3.63 (t, J = 9.1 Hz, 1H), 3.33 (t, J = 7.0 Hz, 2H), 2.67
(ddd, J = 17.9, 8.3, 4.7 Hz, 1H), 2.52 (ddd, J = 13.4, 4.7, 2.1 Hz, 1H),
2.11−1.99 (m, 2H), 1.76−1.70 (m, 2H), 1.67 (s, 9H), 1.48−1.43
(1H). 13C NMR (100 MHz, CDCl3) δ 197.4, 149.7, 148.8, 147.9,
147.6, 138.0, 130.5, 128.6, 128.0, 128.0, 118.7, 117.8, 102.8, 99.4, 85.6,
73.3, 69.5, 56.3, 56.2, 51.9, 41.5, 35.2, 31.1, 28.2, 26.9, 26.7. IR
(Diamond-ATR, neat) vm̃ax: 2930, 2096, 1737, 1654, 1476, 1371, 1309,
1206, 1141, 1105 cm−1. HR-MS (ESI): calcd for (C30H37O6N4)
+ (M +
H)+: 549.2713; found, 549.2706.
Preparation of Tetrahydrocarbazolone 33. (S)-4-[(4-
Methoxyphenyl)oxy]cyclohex-2-en-1-one (30). To a suspension of
(S)-4-hydroxycyclohex-2-en-1-one (29)26 (2.30 mg, 20.5 mmol, 1
equiv), magnesium oxide (1.66 g, 41.0 mmol, 2.00 equiv, vacuum-
dried), and Dudley reagent II14 (11.5 g, 41.0 mmol, 2.00 equiv) in
α,α,α-trifluorotoluene (200 mL) was added dropwise methyl triflate
(4.64 mL, 41.0 mmol, 2.00 equiv) at 0 °C. Upon completion of the
addition, the reaction mixture was allowed to warm to 23 °C. After 75
min, ethyl acetate (40 mL) was added and the suspension was filtered
through a fritted glass funnel. The filter cake was rinsed with ethyl
acetate (2 × 20 mL). The filtrate was washed with water (50 mL), and
the washed solution was dried over sodium sulfate. The dried solution
was filtered, and the filtrate was concentrated. The residual yellow oil
was purified by flash column chromatography on silica gel (9% to 14%
ethyl acetate in hexanes) to afford 30 as a colorless oil (2.60 mg, 55%).
The obtained characterization data were in full agreement with those
values reported in the literature.27
(S)-3-Bromo-4-[(4-methoxyphenyl)oxy]cyclohex-2-en-1-one (27).
(S)-4-[(4-Methoxyphenyl)oxy]cyclohex-2-en-1-one (30) (340 mg,
1.46 mmol, 1 equiv) was added to a mixture of sodium sulfate (643
mg, 4.53 mmol, 3.10 equiv) and tert-butyl carbazate (203 mg, 1.54
mmol, 1.05 equiv) in degassed 1,2-dichloroethane (1.2 mL) in a
pressure flask. The resulting suspension was heated to 85 °C. After 4.5
h, the orange mixture was allowed to cool to 23 °C. Dichloromethane
(4.4 mL) was added, the solution was cooled to 0 °C, and
recrystallized N-bromosuccinimide (274 mg, 1.54 mmol, 1.05 equiv)
was added. After 1 h at 0 °C, triethylamine (427 μL, 3.07 mmol, 2.10
equiv) was added in one portion. The resulting orange solution was
stirred for 24 h at 23 °C. Acetone−water (v/v = 9:2, 6.1 mL) and
Amberlyst 15 (1.76 g) were added, and the yellow suspension was
heated to 50 °C. After 12 h, the reaction mixture was allowed to cool
to 23 °C and then was diluted with dichloromethane (3 mL). The
crude mixture was dried over sodium sulfate, the dried solution was
filtered, and the filtrate was concentrated. The residual yellow oil was
purified by flash column chromatography on silica gel (14% ethyl
acetate in hexanes) to afford 27 as a yellow oil (261 mg, 57%). TLC
(20% ethyl acetate in hexane): Rf = 0.32 (UV, CAM).
1H NMR (400
MHz, CDCl3) δ 7.36−7.31 (m, 2H), 6.94−6.87 (m, 2H), 6.48 (s, 1H),
4.68 (s, 2H), 4.26 (t, J = 4.7 Hz, 1H), 3.81 (s, 3H), 2.72−2.61 (m,
1H), 2.36 (dt, J = 16.9, 5.6 Hz, 1H), 2.23−2.14 (m, 2H). 13C NMR
(100 MHz, CDCl3) δ 195.9, 159.7, 149.4, 133.8, 129.8, 129.4, 114.0,
76.0, 72.6, 55.4, 33.2, 28.0. IR (Diamond-ATR, neat) vm̃ax: 2934, 2836,
1682, 1611, 1513, 1464, 1331, 1302, 1278, 1247, 1174, 1084 cm−1.
HR-MS (EI): calcd for (C14H15
79BrO3)
+, 310.0199; found, 310.0200.
[α]589
20 = −46.4 (c = 1.0 × 10 g·mL−1, CH2Cl2).
Enaminone 31. To an oven-dried pressure tube were added
chloro(2-dicyclohexylphosphino-2′,6′-dimethoxy-1,1′-biphenyl)(2′-
amino-1,1′-biphenyl-2-yl) palladium(II) (126 mg, 0.18 mmol, 0.10
equiv), 2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (72 mg,
0.18 mmol, 0.10 equiv), sodium tert-butoxide (252 mg, 2.63 mmol,
1.50 equiv), 3,4-dimethoxyaniline (15) (402 mg, 2.63 mmol, 1.50
equiv), and toluene (12 mL). (S)-3-Bromo-4-[(4-methoxyphenyl)-
oxy]cyclohex-2-en-1-one (27) (545 mg, 1.75 mmol, 1 equiv) was
added, and the dark red suspension was heated to 80 °C for 18 h. The
reaction mixture was allowed to cool to 23 °C and was filtered through
a short plug of Celite. The filter cake was rinsed with dichloromethane
(30 mL). The filtrate was concentrated and the residual red oil was
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purified by flash column chromatography on silica gel (1% methanol in
dichloromethane) to afford 31 as a brown foam (474 mg, 77%). TLC
(2% methanol in dichloromethane): Rf = 0.22 (UV, CAM).
1H NMR
(400 MHz, CDCl3) δ 7.33 (d, J = 8.3 Hz, 2H), 6.98 (s, 1H), 6.94 (d, J
= 8.3 Hz, 2H), 6.80 (d, J = 8.5 Hz, 1H), 6.69 (dd, J = 8.5, 2.4 Hz, 1H),
6.63 (d, J = 2.4 Hz, 1H), 5.39 (s, 1H), 4.80 (d, J = 11.2 Hz, 1H), 4.56
(d, J = 11.2 Hz, 1H), 4.41 (dd, J = 11.4, 4.4 Hz, 1H), 3.86 (s, 3H), 3.83
(s, 3H), 3.82 (s, 3H), 2.60−2.40 (m, 2H), 2.34 (ddd, J = 17.2, 13.4, 4.6
Hz, 1H), 1.99 (qd, J = 11.9, 4.5 Hz, 1H). 13C NMR (100 MHz,
CDCl3) δ 196.1, 162.0, 159.9, 149.5, 147.3, 130.7, 129.9, 129.1, 116.8,
114.3, 111.5, 108.5, 97.9, 74.1, 71.4, 56.2, 56.1, 55.5, 35.1, 27.7. IR
(Diamond-ATR, neat) vm̃ax: 3250, 2393, 1611, 1581, 1500, 1463, 1235,
1196, 1172, 1026 cm−1. HR-MS (EI): calcd for (C22H25NO5)
+,
383.1727; found, 383.1727. [α]589
20 = +12.8 (c = 0.31 × 10 g·mL−1,
CH2Cl2).
Tetrahydrocarbazolone 32. A solution of enaminone 31 (485 mg,
1.26 mmol, 1 equiv) in N,N-dimethylformamide (16 mL) was added
to an oven-dried pressure tube containing palladium(II) acetate (28.4
mg, 0.13 mmol, 0.10 equiv), copper(II) acetate (689 mg, 3.79 mmol,
3.00 equiv), and potassium carbonate (524 mg, 3.79 mmol, 3.00
equiv). The resulting green-brown mixture was placed in a preheated
oil bath at 140 °C. After 1 h, the reaction mixture was allowed to cool
to 23 °C, and the dark solution was filtered through a short plug of
Celite. The filter cake was rinsed with dichloromethane (40 mL). The
filtrate was concentrated. The residual black oil was purified by flash
column chromatography on silica gel (50% to 66% ethyl acetate in
hexanes) to afford 32 as a gray solid (275 mg, 57%). TLC (1%
methanol in dichloromethane): Rf = 0.12 (UV, CAM).
1H NMR (400
MHz, CDCl3) δ 8.99 (s, 1H), 7.66 (s, 1H), 7.32 (d, J = 8.3 Hz, 2H),
6.89 (d, J = 8.3 Hz, 2H), 6.83 (s, 1H), 4.88 (dt, J = 8.8, 3.2 Hz, 1H),
4.75 (d, J = 11.2 Hz, 1H), 4.56 (d, J = 11.2 Hz, 1H), 3.89 (s, 3H), 3.83
(s, 3H), 3.80 (s, 3H), 2.75 (dt, J = 15.5, 4.0 Hz, 1H), 2.60−2.46 (m,
2H), 2.29−2.10 (m, 1H). 13C NMR (100 MHz, CDCl3) δ 193.7,
159.6, 148.7, 147.8, 146.9, 130.1, 129.8, 129.7, 117.5, 114.2, 112.8,
103.1, 94.8, 71.0, 70.8, 56.3, 56.2, 55.4, 36.3, 30.5. IR (Diamond-ATR,
neat) vm̃ax: 3294, 2949, 1626, 1585, 1540, 1513, 1466, 1340, 1295,
1247, 1135 cm−1. HR-MS (EI): calcd for (C22H23NO5)
+, 381.1571;
found, 381.1570. Mp 196−199 °C. [α]58920 = −1.4 (c = 1.0 × 10 g·
mL−1, CH2Cl2).
N-Benzyltetrahydrocarbazolone 33. Tetrahydrocarbazolone 32
(203 mg, 0.532 mmol, 1 equiv) was dissolved in N,N-dimethyl-
formamide (2.7 mL), and the solution was cooled to 0 °C. Sodium
hydride (25.5 mg, 0.639 mmol, 1.20 equiv, 60% dispersion in mineral
oil) was added, and the suspension was stirred for 1 h at 0 °C. Benzyl
bromide (76 μL, 0.639 mmol, 1.20 equiv) was added, and the reaction
mixture was allowed to warm to 23 °C. After 2 h, saturated aqueous
ammonium chloride solution (5 mL) and ethyl acetate (5 mL) were
added, the layers were separated, and the aqueous layer was extracted
with ethyl acetate (3 × 5 mL). The combined organic layers were
washed with saturated aqueous sodium chloride solution (10 mL), the
washed solution was dried over sodium sulfate, and the dried solution
was filtered. The filtrate was concentrated. The crude product was
purified by flash column chromatography on silica gel (60% ethyl
acetate in hexanes) to afford 33 as a slightly beige solid (224 mg,
89%). Crystals that were suitable for X-ray diffraction analysis were
obtained by crystallization from dichloromethane. TLC (50% ethyl
acetate in hexanes): Rf = 0.22 (UV, KMnO4).
1H NMR (400 MHz,
CD2Cl2) δ 7.67 (s, 1H), 7.27−7.22 (m, 3H), 7.14 (d, J = 8.4 Hz, 2H),
6.95 (dd, J = 6.7, 2.8 Hz, 2H), 6.84−6.76 (m, 2H), 6.64 (s, 1H), 5.22
(q, J = 16.7 Hz, 2H), 4.76 (t, J = 3.6 Hz, 1H), 4.66 (d, J = 11.2 Hz,
1H), 4.43 (d, J = 11.1 Hz, 1H), 3.88 (s, 3H), 3.77 (s, 3H), 3.72 (s,
3H), 2.88 (ddd, J = 16.4, 11.8, 4.4 Hz, 1H), 2.57−2.49 (m, 1H), 2.41
(dt, J = 16.6, 4.2 Hz, 1H), 2.26 (ddt, J = 15.0, 11.7, 4.0 Hz, 1H). 13C
NMR (100 MHz, CD2Cl2) δ 194.2, 160.0, 148.7, 147.8, 146.7, 137.1,
132.1, 130.3, 130.2, 129.3, 128.1, 126.7, 117.6, 114.3, 113.7, 103.8,
94.4, 71.1, 67.5, 56.6, 56.5, 55.8, 47.9, 34.3, 27.9. IR (Diamond-ATR,
neat) vm̃ax: 2943, 1700, 1647, 1558, 1540, 1513, 1483, 1444, 1303,
1270, 1248, 1173, 1106 cm−1. HR-MS (ESI): calcd for (C29H29NO5)
+,
471.2046; found, 471.2054. Mp 139−144 °C. [α]58920 = −6.4 (c = 1.0 ×
10 g·mL−1, CH2Cl2).
Preparation of Tetrahydrocarbazolone 34. Tetrahydrocarba-
zolone 34. N-Benzyltetrahydrocarbazolone 33 (49 mg, 0.10 mmol, 1
equiv) in tetrahydrofuran (0.5 mL) was added dropwise to a solution
of lithium bis(trimethylsilyl)amide (1 M in tetrahydrofuran, 0.12 mL,
0.12 mmol, 1.2 equiv) and hexamethylphosphoramide (36 μL, 0.20
mmol, 2.0 equiv) in tetrahydrofuran (0.5 mL) at −78 °C. After 1 h,
methyl cyanoformate (12 μL, 0.15 mmol, 1.5 equiv) was added in one
portion and the solution was slowly allowed to warm to 23 °C. After
20 h, the solution was diluted with saturated aqueous sodium
bicarbonate solution (10 mL) and ethyl acetate (10 mL). The layers
were separated, and the aqueous layer was extracted with ethyl acetate
(3 × 10 mL). The combined organic layers were washed with
saturated aqueous sodium chloride solution (10 mL), and the washed
solution was dried over sodium sulfate. The dried solution was filtered,
and the filtrate was concentrated. The crude product was purified by
flash column chromatography on silica gel (50% ethyl acetate in
hexanes) to afford the β-keto ester as a red oil (40 mg, 73%)
containing minor impurities. The β-keto ester was used without
additional purification for the next step.
Sodium hydride (2.5 mg, 62 μmol, 1.5 equiv, 60% suspension in
mineral oil) was added a solution of the β-keto ester (22 mg, 41 μmol,
1 equiv) in N,N-dimethylformamide (0.4 mL) at 0 °C. After 1 h, ethyl
iodide (13 μL, 0.16 mmol, 4.0 equiv) was added, the reaction flask was
covered with aluminum foil, and the reaction mixture was allowed to
warm to 23 °C. After 20 h, the reaction mixture was diluted with
saturated aqueous ammonium chloride solution (10 mL) and ethyl
acetate (10 mL). The layers were separated, and the aqueous layer was
extracted with ethyl acetate (3 × 10 mL). The organic layers were
washed with saturated aqueous sodium chloride solution (10 mL), and
the washed solution was dried over sodium sulfate. The dried solution
was filtered, and the filtrate was concentrated. The crude product was
purified by flash column chromatography on silica gel (40% ethyl
acetate in hexanes) to afford 34 as a brown oil (12 mg, 52%, dr = 4:1).
All characterization data refer to the major diastereomer shown in the
scheme. TLC (50% ethyl acetate in hexanes): Rf = 0.40 (UV, CAM).
1H NMR (600 MHz, CDCl3) δ 7.79 (s, 1H), 7.26−7.24 (m, 3H),
7.16−7.11 (m, 2H), 6.98−6.92 (m, 2H), 6.81−6.78 (m, 2H), 6.59 (s,
1H), 5.42−5.29 (m, 2H), 5.21 (dd, J = 7.7, 5.4 Hz, 1H), 4.71 (d, J =
11.1 Hz, 1H), 4.47 (d, J = 11.0 Hz, 1H), 3.95 (s, 3H), 3.79 (s, 3H),
3.76 (s, 3H), 3.66 (s, 3H), 3.05 (dd, J = 13.3, 5.3 Hz, 1H), 2.29 (dd, J
= 13.9, 7.5 Hz, 1H), 2.24 (dd, J = 13.2, 7.8 Hz, 1H), 2.09 (dd, J = 14.1,
7.3 Hz, 1H), 1.00 (t, J = 7.5 Hz, 3H). 13C NMR (150 MHz, CDCl3) δ
189.7, 172.5, 159.6, 148.1, 147.3, 146.2, 136.5, 132.4, 129.8, 128.9,
127.7, 126.3, 117.8, 114.0, 112.7, 103.4, 93.8, 70.5, 68.9, 58.9, 56.3,
55.4, 52.7, 48.3, 36.0, 28.2, 9.4. IR (Diamond-ATR, neat) vm̃ax: 2936,
2252, 1726, 1648, 1483, 1441, 1246, 1162, 1029 cm−1, HR-MS (EI):
calcd for (C33H35NO7)
+, 557.2408; found, 557.2403.
Synthesis of the Tertiary Amine Building Block 14. ((2-
Iodoethoxy)methyl)benzene (37). 2-Benzyloxyethanol (5.00 g, 32.9
mmol, 1 equiv) was dissolved in dichloromethane (95 mL), and
triphenylphosphine (12.9 g, 49.3 mmol, 1.50 equiv) and imidazole
(3.36 g, 49.3 mmol, 1.50 equiv) were added. Iodine (12.5 g, 49.3
mmol, 1.5 equiv) was carefully added in three portions, and the yellow
suspension was stirred at 23 °C. After 18 h, aqueous sodium
thiosulfate solution (1 M, 100 mL) was added and the layers were
separated. The aqueous layer was extracted with dichloromethane (2 ×
100 mL), and the combined organic layers were washed with saturated
aqueous sodium chloride solution (100 mL). The washed solution was
dried over sodium sulfate, and the dried solution was filtered. The
filtrate was concentrated. The crude product was purified by flash
column chromatography on silica gel (5% ethyl acetate in hexanes) to
afford 37 (8.00 g, 93%) as a colorless oil. The obtained character-
ization data were in full agreement with those values reported in the
literature.20
tert-Butyl N-Allyl-N-(2-benzyloxyethyl) Carbamate (38). tert-Butyl
allylcarbamate (36) (3.14 g, 20.0 mmol, 1 equiv) was dissolved in N,N-
dimethylformamide (66 mL) and was added dropwise to a suspension
of sodium hydride (1.20 g, 30.0 mmol, 1.50 equiv, 60% dispersion in
mineral oil) in N,N-dimethylformamide (100 mL) at 0 °C. After 45
min, ((2-iodoethoxy)methyl)benzene (37) (6.81 g, 26.0 mmol, 1.30
The Journal of Organic Chemistry Article
DOI: 10.1021/acs.joc.7b01095
J. Org. Chem. 2017, 82, 7410−7419
7416
68 
Results and Discussion 
equiv) was added dropwise. The reaction mixture then was allowed to
warm to 23 °C. After 16 h, the reaction mixture was carefully diluted
with ammonium chloride solution (200 mL) and ethyl acetate (100
mL). The layers were separated, and the aqueous layer was extracted
with ethyl acetate (3 × 100 mL). The combined organic layers were
washed with saturated aqueous sodium chloride solution (200 mL),
and the washed solution was dried over sodium sulfate. The dried
solution was filtered, and the filtrate was concentrated. The crude
product was purified by flash column chromatography on silica gel
(10% ethyl acetate in hexanes) to afford 38 as a colorless oil (4.65 g,
80%). TLC (33% ethyl acetate in hexanes): Rf = 0.83 (UV, CAM).
1H
NMR (400 MHz, CD2Cl2) δ 7.38−7.25 (m, 5H), 5.79 (dddd, J = 17.7,
9.8, 6.0, 5.2 Hz, 1H), 5.15−5.06 (m, 2H), 4.51 (s, 2H), 3.88 (br s,
2H), 3.58 (t, J = 5.9 Hz, 2H), 3.39 (br s, 2H), 1.42 (s, 9H). 13C NMR
(100 MHz, CD2Cl2) δ 155.8, 139.3, 135.2, 128.8, 128.0, 128.0, 116.3,
116.0, 79.8, 73.4, 69.4, 51.3, 50.7, 46.9, 28.7. IR (Diamond-ATR, neat)
vm̃ax: 2976, 2930, 2861, 1690, 1477, 1454, 1405, 1365, 1244, 1173,
1150, 1103, 1029 cm−1. HR-MS (ESI): calcd for (C17H26NO3)
+ (M +
H)+, 292.1913; found, 292.1909.
tert-Butyl N-(3-Hydroxypropyl)-N-(2-benzyloxyethyl) Carbamate
(39). tert-Butyl N-allyl-N-(2-benzyloxyethyl) carbamate (38) (3.1 g,
10.6 mmol, 1 equiv) was dissolved in tetrahydrofuran (5.6 mL), and a
solution of 9-borabicyclo[3.3.1]nonane (0.5 M solution in tetrahy-
drofuran, 29.8 mL, 14.9 mmol, 1.40 equiv) was added at 0 °C. After 3
h at 0 °C, the reaction mixture was allowed to warm to 23 °C. After 16
h, aqueous sodium hydroxide solution (10 wt %, 4.9 mL) and aqueous
hydrogen peroxide solution (30 wt %, 4.9 mL) were added dropwise
and the reaction was heated to 50 °C. After 2 h, heating was ceased
and the solution was allowed to cool to 23 °C. The reaction mixture
was saturated with sodium carbonate, and the aqueous layer was
extracted with diethyl ether (3 × 50 mL). The combined organic layers
were washed with saturated aqueous sodium chloride solution, and the
washed solution was dried over sodium sulfate. The dried solution was
filtered, and the filtrate was concentrated. The crude product was
purified by flash column chromatography on silica gel (33% ethyl
acetate in hexanes) to afford 39 as a colorless oil (1.64 g, 50%). TLC
(9% ethyl acetate in hexanes): Rf = 0.10 (UV, KMnO4).
1H NMR (400
MHz, CDCl3) δ 7.39−7.27 (m, 5H), 4.51 (s, 2H), 3.80 (t, J = 7.1 Hz,
1H), 3.67−3.31 (m, 8H), 1.87−1.59 (m, 2H), 1.42 (s, 9H). 13C NMR
(100 MHz, CDCl3) δ 157.1, 138.1, 128.6, 127.9, 127.7, 80.4, 73.3,
68.8, 58.4, 47.3, 43.9, 30.7, 28.5. IR (Diamond-ATR, neat) vm̃ax: 3444,
2974, 2866, 1688, 1667, 1479, 1454, 1413, 1366, 1246, 1166, 1139,
1103 cm−1. HR-MS (ESI): calcd for (C17H28NO4)
+ (M + H)+,
310.2018; found, 310.2015.
tert-Butyl N-(3-Iodopropyl)-N-(2-benzyloxyethyl) Carbamate
(14). Iodine (541 mg, 2.13 mmol, 1.20 equiv) was added to a solution
of triphenylphosphine (559 mg, 2.13 mmol, 1.20 equiv) and imidazole
(145 mg, 2.13 mmol, 1.20 equiv) in dichloromethane (17.5 mL) at 0
°C. After 15 min, a solution of tert-butyl N-(3-hydroxypropyl)-N-(2-
phenoxyethyl) carbamate (39) (550 mg, 1.78 mmol, 1 equiv) in
dichloromethane (3.5 mL) was added dropwise. Upon completion of
the addition, the yellow suspension was allowed to warm to 23 °C.
After 3 h, the reaction mixture was diluted with water (15 mL) and
ethyl acetate (15 mL). The layers were separated, and the organic layer
was washed with aqueous sodium thiosulfate solution (1 M, 40 mL)
and saturated aqueous sodium chloride solution (40 mL). The washed
solution was dried over sodium sulfate, the dried solution was filtered,
and the filtrate was concentrated. The crude product was purified by
flash column chromatography on silica gel (10% ethyl acetate in
hexanes) to afford 14 as a yellow oil (592 mg, 79%). TLC (20% ethyl
acetate in hexanes): Rf = 0.68 (UV, KMnO4).
1H NMR (400 MHz,
CDCl3) δ 7.41−7.25 (m, 5H), 4.52 (s, 2H), 3.68−3.51 (m, 2H),
3.49−3.37 (m, 2H), 3.34 (t, J = 7.0 Hz, 2H), 3.18−3.08 (m, 2H),
2.18−1.98 (m, 2H), 1.47 (s, 5H), 1.41 (s, 4H). 13C NMR (100 MHz,
CDCl3, ∼1:1 rotamer ratio, asterisk denotes signals of the second
rotamer) δ 155.6, 138.3, *138.3, 132.5, *132.4, *128.6, 128.6, *127.8,
127.7, 80.0, *79.8, 73.2, 69.1, *69.0, 49.2, *47.9, 47.6, 40.6, 32.7, *32.5,
28.6, *28.6. IR (Diamond-ATR, neat) vm̃ax: 2974, 1671, 1477, 1465,
1454, 1409, 1366, 1241, 1156, 1114 cm−1. HR-MS (ESI): calcd for
(C17H27NO3I)
+ (M + H)+, 420.1036; found, 420.1034.
Preparation of Tetrahydrocarbazolone 40. Tetrahydrocarba-
zolone 40. N-Benzyltetrahydrocarbazolone 33 (50 mg, 0.11 mmol, 1
equiv) was dissolved in tetrahydrofuran (1.1 mL) and was added
dropwise to a solution of lithium diisopropylamide (0.5 M in
tetrahydrofuran, 320 μL, 0.16 mmol, 1.50 equiv; freshly prepared) at
−78 °C. After 1 h, methyl cyanoformate (17 μL, 0.21 mmol, 2.00
equiv) was added in one portion and the solution was slowly allowed
to warm to 23 °C. After 14 h, the red solution was diluted with
saturated aqueous sodium bicarbonate solution (10 mL) and ethyl
acetate (10 mL). The layers were separated, and the aqueous layer was
extracted with ethyl acetate (3 × 10 mL). The combined organic layers
were washed with saturated aqueous sodium chloride solution (10
mL), and the washed solution was dried over sodium sulfate. The
dried solution was filtered, and the filtrate was concentrated. The
crude product was purified by flash column chromatography on silica
gel (50% ethyl acetate in hexanes) to afford β-keto ester as an orange
oil (43 mg, dr = 2.5:1) which contained minor impurities. The β-keto
ester was used without additional purification for the next step. To a
suspension of sodium hydride (4.9 mg, 0.12 mmol, 1.5 equiv, 60%
suspension in mineral oil) in N,N-dimethylformamide (0.4 mL) was
added a solution of β-keto ester (43 mg, 0.08 mmol, 1 equiv) in N,N-
dimethylformamide (0.8 mL) at 0 °C. After 30 min, tert-butyl N-(3-
iodopropyl)-N-(2-phenoxyethyl) carbamate (14) (136 mg, 0.33 mmol,
4.00 equiv) was added, the reaction flask was covered with aluminum
foil, and the reaction mixture was allowed to warm to 23 °C. After 20
h, the reaction mixture was diluted with saturated aqueous ammonium
chloride solution (10 mL) and ethyl acetate (10 mL). The layers were
separated, and the aqueous layer was extracted with ethyl acetate (3 ×
10 mL). The organic layers were washed with saturated aqueous
sodium chloride solution (10 mL), and the washed solution was dried
over sodium sulfate. The dried solution was filtered, and the filtrate
was concentrated. The crude product was purified by flash column
chromatography on silica gel (25% to 50% ethyl acetate in hexanes) to
afford 40 as a yellow solid (54 mg, 60% over 2 steps). Partial
separation of the diastereomeric mixture could be achieved by flash
column chromatography on silica gel (25% ethyl acetate in hexanes).
All characterization data refer to the major diastereomer shown in the
scheme. TLC (50% ethyl acetate in hexanes): Rf = 0.28 (UV, CAM).
1H NMR (400 MHz, CDCl3, 50 °C) δ 7.79 (s, 1H), 7.34−7.27 (m,
5H), 7.27−7.21 (m, 3H), 7.15−7.11 (m, 2H), 6.96−6.92 (m, 2H),
6.81−6.78 (m, 2H), 6.60 (s, 1H), 5.34 (q, J = 16.5 Hz, 2H), 5.19 (dd, J
= 7.9, 5.4 Hz, 1H), 4.68 (d, J = 11.2 Hz, 1H), 4.51 (s, 2H), 4.44 (d, J =
11.2 Hz, 1H), 3.94 (s, 3H), 3.78 (s, 3H), 3.75 (s, 3H), 3.63 (s, 3H),
3.64−3.55 (m, 2H), 3.42 (t, J = 5.9 Hz, 2H), 3.36−3.25 (m, 3H), 3.02
(dd, J = 13.2, 5.5 Hz, 1H), 2.28−2.11 (m, 2H), 2.02 (td, J = 13.3, 12.6,
4.7 Hz, 1H), 1.63 (ddt, J = 31.4, 13.1, 6.2 Hz, 2H), 1.44 (s, 9H). 13C
NMR (100 MHz, CDCl3, 50 °C) δ 189.3, 172.5, 159.8, 155.7, 148.4,
147.7, 146.3, 138.7, 136.6, 132.6, 129.9, 128.9, 128.5, 127.7, 126.4,
118.2, 114.2, 112.8, 103.9, 94.4, 79.5, 73.3, 70.5, 69.1, 69.0, 58.4, 56.5,
56.4, 55.5, 52.6, 48.5, 47.4, 36.8, 32.5, 28.7, 28.6. IR (Diamond-ATR,
neat) vm̃ax: 2935, 1727, 1689, 1658, 1650, 1513, 1494, 1483, 1452,
1365 cm−1. HR-MS (ESI): calcd for (C48H57N2O10)
+, 821.4013;
found, 821.4008. [α]589
20 = −3.6 (c = 0.5 × 10 g·mL−1, CH2Cl2).
Preparation of Amine 42. Amine 42. Tetrahydrocarbazolone 40
(13.5 mg, 16.4 μmol, 1 equiv) was added to a solution of hydrogen
chloride in 1,4-dioxane (4 M, 0.1 mL) at 23 °C. After 2 h, the reaction
mixture was diluted with saturated aqueous potassium carbonate
solution (5 mL) and ethyl acetate (5 mL). The layers were separated,
and the aqueous layer was extracted with ethyl acetate (3 × 10 mL).
The combined organic layers were dried over sodium sulfate, the dried
solution was filtered, and the filtrate was concentrated. The crude
product was purified by flash column chromatography on silica gel
(4% to 8% methanol in dichloromethane) to afford 41 (9.6 mg,
quant.) which contained minor impurities. The product was used
without additional purification for the next step. HR-MS (ESI): calcd
for (C35H39N2O6)
+ (M + H)+: 583.2808; found, 583.2805.
Preparation of Allyl Cyanoformate. Allyl Cyanoformate.
Trimethylsilyl cyanide (1.98 g, 20.0 mmol, 1 equiv) was added to a
suspension of allyl chloroformate (2.41 g, 20.0 mmol, 1 equiv) and 1,4-
diazabicyclo[2.2.2]octane (12.30 mg, 0.110 mmol, 0.005 equiv) at 0
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°C. The solution was allowed to warm to 23 °C. After 12 h, 1,4-
diazabicyclo[2.2.2]octane was removed by filtration to afford allyl
cyanoformate as a yellow oil (1.80 g, 81%). The product was used
without further purification for the next step. The obtained
characterization data were in full agreement with those values reported
in the literature.28
Preparation of Diacylated Tetrahydrocarbazolone 45.
Diacylated Tetrahydrocarbazolone 45. N-Benzyltetrahydro-
carbazolone 33 (92 mg, 0.19 mmol, 1 equiv) was dissolved in
tetrahydrofuran (2 mL) and was added dropwise to a solution of
lithium diisopropylamide (freshly prepared from diisopropylamine
(0.036 mL, 0.25 mmol, 1.3 equiv) and n-butyl lithium (2.3 M in
hexanes, 0.10 mL, 0.23 mmol, 1.2 equiv)) in tetrahydrofuran (3 mL) at
−78 °C. After 1 h, allyl chloroformate (0.041 mL, 0.39 mmol, 2.0
equiv) was added in one portion. The solution was allowed to warm to
23 °C. After 18 h, the reaction was diluted with saturated aqueous
sodium bicarbonate solution (10 mL) and ethyl acetate (10 mL). The
layers were separated, and the aqueous layer was extracted with ethyl
acetate (3 × 10 mL). The combined organic layers were washed with
saturated aqueous sodium chloride solution (10 mL) and dried over
sodium sulfate. The dried solution was filtered, and the filtrate was
concentrated. The crude material was purified by flash column
chromatography on silica gel (50% ethyl acetate in hexanes) to afford
45 as a yellow oil (30 mg, 24%). TLC (50% ethyl acetate in hexanes):
Rf = 0.60 (UV, CAM).
1H NMR (400 MHz, CDCl3) δ 7.76 (s, 1H),
7.27−7.20 (m, 3H), 7.19−7.10 (m, 2H), 6.87−6.78 (m, 4H), 6.59 (s,
1H), 5.94 (ddt, J = 17.2, 10.5, 5.6 Hz, 1H), 5.80 (ddt, J = 17.2, 10.5,
5.6 Hz, 1H), 5.36 (dq, J = 17.2, 1.6 Hz, 1H), 5.27−5.02 (m, 5H),
4.79−4.71 (m, 3H), 4.66 (d, J = 11.2 Hz, 1H), 4.64−4.50 (m, 2H),
4.37 (d, J = 11.2 Hz, 1H), 3.94 (s, 3H), 3.80 (s, 3H), 3.77 (s, 3H), 3.28
(dd, J = 14.5, 3.7 Hz, 1H), 2.99 (dd, J = 14.4, 3.7 Hz, 1H). 13C NMR
(100 MHz, CDCl3) δ 185.1, 168.4, 168.1, 159.7, 148.4, 147.5, 144.9,
136.0, 132.0, 131.5, 130.5, 128.9, 127.9, 126.1, 118.7, 118.4, 117.6,
113.9, 112.1, 103.4, 93.6, 70.5, 66.8, 66.8, 65.1, 64.8, 56.3, 56.2, 55.4,
47.5, 34.0. IR (Diamond-ATR, neat) vm̃ax: 2936, 1731, 1658, 1611,
1542, 1514, 1485, 1443, 1272, 1247, 1164, 1075, 1029 cm−1. HR-MS
(ESI): calcd for (C37H38NO9)
+ (M + H)+, 640,2547; found, 640.2542.
Preparation of Tetrahydrocarbazolone 46.
Tetrahydrocarbazolone 46. N-Benzyltetrahydrocarbazolone ent-33
(10 mg, 0.020 mmol, 1 equiv) was dissolved in tetrahydrofuran (0.5
mL), and hexamethylphosphoramide (0.040 mL, 0.040 mmol, 2.00
equiv) was added. A solution of lithium bis(trimethylsilyl)amide (1 M
in tetrahydrofuran, 0.30 mL, 0.30 mmol, 1.5 equiv) was added
dropwise at −78 °C. After 1 h, allyl cyanoformate (4.71 mg, 0.04
mmol, 2.00 equiv) was added in one portion. The solution was
allowed to warm to 23 °C. After 13 h, the reaction was diluted with
saturated aqueous sodium bicarbonate solution (2 mL) and ethyl
acetate (2 mL). The layers were separated, and the aqueous layer was
extracted with ethyl acetate (3 × 10 mL). The combined organic layers
were washed with saturated aqueous sodium chloride solution (2 mL)
and dried over sodium sulfate. The dried solution was filtered, and the
filtrate was concentrated. The crude material was purified by flash
column chromatography on silica gel (50% ethyl acetate in hexanes) to
afford β-keto ester 44 as a beige foam, which contained minor
impurities. 44 was used without additional purification for the next
step. To a solution of β-keto ester 44 (12 mg, 0.020 mmol, 1 equiv)
and carbamate 7 (36.2 mg, 0.080 mmol, 4.0 equiv) in tetrahydrofuran
(0.5 mL) was added lithium bis(trimethylsilyl)amide (1 M in
tetrahydrofuran, 0.04 mL, 0.040 mmol, 2.0 equiv) dropwise over 15
min at −78 °C. The solution was allowed to warm to 23 °C. After 12
h, the reaction mixture was diluted with ethyl acetate (2 mL) and
saturated aqueous sodium bicarbonate solution (2 mL). The layers
were separated, and the aqueous layer was extracted with ethyl acetate
(3 × 10 mL). The combined organic layers were washed with
saturated aqueous sodium chloride solution (10 mL) and dried over
sodium sulfate. The dried solution was filtered, and the filtrate was
concentrated. The crude product was purified by flash column
chromatography on silica gel (25% to 50% ethyl acetate in hexanes) to
afford 46 as a yellow oil (4.0 mg, 33% over 2 steps). TLC (50% ethyl
acetate in hexanes): Rf = 0.21 (UV, CAM). Protons of diastereotopic
methylene groups are reported as HA and HB, where HA is the more
downf ield shif ted proton. In cases where resonances overlap or cannot be
unambiguously assigned to a single proton or carbon atom, multiple
assignments are listed (e.g., the 13C assignment “130.0 (PMB, Bn)”
indicates that the resonance at 130.0 is either PMB or Bn). 1H NMR (400
MHz, CDCl3,) δ 7.80 (s, 1H, H-4), 7.35−7.27 (m, 4H, Bn), 7.26−7.22
(m, 4H, Bn), 7.16−7.10 (m, 2H, PMB), 6.91−6.89 (m, 2H, Bn),
6.81−6.76 (m, 2H, PMB), 6.59 (s, 1H, H-9), 5.78 (ddt, 3J22/23 = 17.2,
3J22/23 = 10.4,
3J22/21 = 5.5 Hz, 1H, H-22), 5.40 (d,
2JHA/HB = 16.6 Hz,
1H, Bn), 5.28 (d, 2JHA/HB = 16.6 Hz, 1H, Bn), 5.20−5.06 (m, 3H, H-
12, H-23), 4.68 (app t, 2JHA/HB = 11.0 Hz, 1H, PMB), 4.54 (d,
3J21/22 =
5.5 Hz, 2H, H-21), 4.51 (s, 2H, Bn), 4.42 (d, 2JHA/HB = 11.0 Hz, 1H,
PMB), 3.94 (s, 3H, H-6), 3.78 (s, 3H, PMB), 3.76 (s, 3H, H-7), 3.63−
3.52 (m, 2H, H-19), 3.41 (br s, 2H, H-18), 3.31 (br s, 2H, H-17), 3.03
(t, 3J13/12 = 12.7 Hz, 1H, HA-13), 2.31−2.09 (m, 3H, HB-13, H-15),
1.66−1.56 (m, 2H, H-16), 1.43 (app d, J = 10.0 Hz, 9H, Boc). 13C
NMR (100 MHz, CDCl3, asterisks denotes rotamer peaks) δ 189.3
(C-1), 171.5 (C-20), 159.6 (PMB), 155.7 (Boc), 155.5* (Boc), 148.1
(C-8), 147.3 (C-5), 146.1 (C-11), 145.9* (C-11), 138.5 (Bn), 136.4
(Bn), 132.4 (C-10), 131.7 (C-22), 130.0 (PMB, Bn), 129.8 (PMB,
Bn), 129.2 (PMB), 128.9 (Bn), 128.5 (Bn), 127.6 (Bn), 126.2 (Bn),
118.5 (C-3, C-23), 117.7 (C-3, C-23), 114.0 (PMB), 112.7 (C-2),
103.3 (C-4), 93.7 (C-9), 79.5 (Boc), 73.1 (Bn), 70.3 (PMB), 69.0 (C-
12), 68.7 (C-19), 65.9 (C-21), 58.3 (C-14), 56.3 (C-6), 56.2 (C-7),
55.4 (PMB), 48.2 (Bn), 47.2 (C-17), 47.0 (C-18), 36.5 (C-13), 32.3
(C-15), 32.1* (C-15), 28.6 (Boc), 24.2 (C-16), 23.7* (C-16). IR
(Diamond-ATR, neat) vm̃ax: 2932, 1728, 1689, 1513, 1453, 1411, 1365,
1248, 1163, 1103, 1067, 1029 cm−1. HR-MS (ESI): calcd for
(C50H59N2O10)
+ (M + H)+, 847.4170; found, 847.4155.
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6 Conclusion and Further Directions 
In chapter two, the synthesis of an advanced intermediate in the synthesis of the alkaloid jerantinine E was 
presented. The initial route employing a CH2OBn-substituted enone suffered from a base-induced 
elimination of the benzyl ether at C16 of the C-ring. However, utilizing an enantiopure γ-hydroxylated 
enone, we succeeded in the preparation of the functionalized tetrahydrocarbazolone core of jerantinine E. 
The synthesis features an one-pot β-C–H bromination reaction developed in our laboratory, a palladium-
catalyzed amination with 3,4-dimethoxyaniline, and an oxidative indole formation. Benzyl protection 
furnished the tetrahydrocarbazolone core, whose structure could be validated by single-crystal X-ray 
diffraction. 
The installation of the secondary amine building block, which contains all carbon atoms of the D and E 
rings of jerantinine E, was initially accomplished by the incorporation of a methyl ester (Scheme 73A). 
However, the closure of the D-ring failed and, additionally, the methyl ester could not be converted to the 
ethyl side chain. Thus, we replaced the methyl ester with an allyl ester which would allow us to set the 
quaternary stereocenter in a diastereoselective palladium-catalyzed decarboxylative allylation reaction. The 
stereocenter at C16 was predicted to control the stereochemical outcome of the allylation step, prompting 
us to prepare the enantiomeric tetrahydrocarbazolone according to the established route. Acylation with 
allyl cyanoformate followed by alkylation with the secondary amine building block resulted in the 
formation of β-ketoester II.VI, the substrate for the decarboxylative allylation reaction (Scheme 73B). 
 
Scheme 73. Synthesis of advanced intermediates in the synthesis of jerantinine E bearing a methyl ester (A) or an allyl ester (B). 
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In further experiments, the use of different ligand/catalyst/solvent combinations (Pd2(dba)3, Pd(PPh3)4; 
DACH- or PHOX-ligands; THF, 1,4-dioxane)144 for the diastereoselective palladium-catalyzed 
decarboxylative allylation reaction will be investigated. This should ultimately allow us to complete the 
total synthesis of jerantinine E. 
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7 Experimental Procedures 
7.1 General Experimental Details 
All reactions were performed in oven-dried or flame-dried glassware fitted with rubber septa under a 
positive pressure of argon, unless otherwise noted. Air- and moisture-sensitive liquids were transferred via 
syringe or stainless steel cannula through rubber septa. Solids were added under inert gas counter flow or 
were dissolved in appropriate solvents. Low temperature-reactions were carried out in a Dewar vessel 
filled with a cooling agent: acetone/dry ice (–78 °C), H2O/ice (0 °C). Reaction temperatures above 23 °C 
were conducted in a heated oil bath. The ring opening reactions were conducted in a dram vial and were 
heated in an aluminum heating block. The reactions were carried out with magnetic stirring and monitored 
by NMR spectroscopy or analytical thin-layer chromatography (TLC), using aluminium plates pre-coated 
with silica gel (0.25 mm, 60 Å pore size, Merck) impregnated with a fluorescent indicator (254 nm). TLC 
plates were visualized by exposure to ultraviolet light (UV) and/or stained by submersion in aqueous ceric 
ammonium molybdate solution (CAM) or potassium permanganate solution (KMnO4), and were 
developed by heating with a heat gun. Flash column chromatography was performed as described by Still 
et al.145 using silica gel (60 Å, 40-63 μm, Merck KGaA) and with a pressure of 1.3–1.5 bar.  
Materials 
Tetrahydrofuran (THF) and diethyl ether (Et2O) were distilled from benzophenone and sodium prior to 
use. Dichloromethane (CH2Cl2), triethylamine (NEt3), N,N-diisopropylamine (DIPA) and N,N-
diisopropylethylamine (DIPEA, Hünig’s base) were distilled from CaH2 prior to use. Dimethyl sulfoxide 
(DMSO), benzene, toluene (PhMe), acetonitrile (MeCN), dimethyl formamide (DMF), 1,4-dioxane, 
1,2-dichloroethane and methanol (MeOH) were purchased from Acros Organics as ‚extra dry‘ reagents and 
used as received. Commercially available N-bromosuccinimide (NBS) was purified by recrystallization 
from water.146 All other reagents were purchased from chemical suppliers (Sigma-Aldrich, Acros Organics, 
Alfa Aesar, Strem Chemicals, ABCR) and were used without further purification. Solvents for extraction and 
flash column chromatography were purchased in technical grade and distilled under reduced pressure 
prior to use. The molarity of n-butyllithium solutions was determined by titration against diphenylacetic 
acid as an indicator (average of three titraions).147 
NMR Spectroscopy 
1H and 13C NMR spectra were recorded on Varian VNMRS 300, VNMRS 400, INOVA 400, VNMRS 
600, Bruker Avance III HD 400 or Bruker Avance HD 800 spectrometers. Proton chemical shifts are 
expressed in parts per million (ppm, δ scale) and are referenced to residual protium in the NMR solvent 
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(CHCl3: δ 7.26, CDHCl2: δ 5.32, acetone: δ 2.05). Carbon chemical shifts are expressed in parts per 
million (δ scale, assigned carbon atom) and are referenced to the carbon resonance of the NMR solvent 
(CDCl3: δ 77.16, CD2Cl2: δ 53.84, acetone: δ 29.84). Data for 1H NMR are reported as follows: chemical 
shift (δ ppm) (multiplicity, coupling constant (Hz), integration). Following abbreviations were used for 
signal multiplicities: s (singlet), brs (broad singlet), d (doublet), t (triplet), q (quartet), m (multiplet). Except 
for multiplets, the chemical shift of all signals, as well for centrosymmetric multiplets, is reported at the 
center of the resonance range. All raw fid files were processed and the spectra analyzed using the program 
MestReNOVA 9.0 from Mestrelab Research S. L. 
Mass Spectroscopy 
All mass spectra were measured by the analytic section of the Department of Chemistry, Ludwig-
Maximilians-Universität München. Mass spectra were recorded on a Thermo Finnigan MAT 95 (EI) or on a 
Thermo Finnigan LTQ FT (ESI) instrument from. Mass spectra were recorded in high-resolution. 
IR Spectroscopy 
Infrared (IR) spectra were recorded on a PerkinElmer Spectrum BX II FT-IR system. If required, 
substances were dissolved in CH2Cl2 prior to direct application on the ATR unit. Data are presented as 
follows: frequency of absorption (cm–1) and intensity of absorption (br = broad, vs = very strong, s = 
strong, m = medium, w = weak). 
Melting Point 
Melting points (M.p.) were determined on a B-450 melting point apparatus from BÜCHI Labortechnik AG. 
The values are uncorrected. 
Optical Rotation 
Optical rotations were recorded on an Anton Paar MCP 200 polarimeter with a sodium lamp and. The 
specific rotation is calculated as follows: 
[α]λ
φ
=
[𝛼] ∙ 100
𝑐 ∙ 𝑑
 
The optical rotation is measured using the sodium D line (λ = 589 nm) at the given temperature φ in °C 
and concentration (c in 10 mg/ mL) in a cell with a path length (d) of 0.5 dm. α represents the recorded 
optical rotation at the apparatus. The optical rotation is reported as [α]D
T[°C]
(c g/100 mL, solvent).  
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7.2  Supporting Information for Chapter 2.1 
 
 
 
 
 
Rapid Access to Orthogonally Functionalized Naphthalenes: 
Application to the Total Synthesis of the Anticancer Agent 
Chartarin 
 
 
T. A. Unzner, A. S. Grossmann, T. Magauer, Angew. Chem., Int. Ed. 2016, 55, 9763–9767. 
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7.2.1 Experimental Procedures 
Synthesis of Precursors 
5-((Tert-butyldimethylsilyl)oxy)-2,3-dihydro-1H-inden-1-one (S2): 
 
A solution of 5-hydroxy-1-indanone (S1) (0.29 mg, 2.0 mmol, 1 equiv) and tert-butyldimethylsilyl chloride 
(0.45 mg, 3.0 mmol, 1.5 equiv) in dichloromethane (5 mL) was treated with N,N-diisopropylethylamine 
(0.52 mL, 3.0 mmol, 1.5 equiv) at 0 °C. After 1 h, the solution was allowed to warm to 23 °C. After 14 h, 
water (10 mL) was added and the layers were separated. The aqueous layer was extracted with 
dichloromethane (3 × 20 mL) and the combined organic layers were washed with saturated aqueous 
sodium chloride solution (50 mL). The washed solution was dried over sodium sulfate and the dried 
solution was filtered. The filtrate was concentrated and the crude product was purified by flash column 
chromatography on silica gel (20% ethyl acetate in hexanes) to afford S2 (0.47 mg, 91%) as a beige solid. 
Characterization data for S2 were in full agreement with those reported in the literature.148 
Synthesis of Cyclopropanes 
General Procedure for the Cyclopropanation of Indanones: In a pressure vessel, a solution of 
indanone (1 equiv), N-bromosuccinimide (1.1 equiv) and 2,2’-azobis(2-methylpropionitrile) (0.010 equiv) 
in benzene (0.1–0.2 M) was stirred at 80 °C for 12–14 h. The solution was allowed to cool to 23 °C, and 
then was diluted with water and diethyl ether. The layers were separated and the aqueous layer was 
extracted with diethyl ether (3×). The combined organic layers were washed with saturated aqueous 
sodium chloride solution (1×) and the washed solution was dried over magnesium sulfate. The dried 
solution was filtered and the filtrate was concentrated. The crude product was used in the next step 
without further purification. 
To a solution of the crude bromo-indanone in dichloromethane (0.1 M) was added triethylamine 
(5.0 equiv) at 0 °C. The solution was allowed to warm to 23 °C and after 30 min, the solution was 
concentrated. Diethyl ether was added, the mixture was filtered through a short plug of Celite and the 
filtrate was concentrated. The crude product was used in the next step without further purification. 
Methyl dichloroacetate (1.5 equiv) was added dropwise to a solution of lithium bis(trimethylsilyl)amide 
(1.5 equiv) in tetrahydrofuran (0.5 M) at −78 °C. After 30 min, a solution of the crude indenone in 
tetrahydrofuran (0.5 M) was added dropwise at −78 °C. The solution was allowed to warm to 23 °C. After 
16 h, saturated aqueous ammonium chloride solution was added and the layers were separated. The 
aqueous layer was extracted with ethyl acetate (3×) and the combined organic layers were washed with 
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saturated aqueous sodium chloride solution (1×). The washed solution was dried over sodium sulfate and 
the dried solution was filtered. The filtrate was concentrated and the crude product was purified by flash 
column chromatography on silica gel.  
 
 
Following the general procedure, 1-indanone (S42) (1.00 g, 7.57 mmol) provided 
cyclopropane 20 (1.12 g, 62%) as a brown solid after flash column chromatography on 
silica gel (10% ethyl acetate in hexanes). 
TLC (20% ethyl acetate in hexanes), Rf = 0.28 (UV, CAM). M.p.: 78 °C. 1H NMR 
(400 MHz, CDCl3) δ: 7.64 (d, J = 7.6 Hz, 1H), 7.56 (t, J = 7.4 Hz, 1H), 7.49 (d, J = 7.5 Hz, 1H), 7.40 (t, J 
= 7.4 Hz, 1H), 3.82 (s, 3H), 3.66 (d, J = 5.9 Hz, 1H), 3.13 (d, J = 5.9 Hz, 1H). 13C NMR (100 MHz, 
CDCl3) δ: 196.1, 167.0, 147.4, 136.3, 134.7, 129.1, 126.9, 124.3, 62.4, 54.1, 38.6, 35.3. IR (Diamond-ATR, 
neat) 𝜈𝑚𝑎𝑥: 3074 (w), 2956 (w), 2256 (w), 1717 (vs), 1605 (m), 1470 (w), 1436 (m), 1286 (m), 1273 (s), 1252 
(vs), 1204 (m), 1181 (m), 1102 (m), 1055 (m), 953 (w), 907 (s), 863 (m), 773 (s), 725 (vs) cm−1. HRMS (EI) 
calcd for C12H935ClO3 [M]+: 236.0235; found: 236.0235. 
 
 
Following the general procedure, 5-methoxy-1-indanone (453 mg, 2.79 mmol) 
provided cyclopropane S3 (400 mg, 54%) as an orange solid after flash column 
chromatography on silica gel (20% ethyl acetate in hexanes). 
TLC (20% ethyl acetate in hexanes), Rf = 0.20 (UV, CAM). M.p.: 105 °C. 1H 
NMR (400 MHz, CDCl3) δ: 7.61 (dt, J = 8.5, 0.5 Hz, 1H), 6.98 (dt, J = 2.2, 0.4 Hz, 1H), 6.92 (dd, J = 8.5, 
2.3 Hz, 1H), 3.90 (s, 3H), 3.85 (s, 3H), 3.58 (dt, J = 5.9, 0.5 Hz, 1H), 3.12 (d, J = 5.9 Hz, 1H). 13C NMR 
(100 MHz, CDCl3) δ: 194.4, 167.1, 165.2, 150.2, 129.2, 126.0, 115.2, 112.0, 62.1, 56.0, 54.1, 39.0, 34.9. IR 
(Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3066 (w), 2955 (w), 2839 (w), 1712 (vs), 1600 (vs), 1486 (m), 1436 (m), 1340 
(m), 1256 (vs), 1117 (m), 1073 (w), 1025 (w), 829 (w) cm−1. HRMS (ESI) calcd for C13H1235ClO4 [M+H]+: 
267.0419; found: 267.0420. 
 
 
Following the general procedure, indanone S2 (105 mg, 0.400 mmol) provided 
cyclopropane S4 (31.0 mg, 21%) as an orange oil after flash column 
chromatography on silica gel (5% ethyl acetate in hexanes). 
TLC (5% ethyl acetate in hexanes): Rf = 0.24 (UV, CAM). 1H NMR (400 MHz, 
CDCl3) δ: 7.56 (d, J = 8.3 Hz, 1H), 6.92 (d, J = 2.0 Hz, 1H), 6.84 (dd, J = 8.3, 2.0 Hz, 1H), 3.84 (s, 3H), 
3.55 (d, J = 5.9 Hz, 1H), 3.10 (d, J = 5.8 Hz, 1H), 0.99 (s, 9H), 0.25 (s, 6H). 13C NMR (100 MHz, CDCl3) 
δ: 194.5, 167.1, 162.0, 150.1, 129.7, 126.0, 121.0, 118.4, 62.1, 54.1, 38.9, 34.8, 25.7, 18.4, −4.2, −4.2. IR 
(Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2930 (w), 1715 (vs), 1599 (s), 1482 (m), 1298 (s), 1252 (vs), 1105 (m), 949 (m), 
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840 (vs), 784 (s) cm−1. HRMS (EI) calcd for C18H2335ClO4Si [M]+: 366.1049; found: 366.1053.  
 
 
Following the general procedure, 2-methyl-1-indanone (500 mg, 3.42 mmol) provided 
cyclopropane S5 (283 mg, 33%) as a yellow solid after flash column chromatography on 
silica gel (5% ethyl acetate in hexanes). 
TLC (20% ethyl acetate in hexanes), Rf = 0.47 (UV, CAM). M.p.: 59 °C. 1H NMR (600 
MHz, CDCl3) δ: 7.69 (d, J = 7.7 Hz, 1H), 7.57 (td, J = 7.5, 1.0 Hz, 1H), 7.50 (d, J = 7.3 Hz, 1H), 7.41 (td, 
J = 7.5, 1.0 Hz, 1H), 3.87 (s, 3H), 3.74 (s, 1H), 1.53 (s, 3H). 13C NMR (150 MHz, CDCl3) δ: 198.6, 166.2, 
147.8, 135.8, 134.6, 128.7, 126.5, 124.2, 65.6, 53.8, 42.5, 37.9, 9.9. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2954 
(w), 1717 (vs), 1605 (m), 1436 (w), 1280 (s), 1243 (m), 1209 (m), 1096 (w), 953 (m), 758 (m) cm−1. HRMS 
(EI) calcd for C13H1135ClO3 [M]+: 250.0391; found: 250.0384. 
 
 
Following the general procedure, 6-(methylthio)-1-indanone (100 mg, 
0.561 mmol) provided cyclopropane S6 (21.0 mg, 13%) as an orange oil after flash 
column chromatography on silica gel (10% ethyl acetate in hexanes). 
TLC (20% ethyl acetate in hexanes): Rf = 0.28 (UV, CAM). 1H NMR (400 MHz, 
CDCl3) δ: 7.48 (d, J = 1.6 Hz, 1H), 7.44 (dd, J = 7.6, 1.6 Hz, 1H), 7.40 (d, J = 8.0 Hz, 1H), 3.84 (s, 3H), 
3.62 (d, J = 5.9 Hz, 1H), 3.15 (d, J = 5.9 Hz, 1H), 2.50 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 195.7, 
166.8, 143.9, 140.9, 136.9, 132.4, 126.8, 120.6, 62.5, 54.1, 38.7, 35.0, 15.6. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 
2954 (w), 1715 (vs), 1603 (m), 1435 (s), 1250 (vs), 1197 (vs), 1051 (m), 828 (m), 737 (m) cm−1. HRMS (EI) 
calcd for C13H1135ClO3S [M]+: 282.0112; found: 282.0110.  
 
 
Following the general procedure, 6-(trifluoromethyl)-1-indanone (200 mg, 
1.00 mmol) provided cyclopropane S7 (85.5 mg, 28%) as a yellow solid after flash 
column chromatography on silica gel (20% ethyl acetate in hexanes). 
TLC (20% ethyl acetate in hexanes): Rf = 0.20 (UV, CAM). M.p.: 153 °C. 1H 
NMR (400 MHz, CDCl3) δ: 7.93 (dq, J = 1.5, 0.8 Hz, 1H), 7.84 (ddd, J = 7.9, 1.6, 0.7 Hz, 1H), 7.65 (d, J 
= 8.0 Hz, 1H), 3.87 (s, 3H), 3.76 (d, J = 5.8 Hz, 1H), 3.25 (d, J = 5.8 Hz, 1H). 13C NMR (100 MHz, 
CDCl3) δ: 194.5, 166.6, 150.5 (q, J = 1.3 Hz), 136.8, 131.7 (q, J = 33.4 Hz), 131.3 (q, J = 3.6 Hz), 127.4, 
123.6 (q, J = 272.7 Hz), 121.4 (q, J = 3.9 Hz), 61.5, 54.3, 39.1, 35.1. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3073 
(w), 2958 (w), 1728 (vs), 1625 (m), 1438 (w), 1328 (vs), 1257 (vs), 1190 (s), 1169 (s), 1124 (vs), 1053 (m), 848 
(w) cm−1. HRMS (EI) calcd for C13H835ClF3O3 [M]+: 304.0109; found: 304.0094. 
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Following the general procedure, 3-methyl-1-indanone (200 mg, 1.37 mmol) provided 
cyclopropane S8 (62.0 mg, 18%) as a dark orange oil after flash column chromatography 
on silica gel (12.5% ethyl acetate in hexanes). 
TLC (20% ethyl acetate in hexanes), Rf = 0.45 (UV, CAM). 1H NMR (400 MHz, 
CDCl3) δ: 7.71–7.57 (m, 2H), 7.52 (d, J = 7.6 Hz, 1H), 7.42 (t, J = 7.4 Hz, 1H), 3.86 (s, 3H), 3.24 (s, 1H), 
1.76 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 196.8, 166.3, 151.8, 135.9, 134.6, 128.9, 124.9, 123.8, 65.0, 
53.8, 41.7, 40.2, 11.8. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2955 (w), 1714 (vs), 1604 (m), 1435 (m), 1275 (vs), 
1202 (vs), 1055 (s), 862 (s), 767 (vs) cm−1. HRMS (EI) calcd for C13H1135ClO3 [M]+: 250.0391; found: 
250.0386. 
 
 
Following the general procedure, 5-fluoro-1-indanone (200 mg, 1.33 mmol) provided 
cyclopropane S9 (181 mg, 53%) as a yellow solid after flash column chromatography 
on silica gel (10% ethyl acetate in hexanes). 
TLC (dichloromethane), Rf = 0.56 (UV, CAM). M.p.: 125 °C. 1H NMR (400 MHz, 
CDCl3) δ: 7.66 (dd, J = 8.4, 5.2 Hz, 1H), 7.19 (dd, J = 8.1, 2.2 Hz, 1H), 7.10 (td, J = 8.6, 2.3 Hz, 1H), 3.84 
(s, 3H), 3.64 (d, J = 5.9 Hz, 1H), 3.16 (d, J = 5.9 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ: 194.1, 166.8 (d, 
J = 257.3 Hz), 166.7, 150.2 (d, J = 10.6 Hz), 132.5 (d, J = 2.4 Hz), 126.4 (d, J = 10.6 Hz), 116.7 (d, J = 
23.5 Hz), 114.4 (d, J = 23.8 Hz), 61.8, 54.1, 38.9, 34.6 (d, J = 2.5 Hz). IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 
3071 (w), 2956 (w), 1715 (vs), 1613 (s), 1596 (s), 1479 (m), 1436 (m), 1336 (m), 1251 (vs), 1229 (vs), 1197 (s), 
1100 (s), 946 (m), 837 (m), 803 (m), 731 (m) cm−1. HRMS (EI) calcd for C12H835ClFO3 [M]+: 254.0141; 
found: 254.0136. 
 
 
Following the general procedure, 6-chloro-1-indanone (300 mg, 1.80 mmol) 
provided cyclopropane S10 (197 mg, 40%) as a pale yellow solid after flash column 
chromatography on silica gel (10% ethyl acetate in hexanes). 
TLC (ethyl acetate in hexane), Rf = 0.26 (UV, CAM). M.p.: 170 °C. 1H NMR (400 
MHz, CDCl3) δ: 7.64 (dq, J = 2.0, 0.5 Hz, 1H), 7.55 (ddd, J = 8.0, 2.0, 0.3 Hz, 1H), 7.46 (ddt, J = 8.1, 0.6, 
0.3 Hz, 1H), 3.86 (d, J = 0.4 Hz, 3H), 3.68–3.64 (m, 1H), 3.19 (dd, J = 5.9, 0.3 Hz, 1H). 13C NMR (100 
MHz, CDCl3) δ: 194.7, 166.7, 145.5, 137.8, 135.5, 134.5, 127.9, 124.4, 62.0, 54.2, 39.0, 34.9. IR (Diamond-
ATR, neat) 𝜈𝑚𝑎𝑥: 3067 (w), 2956 (w), 1726 (vs), 1467 (w), 1437 (w), 1301 (m), 1254 (vs), 1198 (m), 1121 (w), 
1056 (w) cm−1. HRMS (EI) calcd for C12H835Cl2O3 [M]+: 269.9845; found: 269.9843. 
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Following the general procedure, 4-iodo-1-indanone (200 mg, 0.775 mmol) provided 
cyclopropane S11 (214 mg, 76%) as a white solid after flash column chromatography on 
silica gel (10% ethyl acetate in hexanes). 
TLC (20% ethyl acetate in hexanes): Rf = 0.35 (UV, CAM). M.p.: 112 °C. 1H NMR 
(400 MHz, CDCl3) δ: 7.95 (dd, J = 7.8, 1.0 Hz, 1H), 7.63 (d, J = 7.5 Hz, 1H), 7.17 (t, J = 7.6 Hz, 1H), 3.87 
(s, 3H), 3.64 (d, J = 5.9 Hz, 1H), 3.18 (d, J = 5.9 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ: 195.5, 166.5, 
151.9, 143.6, 137.7, 130.6, 123.8, 95.2, 61.6, 54.3, 39.0, 39.0. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3416 (w), 
2950 (w), 1718 (vs), 1582 (m), 1436 (s), 1398 (m), 1245 (s), 1206 (s), 1017 (m), 922 (m), 771 (m) cm−1. HRMS 
(EI) calcd for C12H835Cl127IO3 [M]+: 361.9201; found: 361.9207. 
 
 
Following the general procedure, 5-bromo-1-indanone (1.06 g, 5.00 mmol) provided 
cyclopropane S12 (642 mg, 41%) as an orange solid after flash column 
chromatography on silica gel (12.5% ethyl acetate in hexanes). 
TLC (20% ethyl acetate in hexanes), Rf = 0.73 (UV, CAM). M.p.: 114 °C. 1H NMR 
(400 MHz, CDCl3) δ: 7.68 (d, J = 1.6 Hz, 1H), 7.57 (dd, J = 8.1, 1.6 Hz, 1H), 7.52 (d, J = 8.1 Hz, 1H), 
3.85 (s, 3H), 3.64 (d, J = 5.9 Hz, 1H), 3.16 (d, J = 5.9 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ: 194.7, 
166.7, 149.0, 135.1, 132.6, 130.2, 129.9, 125.3, 61.7, 54.2, 38.7, 34.8. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2955 
(w), 1718 (vs), 1596 (s), 1435 (m), 1320 (m), 1257 (vs), 1058 (m), 835 (m) cm−1. HRMS (EI) calcd for 
C12H879Br35ClO3[M]+: 313.9340; found: 313.9341. 
 
 
Following the general procedure, 5-chloro-1-indanone (200 mg, 1.20 mmol) 
provided cyclopropane S13 (126 mg, 31%) as an orange solid after flash column 
chromatography on silica gel (10% ethyl acetate in hexanes). 
TLC (20% ethyl acetate in hexanes): Rf = 0.25 (UV). M.p.: 91 °C. 1H NMR (400 
MHz, CDCl3) δ: 7.60 (d, J = 8.1 Hz, 1H), 7.50 (d, J = 1.7 Hz, 1H), 7.41 (dd, J = 8.1, 1.8 Hz, 1H), 3.86 (s, 
3H), 3.64 (d, J = 5.9 Hz, 1H), 3.17 (d, J = 5.9 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ: 194.4, 166.7, 
148.9, 141.2, 134.8, 129.6, 127.3, 125.3, 61.7, 54.2, 38.8, 34.8. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 1748 (m), 
1719 (vs), 1599 (s), 1434 (m), 1252 (vs), 1167 (m), 1110 (s), 844 (vs) cm−1. HRMS (EI) calcd for 
C12H835Cl2O3 [M]+: 269.9845; found: 269.9837.  
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Functionalization of Cyclopropanes 
Cyclopropane S14:  
 
In a pressure vessel, a solution of cyclopropane S12 (0.10 g, 0.32 mmol, 1 equiv), 4-methoxy-
phenylboronic acid (72 mg, 0.48 mmol, 1.5 equiv), tetrakis(triphenylphosphine)palladium(0) (37 mg, 
0.032 mmol, 0.10 equiv) and potassium carbonate (66 mg, 0.48 mmol, 1.5 equiv) in toluene (2 mL) was 
stirred at 100 °C. After 16 h, the solution was allowed to cool to 23 °C, and then was concentrated. The 
crude product was purified by flash column chromatography on silica gel (15% ethyl acetate in hexanes) to 
afford S14 (84 mg, 77%) as a yellow oil. 
TLC (20% ethyl acetate in hexanes), Rf = 0.17 (UV, CAM). 1H NMR (400 MHz, CD2Cl2) δ: 7.71 (s, 1H), 
7.70–7.57 (m, 4H), 7.05–6.96 (m, 2H), 3.85 (s, 3H), 3.84 (s, 3H), 3.71 (d, J = 5.8 Hz, 1H), 3.16 (d, J = 5.9 
Hz, 1H). 13C NMR (100 MHz, CD2Cl2) δ: 195.6, 167.0, 160.7, 148.7, 147.5, 134.7, 132.1, 128.9, 127.6, 
125.0, 124.5, 114.8, 62.6, 55.7, 54.2, 39.2, 35.5. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2956 (w), 2838 (w), 1716 
(vs), 1601 (vs), 1519 (s), 1436 (m), 1248 (vs), 1179 (s), 1119 (s), 1019 (m), 954 (m), 827 (s), 704 (s) cm−1. 
HRMS (EI) calcd for C19H1535ClO4 [M]+: 342.0653; found: 342.0648. 
Cyclopropane S15: 
 
In a pressure vessel, a solution of cyclopropane S12 (32 mg, 0.10 mmol, 1 equiv), 4-bromo-phenylboronic 
acid (31 mg, 0.15 mmol, 1.5 equiv), tetrakis(triphenylphosphine)palladium(0) (12 mg, 0.010 mmol, 
0.10 equiv) and potassium carbonate (21 mg, 0.15 mmol, 1.5 equiv) in toluene (0.4 mL) was stirred at 
100 °C, After 18 h, the solution was allowed to cool to 23 °C, and then was concentrated. The crude 
product was purified by flash column chromatography on silica gel (10% ethyl acetate in hexanes) to 
afford S15 (20 mg, 51%) as an orange oil. 
TLC (20% ethyl acetate in hexanes), Rf = 0.33 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 7.73 (dt, J = 
7.9, 0.7 Hz, 1H), 7.70–7.66 (m, 1H), 7.64–7.57 (m, 3H), 7.53–7.46 (m, 2H), 3.87 (s, 3H), 3.71 (d, J = 5.9 
Hz, 1H), 3.20 (d, J = 5.9 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ: 195.5, 166.9, 148.3, 146.5, 138.6, 135.3, 
132.3, 129.1, 127.9, 125.3, 124.7, 123.3, 62.1, 54.1, 39.0, 35.2. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3064 (w), 
2954 (w), 1717 (vs), 1607 (s), 1435 (m), 1325 (m), 1269 (s), 1250 (s), 1074 (m), 1007 (m), 822 (m) cm−1. 
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HRMS (EI) calcd for C18H1279Br35ClO3 [M]+: 389.9653; found: 389.9667. 
Ring opening Reaction of Cyclopropanes 
Methyl 1-chloro-4-hydroxy-2-naphthoate (6a) and methyl 3-chloro-4-hydroxy-2-naphthoate (6b): 
 
A solution of cyclopropane 20 (47 mg, 0.20 mmol, 1 equiv) in sulfolane (0.4 mL) was stirred at 190 °C for 
30 min. The reaction mixture was allowed to cool to 23 °C and then was diluted with diethyl ether 
(20 mL). The organic layer was washed sequentially with water (2 × 15 mL) and saturated aqueous sodium 
chloride solution (15 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (10% ethyl acetate in hexanes) to afford 6a (31 mg, 66%) and 6b (10 mg, 
21%) as yellow solids. 
6a: TLC (20% ethyl acetate in hexanes), Rf = 0.24 (UV, CAM). M.p.: 177 °C. 1H NMR (400 MHz, 
acetone-d6) δ: 9.64 (s, 1H), 8.35 (t, J = 9.2 Hz, 2H), 7.62 (ddd, J = 8.3, 6.9, 1.3 Hz, 1H), 7.69 (ddd, J = 7.9, 
6.9, 1.2 Hz, 1H), 3.93 (s, 3H). 13C NMR (100 MHz, acetone-d6) δ: 167.2, 153.1, 132.5, 129.7, 129.3, 128.1, 
127.8, 125.9, 123.5, 121.4, 108.6, 52.8. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3285 (m), 3078 (w), 2951 (w), 1695 
(vs), 1596 (s), 1454 (m), 1435 (s), 1391 (m), 1350 (s), 1294 (s), 1244 (vs), 1150 (s), 1078 (s), 1014 (m), 965 (m), 
874 (m), 783 (m), 758 (vs), 658 (s) cm−1. HRMS (EI) calcd for C12H935ClO3 [M]+: 236.0235; found: 
236.0244. 
6b: TLC (20% ethyl acetate in hexanes), Rf = 0.45 (UV, CAM). M.p.: 88 °C. 1H NMR (400 MHz, 
CDCl3) δ: 8.24 (d, J = 8.3 Hz, 1H), 8.06 (s, 1H), 7.85 (d, J = 8.0 Hz, 1H), 7.68–7.47 (m, 2H), 6.46 (d, J = 
1.1 Hz, 1H), 3.99 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 166.1, 148.4, 131.5, 128.8, 128.4, 127.7, 126.4, 
125.7, 124.7, 122.5, 111.6, 52.7. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3426 (w), 2952 (w), 1725 (vs), 1584 (m), 
1453 (m), 1402 (s), 1300 (s), 1230 (vs), 1013 (m), 779 (s) cm−1. HRMS (EI) calcd for C12H935ClO3 [M]+: 
236.0235; found: 236.0228. 
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Methyl 1-chloro-4-hydroxy-7methoxy-2-naphthoate (7a) and methyl 3-chloro-4-hydroxy-7-
methoxy-2-naphthoate (7b): 
 
A solution of cyclopropane S3 (100 mg, 0.375 mmol, 1 equiv) in sulfolane (0.6 mL) was stirred at 190 °C 
for 90 min. The reaction mixture was allowed to cool to 23 °C and then was diluted with diethyl ether 
(40 mL). The organic layer was washed sequentially with water (2 × 30 mL) and saturated aqueous sodium 
chloride solution (30 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (50% dichloromethane in hexanes) to afford 7a (51 mg, 51%) as a yellow 
solid and 7b (11 mg, 11%) as a yellow oil. 
7a: TLC (50% dichloromethane in hexanes), Rf = 0.12 (UV, CAM). M.p.: 168 °C. 1H NMR (400 MHz, 
acetone-d6) δ: 9.51 (s, 1H), 8.23 (dd, J = 9.2, 0.5 Hz, 1H), 7.63 (dt, J = 2.5, 0.4 Hz, 1H), 7.29 (dd, J = 9.2, 
2.5 Hz, 1H), 7.08 (s, 1H), 4.01–3.95 (m, 3H), 3.92 (s, 3H). 13C NMR (100 MHz, acetone-d6) δ: 167.4, 
160.7, 153.2, 134.2, 130.5, 125.4, 122.7, 120.3, 119.9, 106.9, 104.3, 55.8, 52.7. IR (Diamond-ATR, neat) 
𝜈𝑚𝑎𝑥: 3298 (m), 2950 (w), 1690 (vs), 1597 (s), 1442 (s), 1380 (s), 1221 (vs), 1135 (vs), 1083 (s), 1018 (s), 933 
(m), 829 (s), 782 (vs), 714 (m), 667 (s) cm−1. HRMS (ESI) calcd for C13H1035ClO4 [M-H]−: 265.0273; found: 
265.0273. 
7b: TLC (50% dichloromethane in hexanes), Rf = 0.38 (UV, CAM). 1H NMR (800 MHz, CD2Cl2) δ: 8.13 
(d, J = 9.1 Hz, 1H), 7.93 (s, 1H), 7.26 (dd, J = 9.1, 2.5 Hz, 1H), 7.17 (d, J = 2.5 Hz, 1H), 6.46 (s, 1H), 3.95 
(s, 3H), 3.92 (s, 3H). 13C NMR (200 MHz, CD2Cl2) δ: 166.2, 159.4, 148.8, 133.5, 127.6, 124.2, 123.4, 
121.1, 121.1, 109.8, 106.9, 55.8, 52.8. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3430 (w), 2950 (w), 1727 (vs), 1593 
(s), 1438 (s), 1396 (vs), 1230 (vs), 1170 (s), 1093 (m), 1026 (s), 921 (m), 828 (m) cm−1. HRMS (ESI) calcd for 
C13H1035ClO4 [M–H]–: 265.0273; found: 265.0273. 
Methyl 7-((tert-butyldimethylsilyl)oxy)-1-chloro-4-hydroxy-2-naphthoate (8a) and methyl 7-((tert-
butyldimethylsilyl)oxy)-3-chloro-4-hydroxy-2-naphthoate (8b): 
 
A solution of cyclopropane S4 (33 mg, 0.090 mmol, 1 equiv) in sulfolane (0.2 mL) was stirred at 190 °C 
for 30 min. The reaction mixture was allowed to cool 23 °C and then was diluted with diethyl ether 
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20 mL). The organic layer was washed sequentially with water (2 × 15 mL) and saturated aqueous sodium 
chloride solution (15 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (10% ethyl acetate in hexanes) to afford 8a (8 mg, 24%) as an orange solid 
and 8b (5 mg, 15%) as a yellow oil. 
8a: TLC (20% ethyl acetate in hexanes), Rf = 0.27 (UV, CAM). M.p.: 138 °C. 1H NMR (400 MHz, 
acetone-d6) δ: 9.58 (s, 1H), 8.24 (d, J = 9.0 Hz, 1H), 7.71 (d, J = 2.4 Hz, 1H), 7.29 (dd, J = 9.0, 2.4 Hz, 
1H), 7.08 (s, 1H), 3.92 (s, 3H), 1.05 (s, 9H), 0.32 (s, 6H). 13C NMR (100 MHz, acetone-d6) δ: 167.3, 156.8, 
153.3, 134.2, 130.4, 125.7, 123.7, 123.2, 119.6, 113.2, 107.0, 52.8, 26.0, 18.9, −4.3. IR (Diamond-ATR, 
neat) 𝜈𝑚𝑎𝑥: 3405 (w), 2954 (m), 2858 (w), 1711 (m), 1598 (s), 1463 (s), 1384 (s), 1236 (vs), 994 (s), 827 (vs) 
cm−1. HRMS (EI) calcd for C18H2335ClO4Si [M]+: 366.1049; found: 366.1056. 
8b: TLC (20% ethyl acetate in hexanes), Rf = 0.44 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 8.11 (d, J 
= 9.0 Hz, 1H), 7.70 (d, J = 2.4 Hz, 1H), 7.20 (dd, J = 9.1, 2.5 Hz, 1H), 7.00 (s, 1H), 5.39 (s, 1H), 3.98 (s, 
3H), 1.08 (s, 9H), 0.29 (s, 6H). 13C NMR (100 MHz, CDCl3) δ: 167.3, 155.6, 150.9, 133.9, 128.6, 125.5, 
125.4, 122.1, 119.2, 110.7, 108.2, 52.8, 26.0, 18.6, −4.1. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3405 (w), 2929 
(m), 2858 (m), 1713 (m), 1595 (m), 1421 (s), 1364 (s), 1219 (s), 1100 (s), 846 (vs) cm−1. HRMS (EI) calcd for 
C18H2335ClO4Si [M]+: 366.1049; found: 366.1045. 
Methyl 1-chloro-4-hydroxy-3-methyl-2-naphthoate (9): 
 
A solution of cyclopropane S5 (125 mg, 0.500 mmol, 1 equiv) in sulfolane (1 mL) was stirred at 190 °C for 
45 min. The reaction mixture was allowed to cool to 23 °C and then was diluted with diethyl ether 
(40 mL). The organic layer was washed sequentially with water (2 × 30 mL) and saturated aqueous sodium 
chloride solution (30 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (12.5% ethyl acetate in hexanes) to afford 9 (88 mg, 70%) as a colorless oil. 
TLC (20% ethyl acetate in hexanes), Rf = 0.20 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 8.08–7.99 (m, 
2H), 7.53–7.45 (m, 2H), 5.87 (brs, 1H), 4.02 (s, 3H), 2.26 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 169.0, 
148.2, 132.3, 129.4, 127.2, 127.0, 125.8, 124.6, 121.6, 119.9, 114.7, 53.0, 13.2. IR (Diamond-ATR, neat) 
𝜈𝑚𝑎𝑥: 3458 (w, br), 2952 (w), 1712 (vs), 1594 (m), 1438 (s), 1389 (s), 1293 (vs), 1225 (vs), 1052 (s), 920 (s), 757 
(vs) cm−1. HRMS (ESI) calcd for C13H1035ClO3 [M−H]−: 249.0324; found: 249.0323. 
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Methyl 1-chloro-4-hydroxy-6-(methylthio)-2-naphthoate (10a) and methyl 3-chloro-4-hydroxy-6-
(methylthio)-2-naphthoate (10b): 
 
A solution of cyclopropane S6 (21 mg, 0.074 mmol, 1 equiv) in sulfolane (0.2 mL) was stirred at 190 °C 
for 30 min. The reaction mixture was allowed to cool 23 °C and then was diluted with diethyl ether 
(20 mL). The organic layer was washed sequentially with water (2 × 15 mL) and saturated aqueous sodium 
chloride solution (15 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (20% ethyl acetate in hexanes) to afford 10a (9 mg, 43%) as a yellow solid 
and 10b (3 mg, 14%) as a brown solid. 
10a: TLC (20% ethyl acetate in hexanes), Rf = 0.19 (UV, CAM). M.p.: 177 °C. 1H NMR (400 MHz, 
acetone-d6) δ: 9.59 (s, 1H), 8.26 (d, J = 9.0 Hz, 1H), 8.02 (d, J = 1.9 Hz, 1H), 7.62 (dd, J = 9.1, 1.9 Hz, 
1H), 7.25 (s, 1H), 3.92 (s, 3H), 2.65 (s, 3H). 13C NMR (100 MHz, acetone-d6) δ: 167.0, 151.9, 140.4, 130.1, 
128.3, 128.3, 128.1, 126.3, 121.9, 117.6, 109.7, 52.7, 14.9. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3356 (m), 2943 
(w), 1710 (s), 1689 (s), 1614 (m), 1588 (m), 1357 (m), 1296 (m), 1236 (vs), 1099 (m), 966 (m), 778 (s) cm−1. 
HRMS (EI) calcd for C13H1135ClO3S [M]+: 282.0112; found: 282.0113. 
10b: TLC (20% ethyl acetate in hexanes), Rf = 0.28 (UV, CAM). M.p.: 134 °C. 1H NMR (400 MHz, 
CDCl3) δ: 8.01 (s, 1H), 7.90 (d, J = 1.3 Hz, 1H), 7.72 (d, J = 8.7 Hz, 1H), 7.42 (dd, J = 8.8, 1.8 Hz, 1H), 
6.41 (s, 1H), 3.97 (s, 3H), 2.62 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 166.0, 147.3, 140.5, 129.0, 128.8, 
126.9, 126.2, 125.1, 124.7, 116.4, 112.6, 52.7, 15.3. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3426 (w), 2951 (w), 
1722 (vs), 1568 (m), 1450 (s), 1410 (s), 1294 (s), 1227 (vs), 1104 (s), 1017 (m), 929 (m) cm−1. HRMS (EI) 
calcd for C13H1135ClO3S [M]+: 282.0112; found: 282.0115. 
Methyl 1-chloro-4-hydroxy-6-(trifluoromethyl)-2-naphthoate (11a) and methyl 3-chloro-4-hydroxy-
6-(trifluoromethyl)-2-naphthoate (11b): 
 
A solution of cyclopropane S7 (40 mg, 0.13 mmol, 1 equiv) in sulfolane (0.26 mL) was stirred at 190 °C 
for 90 min. The reaction mixture was allowed to cool 23 °C and then was diluted with diethyl ether 
(20 mL). The organic layer was washed sequentially with water (2 × 15 mL) and saturated aqueous sodium 
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chloride solution (15 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (20% ethyl acetate in hexanes) to afford 11a (24 mg, 60%) and 11b (6 mg, 
15%) as yellow solids. 
11a: TLC (20% ethyl acetate in hexanes), Rf = 0.24 (UV, CAM). M.p.: 224 °C. 1H NMR (400 MHz, 
acetone-d6) δ: 10.09 (s, 1H), 8.64 (dp, J = 1.8, 0.9 Hz, 1H), 8.54 (dp, J = 9.1, 0.8 Hz, 1H), 7.97 (ddd, J = 
9.0, 2.0, 0.6 Hz, 1H), 7.34 (s, 1H), 3.96 (s, 3H). 13C NMR (100 MHz, acetone-d6) δ: 166.9, 153.9, 134.0 (q, 
J = 1.0 Hz), 132.5, 129.1 (q, J = 32.5 Hz), 127.7, 126.7, 125.2 (q, J = 271.5 Hz), 124.6 (q (J = 3.1 Hz), 
121.5 (q, J = 4.6 Hz), 110.1, 110.0, 53.0. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3323 (m, br), 1698 (vs), 1600 (m), 
1441 (m), 1359 (m), 1324 (s), 1250 (vs), 1173 (s), 1114 (vs), 822 (m) cm−1. HRMS (EI) calcd for 
C13H835ClF3O3 [M]+: 304.0109; found: 304.0101. 
11b: TLC (20% ethyl acetate in hexanes), Rf = 0.46 (UV, CAM). M.p.: 108 °C. 1H NMR (600 MHz, 
CDCl3) δ: 8.56 (d, J = 0.9 Hz, 1H), 8.07 (s, 1H), 7.97 (dd, J = 8.5, 0.7 Hz, 1H), 7.73 (d, J = 8.7 Hz, 1H), 
6.57 (s, 1H), 4.05–3.98 (m, 3H). 13C NMR (150 MHz, CDCl3) δ: 165.7, 149.2, 132.7, 130.0 (J = 33.1 Hz), 
129.8, 128.9, 124.6, 124.1 (J = 272.2 Hz), 123.9, 123.4, 120.7, 113.1, 52.9. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 
3421 (w), 2957 (w), 1727 (s), 1594 (w), 1417 (m), 1320 (s), 1291 (vs), 1229 (s), 1166 (s), 1124 (vs), 1096 (vs), 
1016 (m), 908 (m), 818 (w) cm−1. HRMS (EI) calcd for C13H835ClF3O3 [M]+:304.0109; found: 304.0111. 
Methyl 3-chloro-4-hydroxy-1-methyl-2-naphthoate (12): 
 
A solution of cyclopropane S8 (50 mg, 0.20 mmol, 1 equiv) in sulfolane (0.2 mL) was stirred at 190 °C for 
60 min. The reaction mixture was allowed to cool to 23 °C and then was diluted with diethyl ether 
(40 mL). The organic layer was washed sequentially with water (2 × 30 mL) and saturated aqueous sodium 
chloride solution (30 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (12.5% ethyl acetate in hexanes) to afford 12 (20 mg, 40%) as a yellow solid. 
TLC (20% ethyl acetate in hexanes), Rf = 0.56 (UV, CAM). M.p.: 112 °C. 1H NMR (400 MHz, CDCl3) δ: 
8.30–8.21 (m, 1H), 8.02–7.93 (m, 1H), 7.64–7.53 (m, 2H), 6.02 (s, 1H), 4.01 (s, 3H), 2.57 (s, 3H). 13C 
NMR (100 MHz, CDCl3) δ: 168.3, 146.1, 131.9, 130.2, 127.5, 127.0, 124.8, 124.7, 124.7, 122.8, 109.4, 
52.9, 16.2. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3433 (w, br), 2950 (w), 1725 (vs), 1588 (s), 1434 (s), 1399 (vs), 
1288 (s), 1225 (vs), 1088 (s), 1047 (vs), 891 (s), 758 (s) cm−1. HRMS (ESI) calcd for C13H1035ClO3 [M−H]−: 
249.03240; found: 249.03208. 
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Methyl 1-chloro-7-fluoro-4-hydroxy-2-naphthoate (13a) and methyl 3-chloro-7-fluoro-4-hydroxy-2-
naphthoate (13b): 
 
A solution of cyclopropane S9 (51 mg, 0.20 mmol, 1 equiv) in sulfolane (0.4 mL) was stirred at 190 °C for 
30 min. The reaction mixture was allowed to cool to 23 °C and then was diluted with diethyl ether 
(20 mL). The organic layer was washed sequentially with water (2 × 15 mL) and saturated aqueous sodium 
chloride solution (15 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (10% ethyl acetate in hexanes) to afford 13a (31 mg, 61%) and 13b (6 mg, 
12%) as yellow solids. 
13a: TLC (20% ethyl acetate in hexanes), Rf = 0.26 (UV, CAM). M.p.: 231 °C. 1H NMR (400 MHz, 
acetone-d6) δ: 9.80 (s, 1H), 8.39 (dd, J = 9.2, 5.8 Hz, 1H), 7.96 (dd, J = 11.0, 2.6 Hz, 1H), 7.52 (ddd, J = 
9.1, 8.2, 2.6 Hz, 1H), 7.19 (s, 1H), 3.94 (s, 3H). 13C NMR (100 MHz, acetone-d6) δ: 167.0, 163.3 (d, J = 
246.8 Hz), 153.4 (d, J = 1.1 Hz), 134.0 (d, J = 9.7 Hz), 131.3, 127.1 (d, J = 9.5 Hz), 124.74 (d, J = 0.7 Hz), 
120.3 (d, J = 5.3 Hz), 118.0 (d, J = 25.4 Hz), 109.6 (d, J = 24.2 Hz), 108.3 (d, J = 2.2 Hz), 52.9. IR 
(Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3312 (s), 1704 (vs), 1598 (s), 1438 (m), 1357 (s), 1310 (s), 1242 (vs), 1198 (s), 
1139 (s), 1083 (s), 990 (m), 937 (m), 859 (vs), 820 (s), 786 (s), 751 (m), 717 (m), 673 (s) cm−1. HRMS (ESI) 
calcd for C12H735ClFO3 [M−H]−: 253.00732; found: 253.00704. 
13b: TLC (10% ethyl acetate in hexanes), Rf = 0.33 (UV, CAM). M.p.: 101 °C. 1H NMR (400 MHz, 
CDCl3) δ: 8.25 (dd, J = 9.2, 5.5 Hz, 1H), 7.96 (s, 1H), 7.45 (d, J = 9.2 Hz, 1H), 7.37 (td, J = 9.1, 2.4 Hz, 
1H), 6.48 (s, 1H), 3.99 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 165.9, 161.7 (d, J = 249.0 Hz), 148.6 (d, J 
= 1.4 Hz), 132.6 (d, J = 9.6 Hz), 127.8, 125.4 (d, J = 9.2 Hz), 123.5 (d, J = 5.3 Hz), 122.7, 118.6 (d, J = 
25.3 Hz), 111.9 (d, J = 21.2 Hz), 111.1 (d, J = 2.6 Hz), 52.8. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3387 (w), 
2954 (w), 1729 (s), 1705 (vs), 1582 (vs), 1446 (s), 1399 (vs), 1281 (s), 1223 (vs), 1018 (s), 821 (m) cm−1. 
HRMS (EI) calcd for C12H835ClFO3 [M]+: 254.0141; found: 254.0143. 
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Methyl 1,6-dichloro-4-hydroxy-2-naphthoate (14a) and methyl 3,6-dichloro-4-hydroxy-2-naph-
thoate (14b): 
 
A solution of cyclopropane S10 (100 mg, 0.37 mmol, 1 equiv) in sulfolane (0.7 mL) was stirred at 190 °C 
for 90 min. The reaction mixture was allowed to cool to 23 °C and then was diluted with diethyl ether 
(20 mL). The organic layer was washed sequentially with water (2 × 15 mL) and saturated aqueous sodium 
chloride solution (15 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (12.5% ethyl acetate in hexanes) to afford 14a (89 mg, 89%) as a white solid 
and 14b (10 mg, 10%) as a yellow solid. 
14a: TLC (20% ethyl acetate in hexanes), Rf = 0.32 (UV, CAM, KMnO4). M.p.: 216 °C. 1H NMR (400 
MHz, acetone-d6) δ: 9.80 (s, 1H), 8.39–8.33 (m, 1H), 8.28 (dt, J = 2.3, 0.4 Hz, 1H), 7.73 (dd, J = 9.1, 2.2 
Hz, 1H), 7.28 (s, 1H), 3.94 (d, J = 0.3 Hz, 3H). 13C NMR (100 MHz, acetone-d6) δ: 166.9, 152.3, 134.1, 
131.1, 130.2, 129.9, 128.5, 128.3, 122.5, 121.5, 110.0, 52.9. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3308 (m, br), 
1699 (vs), 1591 (s), 1466 (w), 1436 (m), 1389 (m), 1293 (m), 1244 (s), 1101 (m), 965 (w), 809 (w), 782 (m) 
cm−1. HRMS (ESI) calcd for C12H735Cl2O3 [M−H]−: 268.9778; found: 268.9777. 
14b: TLC (20% ethyl acetate in hexanes), Rf = 0.54 (UV, CAM, KMnO4). M.p.: 132 °C. 1H NMR (600 
MHz, CDCl3) δ: 8.22 (dt, J = 2.1, 0.7 Hz, 1H), 8.02 (t, J = 0.6 Hz, 1H), 7.78 (dt, J = 8.8, 0.5 Hz, 1H), 7.49 
(dd, J = 8.7, 2.1 Hz, 1H), 6.45 (s, 1H), 3.98 (s, 3H). 13C NMR (150 MHz, CDCl3) δ: 165.8, 147.7, 134.6, 
130.3, 129.7, 128.8, 126.7, 126.3, 124.3, 121.8, 112.9, 52.8. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3359 (m), 1703 
(vs), 1574 (m), 1452 (m), 1412 (s), 1304 (s), 1235 (s), 1192 (m), 1106 (m), 1015 (m), 805 (m) cm−1. HRMS 
(ESI) calcd for C12H735Cl2O3 [M−H]−: 268.9778; found: 268.9776.  
Methyl 1-chloro-4-hydroxy-8-iodo-2-naphthoate (15): 
 
A solution of cyclopropane S11 (25 mg, 0.069 mmol, 1 equiv) in sulfolane (0.2 mL) was stirred at 190 °C 
for 90 min. The reaction mixture was allowed to cool to 23 °C and then was diluted with diethyl ether 
(20 mL). The organic layer was washed sequentially with water (2 × 15 mL) and saturated aqueous sodium 
chloride solution (15 mL). The washed solution was dried over sodium sulfate, the dried solution was 
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filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (5% ethyl acetate in hexanes) to afford 15 (12 mg, 48%) as an orange solid. 
TLC (20% ethyl acetate in hexanes), Rf = 0.35 (UV, CAM). M.p.: 135 °C. 1H NMR (400 MHz, 
Chloroform-d) δ: 8.30–8.21 (m, 1H), 8.15 (dd, J = 7.4, 1.1 Hz, 1H), 7.28 (dd, J = 8.6, 7.4 Hz, 1H), 6.48 (s, 
1H), 4.02 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 165.7, 148.3, 139.2, 132.5, 128.9, 128.4, 127.8, 126.0, 
123.2, 112.6, 99.7, 52.8. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3416 (w), 2950 (w), 1718 (vs), 1582 (m), 1436 (s), 
1206 (s), 1017 (m), 922 (m), 771 (m) cm−1. HRMS (EI) calcd for C12H835Cl127IO3 [M]+: 361.9201; found: 
361.9207. 
Methyl 7-bromo-1-chloro-4-hydroxy-2-naphthoate (16): 
 
A solution of cyclopropane S12 (30 mg, 0.095 mmol, 1 equiv) in sulfolane (0.2 mL) was stirred at 190 °C 
for 30 min. The reaction mixture was allowed to cool to 23 °C and then was diluted with diethyl ether 
(20 mL). The organic layer was washed sequentially with water (2 × 15 mL) and saturated aqueous sodium 
chloride solution (15 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (20% ethyl acetate in hexanes) to afford 16 (20 mg, 67%) as brown solid. 
TLC (20% ethyl acetate in hexanes), Rf = 0.20 (UV, CAM). M.p.: 208 °C. 1H NMR (400 MHz, acetone-
d6) δ: 9.86 (s, 1H), 8.49 (d, J = 1.9 Hz, 1H), 8.25 (d, J = 8.9 Hz, 1H), 7.79 (dd, J = 9.0, 1.8 Hz, 1H), 7.25 (s, 
1H), 3.94 (s, 3H). 13C NMR (100 MHz, acetone-d6) δ: 166.9, 153.4, 133.7, 131.3, 131.1, 127.9, 126.3, 
125.9, 123.6, 120.0, 109.3, 52.9. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3332 (m), 1694 (vs), 1586 (m), 1434 (w), 
1358 (m), 1245 (vs), 1153 (m), 1084 (m), 1031 (m), 970 (m) cm−1. HRMS (EI) calcd for C12H879Br35ClO3 
[M]+: 313.9340; found: 313.9339. 
Methyl 1,7-dichloro-4-hydroxy-2-naphthoate (17): 
 
A solution of cyclopropane S13 (50 mg, 0.18 mmol, 1 equiv) in sulfolane (0.4 mL) was stirred at 190 °C 
for 120 min. The reaction mixture was allowed to cool to 23 °C and then was diluted with diethyl ether 
(20 mL). The organic layer was washed sequentially with water (2 × 15 mL) and saturated aqueous sodium 
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chloride solution (15 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (10% ethyl acetate in hexanes) to afford 17 (25 mg, 50%) as an orange solid. 
TLC (20% ethyl acetate in hexanes), Rf = 0.28 (UV, CAM). M.p.: 209 °C. 1H NMR (400 MHz, acetone-
d6) δ: 9.90 (brs, 1H), 8.33 (d, J = 6.9 Hz, 1H), 8.31 (s, 1H), 7.66 (dd, J = 8.9, 2.1 Hz, 1H), 7.24 (s, 1H), 3.94 
(s, 3H). 13C NMR (100 MHz, acetone-d6) δ: 166.9, 153.3, 135.2, 133.4, 131.2, 128.7, 126.1, 126.0, 124.6, 
120.1, 109.2, 52.9. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3321 (m), 2956 (w), 1705 (vs), 1591 (s), 1433 (s), 1353 
(s), 1261 (vs), 1240 (vs), 1147 (s), 1090 (vs), 977 (s), 865 (s), 815 (vs) cm−1. HRMS (EI) calcd for 
C12H835Cl2O3 [M]+: 269.9845; found: 269.9851. 
Methyl 1-chloro-4-hydroxy-7-(4-methoxyphenyl)-2-naphthoate (18a) and methyl 3-chloro-4-
hydroxy-7-(4-methoxyphenyl)-2-naphthoate (18b): 
 
A solution of cyclopropane S14 (21 mg, 0.061 mmol, 1 equiv) in sulfolane (0.2 mL) was stirred at 190 °C 
for 30 min. The reaction mixture was allowed to cool to 23 °C and then was diluted with diethyl ether 
(20 mL). The organic layer was washed sequentially with water (2 × 15 mL) and saturated aqueous sodium 
chloride solution (15 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (20% ethyl acetate in hexanes) to afford 18a (15 mg, 71%) and 18b (5 mg, 
24%) as a yellow solids. 
18a: TLC (20% ethyl acetate in hexanes), Rf = 0.25 (UV, CAM). M.p.: 160 °C. 1H NMR (400 MHz, 
acetone-d6) δ: 9.64 (s, 1H), 8.51 (t, J = 1.3 Hz, 1H), 8.37 (d, J = 8.7 Hz, 1H), 7.96 (dt, J = 8.7, 1.4 Hz, 1H), 
7.82–7.76 (m, 2H), 7.20 (s, 1H), 7.16–7.07 (m, 2H), 3.94 (s, 3H), 3.88 (s, 3H). 13C NMR (100 MHz, 
acetone-d6) δ: 167.3, 160.9, 153.1, 141.5, 133.3, 133.0, 130.2, 129.3, 127.3, 126.5, 124.3, 122.6, 121.4, 115.4, 
108.5, 55.7, 52.8. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3326 (m), 2955 (w), 1705 (s), 1604 (s), 1522 (m), 1438 
(m), 1386 (m), 1244 (vs), 1180 (s), 1088 (m), 1028 (m), 821 (s) cm−1. HRMS (EI) calcd for C19H1535ClO4 
[M]+: 342.0653; found: 342.0652. 
18b: TLC (20% ethyl acetate in hexanes), Rf = 0.45 (UV, CAM). M.p.: 153 °C. 1H NMR (400 MHz, 
CDCl3) δ: 8.28 (d, J = 8.6 Hz, 1H), 8.09 (s, 1H), 7.98 (s, 1H), 7.85 (dt, J = 8.7, 1.4 Hz, 1H), 7.69–7.61 (m, 
2H), 7.04 (d, J = 8.4 Hz, 2H), 6.45 (s, 1H), 3.99 (s, 3H), 3.88 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 
166.1, 159.8, 148.4, 140.1, 132.7, 132.0, 128.6, 127.9, 126.8, 125.7, 124.8, 124.4, 123.0, 114.6, 111.3, 55.6, 
52.7. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3447 (w), 2953 (w), 1728 (s), 1608 (m), 1519 (s), 1441 (m), 1398 (m), 
1249 (vs), 1180 (s), 1026 (m), 924 (m), 822 (s) cm−1. HRMS (EI) calcd for C19H1535ClO4 [M]+: 342.0653; 
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found: 342.0660. 
Methyl 7-(4-bromophenyl)-1-chloro-4-hydroxy-2-naphthoate (19): 
 
A solution of cyclopropane S15 (15 mg, 0.038 mmol, 1 equiv) in sulfolane (0.2 mL) was stirred at 190 °C 
for 30 min. The reaction mixture was allowed to cool to 23 °C and then was diluted with diethyl ether 
(20 mL). The organic layer was washed sequentially with water (2 × 15 mL) and saturated aqueous sodium 
chloride solution (15 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (10% ethyl acetate in hexanes) to afford 19 (7 mg, 47%) as a brown solid. 
TLC (20% ethyl acetate in hexanes), Rf = 0.09 (UV, CAM). M.p.: 219 °C. 1H NMR (400 MHz, acetone-
d6) δ: 9.73 (s, 1H), 8.57 (s, 1H), 8.42 (d, J = 8.7 Hz, 1H), 8.00 (dd, J = 8.7, 1.7 Hz, 1H), 7.82 (d, J = 8.4 Hz, 
2H), 7.74 (d, J = 8.4 Hz, 2H), 7.24 (s, 1H), 3.95 (s, 3H). 13C NMR (100 MHz, acetone-d6) δ: 167.2, 153.2, 
140.5, 140.3, 133.0, 132.8, 130.5, 130.2, 127.2, 127.0, 124.7, 123.5, 122.8, 121.5, 109.0, 55.0, 52.9. IR 
(Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3311 (m), 2953 (w), 1708 (vs), 1604 (s), 1433 (m), 1356 (s), 1262 (s), 1149 (m), 
1089 (m), 1010 (m), 806 (s) cm−1. HRMS (EI) calcd for C18H1279Br35ClO3 [M]+: 389.9653; found: 389.9647. 
Synthesis of TMS-protected cyclopropane 21 
TMS protected cyclopropane 21: 
 
To a solution of diisopropylamine (60 μL, 0.42 mmol, 2.0 equiv) in tetrahydrofuran (0.8 mL) was added 
dropwise with n-buthyllithium (2.31 M in hexanes, 0.18 mL, 0.42 mmol, 2.0 equiv) at –78 °C. The mixture 
was warmed to 0 °C for 10 min and then was cooled to –78 °C. This lithium diisopropylamide solution 
was added dropwise to a solution of cyclopropane 20 (50 mg, 0.21 mmol, 1 equiv) and freshly distilled 
trimethylsilyl chloride (0.14 mL, 1.1 mmol, 5.0 equiv) in tetrahydrofuran (1.5 mL) at –78 °C. The solution 
was allowed to warm to 23 °C over 5 h. Saturated aqueous sodium bicarbonate solution (10 mL) was 
added and the layers were separated. The aqueous layer was extracted with diethyl ether (3 × 10 mL) and 
the combined organic layers were washed with saturated aqueous sodium chloride solution (20 mL). The 
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washed solution was dried over magnesium sulfate and the dried solution was filtered. The filtrate was 
concentrated and the crude product was purified by flash column chromatography on silica gel (15% ethyl 
acetate in hexanes) to afford 21 (31 mg, 48%) as a pale yellow solid.  
TLC (10% ethyl acetate in hexanes), Rf = 0.68 (UV, CAM). M.p.: 86 °C. 1H NMR (400 MHz, CDCl3) δ: 
7.64 (d, J = 7.6 Hz, 1H), 7.55 (d, J = 4.1 Hz, 2H), 7.40 (dq, J = 8.0, 4.1 Hz, 1H), 3.84 (s, 3H), 3.65 (s, 1H), 
0.18 (s, 9H). 13C NMR (100 MHz, CDCl3) δ: 199.6, 166.8, 148.6, 137.2, 134.0, 128.6, 126.5, 124.0, 66.0, 
53.6, 38.5, 35.7, –1.3. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2954 (w), 1734 (m), 1700 (s), 1602 (m), 1440 (m), 
1285 (s), 1249 (s), 1208 (m), 1183 (m), 1005 (m), 930 (m), 882 (m), 844 (vs), 770 (s), 732 (m), 686 (m) cm−1. 
HRMS (ESI) calcd for C15H1735ClO3Si [M]+: 308.0635; found: 308.0625. 
Synthesis of bicyclo[3.1.0]hex-3-en-2-ones 
Methyl 6-chloro-4-oxobicyclo[3.1.0]hex-2-ene-6-carboxylate (S17): 
 
A solution of cyclopropane S16149 (500 mg, 2.65 mmol, 1 equiv) in tetrahydrofuran (7 mL) was added 
dropwise to a solution of lithium bis(trimethylsilyl)amide (1 M in THF, 3.18 mL, 3.18 mmol, 1.20 equiv) in 
tetrahydrofuran (0.5 mL) at –78 °C. After 1 h, trimethylsilyl chloride (510 μL, 3.98 mmol, 1.50 equiv) was 
added dropwise. After 45 min, the solution was allowed to warm to 23°C over 6 h and then was 
concentrated. The crude product was dissolved in hexanes (10 mL) and filtered through a short plug of 
Celite. The filtrate was concentrated to provide the crude silyl enol ether. 
A solution of crude silyl enol ether in acetonitrile (7 mL) was treated with palladium(II) acetate (655 mg, 
2.92 mmol, 1.10 equiv) at 23 °C. After 15 h, the mixture was filtered through a short plug of Celite and the 
filter cake was washed with diethyl ether (100 mL). The filtrate was concentrated and the crude product 
was purified by flash column chromatography on silica gel (10% ethyl acetate in hexanes) to afford S17 
(384 mg, 78%) as a yellow oil. 
TLC (20% ethylacetate in hexanes): Rf = 0.32 (UV; KMnO4). 1H NMR (400 MHz, CDCl3) δ: 7.45 (dd, J 
= 5.5, 2.9 Hz, 1H), 6.07 (d, J = 5.6 Hz, 1H), 3.81 (s, 3H), 3.27 (dd, J = 5.5, 2.9 Hz, 1H), 2.82 (d, J = 5.5 
Hz, 1H). 13C NMR (100 MHz, CDCl3) δ: 199.4, 167.0, 155.2, 134.0, 63.9, 54.1, 35.9, 35.4. IR (Diamond-
ATR, neat) 𝜈𝑚𝑎𝑥: 3074 (w), 2958 (w), 1706 (vs), 1577 (w), 1436 (m), 1337 (m), 1279 (s), 1246 (vs), 1179 (s), 
1066 (s), 940 (w), 887 (m), 811 (m), 729 (m), 707 (s) cm–1. HRMS (EI) calcd for C8H735ClO3 [M]+: 
186.0078; found: 186.0077. 
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Methyl 6-chloro-4-oxo-1-propylbicyclo[3.1.0]hex-2-ene-6-carboxylate (S19): 
 
A solution of cyclopropane S18 (53 mg, 0.23 mmol, 1 equiv) in tetrahydrofuran (0.75 mL) was added 
dropwise to a solution of lithium bis(trimethylsilyl)amide (1 M in THF, 0.28 mL, 0.28 mmol, 1.2 equiv) in 
tetrahydrofuran (0.5 mL) at –78 °C. After 1 h, trimethylsilyl chloride (44 μL, 0.35 mmol, 1.5 equiv) was 
added dropwise. After 45 min, the solution was allowed to warm to 23°C over 6 h and then was 
concentrated. The crude product was dissolved in hexanes (10 mL) and filtered through a short plug of 
Celite. The filtrate was concentrated to provide the crude silyl enol ether. 
A solution of crude silyl enol ether in acetonitrile (2.5 mL) was treated with palladium(II) acetate (57 mg, 
0.25 mmol, 1.1 equiv) at 23 °C. After 15 h, the mixture was filtered through a short plug of Celite and the 
filter cake was washed with diethyl ether (50 mL). The filtrate was concentrated and the crude product was 
purified by flash column chromatography on silica gel (10% ethyl acetate in hexanes) to afford S19 
(33 mg, 63%) as a colorless oil. 
TLC (10% ethyl acetate in hexanes), Rf = 0.20 (UV, KMnO4). 1H NMR (400 MHz, CDCl3) δ: 7.39 (dd, J 
= 5.5, 1.3 Hz, 1H), 6.04 (dd, J = 5.6, 0.9 Hz, 1H), 3.83 (s, 3H), 2.90 (t, J = 1.1 Hz, 1H), 1.91 (ddd, J = 
14.2, 9.6, 6.0 Hz, 1H), 1.69–1.58 (m, 1H), 1.54–1.35 (m, 2H), 0.92 (t, J = 7.3 Hz, 3H). 13C NMR (100 
MHz, CDCl3) δ: 200.4, 166.4, 159.0, 133.3, 66.3, 53.8, 46.1, 37.8, 28.6, 20.4, 14.0. IR (Diamond-ATR, 
neat) 𝜈𝑚𝑎𝑥: 2961 (w), 1712 (vs), 1436 (m), 1259 (vs), 1177 (m), 1088 (m), 820 (m), 712 (m) cm−1.  
Methyl 6-chloro-5-methyl-4-oxobicyclo[3.1.0]hex-2-ene-6-carboxylate (S21): 
 
A solution of cyclopropane S20 (50 mg, 0.25 mmol, 1 equiv) in tetrahydrofuran (0.75 mL) was added 
dropwise to a solution of lithium bis(trimethylsilyl)amide (1 M in THF, 0.29 mL, 0.29 mmol, 1.2 equiv) in 
tetrahydrofuran (0.5 mL) at –78 °C. After 1 h, trimethylsilyl chloride (47 μL, 0.37 mmol, 1.5 equiv) was 
added dropwise. After 45 min. The solution was allowed to warm to 23°C over 6 h and then was 
concentrated. The crude product was dissolved in hexanes (10 mL) and filtered through a short plug of 
Celite. The filtrate was concentrated to provide the crude silyl enol ether. 
A solution of crude silyl enol ether in acetonitrile (2.5 mL) was treated with palladium(II) acetate (61 mg, 
0.27 mmol, 1.1 equiv) at 23 °C. After 15 h, the mixture was filtered through a short plug of Celite and the 
filter cake was washed with diethyl ether (50 mL). The filtrate was concentrated and the crude product was 
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purified by flash column chromatography on silica gel (10% ethyl acetate in hexanes) to afford S21 
(35 mg, 71%) as a colorless oil. 
TLC (10% ethyl acetate in hexanes), Rf = 0.20 (UV, KMnO4). 1H NMR (400 MHz, CDCl3) δ: 7.48 (dd, J 
= 5.6, 3.2 Hz, 1H), 6.09 (d, J = 5.6 Hz, 1H), 3.83 (s, 3H), 3.33 (d, J = 3.2 Hz, 1H), 1.37 (s, 3H). 13C NMR 
(100 MHz, CDCl3) δ: 201.8, 166.1, 155.9, 132.7, 67.1, 53.8, 39.3, 38.2, 9.8. IR (Diamond-ATR, neat) 
𝜈𝑚𝑎𝑥: 2956 (w), 1711 (vs), 1436 (m), 1282 (s), 1216 (vs), 1300 (s), 1032 (m), 823 (m), 712 (m) cm−1. HRMS 
(EI) calcd for C9H1035ClO3 [M+H]+: 201.0313; found: 201.0314. 
Ring opening of bicyclo[3.1.0]hex-3-en-2-ones 
Methyl 2-chloro-3-hydroxybenzoate (23a) and methyl 2-chloro-5-hydroxybenzoate (23b): 
 
A solution of cyclopropane S17 (30 mg, 0.16 mmol, 1 equiv) in sulfolane (0.3 mL) was stirred at 200 °C 
for 15 min. The reaction mixture was allowed to cool to 23 °C and then was diluted with diethyl ether 
(20 mL). The organic layer was washed sequentially with water (2 × 15 mL) and saturated aqueous sodium 
chloride solution (15 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (10% ethyl acetate in hexanes) to afford 23a (15 mg, 50%) as a yellow oil and 
23b (3 mg, 10%) as a white solid. 
23a: TLC (20% ethyl acetate in hexanes), Rf = 0.70 (UV, KMnO4). 1H NMR (400 MHz, CDCl3) δ: 11.35 
(s, 1H), 7.77 (dd, J = 8.0, 1.6 Hz, 1H), 7.55 (dd, J = 7.8, 1.5 Hz, 1H), 6.84 (t, J = 7.9 Hz, 1H), 3.97 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ: 170.4, 157.4, 135.9, 128.5, 122.3, 119.4, 113.8, 52.9. IR (Diamond-ATR, 
neat) 𝜈𝑚𝑎𝑥: 3095 (w, br), 2956 (m), 1677 (vs), 1608 (m), 1439 (vs), 1324 (vs), 1255 (vs), 1199 (s), 1153 (vs), 
1074 (m), 975 (m), 754 (vs) cm−1. HRMS (EI) calcd for C8H735ClO3 [M]+: 186.0078; found: 186.0084. 
23b: Characterization data for 23b were in full agreement with those reported in the literature.150 
Methyl 2-chloro-3-hydroxy-6-propylbenzoate (24): 
 
A solution of cyclopropane S19 (30 mg, 0.13 mmol, 1 equiv) in sulfolane (0.3 mL) was stirred at 200 °C 
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for 15 min. The reaction mixture was allowed to cool to 23 °C and then was diluted with diethyl ether 
(20 mL). The organic layer was washed sequentially with water (2 × 15 mL) and saturated aqueous sodium 
chloride solution (15 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (10% ethyl acetate in hexanes) to afford 24 (19 mg, 63%) as a colorless oil. 
TLC (10% ethyl acetate in hexanes), Rf = 0.42 (UV, KMnO4). 1H NMR (400 MHz, CDCl3) δ: 11.14 (s, 
1H), 7.56 (d, J = 2.1 Hz, 1H), 7.38 (d, J = 2.1 Hz, 1H), 3.96 (s, 3H), 2.55–2.46 (m, 2H), 1.59 (dt, J = 15.0, 
7.5 Hz, 2H), 0.92 (t, J = 7.3 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ: 170.5, 155.4, 136.1, 133.9, 128.0, 
121.8, 113.3, 52.8, 36.9, 24.6, 13.7. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3111 (w), 2958 (m), 2360 (w), 1678 (vs), 
1442 (vs), 1331 (s), 1256 (vs), 1197 (s), 1103 (w), 988 (w), 792 (s), 745 (m) cm−1. HRMS (EI) calcd for 
C11H1335ClO3 [M]+: 228.0548; found: 228.0543. 
Methyl 6-chloro-3-hydroxy-2-methylbenzoate (25): 
 
A solution of cyclopropane S21 (30 mg, 0.090 mmol, 1 equiv) in sulfolane (0.3 mL) was stirred at 200 °C 
for 15 min. The reaction mixture was allowed to cool to 23 °C. Diethyl ether (20 mL) was added and the 
organic layer was washed sequentially with water (2 × 15 mL) and saturated aqueous sodium chloride 
solution (15 mL). The washed solution was dried over sodium sulfate, the dried solution was filtered and 
the filtrate was concentrated. The crude product was purified by flash column chromatography on silica 
gel (10% ethyl acetate in hexanes) to afford 25 (13.2 mg, 44%) as a white solid. 
TLC (10% ethyl acetate in hexanes), Rf = 0.36 (UV, KMnO4). M.p.: 54 °C. 1H NMR (400 MHz, CDCl3) 
δ: 7.38 (d, J = 8.5 Hz, 1H), 7.21 (d, J = 8.5 Hz, 1H), 5.74 (s, 1H), 3.89 (s, 3H), 2.51 (s, 3H). 13C NMR (100 
MHz, CDCl3) δ: 167.7, 150.1, 130.5, 128.1, 125.7, 123.4, 122.7, 52.3, 13.6. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 
3412 (m), 2970 (m), 1713 (vs), 1592 (m), 1440 (s), 1312 (s), 1228 (vs), 1190 (s), 1051 (vs), 857 (m), 763 (s) 
cm−1. HRMS (EI) calcd for C9H935ClO3 [M]+: 200.0235; found: 200.0242. 
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Synthesis and One-pot Claisen-Cope-cyclization Cascade of Naphthyl Allyl Ether (26): 
Methyl 4-(allyloxy)-1-chloro-3-methyl-2-naphthoate (26): 
 
A suspension of naphthol 9 (180 mg, 0.718 mmol, 1 equiv), potassium carbonate (149 mg, 1.08 mmol, 
1.50 equiv) and allyl bromide (68.3 μL, 0.790 mmol, 1.10 equiv) in dimethylformamide (2.5 mL) was 
stirred at 70 °C. After 1.5 h, the reaction mixture was allowed to cool to 23 °C and then was diluted with 
diethyl ether (20 mL). The organic layer was washed sequentially with aqueous 2 M hydrochloric acid 
solution (15 mL) and saturated aqueous sodium chloride solution (15 mL). The washed solution was dried 
over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. Product 26 was 
obtained as yellow oil (185 mg, 89%) which was used in the next step without further purification.  
TLC (9% ethyl acetate in hexanes), Rf = 0.32 (UV; KMnO4). 1H NMR (400 MHz, CDCl3) δ: 8.25 (dd, J 
= 6.1, 3.5 Hz, 1H), 8.10 (dd, J = 6.2, 3.4 Hz, 1H), 7.59 (dd, J = 6.4, 3.2 Hz, 2H), 6.18 (ddt, J = 17.2, 10.5, 
5.5 Hz, 1H), 5.51 (dq, J = 17.1, 1.6 Hz, 1H), 5.34 (dq, J = 10.5, 1.3 Hz, 1H), 4.46 (dt, J = 5.5, 1.5 Hz, 2H), 
4.02 (s, 3H), 2.39 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 168.0, 152.0, 133.4, 133.3, 130.2, 129.4, 127.8, 
127.3, 125.2, 124.0, 123.9, 122.5, 118.1, 75.1, 52.9, 13.6. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2951 (w), 1735 
(vs), 1331 (m), 1280 (vs), 1213 (vs), 1051 (s), 924 (w), 764 (m) cm–1. HRMS (EI) calcd for C16H1535ClO3 
[M]+: 290.0704; found: 290.0707. 
5-Hydroxy-4-methyl-1-vinylnaphtho[1,2-c]furan-3(1H)-one (31): 
 
A solution of 26 (20.0 mg, 0.0688 mmol, 1 equiv) and p-toluenesolfonic acid monohydrate (13.1 mg, 
0.0688 mmol, 1 equiv) in sulfolane (0.2 mL) was stirred at 190 °C for 15 min. The reaction mixture was 
allowed to cool to 23 °C and then was diluted with diethyl ether (20 mL). The organic layer was washed 
sequentially with water (3 × 15 mL) and saturated aqueous sodium chloride solution (15 mL). The washed 
solution was dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. 
The crude product was purified by flash column chromatography on silica gel (17% ethyl acetate in 
hexanes) to afford 31 (6.6 mg, 40%) as a yellow solid.  
TLC (20% ethyl acetate in hexanes), Rf = 0.19 (UV; KMnO4). M.p.: 118 °C. 1H NMR (400 MHz, 
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CDCl3) δ: 8.32 (dt, J = 8.6, 1.0 Hz, 1H), 7.88 (dt, J = 8.3, 1.0 Hz, 1H), 7.67 (ddd, J = 8.4, 6.8, 1.2 Hz, 1H), 
7.58 (ddd, J = 8.2, 6.8, 1.2 Hz, 1H), 6.05 (d, J = 6.1 Hz, 1H), 5.91 (ddd, J = 17.0, 10.0, 7.9 Hz, 1H), 5.76 
(dt, J = 17.0, 1.0 Hz, 1H), 5.52 (ddd, J = 10.0, 1.2, 0.7 Hz, 1H), 5.49 (brs, 1H), 2.73 (s, 3H). 13C NMR 
(100 MHz, CDCl3) δ: 171.2, 150.8, 140.5, 134.5, 128.6, 127.4, 127.2, 126.4, 124.0, 123.2, 122.1, 121.5, 
113.2, 80.7, 9.3. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3417 (w), 1732 (vs), 1579 (w), 1404 (w), 1032 (w), 978 (w), 
764 (w) cm–1. HRMS (EI) calcd for C15H12O3 [M]+: 240.0781; found: 240.0787. 
Synthesis of Chartarin (1) 
β-Ketoester 33: 
 
A solution of 7-methoxy-1-indanone (S22) (1.85 g, 11.4 mmol, 1 equiv) and tert-butyl 1H-imidazole-1-
carboxylate (2.87 g, 17.1 mmol, 1.50 equiv) in tetrahydrofuran (60 mL) was treated with sodium hydride 
(910 mg, 22.8 mmol, 2.00 equiv) at 0 °C. The resulting mixture was stirred at 70 °C for 5 h. The reaction 
mixture was allowed to cool to 23 °C and then was diluted with saturated aqueous ammonium chloride 
solution (50 mL). The layers were separated and the aqueous layer was extracted with ethyl acetate 
(3 × 100 mL). The combined organic layers were washed with saturated aqueous sodium chloride solution 
(200 mL), the washed organic solution was dried over sodium sulfate and the dried solution was filtered. 
The filtrate was concentrated and the crude product was purified by flash column chromatography on 
silica gel (30% ethyl acetate in hexanes) to afford 33 (2.87 g, 96%) as a colorless oil. 
TLC (20% ethyl acetate in hexanes), Rf = 0.33 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 7.53 (t, J = 
7.9 Hz, 1H), 7.02 (d, J = 7.5 Hz, 1H), 6.78 (d, J = 8.2 Hz, 1H), 3.94 (s, 3H), 3.58 (dd, J = 8.3, 4.1 Hz, 1H), 
3.43 (dd, J = 17.4, 4.0 Hz, 1H), 3.24 (dd, J = 17.3, 8.3 Hz, 1H), 1.48 (s, 9H). 13C NMR (100 MHz, CDCl3) 
δ: 197.6, 168.7, 158.8, 156.4, 137.1, 123.7, 118.3, 109.3, 82.1, 55.9, 54.9, 30.0, 28.2. IR (Diamond-ATR, 
neat) 𝜈𝑚𝑎𝑥: 2977 (w), 1705 (vs), 1595 (s), 1481 (s), 1367 (m), 1276 (s), (vs), 1067 (m), 984 (m) cm–1. HRMS 
(EI) calcd for C15H18O4 [M]+: 262.1200; found: 262.1205. 
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α-Aryl S23: 
 
A solution of β-ketoester 33 (2.86 g, 10.9 mmol, 1 equiv) and quinone 34151 (1.81 g, 10.9 mmol, 1 equiv) in 
dichloromethane (40 mL) was cooled −20 °C. After 15 min, hydroquinidine (712 mg, 2.18 mmol, 
0.200 equiv) was added. After 3 h, triethylamine (7.58 mL, 54.5 mmol, 5.00 equiv) was added and the 
mixture was allowed to warm to 23 °C. After 1 h, pivalic acid chloride (5.57 mL, 54.5 mmol, 5.00 equiv) 
was added. After 2 h, saturated aqueous sodium bicarbonate solution (50 mL) was added and the layers 
were separated. The aqueous layer was extracted with dichloromethane (3 × 100 mL) and the combined 
organic layers were washed with saturated aqueous sodium chloride solution (200 mL). The washed 
organic solution was dried over sodium sulfate and the dried solution was filtered. The filtrate was 
concentrated and the crude product was purified by flash column chromatography on silica gel (30% ethyl 
acetate in hexanes) to afford S23 (4.58 g, 70%) as a foam. 
TLC (30% ethyl acetate in hexanes), Rf = 0.28 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 7.50 (t, J = 
7.9 Hz, 1H), 7.02 (d, J = 8.8 Hz, 1H), 7.00–6.94 (m, 2H), 6.76 (d, J = 8.2 Hz, 1H), 3.99 (d, J = 17.2 Hz, 
1H), 3.89 (s, 3H), 3.57 (s, 3H), 3.17 (d, J = 17.2 Hz, 1H), 1.29 (s, 9H), 1.28 (s, 9H), 1.22 (brs, 9H). 13C 
NMR (100 MHz, CDCl3) δ: 195.3, 177.1, 176.2, 167.9, 165.6, 158.8, 154.9, 147.9, 145.9, 137.0, 133.1, 
127.1, 124.8, 123.2, 122.4, 117.7, 109.1, 82.9, 65.6, 55.7, 52.0, 39.4, 39.1, 39.0, 27.6, 27.1, 27.0. IR 
(Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2977 (w), 1751 (s), 1711 (s), 1596 (m), 1481 (m), 1369 (m), 1278 (s), 1151 (s), 
1086 (vs), 1001 (m), 912 (m), 729 (s) cm–1. HRMS (EI) calcd for C33H40O10 [M]+: 596.2616; found: 
596.2623. 
Aryl Indanone 35: 
 
A solution of S23 (4.58 g, 7.68 mmol, 1 equiv) in dichloromethane (60 mL) was treated with 
trifluoroacetic acid (5.71 mL, 76.8 mmol, 10.0 equiv) at 23 °C. After 12 h, the mixture was diluted with 
dichloromethane (600 mL) and washed sequentially with water (100 mL) and saturated aqueous sodium 
chloride solution (100 mL). The washed organic solution was dried over sodium sulfate and the dried 
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solution was filtered. The filtrate was concentrated and the crude product was purified by flash column 
chromatography on silica gel (30% ethyl acetate in hexanes) to afford 35 (3.40 g, 89%) as a white foam. 
TLC (33% ethyl acetate in hexanes), Rf = 0.22 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 7.53 (t, J = 
7.9 Hz, 1H), 7.07 (brs, 2H), 6.98 (d, J = 7.5 Hz, 1H), 6.80 (d, J = 8.2 Hz, 1H), 4.04–2.96 (brm, 9H), 1.30 
(s, 9H), 1.05 (brs, 9H). 13C NMR (100 MHz, CDCl3) δ: 200.9, 176.7, 176.2, 166.3, 158.4, 154.7, 136.6, 
131.4, 131.3, 125.1, 124.6, 122.5, 118.2, 115.4, 109.3, 55.8, 52.5, 39.2, 39.2, 34.6, 27.1, 26.8. IR (Diamond-
ATR, neat) 𝜈𝑚𝑎𝑥: 2974 (w), 1753 (s), 1717 (s), 1595 (m), 1480 (m), 1272 (s), 1094 (vs), 732 (m) cm–1. HRMS 
(EI) calcd for C28H31O8 [M]+: 496.2092; found: 496.2088. 
Aryl Indenone S24: 
 
A Schlenk tube was charged with indanone 35 (3.40 g, 6.84 mmol, 1 equiv), palladium(II) trifluoroacetate 
(455 mg, 1.37 mmol, 0.200 equiv) and 4,5-diazofluoren-9-one (249 mg, 1.37 mmol, 0.200 equiv). The 
Schlenk tube was equipped with an O2-balloon and the tube was flushed with O2. Dimethyl sulfoxide 
(60 mL) was added. The solution was sparged with O2 for 1 min and then was stirred at 80 °C under an 
O2-atmosphere. After for 5 d, the solution was allowed to cool to 23 °C and then was diluted with diethyl 
ether (100 mL) and water (100 mL). The layers were separated and the aqueous layer was extracted with 
diethyl ether (3 × 100 mL). The combined organic layers were washed with water (200 mL) and saturated 
aqueous sodium chloride solution (200 mL), the washed organic solution was dried over sodium sulfate 
and the dried solution was filtered. The filtrate was concentrated and the crude product was purified by 
flash column chromatography on silica gel (30% ethyl acetate in hexanes) to afford S24 (2.28 mg, 67%) as 
yellow foam and 35 (800 mg, 24%). 
TLC (33% ethyl acetate in hexanes), Rf = 0.38 (UV, KMnO4, CAM). 1H NMR (400 MHz, CD2Cl2) δ: 
7.37 (dd, J = 8.7, 7.0 Hz, 1H), 7.30 (s, 1H), 7.21 (d, J = 8.9 Hz, 1H), 7.12 (d, J = 8.8 Hz, 1H), 6.88 (d, J = 
8.7 Hz, 1H), 6.74 (dd, J = 7.1, 0.6 Hz, 1H), 3.94 (s, 3H), 3.68 (s, 3H), 1.33 (s, 9H), 1.20 (s, 9H). 13C NMR 
(100 MHz, CD2Cl2) δ: 192.8, 176.8, 176.8, 165.6, 157.4, 147.2, 146.5, 146.3, 144.5, 136.8, 133.4, 128.0, 
126.4, 125.7, 124.1, 116.2, 115.3, 114.9, 56.3, 52.8, 39.4, 39.3, 27.2, 27.2. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 
2974 (w), 1752 (s), 1709 (s), 1595 (m), 1463 (m), 1271 (s), 1095 (vs), 955 (m), 708 (s) cm–1. HRMS (EI) calcd 
for C28H30O8 [M]+: 494.1935; found: 494.1943. 
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Cyclopropane 36: 
 
Methyl dichloroacetate (0.715 mL, 6.91 mmol, 1.50 equiv) was added dropwise to a solution of potassium 
bis(trimethylsilyl)amide (1 M in tetrahydrofuran, 7.37 mL, 7.37 mmol, 1.60 equiv) and 18-crown-6 
(122 mg, 0.461 mmol, 0.100 equiv) in tetrahydrofuran (10 mL) at –78 °C. After 30 min, indenone S24 
(2.28 mg, 4.61 mmol, 1 equiv) in tetrahydrofuran (13 mL) was added dropwise. The solution was then 
allowed to warm to 23 °C. After 18 h, saturated aqueous ammonium chloride solution (30 mL) was added 
and the layers were separated. The aqueous layer was extracted with ethyl acetate (3 × 50 mL) and the 
combined organic layers were washed with saturated aqueous sodium chloride solution (100 mL). The 
washed organic solution was dried over sodium sulfate and the dried solution was filtered. The filtrate was 
concentrated and the crude product was purified by flash column chromatography on silica gel (30% ethyl 
acetate in hexanes) to afford 36 (2.08 g, 75%, mixture of two diastereoisomers) as a white foam. 
36a: TLC (30% ethyl acetate in hexanes), Rf = 0.17 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 7.53 (dd, 
J = 8.4, 7.4 Hz, 1H), 7.22 (d, J = 9.0 Hz, 1H), 7.10–7.05 (m, 2H), 6.93 (d, J = 8.5 Hz, 1H), 3.94 (s, 3H), 
3.83 (s, 1H), 3.48 (s, 3H), 3.22 (s, 3H), 1.39 (s, 9H), 1.28 (s, 9H). 13C NMR (100 MHz, CDCl3) δ: 190.3, 
177.0, 176.3, 165.2, 164.6, 158.6, 149.1, 148.9, 145.1, 136.2, 128.4, 125.2, 123.5, 123.5, 122.1, 118.5, 112.1, 
65.5, 56.1, 53.7, 52.0, 47.5, 39.6, 39.2, 38.2, 27.4, 27.2. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2975 (w), 1754 (s), 
1727 (s), 1598 (m), 1473 (m), 1268 (s), 1205 (m), 1091 (vs), 1029 (w), 728 (w) cm–1. HRMS (EI) calcd for 
C31H3335ClO10 [M]+: 600.1762; found: 600.1748. 
36b: TLC (30% ethyl acetate in hexanes), Rf = 0.14 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 7.53 (dd, 
J = 8.4, 7.4 Hz, 1H), 7.11–7.05 (m, 2H), 6.99 (d, J = 8.9 Hz, 1H), 6.90 (d, J = 8.5 Hz, 1H), 3.98 (s, 1H), 
3.92 (s, 3H), 3.87 (s, 3H), 3.61 (s, 3H), 1.32 (s, 9H), 1.03 (s, 9H). 13C NMR (100 MHz, CDCl3) δ: 190.7, 
176.5, 176.2, 165.5, 165.1, 158.6, 148.9, 148.4, 146.7, 136.3, 129.1, 125.3, 124.7, 123.9, 122.8, 118.9, 112.1, 
66.6, 56.2, 53.9, 53.4, 46.5, 40.3, 39.2, 38.2, 27.2, 27.0. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2974 (w), 1753 (s), 
1728 (s), 1597 (m), 1466 (m), 1266 (s), 1219 (m), 1093 (vs), 1030 (w), 734 (w) cm–1. HRMS (EI) calcd for 
C31H3335ClO10 [M]+: 600.1757; found: 600.1763. 
Experimental Procedures 
103 
 
Phenol S25: 
 
A solution of cyclopropane 36 (2.08 g, 3.45 mmol, 1 equiv) in methanol (8.5 mL) was treated with 
potassium carbonate (477 mg, 3.45 mmol, 1 equiv) at 23 °C. After 2 h, saturated aqueous ammonium 
chloride solution (20 mL) and ethyl acetate (40 mL) were added and the layers were separated. The 
aqueous layer was extracted with ethyl acetate (3 × 40 mL) and the combined organic layers were washed 
with saturated aqueous sodium chloride solution (100 mL). The washed organic solution was dried over 
sodium sulfate and the dried solution was filtered. The filtrate was concentrated and the crude product 
was purified by flash column chromatography on silica gel (30% ethyl acetate in hexanes) to afford S25 
(1.32 mg, 74%, mixture of two diastereoisomers) as a yellow foam. 
S25a: TLC (30% ethyl acetate in hexanes), Rf = 0.28 (UV, CAM). 1H NMR (800 MHz, CDCl3) δ: 11.28 
(s, 1H), 7.55 (dd, J = 8.4, 7.4 Hz, 1H), 7.09 (d, J = 7.3 Hz, 1H), 7.00 (d, J = 9.0 Hz, 1H), 6.94 (d, J = 9.0 
Hz, 1H), 6.92 (d, J = 8.4 Hz, 1H), 4.05 (s, 1H), 3.99 (s, 3H), 3.94 (s, 3H), 3.55 (s, 3H), 0.98 (s, 9H). 13C 
NMR (200 MHz, CDCl3) δ: 191.1, 177.2, 170.8, 165.5, 160.3, 158.6, 149.1, 144.3, 136.4, 129.2, 125.7, 
122.7, 119.5, 118.9, 113.9, 111.9, 67.6, 56.2, 54.4, 53.8, 47.3, 40.5, 39.2, 26.9. IR (Diamond-ATR, 
neat) 𝜈𝑚𝑎𝑥: 2956 (w), 1747 (s), 1721 (s), 1668 (s), 1596 (s), 1458 (s), 1268 (s), 1213 (vs), 1092 (vs), 981 (m), 
912 (s), 730 (vs) cm–1. HRMS (EI) calcd for C26H2535ClO9 [M]+: 516.1182; found: 516.1190. 
S25b: TLC (30% ethyl acetate in hexanes), Rf = 0.10 (UV, CAM). 1H NMR (800 MHz, CDCl3) δ: 10.18 
(s, 1H), 7.56 (dd, J = 8.4, 7.3 Hz, 1H), 7.17 (d, J = 9.2 Hz, 1H), 7.11 (d, J = 7.2 Hz, 1H), 6.97 (d, J = 9.2 
Hz, 1H), 6.96 (d, J = 8.3 Hz, 1H), 3.96 (s, 3H), 3.76 (s, 1H), 3.51 (s, 3H), 3.13 (s, 3H), 1.38 (s, 9H). 13C 
NMR (200 MHz, CDCl3) δ: 191.3, 177.5, 169.7, 165.2, 158.5, 158.3, 149.6, 145.3, 136.0, 129.2, 124.8, 
122.3, 118.6, 118.5, 113.7, 112.0, 66.3, 56.1, 53.7, 52.3, 48.1, 40.5, 39.5, 27.5. IR (Diamond-ATR, 
neat) 𝜈𝑚𝑎𝑥: 3424 (w), 2957 (w), 1749 (s), 1723 (vs), 1673 (m), 1597 (s), 1461 (s), 1270 (vs), 1210 (vs), 1092 
(vs), 981 (m), 911 (m), 735 (s) cm–1. HRMS (EI) calcd for C26H2535ClO9 [M]+: 516.1187; found: 516.1182. 
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Triflate 37: 
 
A solution of phenol S25 (1.32 g, 2.55 mmol, 1 equiv) in dichloromethane (25 mL) was treated 
sequentially with triethylamine (0.532 mL, 3.82 mmol, 1.50 equiv) and trifluoromethanesulfonic anhydride 
(0.635 mL, 3.82 mmol, 1.50 equiv) at –78 °C. The mixture was stirred at –78 °C for 15 min, then at 0 °C 
for further 15 min and was then allowed to warm to 23 °C. After 30 min, saturated aqueous sodium 
bicarbonate solution (30 mL) and dichloromethane (100 mL) were added and the layers were separated. 
The organic layer was washed with saturated aqueous sodium chloride solution (40 mL). The washed 
organic solution was dried over sodium sulfate and the dried solution was filtered. The filtrate was 
concentrated and the crude product was purified by flash column chromatography on silica gel (30% ethyl 
acetate in hexanes) to afford 37 (1.62 mg, 98%, inseparable mixture of two diastereoisomers) as a yellow 
oil. 
TLC (30% ethyl acetate in hexanes), Rf = 0.20 (UV, CAM). 1H NMR (600 MHz, CDCl3) δ: 7.59–7.52 (m, 
1.5H), 7.33 (d, J = 9.0 Hz, 0.5H), 7.31 (s, 2H), 7.12–7.08 (m, 1.5H), 6.95 (d, J = 8.5 Hz, 1H), 6.91 (d, J = 
7.8 Hz, 0.5H), 4.02 (s, 0.4H), 3.97 (s, 1H), 3.95 (s, 3H), 3.93 (s, 1H), 3.84 (s, 1H), 3.64 (s, 1H), 3.49 (s, 3H), 
3.39 (s, 3H), 1.39 (s, 9H), 1.06 (s, 3H). Note: Asterisks denotes signal of the major isomer. 13C NMR (150 MHz, 
CDCl3) δ: 190.3, 190.0*, 176.8*, 176.2, 165.7, 164.6*, 163.9, 163.8*, 158.7*, 151.3*, 150.6, 148.7, 148.6*, 
144.5, 142.7*, 136.6, 136.5*, 129.9, 129.4*, 127.1, 125.9*, 125.6, 125.4*, 122.8, 122.7, 122.3*, 121.8*, 118.9, 
118.6 (q, J = 320.4 Hz)*, 118.5*, 112.3*, 112.1, 66.7, 65.3*, 56.2*, 53.9, 53.8*, 52.7*, 47.4, 46.22 40.3, 
39.7*, 39.3, 38.5*, 27.4*, 26.9. Note: One CF3 group is not visible in the 13C NMR spectra. The presence of the CF3 
group was verified by the 19F NMR spectra. 19F NMR (375 MHz, CDCl3) δ: –73.5, –73.6. IR (Diamond-ATR, 
neat) 𝜈𝑚𝑎𝑥: 2958 (w), 1726 (s), 1598 (s), 1483 (m), 1426 (s), 1267 (s), 1209 (vs), 1139 (m), 1089 (vs), 1026 (w), 
912 (w), 857 (m), 735 (m) cm–1. HRMS (EI) calcd for C27H2435ClF3O1132S [M]+: 648.0674; found: 648.0679. 
Naphthol 38: 
 
A solution of triflate 37 (1.62 g, 2.49 mmol, 1 equiv) in sulfolane (5 mL) was stirred at 200 °C for 15 min. 
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The reaction mixture was allowed to cool to 23 °C and then was diluted with diethyl ether (50 mL) and 
water (50 mL). The layers were separated and the aqueous layer was extracted with diethyl ether 
(3 × 50 mL). The combined organic layers were washed with water (100 mL) and saturated aqueous 
sodium chloride solution (100 mL). The washed organic solution was dried over sodium sulfate and the 
dried solution was filtered. The filtrate was concentrated and the crude product was purified by flash 
column chromatography on silica gel (30% ethyl acetate in hexanes) to afford 38 (1.21 mg, 75%) as a 
yellow oil. 
TLC (30% ethyl acetate in hexanes), Rf = 0.36 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 9.77 (s, 1H), 
7.96 (d, J = 8.6 Hz, 1H), 7.54 (t, J = 8.3 Hz, 1H), 7.49 (d, J = 9.1 Hz, 1H), 7.39 (d, J = 9.0 Hz, 1H), 6.96 
(d, J = 7.8 Hz, 1H), 4.06 (s, 3H), 3.71 (s, 3H), 3.59 (s, 3H), 0.92 (s, 9H). 13C NMR (200 MHz, CDCl3) δ: 
175.4, 166.0, 163.4, 156.4, 151.4, 148.9, 144.1, 133.1, 132.5, 130.9, 128.6, 128.3, 126.4, 122.5, 119.3, 118.7, 
115.5, 113.9, 106.4, 56.7, 52.7, 52.4, 39.2, 26.6. Note: The CF3 group is not visible in the 13C NMR spectra. The 
presence of the CF3 group was verified by the 19F NMR spectra. 19F NMR (375 MHz, CDCl3) δ: –73:6. IR 
(Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3352 (w), 2956 (w), 1740 (s), 1606 (w), 1425 (s), 1366 (s), 1282 (s), 1213 (vs), 
1100 (vs), 983 (m), 904 (m) cm–1. HRMS (ESI) calcd for C27H2335ClF3O11S [M−H]−: 647.06072; found: 
647.06065. 
Naphthol S26: 
 
Based on a literature procedure,152 a solution of triflate 38 (1.20 g, 1.85 mmol, 1 equiv) and 1,1-
bis(diphenylphosphino)-ferrocenedichloropalladium(II) (135 mg, 0.185 mmol, 0.100 equiv) in 1,4-dioxane 
(18.5 mL) was treated with dimethylzinc (1.2 M in toluene, 7.70 mL, 9.25 mmol, 5.00 equiv) and the 
solution was stirred at 95 °C. After 1 h, the reaction was allowed to cool to 23 °C, and then was diluted 
with methanol (0.5 mL) and diethyl ether (200 mL). The organic layer was washed with 1 M hydrochloric 
acid solution (20 mL) and with saturated aqueous sodium chloride (20 mL), the washed organic solution 
was dried over sodium sulfate and the dried solution was filtered. The filtrate was concentrated and the 
crude product was purified by flash column chromatography on silica gel (30% ethyl acetate in hexanes) to 
afford S26 (792 mg, 83%) as a pale yellow foam. 
TLC (40% ethyl acetate in hexanes), Rf = 0.30 (UV, CAM). 1H NMR (400 MHz, CD2Cl2) δ: 9.76 (s, 1H), 
7.93 (dd, J = 8.7, 0.9 Hz, 1H), 7.55 (dd, J = 8.7, 7.8 Hz, 1H), 7.30 (dd, J = 8.5, 0.8 Hz, 1H), 7.23 (d, J = 8.4 
Hz, 1H), 6.99 (dd, J = 7.9, 0.9 Hz, 1H), 4.06 (s, 3H), 3.57 (s, 3H), 3.53 (s, 3H), 2.42 (s, 3H), 0.89 (s, 9H). 
13C NMR (100 MHz, CD2Cl2): δ: 175.9, 168.1, 166.4, 156.7, 151.8, 147.5, 135.2, 133.8, 133.6, 132.9, 131.4, 
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128.4, 127.2, 124.4, 118.9, 118.1, 115.8, 115.7, 106.6, 57.0, 52.2, 51.9, 39.1, 26.7, 20.3. IR (Diamond-ATR, 
neat) 𝜈𝑚𝑎𝑥: 3358 (w, br), 2952 (w), 1730 (s), 1606 (w), 1435 (m), 1364 (s), 1263 (s), 1237 (s), 1207 (s), 1098 
(vs), 982 (s), 908 (s), 806 (m), 726 (vs) cm–1. HRMS (EI) calcd for C27H2735ClO8 [M]+: 514.1389; found: 
514.1402. 
Lactone 39: 
 
A solution of naphthol S26 (410 mg, 0.796 mmol, 1 equiv) in dichloromethane/methanol (9:1, 8 mL) was 
treated with sodium hydroxide (318 mg, 7.96 mmol, 10.0 equiv) at 23 °C. After 30 min, the mixture was 
acidified with 1 M hydrochloric acid (20 mL) and the aqueous phase was extracted with dichloromethane 
(3 × 30 mL). The combined organic layers were washed with saturated aqueous sodium chloride (50 mL) 
and the washed organic solution was dried over sodium sulfate. The dried solution was filtered and the 
filtrate was concentrated. 
A solution of the crude diol in toluene (20 mL) was treated with p-toluenesulfonic acid monohydrate 
(30.3 mg, 0.159 mmol, 0.200 equiv) and the resulting mixture was stirred at 80 °C. After 1 h, the solution 
was allowed to cool to 23 °C and the yellow precipitate was separated by filtration and washed with 
toluene (30 mL) and hexanes (30 mL) to afford 39 (285 mg, 98%) as an amorphous yellow solid. 
TLC (30% ethyl acetate in hexanes), Rf = 0.23 (UV, CAM). 1H NMR (800 MHz, CDCl3) δ: 8.35 (d, J = 
8.5 Hz, 1H), 7.74 (t, J = 8.2 Hz, 1H), 7.58 (d, J = 8.3 Hz, 1H), 7.54 (d, J = 8.2 Hz, 1H), 7.24 (d, J = 7.8 
Hz, 1H), 4.14 (s, 3H), 2.91 (s, 3H). 13C NMR (200 MHz, CDCl3) δ: 158.6, 157.5, 156.8, 146.9, 146.0, 
139.7, 134.6, 133.5, 133.2, 130.2, 121.1, 119.1, 118.9, 117.8, 117.0, 114.4, 111.6, 110.6, 56.8, 22.5. IR 
(Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2933 (w), 2360 (w), 1748 (vs), 1738 (vs), 1608 (w), 1490 (m), 1347 (s), 1250 (s), 
1129 (m), 1069 (s), 914 (m), 770 (s) cm–1. HRMS (EI) calcd for C20H1135ClO5 [M]+: 366.0290; found: 
366.0274. 
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Chartarin dimethylether(S27): 
 
A solution of lactone 39 (77 mg, 0.21 mmol, 1 equiv), bis(acetonitrile)palladium(II) dichloride (3.0 mg, 
0.011 mmol, 0.050 equiv), 2-dicyclohexylphosphino-2',6'-dimethoxy-1,1’-biphenyl (6.9 mg, 0.017 mmol, 
0.080 equiv) and potassium tetramethoxyborate (55 mg, 0.32 mmol, 1.5 equiv) in 1,4-dioxane (3 mL) was 
stirred at 95 °C. After 3 h, the solution was allowed to cool to 23 °C, and then was filtered through a short 
plug of Celite. The filter cake was washed with ethyl acetate (200 mL). The filtrate was concentrated to 
provide a brown solid. The crude product was suspended in hexanes and the resulting yellow precipitate 
was separated by filtration and washed with hexanes (30 mL) to afford chartarin dimethylether (S27) 
(66 mg, 87%) as a yellow solid. 
TLC (30% ethyl acetate in hexanes), Rf = 0.14 (UV, CAM). M.p.: 240 °C (dec.). 1H NMR (800 MHz, 
CDCl3) δ: 8.09 (dd, J = 8.4, 0.9 Hz, 1H), 7.70–7.65 (m, 1H), 7.55 (d, J = 8.2 Hz, 1H), 7.51–7.49 (m, 1H), 
7.22 (d, J = 7.7 Hz, 1H), 4.16 (s, 3H), 4.14 (s, 3H), 2.92 (s, 4H). 13C NMR (200 MHz, CDCl3) δ: 159.2, 
157.5, 156.7, 147.2, 143.2, 139.4, 133.1, 132.2, 129.1, 120.9, 119.5, 118.8, 117.3, 116.5, 110.8, 110.7, 109.9, 
107.9, 63.6, 56.7, 22.5. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2935 (w), 2847 (w), 1748 (vs), 1610 (w), 1491 (m), 
1453 (m), 1363 (m), 1250 (s), 1104 (m), 1073 (s), 917 (w), 775 (m) cm–1. HRMS (EI) calcd for C21H14O6 
[M]+: 362.0785; found: 362.0785. 
Chartarin (1): 
 
A mixture of chartarin dimethylether (30.0 mg, 82.8 μmol, 1 equiv) and pyridine hydrochloride (478 mg, 
4.14 mmol, 50.0 equiv) was stirred at 195 °C. After 16 h, methanol (3 mL) was added to the warm 
solution. The yellow precipitate was separated by filtration and washed with cold methanol (5 mL) to 
afford chartarin (1) (19 mg, 69%) as a yellow-brownish solid. 
TLC (5% methanol in chloroform), Rf = 0.85 (UV, CAM). M.p.: 295 °C (Lit. 280 °C (sublimed),153 
306.5 °C).53a 1H NMR (800 MHz, CDCl3) δ: 11.63 (s, 1H), 8.66 (s, 1H), 8.14 (d, J = 8.2 Hz, 1H), 7.65 (t, J 
= 8.0 Hz, 1H), 7.61 (d, J = 8.3 Hz, 1H), 7.53 (d, J = 8.3 Hz, 1H), 7.36 (d, J = 7.8 Hz, 1H), 2.92 (s, 3H). 13C 
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NMR (200 MHz, CDCl3) δ: 164.7, 158.6, 157.3, 153.8, 146.9, 140.9, 139.2, 133.2, 129.5, 126.7, 122.4, 
121.9, 117.8, 117.2, 116.6, 116.1, 107.6, 96.0, 22.5. 1H NMR (400 MHz, pyridine-d5) δ: 8.16 (d, J = 7.9 Hz, 
1H), 7.55 (d, J = 7.6 Hz, 1H), 7.49 (d, J = 7.4 Hz, 2H), 7.35 (d, J = 8.0 Hz, 1H), 2.84 (s, 3H). 13C NMR 
(100 MHz, pyridine) δ: 165.1, 159.4, 157.7, 156.6, 147.2, 140.2, 139.8, 133.1, 129.4, 127.8, 121.3, 120.6, 
118.4, 118.2, 117.3, 115.6, 108.3, 97.3, 22.6. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3227 (w), 2925 (w), 1754 (m), 
1692 (vs), 1608 (m), 1582 (w), 1506 (w), 1372 (s), 1291 (m), 1255 (m), 1221 (m), 1151 (m), 1117 (m), 1074 (w), 
986 (w), 778 (s) cm–1. HRMS (EI) calcd for C19H10O6 [M]+: 334.0472; found: 334.0473. 
1H and 13C NMR Comparison of Synthetic Chartarin with Literature Values53a 
 
1H Position 
Literature 
(600 MHz, pyridine-d5) 
synthetic chartarin (1) 
(400 MHz, pyridine-d5) 
Δδ (ppm) 
1-CH3 2.88 (s, 3 H) 2.84 (s, 3H) 0.04 
2 7.39 (d, J = 8.4 Hz, 1 H) 7.35 (d, J = 8.0 Hz, 1H) 0.04 
7 8.26 (dd, J = 8.2, 1.1 Hz, 1 H) 8.16 (d, J = 7.9 Hz, 1H) 0.1 
8 7.63 (t, J = 7.9 Hz, 1 H) 7.55 (d, J = 7.6 Hz, 1H) 0.08 
 Resonances of all other protons occur as overlapping multiplets and are not listed in this table. 
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13C Position 
Literature 
(150 MHz, pyridine) 
synthetic chartarin (1) 
(100 MHz, pyridine) 
Δδ (ppm) 
1-CH3 22.6 22.6 0 
1 139.9 139.8 0.1 
2 133.2 133.1 0.1 
3 121.3 121.3 0 
3a 147.3 147.2 0.1 
5 165.2 165.1 0.1 
5a 97.4 97.3 0.1 
6 157.4 157.7 0 
6a 128.0 127.8 0.2 
7 115.7 115.6 0.1 
8 129.5 129.4 0.1 
9 117.4 117.3 0.1 
10 156.6 156.6 0 
10a 120.7 120.6 0.1 
10b 140.3 140.2 0.1 
12 159.5 159.4 0.1 
12a 118.3 118.2 0.1 
12b 118.6 118.4 0.2 
12c 108.5 108.3 0.2 
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Screening of Conditions for the Substitution of the Chloride with a Hydroxyl Group 
The substitution reaction was investigated on model substrate S28.  
Table 14. Tested conditions for the coupling of aryl chloride S28. 
 
 R Reagent Catalyst Additive Condition Result 
1 OH KOH Pd2dba3, 4Me-t-
BuXPhosa 
- 1,4-dioxane/H2O 
1:1, 100 °C 
no conversion 
2 OH KOH Pd2dba3, 
t-BuXPhosb 
- 1,4-dioxane/H2O 
1:1, 100 °C 
decomposition 
3 BPin B2Pin2 Pd2dba3, XPhosc KOAc 1,4-dioxane, 80 °C traces of S30d 
4 BPin B2Pin2 XPhos Pd G3, 
XPhos 
KOAc 1,4-dioxane, 80 °C traces of S30d 
5 BPin B2Pin2 Pd(OAc)2e KOAc DMF, 80 °C traces of S30d 
6 BPin B2Pin2 Pd(dppf)Cl2 KOAc DMF, 80 °C decomposition 
7 BPin HBPin Pd(CH3CN)2Cl2, 
SPhosf 
NEt3 1,4-dioxane, 110 °C traces of S30d 
8 BPin B2Pin2 Pd(CH3CN)2Cl2, 
SPhos 
CsF 1,4-dioxane, 90 °C traces of S30d 
9 Ph PhB(OH)2 Pd(OAc)2, SPhosg K3PO4 THF, 23 °C decomposition 
10 C(O)Me butyl vinyl 
ether, 
Pd(OAc)2, dppph KOH ethylene glycol, 
145 °C 
no reaction 
11 OMe - Pd(OAc)2,  
t-BuXPhosi 
Cs2CO3 toluene, MeOH, 
70 °C 
decomposition 
12 TMS Si2Me6 Pd2dba3,  
t-BuDavePhosj 
H2O, KF DMF, 100 °C traces of S30d 
13 O(CH2)2OH - CuCl2k K2CO3 ethylene glycol, 
130 °C 
no reaction 
14 I Zn, then I2 CoCl2, XantPhos, LiCl THF, 70 °C traces of S30d 
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1,2-dibromoethan, 
TMSCll 
15 B(OMe)2 Zn, then 
B(OMe)3 
CoCl2, XantPhos, 
1,2-dibromoethan, 
TMSCll 
LiCl THF, 70 °C decomposition 
16 Et Et2Zn Pd(CH3CN)2Cl2, 
SPhos 
- 1,4-dioxane, 95 °C S31 (56%)m 
17 OMe MeOH Pd(CH3CN)2Cl2, 
SPhos 
NEt3 1,4-dioxane, 95 °C decomposition 
18 CH2OPiv ClZnCH2OPiv Pd(CH3CN)2Cl2, 
SPhos 
- 1,4-dioxane, 95 °C decomposition 
19 TMS TMSZnCln Pd(CH3CN)2Cl2, 
SPhos 
- 1,4-dioxane, 90 °C traces of S32d 
20 C(O)Me 
 
Pd(CH3CN)2Cl2, 
SPhos 
- 1,4-dioxane, 90 °C S33 (65%)p 
21 OMe KB(OMe)4 Pd(CH3CN)2Cl2, 
SPhos 
- 1,4-dioxane, 95 °C decomposition 
a K. W. Anderson, T. Ikawa, R. E. Tundel, S. L. Buchwald, J. Am. Chem. Soc. 2006, 128, 10694–10695. b B. J. Morgan, S. Dey, S. 
W. Johnson, M. C. Kozlowski, J. Am. Chem. Soc. 2009, 131, 9413–9425. c K. L. Billingsley, T. E. Barder, S. L. Buchwald, Angew. 
Chem. Int. Ed. 2007, 46, 5359–5363. d Detected with HRMS (EI). e T. Kano, M. Takeda, R. Sakamoto, K. Maruoka, J. Org. Chem 
2014, 79, 4240–4244. f S. Birkett, D. Ganame, B. C. Hawkins, S. Meiries, T. Quach, M. A. Rizzacasa, Org. Lett. 2011, 13, 1964–
1967. g T. Iwasawa, T. Komano, A. Tajima, M. Tokunaga, Y. Obora, T. Fujihara, Y. Tsuji, Organometallics 2006, 25, 4665–4669. h J. 
Ruan, J. A. Iggo, N. G. Berry, J. Xiao, J. Am. Chem. Soc. 2010, 132, 16689–16699. i P. Dash, M. Janni, S. Peruncheralathan, Eur. J. 
Org. Chem. 2012, 4914–4917. j E. McNeill, T. E. Barder, S. L. Buchwald, Org. Lett. 2007, 9, 3785–3788. k Y. Liu, S. K. Park, Y. 
Xiao, J. Chae, Org. Biomol. Chem. 2014, 12, 4747–4753. l M.-Y. Jin, N. Yoshikai, J. Org. Chem. 2011, 76, 1972–1978. m The ethyl side 
chain could not be converted into a hydroxyl group. n TMSZnCl was prepared from hexamethyldisilane, MeLi and ZnCl2: H. 
Azuma, K. Okano, H. Tokuyama, Chem. Lett. 2011, 40, 959–961. o Prepared from ethyl vinyl ether, t-BuLi and ZnCl2: A. B. Smith, 
III, G. K. Friestad, J. Barbosa, E. Bertounesque, J. J.-W. Duan, K. G. Hull, M. Iwashima, Y. Qiu, P. G. Spoors, B. A. Salvatore, J. 
Am. Chem. Soc.1999, 121, 10478–10486. p Product after hydrolysis with 1 M HCl. The ketone substituent could not be converted 
into a hydroxyl group via a Baeyer-Villiger oxidation. 
Synthesis of Model System S28 
α-Aryl S35: 
 
A solution of β-ketoester S34 (814 mg g, 3.50 mmol, 1 equiv) and quinone 34151 (657 mg, 3.96 mmol, 
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1 equiv) in dichloromethane (40 mL) was cooled to −20 °C. After 15 min, hydroquinidine (229 mg, 
0.700 mmol, 0.200 equiv) was added. After 3 h, triethyamine (2.44 mL, 17.5 mmol, 5.00 equiv) was added 
and the mixture was allowed to warm to 23 °C. After 1 h, pivalic acid chloride (1.79 mL, 17.5 mmol, 
5.00 equiv) was added. After 20 h, saturated aqueous sodium bicarbonate solution (20 mL) was added and 
the layers were separated. The aqueous layer was extracted with dichloromethane (3 × 30 mL) and the 
combined organic layers were washed with saturated aqueous sodium chloride solution (40 mL). The 
washed organic solution was dried over sodium sulfate and the dried solution was filtered. The filtrate was 
concentrated and the crude product was purified by flash column chromatography on silica gel (15% ethyl 
acetate in hexanes) to afford S35 (1.85 g, 93%) as a white foam. 
TLC (20% ethyl acetate in hexanes), Rf = 0.36 (UV, CAM). 1H NMR (400 MHz, CD2Cl2) δ: 7.75 (d, J = 
7.6 Hz, 1H), 7.66 (t, J = 7.4 Hz, 1H), 7.51 (d, J = 7.7 Hz, 1H), 7.41 (t, J = 7.4 Hz, 1H), 7.05 (s, 2H), 4.03 
(d, J = 17.0 Hz, 1H), 3.44 (s, 3H), 3.23 (d, J = 17.0 Hz, 1H), 1.31(s, 9H), 1.26 (s, 9H), 1.22 (s, 9H). 13C 
NMR (100 MHz, CD2Cl2) δ: 198.7, 177.6, 176.9, 167.6, 165.6, 153.1, 148.5, 146.6, 135.8, 135.3, 133.2, 
127.7, 126.5, 125.7, 125.0, 123.2, 83.3, 66.2, 52.1, 39.7, 39.3, 27.6, 27.2, 27.1. IR (Diamond-ATR, neat) 
𝜈𝑚𝑎𝑥: 2977 (w), 2875 (w), 1751 (s), 1714 (s), 1607 (w), 1460 (m), 1368 (m), 1264 (s), 1248 (s), 1216 (m), 1150 
(s), 1087 (vs), 1028 (s), 956 (m), 896 (m), 841 (m), 742 (m), 710 (m) cm–1. HRMS (EI) calcd for C32H38O9 
[M]+: 566.2510; found: 566.2514. 
Aryl Indanone S36: 
 
A solution of S35 (1.64 g, 2.89 mmol, 1 equiv) in dichloromethane (30 mL) was treated with 
trifluoroacetic acid (2.14 mL, 28.9 mmol, 10.0 equiv at 23 °C. After 4.5 h, the mixture was diluted with 
dichloromethane (30 mL) and washed sequentially with water (50 mL) and saturated aqueous sodium 
chloride solution (50 mL). The washed organic solution was dried over sodium sulfate and the dried 
solution was filtered. The filtrate was concentrated and the crude product was purified by flash column 
chromatography on silica gel (30% ethyl acetate in hexanes) to afford S36 (1.35 g, quant.) as a white foam. 
TLC (20% ethyl acetate in hexanes), Rf = 0.33 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 7.80 (d, J = 
7.6 Hz, 1H), 7.61 (td, J = 7.5, 1.3 Hz, 1H), 7.46 (dt, J = 7.7, 1.0 Hz, 1H), 7.40 (t, J = 7.5 Hz, 1H), 7.09 (s, 
2H), 4.13–3.06 (brm, 6H), 1.31 (s, 9H), 1.01 (s, 9H). 13C NMR (100 MHz, CDCl3) δ: 203.5, 176.8, 176.2, 
166.2, 152.3, 147.2, 146.1, 136.6, 134.9, 131.1, 127.8, 126.6, 125.3, 124.3, 122.7, 52.4, 48.5, 39.3, 39.2, 35.1, 
27.2, 26.9. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2976 (w), 2875 (w), 2362 (w), 1753 (s), 1724 (s), 1609 (w), 1466 
(m), 1267 (s), 1204 (m), 1091 (vs), 1028 (m), 999 (m), 954 (m), 890 (w), 755 (m), 709 (s) cm–1. HRMS (EI) 
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calcd for C27H30O7 [M]+: 466.1986; found: 466.1990. 
Cyclopropane S37: 
 
A Schlenk tube was charged with indanone S36 (550 mg, 1.18 mmol, 1 equiv) and palladium(II) 
trifluoroacetate (78.4 mg, 0.236 mmol, 0.200 equiv). The Schlenk tube was equipped with an O2-balloon 
and the tube was flushed with O2. Dimethyl sulfoxide (33.5 μL, 0.472 mmol, 0.400 equiv) and toluene 
(10 mL) were added. The solution was sparged with O2 for 1 min and then was stirred at 80 °C under an 
O2-atmosphere. After 2.5 days, the solution was allowed to cool to 23 °C and then was concentrated. The 
crude product was purified by flash column chromatography on silica gel (15% ethyl acetate in hexanes) to 
afford the corresponding indenone. 
Methyl dichloroacetate (183 μL, 1.77 mmol, 1.50 equiv) was added dropwise to a solution of potassium 
bis(trimethylsilyl)amide (0.5 M in toluene, 3.78 mL, 1.89 mmol, 1.60 equiv) and 18-crown-6 (31.2 mg, 
0.118 mmol, 0.100 equiv) in tetrahydrofuran (4 mL) at –78 °C. After 30 min, indenone in tetrahydrofuran 
(10 mL) was added dropwise. The solution was then allowed to warm to 23 °C. After 18 h, saturated 
aqueous ammonium chloride solution (10 mL) was added and the layers were separated. The aqueous 
layer was extracted with ethyl acetate (3 × 30 mL) and the combined organic layers were washed with 
saturated aqueous sodium chloride solution (40 mL). The washed organic solution was dried over sodium 
sulfate and the dried solution was filtered. The filtrate was concentrated and the crude product was 
purified by flash column chromatography on silica gel (30% ethyl acetate in hexanes) to afford S37 
(413 mg, 61%, mixture of two diastereoisomers) as a colorless oil. 
S37a: TLC (20% ethyl acetate in hexanes), Rf = 0.18 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 7.76 (d, 
J = 7.4 Hz, 1H), 7.61 (td, J = 7.4, 1.1 Hz, 1H), 7.52 (d, J = 7.5 Hz, 1H), 7.47 (td, J = 7.5, 1.0 Hz, 1H), 7.26 
(d, J = 9.0 Hz, 1H), 7.10 (d, J = 9.0 Hz, 1H), 3.93 (s, 1H), 3.49 (s, 3H), 3.14 (s, 3H), 1.39 (s, 9H), 1.29 (s, 
9H). 13C NMR (100 MHz, CDCl3) δ: 193.1, 177.1, 176.5, 165.1, 164.4, 149.0, 146.6, 145.3, 135.2, 134.4, 
129.3, 128.4, 126.3, 125.4, 124.9, 123.7, 123.4, 66.5, 53.8, 52.0, 47.3, 39.6, 39.2, 38.6, 27.4, 27.2. IR 
(Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2975 (w), 1753 (s), 1730 (vs), 1473 (m), 1267 (s), 1221 (m), 1093 (vs), 1029 (m), 
730 (m) cm–1. HRMS (EI) calcd for C30H3135ClO9 [M]+: 570.1651; found: 570.1652. 
S37b: TLC (20% ethyl acetate in hexanes), Rf = 0.15 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 7.74 (d, 
J = 7.5 Hz, 1H), 7.60 (td, J = 7.4, 1.2 Hz, 1H), 7.53 (d, J = 7.5 Hz, 1H), 7.45 (td, J = 7.4, 1.1 Hz, 1H), 7.12 
(d, J = 8.9 Hz, 1H), 7.01 (d, J = 8.9 Hz, 1H), 4.09 (s, 1H), 3.87 (s, 3H), 3.62 (s, 3H), 1.33 (s, 9H), 0.98 (s, 
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9H). 13C NMR (75 MHz, CDCl3) δ: 193.1, 176.5, 176.3, 165.3, 165.1, 148.4, 146.7, 146.6, 135.7, 134.4, 
129.3, 129.1, 126.7, 125.3, 125.1, 124.9, 124.1, 67.3, 54.0, 53.4, 46.3, 40.8, 39.2, 39.2, 27.2, 26.9. IR 
(Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2975 (w), 1754 (vs), 1732 (s), 1471 (m), 1269 (s), 1098 (vs) cm–1. HRMS (EI) 
calcd for C30H3135ClO9 [M]+: 570.1651; found: 570.1648. 
Phenol S38: 
 
A solution of cyclopropane S37 (440 mg, 0.771 mmol, 1 equiv) in methanol (5 mL) was treated with 
potassium carbonate (106 mg, 0.771 mmol, 1 equiv) at 23 °C. After 4 h, saturated aqueous ammonium 
chloride solution (10 mL) and ethyl acetate (20 mL) were added and the layers were separated. The 
aqueous layer was extracted with ethyl acetate (3 × 30 mL) and the combined organic layers were washed 
with saturated aqueous sodium chloride solution (40 mL). The washed organic solution was dried over 
sodium sulfate and the dried solution was filtered. The filtrate was concentrated and the crude product 
was purified by flash column chromatography on silica gel (20% ethyl acetate in hexanes) to afford S38 
(268 mg, 71%, mixture of two diastereoisomers) as a yellow foam. 
S38a: TLC (20% ethyl acetate in hexanes), Rf = 0.46 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 11.28 
(s, 1H), 7.74 (d, J = 7.5 Hz, 1H), 7.62 (td, J = 7.5, 1.1 Hz, 1H), 7.54 (d, J = 7.5 Hz, 1H), 7.46 (td, J = 7.3, 
1.0 Hz, 1H), 7.02 (d, J = 9.0 Hz, 1H), 6.96 (d, J = 9.1 Hz, 1H), 4.13 (s, 1H), 3.99 (s, 3H), 3.56 (s, 3H), 0.92 
(s, 9H). 13C NMR (100 MHz, CDCl3) δ: 193.6, 177.1, 170.6, 165.3, 160.4, 146.8, 144.3, 135.7, 134.6, 129.3, 
129.2, 127.1, 126.7, 125.7, 125.0, 119.7, 113.7, 68.4, 54.4, 53.9, 47.1, 41.0, 39.1, 26.8. IR (Diamond-ATR, 
neat) 𝜈𝑚𝑎𝑥: 2957 (w), 2359 (w), 2257 (w), 1747 (s), 1727 (vs), 1669 (s), 1605 (m), 1458 (s), 1437 (s), 1341 (m), 
1272 (s), 1215 (vs), 1105 (vs), 914 (m), 731 (m) cm–1. HRMS (EI) calcd for C25H2335ClO8 [M]+: 486.1076; 
found: 486.1076. 
S38b: TLC (20% ethyl acetate in hexanes), Rf = 0.26 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 10.15 
(s, 1H), 7.79 (d, J = 7.4 Hz, 1H), 7.63 (td, J = 7.4, 1.2 Hz, 1H), 7.56 (d, J = 7.4 Hz, 1H), 7.50 (td, J = 7.4, 
1.1 Hz, 1H), 7.19 (d, J = 9.2 Hz, 1H), 7.00 (d, J = 9.2 Hz, 1H), 3.85 (s, 1H), 3.53 (s, 3H), 3.04 (s, 3H), 1.38 
(s, 9H). 13C NMR (100 MHz, CDCl3) δ: 194.0, 177.6, 169.6, 165.0, 158.4, 147.3, 145.2, 135.5, 134.2, 129.4, 
129.1, 126.3, 124.8, 124.6, 118.8, 113.8, 67.2, 53.8, 52.3, 47.9, 40.9, 39.5, 27.4. IR (Diamond-ATR, 
neat) 𝜈𝑚𝑎𝑥: 2956 (w), 2360 (w), 2257 (w), 1748 (s), 1726 (vs), 1673 (s), 1607 (m), 1460 (s), 1436 (s), 1328 (m), 
1270 (s), 1209 (vs), 1099 (vs), 912 (s), 728 (vs) cm–1. HRMS (EI) calcd for C25H2335ClO8 [M]+: 486.1076; 
found: 486.1072. 
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Triflate S39: 
 
A solution of phenol S38 (259 mg, 0.532 mmol, 1 equiv) in dichloromethane (1 mL) was treated 
sequentially with triethylamine (0.111 mL, 0.798 mmol, 1.50 equiv) and trifluoromethanesulfonic 
anhydride (0.132 mL, 0.798 mmol, 1.50 equiv) at –78 °C. The mixture was stirred at –78 °C for 15 min, 
then at 0 °C for further 15 min and was then allowed to warm to 23 °C. After 30 min, saturated aqueous 
sodium bicarbonate solution (10 mL) and dichloromethane (10 mL) were added and the layers were 
separated. The organic layer was washed with saturated aqueous sodium chloride solution (40 mL). The 
washed organic solution was dried over sodium sulfate and the dried solution was filtered. The filtrate was 
concentrated and the crude product was purified by flash column chromatography on silica gel (30% ethyl 
acetate in hexanes) to afford S39 (297 mg, 90%, mixture of two diastereoisomers) as a yellow oil. 
S39a: TLC (20% ethyl acetate in hexanes), Rf = 0.21 (UV, CAM). Note: the second isomer is visible in the 1H 
and 13C NMR! 1H NMR (400 MHz, CDCl3) δ: 7.74 (d, J = 8.0 Hz, 1H), 7.65–7.57 (m, 1H), 7.55 (d, J = 
7.5 Hz, 1H), 7.47 (td, J = 7.5, 1.1 Hz, 1H), 7.35 (d, J = 8.9 Hz, 1H), 7.12 (d, J = 9.0 Hz, 1H), 4.11 (s, 1H), 
3.97 (s, 3H), 3.66 (s, 3H), 1.00 (s, 9H). 13C NMR (100 MHz, CDCl3) δ: 192.8, 176.1, 165.5, 163.9, 150.6, 
146.4, 144.5, 135.5, 134.7, 129.8, 129.4, 127.2, 126.7, 125.8, 125.2, 123.0, 118.6 (q, J = 325.4 Hz), 67.4, 
54.1, 53.8, 46.1, 40.9, 39.2, 26.8. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2959 (w), 2361 (w), 1731 (vs), 1607 (w), 
1466 (m), 1426 (s), 1278 (s), 1216 (vs), 1139 (s), 1090 (vs), 1023 (m), 869 (m) cm–1. HRMS (EI) calcd for 
C26H2235ClF3O1032S [M]+: 618.0569; found: 618.0575. 
S39b: TLC (20% ethyl acetate in hexanes), Rf = 0.18 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 7.78 (d, 
J = 7.5 Hz, 1H), 7.64 (td, J = 7.5, 1.2 Hz, 1H), 7.55 (d, J = 7.4 Hz, 1H), 7.50 (td, J = 7.6, 1.0 Hz, 1H), 
7.39–7.29 (m, 2H), 3.93 (s, 1H), 3.50 (s, 3H), 3.31 (s, 3H), 1.40 (s, 9H). 13C NMR (100 MHz, CDCl3) δ: 
192.8, 176.8, 164.4, 163.7, 151.2, 146.4, 142.9, 134.9, 134.7, 129.5, 129.3, 126.4, 126.2, 125.3, 125.1, 122.5, 
118.6 (q, J = 320.5 Hz), 66.3, 53.9, 52.7, 47.2, 39.7, 39.0, 27.3. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2959 (w), 
2361 (w), 1731 (vs), 1607 (w), 1470 (m), 1427 (s), 1278 (s), 1216 (vs), 1139 (s), 1089 (vs), 1023 (m), 9456 (m), 
868 (m) cm–1. HRMS (EI) calcd for C26H2235ClF3O1032S [M]+: 618.0569; found: 618.0573. 
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Naphthol S40: 
 
A solution of triflate S39 (100 mg, 0.162 mmol, 1 equiv) in sulfolane (2 mL) was stirred at 190 °C for 
40 min. The reaction mixture was allowed to cool to 23 °C and then was diluted with diethyl ether 
(20 mL) and water (20 mL). The layers were separated and the aqueous layer was extracted with diethyl 
ether (3 × 30 mL). The combined organic layers were washed with water (50 mL) and saturated aqueous 
sodium chloride solution (50 mL). The washed organic solution was dried over sodium sulfate and the 
dried solution was filtered. The filtrate was concentrated and the crude product was purified by flash 
column chromatography on silica gel (20% ethyl acetate in hexanes) to afford S40 (78.0 mg, 78%) as a 
yellow foam. 
TLC (20% ethyl acetate in hexanes), Rf = 0.26 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 8.40–8.34 (m, 
1H), 8.33–8.27 (m, 1H), 7.71 (ddd, J = 8.5, 6.9, 1.4 Hz, 1H), 7.64 (ddd, J = 8.2, 6.9, 1.3 Hz, 1H), 7.49 (d, J 
= 9.0 Hz, 1H), 7.41 (d, J = 9.0 Hz, 1H), 5.84 (s, 1H), 3.71 (s, 3H), 3.59 (s, 3H), 0.85 (s, 9H). 13C NMR 
(100 MHz, CDCl3) δ: 177.1, 166.2, 163.8, 149.9, 149.3, 144.0, 131.4, 130.9, 130.4, 129.2, 129.1, 127.8, 
126.7, 126.5, 125.0, 124.1, 123.5, 121.3, 118.7 (q, J = 320.2 Hz), 112.8, 53.3, 52.5, 39.1, 26.5. IR 
(Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3460 (w, br), 2958 (w), 2361 (w), 1738 (vs), 1591 (w), 1465 (m), 1427 (s), 1297 
(s), 1267 (s), 1215 (vs), 1139 (s), 1103 (s), 1025 (m), 949 (m), 885 (w), 832 (m) 761 (m) cm–1. HRMS (EI) calcd 
for C26H2235ClF3O1032S [M]+: 618.0569; found: 618.0565. 
Naphthol S41: 
 
A solution of triflate S40 (76 mg, 0.12 mmol, 1 equiv) and 1,1-bis(diphenylphosphino)-
ferrocenedichloropalladium(II) (4.5 mg, 0.0061 mmol, 0.050 equiv) in 1,4-dioxane (3 mL) was treated with 
dimethylzinc (1.2 M in toluene, 0.21 mL, 0.25 mmol, 2.0 equiv) and the solution was stirred at 95 °C. After 
3 h, the reaction was allowed to cool to 23 °C, and then was diluted with methanol (3 drops) and diethyl 
ether (30 mL). The organic layer was washed with 1 M hydrochloric acid solution (20 mL) and with 
saturated aqueous sodium chloride (20 mL). The washed organic solution was dried over sodium sulfate 
and the dried solution was filtered. The filtrate was concentrated and the crude product was purified by 
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flash column chromatography on silica gel (20% ethyl acetate in hexanes) to afford S41 (41 mg, 69%) as 
an amorphous pale yellow foam. 
TLC (20% ethyl acetate in hexanes), Rf = 0.12 (UV, CAM) 1H NMR (400 MHz, CDCl3) δ: 8.36 (d, J = 
8.2 Hz, 1H), 8.27 (d, J = 8.5 Hz, 1H), 7.67 (ddd, J = 8.4, 7.1, 1.3 Hz, 1H), 7.60 (ddd, J = 8.1, 6.8, 1.2 Hz, 
1H), 7.36 (d, J = 8.3 Hz, 1H), 7.17 (d, J = 8.3 Hz, 1H), 5.82 (s, 1H), 3.61 (s, 3H), 3.54 (s, 3H), 2.43 (s, 3H), 
0.84 (s, 9H). 13C NMR (100 MHz, CDCl3) δ: 177.8, 168.2, 166.5, 149.3, 148.1, 136.5, 134.0, 132.8, 131.7, 
131.1, 128.6, 127.4, 126.2, 124.9, 124.8, 124.3, 123.5, 120.4, 113.9, 52.3, 52.3, 39.0, 26.6, 19.9. IR 
(Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3449 (w, br), 2953 (w), 2258 (w), 1731 (s), 1448 (m), 1386 (m), 1269 (s), 1237 
(s), 1109 (vs), 1030 (s), 907 (s), 727 (vs) cm–1. HRMS (EI) calcd for C26H2535ClO7 [M]+: 484.1283; found: 
484.1283. 
Lactone S28: 
 
A solution of naphthol S41 (78 mg, 0.16 mmol, 1 equiv) in dichloromethane/methanol (9:1, 2 mL) was 
treated with sodium hydroxide (64 mg, 1.6 mmol, 10 equiv) at 23 °C. After 2 h, the mixture was acidified 
with 1 M hydrochloric acid (5 mL) and the aqueous phase was extracted with dichloromethane 
(3 × 10 mL). The combined organic layers were with washed with saturated aqueous sodium chloride 
solution (30 mL) and the washed organic solution was dried over sodium sulfate. The dried solution was 
filtered and the filtrate was concentrated. 
A solution of the crude diol in toluene (2 mL) was treated with p-toluenesulfonic acid monohydrate 
(6.1 mg, 32 μmol, 0.20 equiv) and the resulting mixture was stirred at 80 °C. After 2 h, the solution was 
allowed to cool to 23 °C and the yellow precipitate was separated by filtration and washed with hexanes 
(30 mL) to afford S28 (53 mg, 98%) as an amorphous yellow solid. 
TLC (20% ethyl acetate in hexanes), Rf = 0.24 (UV, CAM). 1H NMR (800 MHz, CDCl3) δ: 8.77–8.73 (m, 
1H), 8.67–8.64 (m, 1H), 7.90 (ddd, J = 8.2, 6.8, 1.2 Hz, 1H), 7.87 (ddd, J = 8.3, 6.8, 1.4 Hz, 1H), 7.59 (d, J 
= 8.3 Hz, 1H), 7.57–7.53 (m, 1H), 2.93 (d, J = 0.8 Hz, 3H), 1.52 (s, 3H). 13C NMR (200 MHz, CDCl3) δ: 
158.5, 156.8, 147.2, 144.6, 140.1, 133.9, 133.7, 132.4, 130.9, 129.9, 127.2, 125.7, 122.3, 121.4, 118.8, 117.7, 
113.6, 111.6, 22.6. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3368 (w, br), 2918 (w), 2850 (w), 2361 (w), 1763 (vs), 
1752 (vs), 1487 (w), 1438 (w), 1371 (w), 1339 (w), 1241 (m), 1185 (m), 1124 (s), 1082 (m), 1026 (m), 952 (m), 
832 (m), 760 (s) cm–1. HRMS (EI) calcd for C19H9ClO4 [M]+: 336.0184; found: 36.0180. 
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Ketone S33:  
 
A solution of S28 (15 mg, 0.045 mmol, 1 equiv), bis(acetonitrile)palladium(II) dichloride (0.30 mg, 
0.89 μmol, 0.020 equiv) and 2-dicyclohexylphosphino-2',6'-dimethoxy-1,1’-biphenyl (1.5 mg, 3.6 μmol, 
0.080 equiv) in 1,4-dioxane (2 mL) was treated with vinyl zinc (0.14 M in THF, 0.96 mL, 0.13 mmol, 
3.0 equiv) and the mixture was stirred at 90 °C. After 3 h, the mixture was allowed to cool to 23 °C, and 
then was diluted with 6 M aqueous hydrochloric acid solution (3 mL), After 1.5 h, the layers were 
separated, the aqueous layer was extracted with dichloromethane (3 × 10 mL) and the combined organic 
layers were washed with saturated aqueous sodium chloride solution (40 mL). The washed organic 
solution was dried over sodium sulfate and the dried solution was filtered. The filtrate was concentrated 
and the crude product was purified by flash column chromatography on silica gel (25% ethyl acetate in 
hexanes) to afford S38 (10 mg, 65) as an amorphous yellow solid. 
TLC (% ethyl acetate in hexanes), Rf = 0.12 (UV, CAM). 1H NMR (800 MHz, CDCl3) δ: 8.68 (dt, J = 8.5, 
1.0 Hz, 1H), 7.93 (dt, J = 8.5, 0.9 Hz, 1H), 7.88 (ddd, J = 8.1, 6.8, 1.1 Hz, 1H), 7.78 (ddd, J = 8.2, 6.8, 1.3 
Hz, 1H), 7.62 (d, J = 8.3 Hz, 1H), 7.56 (dd, J = 8.2, 1.0 Hz, 1H), 2.93 (s, 3H), 2.79 (s, 3H). 13C NMR (200 
MHz, CDCl3) δ: 204.1, 158.9, 158.7, 147.1, 146.0, 141.2, 140.6, 133.8, 130.5, 129.9, 129.7, 126.6, 125.2, 
122.6, 121.7, 118.9, 117.9, 112.2, 110.0, 32.7, 22.5. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2931 (w), 2367 (w), 
2260 (w), 1733 (vs), 1702 (s), 1614 (w), 1491 (m), 1407 (m), 1255 (s), 1205 (vs), 1150 (s), 1078 (vs), 1044 (s), 
916 (m), 758 (m), 725 (s) cm–1. HRMS (EI) calcd for C21H12O5 [M]+: 344.0679; found: 344.0680. 
Synthesis and Ring opening reaction of Bromo-cyclopropane S43 
Cyclopropane S43: 
 
In a pressure vessel, a solution of 1-indanone (S42) (200 mg, 1.51 mmol, 1 equiv), N-bromosuccinimide 
(296 mg, 1.66 mmol, 1.10 equiv) and 2,2’-azobis(2-methylpropionitrile) (2.49 mg, 15.1 μmol, 0.0100 equiv) 
in benzene (5 mL) was stirred at 80 °C. After 16 h, the solution was allowed to cool to 23 °C, and then 
was diluted with water (10 mL) and diethyl ether (10 mL). The layers were separated and the aqueous layer 
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was extracted with diethyl ether (3 × 20 mL). The combined organic layers were washed with saturated 
aqueous sodium chloride solution (1 × 40 mL) and the washed solution was dried over magnesium sulfate. 
The dried solution was filtered and the filtrate was concentrated. The crude product was used in the next 
step without further purification. 
To a solution of the crude bromo-indanone in dichloromethane (15 mL) was added triethylamine 
(1.05 mL, 7.55 mmol, 5.00 equiv) at 0 °C. The solution was allowed to warm to 23 °C and after 30 min, 
the solution was concentrated. Diethyl ether (50 mL) was added, the mixture was filtered through a short 
plug of Celite and the filtrate was concentrated. The crude product was used in the next step without 
further purification. 
Ethyl dibromoacetate (293 μL, 2.27 mmol, 1.50 equiv) was added dropwise to a solution of lithium 
bis(trimethylsilyl)amide (1 M in THF, 2.27 mL, 2.27 mmol, 1.50 equiv) in tetrahydrofuran (2 mL) at 
−78 °C. After 30 min, a solution of the crude indenone in tetrahydrofuran (8 mL) was added dropwise at 
−78 °C. The solution was allowed to warm to 23 °C. After 15 h, saturated aqueous ammonium chloride 
solution (20 mL) was added and the layers were separated. The aqueous layer was extracted with ethyl 
acetate (3 × 20 mL) and the combined organic layers were washed with saturated aqueous sodium chloride 
solution (20 mL). The washed solution was dried over sodium sulfate and the dried solution was filtered. 
The filtrate was concentrated and the crude product was purified by flash column chromatography on 
silica gel (10% ethyl acetate in hexanes) to afford S43 (215 mg, 48%) as an orange oil.  
TLC (40% ethyl acetate in hexanes): Rf = 0.27 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ = 7.68 (ddt, J 
= 7.6, 1.3, 0.7 Hz, 1H), 7.58 (td, J = 7.4, 1.2 Hz, 1H), 7.50 (dt, J = 7.6, 1.0 Hz, 1H), 7.43 (td, J = 7.4, 
1.1 Hz, 1H), 4.28 (q, J = 7.1 Hz, 2H), 3.54 (d, J = 5.9 Hz, 1H), 3.10 (d, J = 5.9 Hz, H), 1.34 (t, J = 7.1 Hz, 
3H). 13C NMR (100 MHz, CDCl3) δ = 196.7, 166.1, 149.1, 136.1, 134.5, 129.1, 126.6, 124.4, 63.6, 54.4, 
38.4, 34.7, 14.2. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2983 (w), 1713 (vs), 1606 (m), 1470 (m), 1368 (w), 1241 
(vs), 1203 (s), 1101 (m), 1050 (m), 996 (m), 771 (s) cm–1. HRMS (ESI) calcd for C13H1279BrO3 [M+H]+: 
294.9964; found: 294.9968. 
Ethyl 3-bromo-4-hydroxy-2-naphthoate (S44a) and ethyl 1-bromo-4-hydroxy-2-naphtoate (S44b): 
 
A solution of cyclopropane S43 (20 mg, 0.68 mmol, 1 equiv) in dimethyl sulfoxide (1 mL) was stirred at 
120 °C for 2 h. The reaction mixture was allowed to cool to 23 °C and then was diluted with diethyl ether 
(20 mL). The organic layer was washed sequentially with water (2 × 15 mL) and saturated aqueous sodium 
chloride solution (15 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
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chromatography on silica gel (10% ethyl acetate in hexanes) to afford S44a (89 mg, 89%) and S44b 
(10 mg, 10%) as orange oils. 
S44a: TLC (20% ethyl acetate in hexanes): Rf = 0.29 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 8.40 
(ddd, J = 8.5, 1.3, 0.7 Hz, 1H), 8.23 (ddd, J = 8.3, 1.5, 0.7 Hz, 1H), 7.66 (ddd, J = 8.5, 6.9, 1.5 Hz, 1H), 
7.60 (ddd, J = 8.2, 6.9, 1.3 Hz, 1H), 7.12 (s, 1H), 5.99 (s, 1H), 4.47 (q, J = 7.1 Hz, 2H), 1.45 (t, J = 7.1 Hz, 
3H). 13C NMR (100 MHz, CDCl3) δ: 167.8, 151.4, 133.3, 131.2, 128.7, 128.6, 127.6, 126.7, 122.4, 113.1, 
108.9, 62.3, 14.4. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3392 (m), 2359 (m), 1706 (vs), 1597 (s), 1465 (m), 1396 
(s), 1352 (s), 1299 (s), 1243 (vs), 1172 (m), 1079 (s), 1019 (m), 760 (s) cm–1. HRMS (EI) calcd for 
C13H1179BrO3 [M]+: 293.9886; found: 293.9883. 
S44b: TLC (20% ethyl acetate in hexanes): Rf = 0.56 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 8.30–
8.23 (m, 1H), 8.01 (s, 1H), 7.90–7.82 (m, 1H), 7.66–7.55 (m, 2H), 6.52 (s, 1H), 4.45 (q, J = 7.1 Hz, 2H), 
1.46 (t, J = 7.1 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ: 166.1, 149.4, 132.1, 128.6, 128.4, 128.3, 127.9, 
125.6, 124.5, 122.8, 102.0, 61.9, 14.4. IR (Diamond-ATR, neat)  𝜈𝑚𝑎𝑥: 3447 (w), 2983 (w), 2363 (m), 1726 
(vs), 1577 (m), 1399 (s), 1298 (s), 1229 (vs), 1080 (m), 1023 (m), 778 (m), cm–1. HRMS (EI) calcd for 
C13H1179BrO3 [M]+: 293.9886; found 293.9887. 
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7.2.2 1H and 13C NMR Spectra 
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7.3 Supporting Information for Chapter 2.2 
7.3.1 Experimental Procedures 
Tertiary alcohol I.255: 
 
In a pressure vessel, a solution of 5-methoxy-1-indanone (I.265) (300 mg, 1.85 mmol, 1 equiv), N-
bromosuccinimide (362 mg, 2.03 mmol, 1.10 equiv) and 2,2’-azobis(2-methylpropionitrile) (3.00 mg, 
0.0185 mmol, 0.0100 equiv) in carbon tetrachloride (8 mL) was stirred at 80 °C for 2 h. The solution was 
allowed to cool to 23 °C, and then was diluted with water and diethyl ether. The layers were separated and 
the aqueous layer was extracted with diethyl ether (3 × 20 mL). The combined organic layers were washed 
with saturated aqueous sodium chloride solution (50 mL) and the washed solution was dried over 
magnesium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude product 
was used in the next step without further purification.  
To a solution of the crude bromo-indanone in carbon tetrachloride (10 mL) was added triethylamine 
(0.900 mL, 6.47 mmol, 3.50 equiv) at 0 °C. The solution was allowed to warm to 23 °C and after 1 h, 
dichloromethane (9 mL) and hexanes (21 mL) were added. The mixture was filtered through a short plug 
of Celite and the filtrate was concentrated. The crude product was used in the next step without further 
purification.  
To a solution of lithium bis(trimethylsilyl)amide (1 M in THF, 2.03 mL, 2.03 mmol, 1.10 equiv) in 
tetrahydrofuran (2 mL) was added ethyl chlorofluoroacetate (I.252) (0.225 mL, 1.94 mmol, 1.05 equiv) 
dropwise at −78 °C. After 30 min, a solution of the crude indenone in tetrahydrofuran (4 mL) was added 
dropwise at −78 °C. The solution was allowed to warm to 23 °C. After 2 h, saturated aqueous ammonium 
chloride solution (10 mL) was added and the layers were separated. The aqueous layer was extracted with 
diethyl ether (3 × 10 mL) and the combined organic layers were washed with water (30 mL) and saturated 
aqueous sodium chloride solution (30 mL). The washed solution was dried over magnesium sulfate and 
the dried solution was filtered. The filtrate was concentrated and the crude product was purified by flash 
column chromatography on silica gel (20% ethyl acetate in hexanes) to provide I.255 (36 mg, 6%, dr = 
1:0.8) as an orange oil. 
TLC (20% ethyl acetate in hexanes) Rf = 0.20 (UV, KMnO4). Note: Asterix denote the major isomer. 1H NMR 
(300 MHz, CDCl3) δ: 7.51 (dd, J = 8.2, 1.5 Hz, 1H), 7.43 (dd, J = 8.3, 2.2Hz, 1H)*, 6.78 (d, J = 2.4 Hz, 
1H)*, 6.77–6.66 (m, 5H, 2 protons of the major isomer and 3 protons of the minor isomer), 6.55 (d, J = 5.8 Hz, 
1H)*, 6.30 (d, J = 5.8 Hz), 1H), 4.35 (qd, J = 7.1, 1.9 Hz, 2H)*, 4.16 (q, J = 7.1 Hz, 2H), 3.81 (s, 3H)*, 
3.79 (s, 3H), 3.29 (s, 1H), 3.13 (s, 1H)*, 1.33 (t, J = 7.1 Hz, 3H)*, 1.12 (t, J = 7.1 Hz, 3H). 13C NMR (75 
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MHz, CDCl3) δ: 165.2 (d, J = 28.6 Hz)*, 164.5 (d, J = 27.2 Hz), 161.6, 161.5*, 145.2*, 145.0, 137.3 (d, J = 
2.4 Hz), 137.2 (d, J = 2.8 Hz)*, 135.4 (d, J = 0.8 Hz), 135.4 (d, J = 0.8 Hz)*, 134.3 (d, J = 0.4 Hz), 133.6*, 
125.5 (d, J = 2.8 Hz), 125.1 (d, J = 4.5 Hz)*, 111.0, 110.9*, 109.0, 109.0*, 107.0 (d, J = 263,5 Hz), 105.0 (d, 
J = 263.2 Hz)*, 87.3 (d, J = 21.9 Hz)*, 86.5 (d, J = 22.0 Hz), 63.6 (d, J = 0.6 Hz)*, 63.4 (d, J = 0.5 Hz), 
55.6 (1 carbon of the major isomer and 1 carbon of the minor isomer), 14.0*, 13.8. 19F NMR (282 MHz, CDCl3) δ: 
−121.3*, −124.1. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3455 (br, w), 2981 (w), 1752 (s), 1613 (m), 1568 (m), 1474 
(m), 1273 (vs), 1070 (vs), 1013 (vs), 956 (s), 855 (vs), 729 (s), 691 (s) cm–1. HRMS (EI) calcd for 
C14H14O4ClF [M]+: 300.0559; found: 300.0565. 
Tertiary alcohol I.256: 
 
To a solution of lithium bis(trimethylsilyl)amide (1 M in THF, 1.86 mL, 1.86 mmol, 1.05 equiv) in 
tetrahydrofuran (15 mL) was added ethyl chlorofluoroacetate (I.252) (0.226 mL, 1.95 mmol, 1.10 equiv) 
dropwise at −78 °C. After 30 min, 2,3-diphenyl-indenone (I.S1) (500 mg, 1.77 mmol, 1 equiv) was added 
at −78 °C. The solution was allowed to warm to 23 °C. After 4 h, saturated aqueous ammonium chloride 
solution was added and the layers were separated. The aqueous layer was extracted with diethyl ether (3 × 
10 mL) and the combined organic layers were washed with water (30 mL) and saturated aqueous sodium 
chloride solution (30 mL). The washed solution was dried over magnesium sulfate and the dried solution 
was filtered. The filtrate was concentrated and the crude product was purified by flash column 
chromatography on silica gel (12.5% ethyl acetate in hexanes) to provide I.256 (667 mg, 89%, dr = 1:0.6) 
as a colorless oil. 
TLC (20% ethyl acetate in hexanes), Rf = 0.37 (UV, KMnO4). Note: Asterix denote the major isomer. 1H NMR 
(400 MHz, CDCl3) 7.87 (ddd, J = 7.0, 1.6, 0.7 Hz, 1H)*, 7.72 (7.71 (ddd, J = 7.3, 2.1, 1.0 Hz, 1H), 7.38–
7.14 (m, 22.4H, 14 protons of the major isomer and 14 protons of the minor isomer), 4.48 (s, 1H)*, 4.08–3.79 (m, 
2H), 3.97 (s, 1H), 3.76–3.59 (m, 2H)*, 1.10 (t, J = 7.2 Hz, 3H)*, 1.07 (t, J = 7.1 Hz, 3H). 13C NMR (100 
MHz, CDCl3) δ: 165.3 (d, J = 26.7 Hz)*, 164.4 (d, J = 280 Hz), 145.2 (d, J = 1.5 Hz)*, 145.1, 144.1, 
144.0*, 142.8 (d = 1.5 Hz), 141,9*, 141,4, 141.3*, 134.4, 133.8*, 133.5, 133.5*, 130.4*, 130.1, 130.1*, 129.9, 
129.2*, 129.2, 128.5, 128.4*, 128.1*, 128.0, 128,0*, 128.0*, 127.9, 127.8, 127.1, 126.8*, 125.8 (d, J = 1.6 
Hz)*, 124.4 (d, J = 2.2 Hz), 121.3*, 121.2, 107.9 (d, J = 261.8 Hz), 105.4 (d, J = 266.4 Hz)*, 88.5 (d, J = 
21.7 Hz), 87.9 (d, J = 24.4 Hz)*, 63.6, 63.6*, 13.7, 13.6*. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3462 (br, w), 
3055 (w), 2984 (w), 1754 (m), 1443 (m), 1266 (m), 1116 (m), 1040 (m), 953 (s), 881 (m), 697 (vs) cm–1. HRMS 
(ESI) calcd for C25H20O3ClFNa [M+Na]+: 445.09789; found: 445.09827. 
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Cyclopropane I.257: 
 
To a solution of lithium bis(trimethylsilyl)amide (1 M in THF, 1.06 mL, 1.06 mmol, 3.00 equiv) in 
tetrahydrofuran (1 mL) and hexamethylphosphoramide (1 mL) was added ethyl chlorofluoroacetate 
(I.252) (0.123 mL, 1.49 mmol, 3.00 equiv dropwise at −78 °C. After 30 min, 2,3-diphenyl-indenone (I.S1) 
(100 mg, 0.354 mmol, 1 equiv) was added in one portion at −78 °C. The solution was allowed to warm to 
23 °C. After 4 h, saturated aqueous ammonium chloride solution was added and the layers were separated. 
The aqueous layer was extracted with diethyl ether (3 × 10 mL) and the combined organic layers were 
washed with water (30 mL) and saturated aqueous sodium chloride solution (30 mL). The washed solution 
was dried over magnesium sulfate and the dried solution was filtered. The filtrate was concentrated and 
the crude product was purified by flash column chromatography on silica gel (10% ethyl acetate in 
hexanes) to provide I.257 (40 mg, 29%) as a yellow solid. Crystals that were suitable for X-Ray diffraction 
analysis were obtained by crystalliza-tion from dichloromethane/hexanes. 
TLC (20% ethyl acetate in hexanes) Rf = 0.27 (UV). 1H NMR (400 MHz, CDCl3) δ: 7.80 (ddd, J = 7.5, 
1.3, 0.7 Hz, 1H), 7.52 (td, J = 7.5, 1.3 Hz, 1H), 7.48–7.26 (m, 11H), 7.02 (dt, J = 7.7, 0.8 Hz, 1H), 3.83 (qd, 
J = 7.1, 1.5 Hz, 2H), 0.64 (t, J = 7.1 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ: 195.7 (d, J = 4.9 Hz), 164.0 
(d, J = 29.4 Hz), 150.7 (d, J = 5.1 Hz), 135.1, 133.5 (d, J = 0.9 Hz), 132.1 (d, J = 1.9 Hz), 130.8 (d, J = 1.4 
Hz), 130.7 (d, J = 1.6 Hz), 130.4 (d, J = 1.5 Hz), 128.7, 128.7, 128.3, 128.2, 128.0, 126.4, 124.2, 92.0 (d, J = 
248.9 Hz), 61.8 (d, J = 0.8 Hz), 56.1 (d, J = 13.8 Hz), 53.4 (d, J = 12.5 Hz), 13.2. 19F NMR (282 MHz, 
CDCl3) δ: −194.0. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2983 (w), 1741 (vs), 1726 (vs), 1602 (w) 1463 (m), 1277 
(s), 1113 (m), 1014 (m), 743 (m), 699 (vs) cm–1. HRMS (ESI) calcd for C25H19O3FNa [M+Na]+: 409.12159; 
found: 409.12122. 
2-Bromo-2-fluoro-1-morpholine-1-yl-ethanone (I.258): 
 
To a solution of dimethylaluminum chloride (1 M in hexanes, 50 mL, 50 mmol, 2.0 equiv) in 
dichloromethane (100 mL) was added morpholine (4.4 mL, 50 mmol, 2.0 equiv) dropwise at 0 °C. After 
30 min, ethyl bromofluoroacetate (I.253) (3.0 mL, 25 mmol, 1 equiv) was added dropwise and the solution 
was allowed to warm to 23 °C, After 3 h, 0.5 M aqueous hydrochloric acid (100 mL) was carefully added 
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and the layers were separated. The aqueous layer was extracted with dichloromethane (3 × 100 mL) and 
the combined organic layers were washed with saturated aqueous sodium chloride solution (300 mL). The 
washed solution was dried over magnesium sulfate and the dried solution was filtered. The filtrate was 
concentrated and the crude product was purified by flash column chromatography on silica gel (40% ethyl 
acetate in hexanes) to provide I.258 (5.14 g, 91%) as a white solid. The obtained characterization data 
were in full agreement with those values reported in the literature.112e 
DABCO salt (I.259): 
 
To a solution of 2-bromo-2-fluoro-1-morpholine-1-yl-ethanone (I.258) (5.14 g, 22.7 mmol, 1 equiv) in 
dichloromethane (55 mL) was added 1,4-diazabicyclo[2.2.2]octane (2.63 g, 23.4 mmol, 1.03 equiv) at 
23 °C. After 5 h, the precipitate was filtered and the filter cake was washed with dichloromethane 
(100 mL). The crude product was dried under high vacuum to give I.259 (7.40 g, 94%) as a white solid. 
The product was used without further purification. The obtained characterization data were in full 
agreement with those values reported in the literature.112e 
Sulfone I.261a: 
 
Based on a slightly modified literature procedure,116 a solution of 2-mercaptobenzothiazole (I.S2) (1.53 g, 
9.16 mmol, 1.10 equiv) and ethyl bromofluoroacetate (I.253) (1.00 mL, 8.33 mmol, 1 equiv) in 
dichloromethane (10 mL) was treated with triethylamine (1.27 mL, 9.16 mmol, 1.10 equiv) at 23 °C. After 
3 h, dichloromethane (10 mL) was added and the organic layer was washed with 1 M aqueous hydrochloric 
acid (10 mL), saturated aqueous sodium bicarbonate solution (10 mL) and water (10 mL). The washed 
solution was dried over magnesium sulfate and the dried solution was filtered. The filtrate was 
concentrated and the crude product was used in the next step without further purification.  
To a solution of crude thioether in dichloromethane (50 mL) was added meta-chloroperbenzoic acid 
(6.32 g, 27.5 mmol, 3.00 equiv) in three portions at 0 °C. After 30 min, the solution was allowed to warm 
to 23 °C. After 4.5 h, saturated aqueous sodium thiosulfate solution (50 mL) was added and the layers 
were separated. The aqueous layer was extracted with dichloromethane (3 × 50 mL), the combined 
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organic layers were washed with saturated aqueous sodium bicarbonate solution (100 mL) and saturated 
aqueous sodium chloride solution (100 mL). The washed solution was dried over magnesium sulfate and 
the dried solution was filtered. The filtrate was concentrated and the crude product was purified by flash 
column chromatography on silica gel (50% dichloromethane in hexanes) to provide I.261a (616 mg, 22%) 
as a yellow solid. The obtained characterization data were in full agreement with those values reported in 
the literature.154 
Sulfone I.261b: 
 
Based on a slightly modified literature procedure,116 a solution of thiophenol (I.S3) (0.469 mL, 4.58 mmol, 
1.1 equiv) and ethyl bromofluoroacetate (I.253) (0.500 mL, 4.16 mmol, 1 equiv) in dichloromethane 
(5 mL) was treated with triethylamine (0.637 mL, 4.58 mmol, 1.10 equiv) at 23 °C. After 3 h, 
dichloromethane (10 mL) was added and the organic layer was washed with 1 M aqueous hydrochloric 
acid (10 mL), saturated aqueous sodium bicarbonate solution (10 mL) and water (10 mL). The washed 
solution was dried over magnesium sulfate and the dried solution was filtered. The filtrate was 
concentrated and the crude product was used in the next step without further purification.  
To a solution of crude thioether in dichloromethane (25 mL) was added meta-chloroperbenzoic acid 
(2.87 g, 12.5 mmol, 3.00 equiv) in three portions at 0 °C. After 30 min, the solution was allowed to warm 
to 23 °C. After 16 h, saturated aqueous sodium thiosulfate solution (20 mL) was added and the layers were 
separated. The aqueous layer was extracted with dichloromethane (3 × 20 mL), the combined organic 
layers were washed with saturated aqueous sodium bicarbonate solution (50 mL) and saturated aqueous 
sodium chloride solution (50 mL). The washed solution was dried over magnesium sulfate and the dried 
solution was filtered. The filtrate was concentrated and the crude product was purified by flash column 
chromatography on silica gel (20% ethyl acetate in hexanes) to provide I.261b (590 mg, 58%) as a 
colorless oil.  
TLC (20% ethyl acetate in hexanes) Rf = 0.23 (UV, KMnO4). 1H NMR (400 MHz, CDCl3) δ: 7.98–7.91 
(m, 2H), 7.79–7.72 (m, 1H), 7.66–7.58 (m, 2H), 5.56 (d, J = 48.0 Hz, 1H), 4.30 (qd, J = 7.2, 1.1 Hz, 2H), 
1.29 (t, J = 7.1 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ: 161.1 (d, J = 23.8 Hz), 135.5, 134.8, 130.0, 129.5, 
97.5 (d, J = 232.3 Hz), 63.7, 14.1. 19F NMR (376 MHz, CDCl3) δ: –180.33 (d, J = 48.0 Hz). IR 
(Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2985 (w), 1756 (vs), 1448 (m), 1338 (vs), 1243 (s), 1148 (s), 1080 (s), 1019 (m), 
837 (m), 762 (m), 686 (s) cm–1. HRMS (EI) calcd for C10H11FO432S [M]+: 246.0357; found: 246.0361. 
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1,4-Addukt I.262: 
 
In a pressure vessel, a solution of 1-indanone (I.263) (54 mg, 0.407 mmol, 1 equiv), N-bromosuccinimide 
(80 mg, 0.45 mmol, 1.1 equiv) and 2,2’-azobis(2-methylpropionitrile) (0.7 mg, 4.1 µmol, 0.010 equiv) in 
benzene (2.5 mL) was stirred at 80 °C for 18 h. The solution was allowed to cool to 23 °C, and then was 
diluted with water and diethyl ether. The layers were separated and the aqueous layer was extracted with 
diethyl ether (3 × 20 mL). The combined organic layers were washed with water (50 mL) and saturated 
aqueous sodium chloride solution (50 mL) and the washed solution was dried over magnesium sulfate. 
The dried solution was filtered and the filtrate was concentrated. The crude product was used in the next 
step without further purification. 
To a solution of the bromo-indanone in dichloromethane (10 mL) was added triethylamine (0.198 mL, 
1.43 mmol, 3.50 equiv) at 0 °C. The solution was allowed to warm to 23 °C and after 30 min., the solution 
was concentrated. Diethyl ether (20 mL) was added and the mixture was filtered through a short plug of 
Celite. The filtrate was concentrated and the crude product was used in the next step without further 
purification.  
To a solution of the crude indenone, sulfone I.261b (120 mg, 0.488 mmol, 1.20 equiv) and 
hexamethylphosphoramide (0.106 mL, 0.610 mmol, 1.5 equiv) in tetrahydrofuran (2 mL) was added 
lithium bis(trimethylsilyl)amide (1 M in THF, 0.610 mL, 0.610 mmol, 1.50 equiv) dropwise at −78 °C. 
After 2 h, saturated aqueous ammonium chloride solution (10 mL) was added and the layers were 
separated. The aqueous layer was extracted with ethyl acetate (3 × 10 mL) and the combined organic 
layers were washed with saturated aqueous sodium chloride solution (30 mL). The washed solution was 
dried over magnesium sulfate and the dried solution was filtered. The filtrate was concentrated and the 
crude product was purified by flash column chromatography on silica gel (20% ethyl acetate in hexanes) to 
provide I.262 (610 mg, 7%) as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ: 7.95–7.89 (m, 2H), 7.84–7.78 (m, 1H), 7.76–7.70 (m, 1H), 7.61–7.51 (m, 
3H), 7.46 (tt, J = 7.4, 0.9 Hz, 1H), 7.32 (dq, J = 7.9, 0.9 Hz, 1H), 4.74 (ddd, J = 28.2, 8.2, 3.2 Hz, 1H), 
4.14–4.00 (m, 2H), 3.43 (ddd, J = 19.3, 3.1, 0.9 Hz, 1H), 3.00 (ddd, J = 19.3, 8.2, 1.1 Hz, 1H), 1.09 (t, J = 
7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ: 202.9, 164.2 (d, J = 23.5 Hz), 148.9, 138.3, 135.4, 135.2, 
134.9, 130.4, 129.5, 129.4, 126.3, 124.5, 107.5 (d, J = 244.6 Hz), 63.6, 41.0 (d, J = 20.7 Hz), 37.5 (d, J = 3.8 
Hz), 13.7. 19F NMR (282 MHz, CDCl3) δ: −164.3 (d, J = 28.1 Hz). IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2984 
(w), 1717 (vs), 1602 (w), 1448 (m), 1336 (s), 1283 (s), 1159 (s), 1084 (m), 1012 (w), 718 (s) cm–1. HRMS (EI) 
calcd for C19H18FO532S [M+H]+: 377.0853; found: 377.0872. 
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Exo-elimination product I.S4: 
 
To a solution of 1,4-adduct I.262 (10 mg, 0.027 mmol, 1 equiv) in N,N-dimethylformamide (0.3 mL) was 
added 1,4-diazabicyclo[2.2.2]octane (40 µL, 0.27 mmol, 10 equiv) at 23 °C. After 1 h, 1 M aqueous 
hydrochloric acid (5 mL) was carefully added. The aqueous layer was extracted with ethylacetate (3 × 
10 mL) and the combined organic layers were washed with saturated aqueous sodium chloride solution 
(20 mL). The washed solution was dried over magnesium sulfate and the dried solution was filtered. The 
filtrate was concentrated and the crude product was purified by flash column chromatography on silica gel 
(20% ethyl acetate in hexanes) to provide traces I.S4 as yellow oil. The configuration of the double bond 
was not assigned. 
TLC (25% ethyl acetate in hexanes) Rf = 0.51 (UV, CAM). Note: The geometry of the double bond was not 
assigned. 1H NMR (600 MHz, CDCl3) δ: 8.16 (dt, J = 8.0, 0.9 Hz, 1H), 7.88 (ddd, J = 7.7, 1.3, 0.8 Hz, 1H), 
7.74 (dddd, J = 7.9, 7.3, 1.2, 0.6 Hz, 1H), 7.57 (td, J = 7.5, 0.9 Hz, 1H), 4.39 (q, J = 7.2 Hz, 2H), 3.69 (d, J 
= 1.9 Hz, 2H), 1.41 (t, J = 7.1 Hz, 3H). 13C NMR (200 MHz, CDCl3) δ: 201.0, 161.1 (d, J = 33.5 Hz), 
145.9, 143.0 (d, J = 265.4 Hz), 138.0, 135.6, 131.1, 123.8, 128.2 (d, J = 15.6 Hz), 125.2 (d, J = 11.4 Hz), 
62.2, 40.8, 14.4. 19F NMR (376 MHz, Chloroform-d) δ: –123.1 (t, J = 2.0 Hz). IR (Diamond-ATR, neat) 
𝜈𝑚𝑎𝑥: 2988 (w), 1718 (vs), 1663 (m), 1595 (w), 1469 (w), 1371 (m), 1285 (vs), 1136 (m), 1043 (m), 768 (m) cm–
1. HRMS (EI) calcd for C13H11FO3 [M]+: 234.0687; found: 234.0686. 
α-Selenide I.264: 
 
To a solution of sodium hydride (182 mg, 4.54 mmol, 2.00 equiv) and dimethyl carbonate (0.383 mL, 
4.54 mmol, 2.00 equiv) in tetrahydrofuran (10 mL) was added a solution of 1-indanone (I.263) (300 mg, 
2.27 mmol, 1 equiv) in tetrahydrofuran (10 mL) at 23 °C and the mixture was heated to 70 °C. After 14 h, 
saturated aqueous ammonium chloride solution (20 mL) was added and the layers were separated. The 
aqueous layer was extracted with ethyl acetate (3 × 20 mL) and the combined organic layers were washed 
with saturated aqueous sodium chloride solution (40 mL). The washed solution was dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The crude product was used in 
the next step without further purification. 
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To a solution of phenylselenyl chloride (478 mg, 2.50 mmol, 1.10 equiv) in dichloromethane (4 mL) were 
added pyridine (0.275 mL, 3.41 mmol, 1.5 equiv) and a solution of the crude indanone in dichloromethane 
(5 mL) at 0 °C. After 4 h, 1 M aqueous hydrochloric acid (10 mL) was added and the layers were separated. 
The aqueous layer was extracted with dichloromethane (3 × 20 mL) and the combined organic layers were 
washed with saturated sodium bicarbonate solution (40 mL) and saturated aqueous sodium chloride 
solution (40 mL). The washed solution was dried over sodium sulfate and the dried solution was filtered. 
The filtrate was concentrated and the crude product was purified by flash column chromatography on 
silica gel (20% ethyl acetate in hexanes) to provide I.264 (693 mg, 80%) as an orange oil. 
TLC (20% ethyl acetate in hexanes) Rf = 0.26 (UV, KMnO4). 1H NMR (400 MHz, CD2Cl2) δ: 7.69 (d, J 
= 7.7 Hz, 1H), 7.52 (td, J = 7.5, 1.2 Hz, 1H), 7.50–7.45 (m, 2H), 7.37–7.28 (m, 2H), 7.23 (dt, J = 7.7, 1.0 
Hz, 1H), 7.21–7.16 (m, 2H), 3.91 (d, J = 18.3 Hz, 1H), 3.74 (s, 3H), 3.28 (d, J = 18.3 Hz, 1H). 13C NMR 
(100 MHz, CD2Cl2) δ: 197.6, 170.1, 150.9, 138.1, 135.6, 134.9, 130.1, 129.1, 128.3, 126.7, 126.3, 125.0, 
57.3, 39.4. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3056 (w), 2951 (w), 1736 (s), 1708 (vs), 1606 (m), 1437 (m), 
1242 (s), 1172 (m), 1074 (m), 1000 (m), 743 (s), 692 (s) cm–1. HRMS (EI) calcd for C17H14O3Se [M]+: 
346.0103; found: 346.0101. 
β-Keto ester I.266: 
 
A solution of 1-indanone (I.263) (1.66 g, 12.5 mmol, 1 equiv) and tert-butyl 1H-imidazole-1-carboxylate 
(4.22 g, 25.1 mmol, 2.00 equiv) in tetrahydrofuran (20 mL) was added to a suspension of sodium hydride 
(1.00 g, 25.1 mmol, 2.00 equiv) at 0 °C. The resulting mixture was stirred at 70 °C for 7.5 h. The reaction 
mixture was allowed to cool to 23 °C and then was diluted with saturated aqueous ammonium chloride 
solution (40 mL). The layers were separated and the aqueous layer was extracted with ethyl acetate 
(3 × 50 mL). The combined organic layers were washed with saturated aqueous sodium chloride solution 
(100 mL), the washed organic solution was dried over sodium sulfate and the dried solution was filtered. 
The filtrate was concentrated and the crude product was purified by flash column chromatography on 
silica gel (15% ethyl acetate in hexanes) to afford I.266 (2.59 g, 89%) as a brown oil. The obtained 
characterization data were in full agreement with those values reported in the literature.155 
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α-Selenide I.268: 
 
To a solution of phenylselenyl chloride (91 mg, 0.47 mmol, 1.1 equiv) in dichloromethane (2 mL) were 
added pyridine (0.052 mL, 0.65 mmol, 1.5 equiv) and a solution of the β-keto ester I.266 (0.10 g, 
0.43 mmol, 1 equiv) in dichloromethane (2 mL) at 0 °C. After 3.5 h, 1 M aqueous hydrochloric acid 
(10 mL) was added and the layers were separated. The aqueous layer was extracted with dichloromethane 
(3 × 20 mL) and the combined organic layers were washed with saturated sodium bicarbonate solution 
(40 mL) and saturated aqueous sodium chloride solution (40 mL). The washed solution was dried over 
sodium sulfate and the dried solution was filtered. The filtrate was concentrated and the crude product 
was purified by flash column chromatography on silica gel (15% ethyl acetate in hexanes) to provide I.268 
(152 mg, 95%) as an orange oil. 
TLC (20% ethyl acetate in hexanes) Rf = 0.53 (UV, KMnO4). 1H NMR (400 MHz, CD2Cl2) δ: 7.66 (d, J 
= 7.7 Hz, 1H), 7.50–7.40 (m, 3H), 7.31 (t, J = 7.5 Hz, 1H), 7.25 (t, J = 7.3 Hz, 1H), 7.17 (d, J = 7.8 Hz, 
1H), 7.13 (t, J = 7.6 Hz, 2H), 3.86 (d, J = 18.2 Hz, 1H), 3.25 (d, J = 18.2 Hz, 1H), 1.43 (s, 9H). 13C NMR 
(101 MHz, CD2Cl2) δ: 198.5, 168.5, 151.2, 137.9, 135.3, 135.2, 129.7, 128.9, 128.1, 126.9, 126.2, 124.8, 
83.5, 58.6, 39.6, 27.9. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2979 (w), 1705 (vs), 1605 (m) 1464 (m), 1368 (m), 
1249 (s), 1146 (vs), 1079 (m), 989 (m), 906 (m), 954 (s), 839 (m), 740 (vs), 692 (s) cm–1. HRMS (EI) calcd for 
C20H20O380Se [M]+: 388.0572; found: 388.0575. 
β-Keto ester I.267: 
 
To a solution of lithium diisopropylamide (freshly prepared from diisopropylamine (0.32 mL, 2.3 mmol, 
1.5 equiv) and n-butyl lithium (2.3 M in hexanes, 0.97 mL, 2.3 mmol, 1.5 equiv)) in tetrahydrofuran (1 mL) 
was added a solution of 5-methoxy-1.indanone (I.265) (0.24 g, 1.5 mmol, 1 equiv) in tetrahydrofuran 
(2 mL) at −78 °C. After 15 min, tert-butyl 1H-imidazole-1-carboxylate (0.38 g, 2.3 mmol, 1.5 equiv) in one 
portion and the reaction mixture was allowed to warm slowly to 23 °C. After 23 h, saturated aqueous 
ammonium chloride solution (10 mL) was added and the layers were separated. The aqueous layer was 
extracted with diethyl ether (3 × 20 mL) and the combined organic layers were washed with saturated 
aqueous sodium chloride solution (40 mL). The washed solution was dried over sodium sulfate and the 
dried solution was filtered. The filtrate was concentrated and the crude product was purified by flash 
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column chromatography on silica gel (5% ethyl acetate in hexanes) to provide I.267 (0.17 g, 42%) as a 
white solid.156 
α-Selenide I.269: 
 
To a solution of phenylselenyl chloride (133 mg, 0.692 mmol, 1.10 equiv) in dichloromethane (3 mL) were 
added pyridine (76.0 µL, 0.944 mmol, 1.50 equiv) and a solution of the β-keto ester I.267 (165 mg, 
0.629 mmol, 1 equiv) in dichloromethane (2 mL) at 0 °C. After 6 h, 1 M aqueous hydrochloric acid 
(20 mL) was added and the layers were separated. The aqueous layer was extracted with dichloromethane 
(3 × 20 mL) and the combined organic layers were washed with saturated sodium bicarbonate solution 
(40 mL) and saturated aqueous sodium chloride solution (40 mL). The washed solution was dried over 
sodium sulfate and the dried solution was filtered. The filtrate was concentrated and the crude product 
was purified by flash column chromatography on silica gel (dichloromethane) to provide I.269 (205 mg, 
71%) as a yellow oil. 
TLC (dichloromethane): Rf = 0.56 (UV, CAM, KMnO4). 1H NMR (400 MHz, CH2Cl2) δ: 7.57 (d, J = 8.6 
Hz, 1H), 7.50–7.44 (m, 2H), 7.28–7.22 (m, 1H), 7.13 (t, J = 7.6 Hz, 2H), 6.83 (dd, J = 8.5, 2.1 Hz, 1H), 
6.62–6.52 (m, 1H), 3.81 (d, J = 18.1 Hz, 1H), 3.78 (s, 3H), 3.20 (d, J = 18.2 Hz, 1H), 1.43 (s, 9H). 13C 
NMR (100 MHz, CD2Cl2) δ: 196.5, 168.3, 165.7, 154.1, 137.5, 129.2, 128.5, 127.9, 126.6, 126.1, 115.7, 
108.8, 83.0, 59.0, 55.7, 39.3, 27.6. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2980 (w), 1703 (s), 1598 (s), 1490 (w), 
1369 (m), 1253 (vs), 1148 (vs), 1082 (m), 1023 (m), 953 (vs), 845 (m), 709 (m) cm–1. HRMS (EI) calcd for 
C21H22O480Se [M]+: 418.0678; found: 418.0665. 
Triethylamine salt I.276: 
 
To a solution of diethylaluminum chloride (1 M in hexanes, 3.33 mL, 3.33 mmlol, 2.00 equiv) in 
dichloromethane (15 mL) was added diethylamine (0.343 mL, 3.33 mmol, 2.00 equiv) dropwise at 0 °C. 
After 30 min, ethyl bromofluoroacetate (I.253) (0.200 mL, 1.67 mmol, 1 equiv) was added dropwise and 
the solution was allowed to warm to 23 °C, After 4 h, 0.5 M aqueous hydrochloric acid (15 mL) was 
carefully added and the layers were separated. The aqueous layer was extracted with dichloromethane (3 × 
20 mL) and the combined organic layers were washed with saturated aqueous sodium chloride solution 
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(30 mL). The washed solution was dried over sodium sulfate, the dried solution was filtered and the 
filtrate was concentrated. The crude product was used in the next step without further purification.  
To a solution of crude 2-bromo-2-fluoro-N,N-dimethylacetamide (354 mg 1.67 mmol, 1 equiv) in 
tetrahydrofuran (3 mL) was added triehylamine (0.136 mL, 1.72 mmol, 1.03 equiv) at 23 °C. After 2 h, the 
precipitate was filtered and the filter cake was washed with ethyl acetate (20 mL). The crude product was 
dried under high vacuum to give I.276 (393 mg, 84%) as a white solid. The product was used without 
further purification.  
M.p.: 142 °C. 1H NMR (400 MHz, CDCl3) δ: 7.74 (d, J = 42.8 Hz, 1H), 4.07 (dqd, J = 14.5, 7.1, 2.8 Hz, 
1H), 3.67 (d, J = 1.7 Hz, 11H), 3.58–3.45 (m, 1H), 3.47–3.35 (m, 1H), 3.38–3.26 (m, 1H), 1.30 (t, J = 7.1 
Hz, 3H), 1.19 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ: 159.2 (d, J = 21.1 Hz), 96.0 (d, J = 
228.0 Hz), 51.1 (d, J = 2.5 Hz), 43.4, 41.9, 14.8, 12.6. 19F NMR (376 MHz, CDCl3) δ: –165.2 (d, J = 43.4 
Hz). IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2976 (w), 1666 (vs), 1473 (m), 1360 (m), 1276 (m), 1212 (m), 1130 (m), 
1105 (s), 961 (s), 877 (s), 694 (s) cm–1. HRMS (ESI) calcd for C9H20FN2O [M–Br]+: 191.15542; 
found:191.15553. 
Fluoro-cyclopropane I.277: 
 
T a solution of α-selenide I.268 (103 mg, 0.266 mmol, 1 equiv) in dichloromethane (20 mL) was added 
hydrogen peroxide (30% in H2O, 81.5 µL, 0.798 mmol, 3.00 equiv) dropwise at 0 °C. After 2 h, 
dichlormethane (20 mL) and the solution was washed with saturated aqueous sodium bicarbonate solution 
(40 mL). The washed solution was dried over sodium sulfate and the dried soltion was concentrated. The 
crude product was used in the next step without further purification.  
To DABCO salt I.259 (98.9 mg, 0.293 mmol, 1.10 equiv) and cesium carbonate (433 mg, 1.33 mmol, 
5.00 equiv) was added a solution of crude indenone in 1,4-dioxane (5 mL) and the mixture was heated to 
50 °C. After 14 h, the suspension was filtered through a short plug of Celite. The filtrate was concentrated 
and the crude product was purified by flash column chromatography on silica gel (25% ethyl acetate in 
hexanes) to provide I.277 (15 mg, 15%) as a yellow oil. 
TLC (25% ethyl acetate in hexanes) Rf = 0.21 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 7.73 (d, J = 
7.6 Hz, 1H), 7.66–7.57 (m, 2H), 7.47–7.41 (m, 1H), 4.22 (s, 1H), 3.86–3.45 (m, 8H), 1.46 (s, 9H). 13C 
NMR (100 MHz, CDCl3) δ: 191.3 (d, J = 4.3 Hz), 163.3, 161.1 (d, J = 22.4 Hz), 144.2 (d, J = 3.6 Hz), 
135.8, 135.4, 128.8, 126.9, 124.6, 94.0 (d, J = 259.9 Hz), 83.7, 66.6, 66.5, 49.5 (d, J = 14.9 Hz), 46.5 (d, J = 
6.6 Hz), 43.3, 36.3 (d, J = 12.3 Hz), 28.1. 19F NMR (376 MHz, CDCl3) δ: –193.3. IR (Diamond-ATR, 
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neat) 𝜈𝑚𝑎𝑥: 2979 (w), 1622 (vs), 1665 (vs) 1441 (s), 1370 (s), 1303 (s), 1238 (s), 1152 (vs), 1116 (vs), 914 (s), 
849 (m), 731 (m) cm–1. HRMS (EI) calcd for C20H22FNO5 [M]+: 375.1482; found: 375.1473. 
Fluoro-cyclopropane I.278: 
 
T a solution of α-selenide I.269 (185 mg, 0.443 mmol, 1 equiv) in dichloromethane (20 mL) was added 
hydrogen peroxide (30% in H2O, 0.136 mL, 1.33 mmol, 3.00 equiv) dropwise at 0 °C. After 2 h, 
dichlormethane (20 mL) and the solution was washed with saturated aqueous sodium bicarbonate solution 
(40 mL). The washed solution was dried over sodium sulfate and the dried soltion was concentrated. The 
crude product was used in the next step without further purification.  
To DABCO salt I.259 (165 mg, 0.488 mmol, 1.10 equiv) and cesium carbonate (722 mg, 2.22 mmol, 
5.00 equiv) was added a solution of crude indenone in 1,4-dioxane (9 mL) and the mixture was heated to 
50 °C. After 12 h, the suspension was filtered through a short plug of Celite. The filtrate was concentrated 
and the crude product was purified by flash column chromatography on silica gel (25% ethyl acetate in 
hexanes) to provide I.278 (37 mg, 21%) as a yellow oil. 
TLC (25% ethyl acetate in hexanes): Rf = 0.14 (UV, CAM). 1H NMR (300 MHz, CDCl3) δ: 7.64 (d, J = 
8.5 Hz, 1H), 7.04 (d, J = 2.2 Hz, 1H), 6.91 (dd, J = 8.5, 2.3 Hz, 1H), 4.10 (d, J = 1.3 Hz, 1H), 3.89 (s, 3H), 
3.81–3.47 (m, 8H), 1.45 (s, 9H). 13C NMR (75 MHz, CDCl3) δ: 189.4 (d, J = 4.0 Hz), 165.8, 163.4, 161.2 
(d, J = 22.5 Hz), 147.2 (d, J = 3.9 Hz), 128.6, 126.4, 115.5, 111.5, 93.5 (d, J = 259.8 Hz), 83.5, 66.6, 66.5, 
56.0, 49.7 (d, J = 15.1 Hz), 46.5 (d, J = 6.7 Hz), 43.3, 35.7 (d, J = 12.3 Hz), 28.1. 19F NMR (282 MHz, 
CDCl3) δ: –193.4. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2977 (w), 1716 (s), 1661 (s), 1600 (s), 1441 (m), 1369 
(m), 1248 (vs), 1152 (vs), 1084 (vs), 907 (s), 834 (s), 728 (vs) cm–1. HRMS (EI) calcd for C21H24FNO6 [M]+: 
405.1582; found: 405.1572. 
Bromo-cyclopropane I.286: 
 
To a solution of bromo-cyclopropane I.284 (20 mg, 0.068 mmol, 1 equiv) in methanol (1.2 mL) and water 
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(0.6 mL) was added potassium carbonate (47 mg, 0.34 mmol, 5.0 equiv) at 23 °C. After 2 h, 2 M aqueous 
hydrochloric acid (5 mL) was carefully added and the layers were separated. The aqueous layer was 
extracted with dichloromethane (3 × 10 mL) and the combined organic layers were washed with saturated 
aqueous sodium chloride solution (20 mL). The washed solution was dried over sodium sulfate, the dried 
solution was filtered and the filtrate was concentrated. The crude product was used in the next step 
without further purification.  
To a solution of the crude acid in dichloromethane (3 mL) were added 3,4-dimethoxyaniline (13 mg, 
0.081 mmol, 1.2 equiv), N,N’-dicyclohexylcarbidiimide (DCC) (17 mg, 0.081 mmol, 1.2 equiv) and 4-
dimethylaminopyridine (1.7 mg, 0.014 mmol, 0.20 equiv) at 23 °C, After 20 h, the solution was 
concentrated and the crude product was purified by flash column chromatography (10% ethyl acetate in 
hexanes) to provide I.286 (12 mg, 44%) as colorless oil, which contains minor impurities of N,N’-
dicyclohexylcarbidiimide. 
TLC (50% ethyl acetate in hexanes) Rf = 0.47 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 8.52 (s, 1H), 
7.70 (ddt, J = 7.6, 1.3, 0.6 Hz, 1H), 7.60 (td, J = 7.4, 1.2 Hz, 1H), 7.53 (dt, J = 7.6, 0.9 Hz, 1H), 7.45 (td, J 
= 7.4, 1.1 Hz, 1H), 7.25 (d, J = 2.5 Hz, 1H), 6.93 (dd, J = 8.6, 2.4 Hz, 1H), 6.84 (d, J = 8.6 Hz, 1H), 3.90 
(s, 3H), 3.88 (s, 3H), 3.73 (d, J = 5.9 Hz, 1H), 3.21 (d, J = 5.9 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ: 
197.4, 162.8, 149.8, 149.2, 146.8, 136.1, 134.6, 130.3, 129.0, 126.6, 124.5, 112.7, 111.3, 105.1, 60.0, 56.2, 
56.1, 38.7, 34.4. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3336 (w), 2935 (w), 2254 (w), 1715 (s) 1669 (s), 1605 (s), 
1512 (vs), 1464 (s), 1406 (m), 1226 (s), 1136 (s), 1025 (s), 910 (s), 727 (vs) cm–1. HRMS (EI) calcd for 
C19H16BrNO4 [M]+: 401.0257; found: 401.0250. 
Chloronaphthol I.292: 
 
A solution of cyclopropane I.279 (50 mg, 0.21 mmol, 1 equiv) potassium fluoride (14 mg, 0.23 mmol, 
1.1 equiv), tetraphenylphosphonium bromide (4.4 mg, 0.011 mmol, 0.050 equiv) and 4-fluoronitrobenzene 
(25 µL, 0.23 mmol, 1.1 equiv) in sulfolane (2 mL) was heated to 170 °C. After 0.5 h, water (10 mL) and 
diethyl ether (10 mL) were added and the layers were separated. The aqueous layer was extracted with 
diethyl ether (3 × 20 mL) and the combined organic layers were washed with saturated aqueous sodium 
chloride solution (30 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography (15% ethyl acetate in hexanes) to provide I.292 (47 mg, 62%) as an orange solid. 
TLC (20% ethyl acetate in hexanes) Rf = 0.61 (UV). 1H NMR (400 MHz, CDCl3) δ: 8.54 (dt, J = 8.5, 1.0 
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Hz, 1H), 8.25–8.19 (m, 2H), 8.03 (ddd, J = 8.3, 1.3, 0.7 Hz, 1H), 7.74 (ddd, J = 8.5, 6.9, 1.3 Hz, 1H), 7.65 
(ddd, J = 8.3, 6.9, 1.2 Hz, 1H), 7.48 (s, 1H), 7.10–7.03 (m, 2H), 3.97 (s, 3H). 13C NMR (100 MHz, CDCl3) 
δ: 166.0, 163.1, 149.5, 143.3, 132.7, 129.4, 129.2, 129.0, 129.0, 127.8, 126.6, 126.4, 122.1, 117.4, 116.4, 53.0. 
IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2952 (w), 1732 (m), 1589 (s), 1517 (s), 1454 (m), 1339 (vs), 1240 (vs), 1163 
(m), 1110 (m), 1062 (m), 861 (m), 764 (m) (vs) cm–1. HRMS (EI) calcd for C18H1235ClNO5 [M]+: 357.0399; 
found: 357.0401. 
Cyclopropane I.293: 
 
In a pressure vessel, a solution of 1-indanone (I.263) (106 mg, 0.800 mmol, 1 equiv), N-bromosuccinimide 
(157 mg, 0.88 mmol, 1.10 equiv) and 2,2’-azobis(2-methylpropionitrile) (1.3 mg, 8.00 µmol, 0.0100 equiv) 
in benzene (4 mL) was stirred at 80 °C for 8 h. The solution was allowed to cool to 23 °C, and then was 
diluted with water and diethyl ether. The layers were separated and the aqueous layer was extracted with 
diethyl ether (3 × 20 mL). The combined organic layers were washed with water (50 mL) and saturated 
aqueous sodium chloride solution (50 mL) and the washed solution was dried over magnesium sulfate. 
The dried solution was filtered and the filtrate was concentrated. The crude product was used in the next 
step without further purification. 
To a solution of the bromo-indanone in dichloromethane (8 mL) was added triethylamine (0.556 mL, 
4.00 mmol, 5.00 equiv) at 0 °C. The solution was allowed to warm to 23 °C and after 30 min., the solution 
was concentrated. Diethyl ether (20 mL) was added and the mixture was filtered through a short plug of 
Celite. The filtrate was concentrated and the crude product was used in the next step without further 
purification.  
To a solution of (ethoxycarbonylmethyl)dimethylsulfonium bromide (I.296) (183 mg, 0.800 mmol, 
1 equiv) in acetonitrile (1 mL) was added 1,8-diazabicyclo[5.4.0]undec-7-ene (0.143 mL, 0.960 mmol, 
1.20 equiv) dropwise at 0 °C. After 45 min the crude indenone (I.295) in acetonitrile (3 mL) was dropwise 
and the solution was allowed to warm to 23 °C. After 15 h, 1 M aqueous hydrochloric acid (10 mL) was 
added and the layers were separated. The aqueous layer was extracted with ethyl acetate (3 × 20 mL) and 
the combined organic layers were washed with water (30 mL) and saturated aqueous sodium chloride 
solution (30 mL). The washed solution was dried over magnesium sulfate and the dried solution was 
filtered. The filtrate was concentrated and the crude product was purified by flash column 
chromatography on silica gel (10% ethyl acetate in hexanes) to provide I.293 (54 mg, 31%) as a yellow oil. 
The obtained characterization data were in full agreement with those values reported in the literature.157 
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TMS-cyclopropanes I.297 and I.S5: 
 
To a solution of cyclopropane I.293 (156 mg, 0.721 mmol, 1 equiv) and trimethylsilyl chloride (0.461 mL, 
3.60 mmol, 5.00 equiv) was added a solution of lithium diisopropylamide (freshly prepared from 
diisopropylamine (0.204 mL, 1.44 mmol, 2.00 equiv) and n-butyl lithium (2.3 M in hexanes, 0.624 mL, 
1.44 mmol, 2.00 equiv)) in tetrahydrofuran (0.4 mL) dropwise at −78 °C and the solution was allowed to 
warm slowly to 23 °C. After 23.5 h, saturated aqueous bicarbonate solution (10 mL) was added and the 
layers were separated. The aqueous layer was extracted with ethyl acetate (3 × 10 mL) and the combined 
organic layers were washed with saturated aqueous sodium chloride solution (30 mL). The washed 
solution was dried over magnesium sulfate and the dried solution was filtered. The filtrate was 
concentrated and the crude mixture was purified by flash column chromatography on silica gel (15% ethyl 
acetate in hexanes) to provide I.297 (62 mg, 30%) as a yellow oil and I.S5 (54 mg, 26%) as a yellow oil. 
I.297: TLC (20% ethyl acetate in hexanes), Rf = 0.72 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 7.61 (d, 
J = 7.5 Hz, 1H), 7.53–7.43 (m, 2H), 7.34–7.25 (m, 1H), 4.23–4.07 (m, 2H), 3.28 (d, J = 3.0 Hz, 1H), 2.14 
(d, J = 3.0 Hz, 1H), 1.27 (t, J = 7.1 Hz, 3H), 0.23 (s, 9H). 13C NMR (100 MHz, CDCl3) δ: 203.3, 168.3, 
153.2, 133.9, 133.8, 127.5, 125.0, 124.8, 61.4, 48.5, 33.6, 31.0, 14.3, −0.8. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 
2955 (w), 1729 (s), 1703 (vs), 1603 (m), 1468 (m), 1406 (m), 1247 (s), 1182 (vs), 1110 (s), 1048 (m), 992 (m), 
803 (vs), 759 (vs) cm–1. HRMS (EI) calcd for C16H20O3Si [M]+: 288.1176; found: 288.1164. 
I.S5: TLC (15% ethyl acetate in hexanes), Rf = 0.47 (UV, CAM). 1H NMR (600 MHz, CDCl3) δ: 7.62–
7.56 (m, 1H), 7.54–7.42 (m, 2H), 7.31 (ddd, J = 7.5, 6.2, 2.2 Hz, 1H), 3.83 (dddd, J = 17.9, 10.8, 7.1, 3.7 
Hz, 2H), 3.15 (d, J = 7.9 Hz, 1H), 2.54 (d, J = 7.8 Hz, 1H), 0.93 (t, J = 7.1 Hz, 2H), 0.18 (s, 9H). 13C 
NMR (150 MHz, CDCl3) δ: 202.3, 168.5, 147.2, 138.2, 133.3, 127.9, 125.7, 123.0, 61.2, 44.9, 32.4, 31.1, 
13.8, –2.7. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2957 (w), 1701 (vs), 1606 (m), 1464 (m), 1382 (w), 1249 (s), 
1173 (vs), 1113 (s), 1029 (m), 924 (m), 840 (vs), 756 (s) cm–1. HRMS (EI) calcd for C16H20O3Si [M]+: 
288.1176; found: 288.1164. 
Exo-enone I.299: 
 
To a solution of lithium diisopropylamide (freshly prepared from diisopropylamine (0.071 mL, 0.16 mmol, 
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1.1 equiv) and n-butyl lithium (2.3 M in hexanes, 0.023 mL, 0.16 mmol, 1.1 equiv)) in tetrahydrofuran 
(0.5 mL) was added a solution of cyclopropane I.297 (43 mg, 0.15 mmol, 1 equiv) in tetrahydrofuran 
(1 mL) dropwise at −78 °C and the solution was allowed to warm slowly to −15 °C. After 1 h, the 
solution was allowed to warm to −8 °C and NFSI (I.170) (71 mg, 0.22 mmol, 1.5 equiv) was added. After 
45 min, saturated aqueous ammonium chloride solution (10 mL) was added and the layers were separated. 
The aqueous layer was extracted with diethyl ether (3 × 15 mL) and the combined organic layers were 
washed with water (30 mL) and saturated aqueous sodium chloride solution (30 mL). The washed solution 
was dried over magnesium sulfate and the dried solution was filtered. The filtrate was concentrated and 
the crude product was purified by flash column chromatography (10% ethyl acetate in hexanes) to provide 
I.298 (15 mg, 33%) as colorless oil, which contains minor impurities. 
A solution of cyclopropane I.298 (10 mg, 0.33 mmol, 1 equiv) in sulfolane (0.2 mL) was heated to 190 °C. 
After 1 h, water (10 mL) and diethyl ether (10 mL) were added and the layers were separated. The aqueous 
layer was extracted with diethyl ether (3 × 20 mL) and the combined organic layers were washed with 
saturated aqueous sodium chloride solution (30 mL). The washed solution was dried over magnesium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The crude product was purified by 
flash column chromatography (10% ethyl acetate in hexanes) to provide I.299 (1 mg, 13%) as a yellow oil. 
Crystals that were suitable for X-Ray diffraction analysis were obtained by crystalliza-tion from 
dichloromethane/hexanes. 
1H NMR (800 MHz, CDCl3) δ: 7.86 (d, J = 7.6 Hz, 1H), 7.64 (td, J = 7.5, 1.2 Hz, 1H), 7.52 (ddt, J = 7.6, 
1.9, 0.8 Hz, 1H), 7.44–7.41 (m, 1H), 4.41 (q, J = 7.1 Hz, 2H), 4.12 (d, J = 0.9 Hz, 2H), 1.42 (t, J = 7.1 Hz, 
3H). 13C NMR (200 MHz, CDCl3) δ: 191.2, 161.2 (d, J = 33.9 Hz), 149.4, 147.0 (d, J = 290.2 Hz), 137.9, 
135.5, 128.1, 126.3, 125.1 (d, J = 5.0 Hz), 124.7, 62.7, 31.6, 14.3. 19F NMR (376 MHz, CDCl3) δ: –115.3. 
IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2924 (w), 1706 (vs), 1603 (m), 1469 (w), 1365 (m), 1308 (vs), 1274 (s), 1182 
(s), 1122 (m), 1008 (m), 895 (m), 744 (s) cm–1. HRMS (EI) calcd for C13H11FO3 [M]+: 234.0687; found: 
234.0687. 
2-Bromo-2-methyl-1-indanone (I.319): 
 
To a solution of 2-methyl-1-indanone (I.300) (0.940 mL, 6.84 mmol, 1 equiv) in ethyl acetate (30 mL) and 
chloroform (30 mL) was added 4 Å molecular sieves (6.84 g) and copper(II) bromide (3.06 g, 13.7 mmol, 
2.00 equiv) and the suspension was heated to 70 °C. After 16 h, the solution was filtered through a short 
plug of silica and the filter cake was washed with ethyl acetate. The filtrate was concentrated and I.319 was 
obtained a pale yellow solid. The crude product was used in the next step without further purification. The 
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obtained characterization data were in full agreement with those values reported in the literature.158 
Cyclopropane I.302: 
 
To a solution of the bromo-indanone I.319 (1.54 g, 6.84 mmol, 1 equiv) in benzene (14 mL) was added 
1,8-diazabicyclo[5.4.0]undec-7-ene (3.07 mL, 20.5 mmol, 3.00 equiv) at 0 °C. After 1 h, diethyl ether 
(40 mL) was added and the organic layer was washed with saturated aqueous ammonium chloride solution 
(2 × 30 mL) saturated aqueous sodium chloride solution (30 mL). The washed solution was dried over 
magnesium sulfate, the dried solution was filtered and the filtrate was concentrated. The crude product 
was used in the next step without further purification. 
To a solution of (ethoxycarbonylmethyl)dimethylsulfonium bromide (I.296) (1.57 g, 6.84 mmol, 1 equiv) 
in acetonitrile (8.5 mL) was added 1,8-diazabicyclo[5.4.0]undec-7-ene (1.23 mL, 8.21 mmol, 1.20 equiv) 
dropwise at 0 °C. After 45 min the crude indenone I.301 in acetonitrile (20 mL) was dropwise and the 
solution was allowed to warm to 23 °C. After 15 h, 1 M aqueous hydrochloric acid (30 mL) was added and 
the layers were separated. The aqueous layer was extracted with ethyl acetate (3 × 30 mL) and the 
combined organic layers were washed with water (100 mL) and saturated aqueous sodium chloride 
solution (100 mL). The washed solution was dried over magnesium sulfate and the dried solution was 
filtered. The filtrate was concentrated and the crude product was purified by flash column 
chromatography on silica gel (5% ethyl acetate in hexanes) to provide I.302 (784 mg, 50%) as a yellow oil.  
TLC (20% ethyl acetate in hexanes), Rf = 0.40 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 7.65 (d, J = 
7.7 Hz, 1H), 7.48 (t, J = 7.5 Hz, 1H), 7.43 (d, J = 7.6 Hz, 1H), 7.30 (t, J = 7.5 Hz, 1H), 4.16 (q, J = 7.4 Hz, 
2H), 3.25 (d, J = 2.8 Hz, 1H), 2.22 (d, J = 2.2 Hz, 2H), 1.58 (s, 3H), 1.25 (t, J = 7.1 Hz, 3H). 13C NMR 
(100 MHz, CDCl3) δ: 202.4, 167.4, 152.0, 134.5, 133.0, 127.7, 125.2, 124.8, 61.4, 48.0, 38.2, 32.4, 14.5, 8.4. 
IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2981 (w), 1711 (vs), 1609 (m), 1469 (m), 1406 (m), 1296 (m), 1177 (s), 1096 
(w), 1045 (w), 964 (w), 757 (m) cm–1. HRMS (EI) calcd for C14H14O3 [M]+: 230.0937; found: 230.0945. 
Experimental Procedures 
215 
 
Tosyl acetate I.309: 
 
A solution of ethyl bromofluoroacetate (I.253) (60 µL, 0.50 mmol, 1 equiv), N,N-ditosylhydrazine (0.17 g, 
0.50 mmol, 1 equiv) and potassium carbonate (69 mg, 0.50 mol, 1 equiv) in toluene (2 mL) was heated to 
110 °C. After 5 h, the solution was allowed to cool to 23 °C. The solution was filtered and the filter cake 
was washed with ethyl acetate. The filtrate was concentrated and the crude product was purified by flash 
column chromatography (10% ethyl acetate in hexanes) to provide I.309 (92 mg, 71%) as colorless oil. 
1H NMR (400 MHz, CDCl3) δ: 7.81 (d, J = 8.3 Hz, 2H), 7.40 (d, J = 8.0 Hz, 2H), 5.54 (d, J = 48.1 Hz, 
1H), 4.31 (q, J = 7.2 Hz, 2H), 2.47 (s, 3H), 1.30 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ: 161.3 
(d, J = 23.2 Hz), 146.9, 131.6, 130.2, 130.0, 97.5 (d, J = 231.6, Hz) 63.6, 22.0, 14.1. IR (Diamond-ATR, 
neat) 𝜈𝑚𝑎𝑥: 2984 (w), 1758 (vs), 1596 (m), 1340 (vs), 1242 (s), 1198 (m), 1146 (s), 1109 (s), 1018 (m), 816 (m), 
669 (m) cm–1. HRMS (EI) calcd for C11H13FO432S [M]+: 260.0513; found: 260.0513. 
Diol I.316: 
 
In a pressure vessel, a solution of 1-indanone (I.263) (96.0 mg, 0.725 mmol, 1 equiv), N-
bromosuccinimide (142 mg, 0.798 mmol, 1.1 equiv) and 2,2’-azobis(2-methylpropionitrile) (1.2 mg, 4.1 
µmol, 0.010 equiv) in benzene (3.5 mL) was stirred at 80 °C for 18 h. The solution was allowed to cool to 
23 °C, and then was diluted with water and diethyl ether. The layers were separated and the aqueous layer 
was extracted with diethyl ether (3 × 20 mL). The combined organic layers were washed with water 
(50 mL) and saturated aqueous sodium chloride solution (50 mL) and the washed solution was dried over 
magnesium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude product 
was used in the next step without further purification. 
To a solution of the bromo-indanone in dichloromethane (5 mL) was added triethylamine (0.353 mL, 
2.54 mmol, 3.50 equiv) at 0 °C. The solution was allowed to warm to 23 °C and after 30 min., the solution 
was concentrated. Diethyl ether (20 mL) was added and the mixture was filtered through a short plug of 
Celite. The filtrate was concentrated and the crude product was used in the next step without further 
purification.  
To a solution of the crude indenone in acetone (2.8 mL), tert-butanol (1.1 mL) and water (1.1 mL) was 
added osmium tetroxide (4% in water, 71.0 µL, 7.25 µmol, 0.0100 equiv) and N-methylmorpholine N-
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oxide (127 mg, 1.09 mmol, 1.5 equiv) at 23 °C. After 1 h, sodium thiosulfite (1 spatula) and water (5 mL) 
were added and the mixture was stirred for 5 min. The aqueous layer was extracted with ethyl acetate (3 × 
20 mL) and the combined organic layers were washed with saturated aqueous sodium chloride solution 
(50 mL). The washed solution was dried over sodium sulfate and the dried solution was filtered. The 
filtrate was concentrated and the crude product was purified by flash column chromatography on silica gel 
(20% ethyl acetate in hexanes) to provide I.316 (16 mg, 13%) as a colorless oil.  
1H NMR (400 MHz, acetone-d6) δ 7.80–7.73 (m, 2H), 7.65 (dt, J = 7.7, 1.0 Hz, 1H), 7.56–7.51 (m, 1H), 
5.35 (d, J = 6.3 Hz, 1H), 5.02 (dd, J = 6.2, 4.5 Hz, 1H), 4.96 (d, J = 5.4 Hz, 1H), 4.31 (dd, J = 5.4, 4.4 Hz, 
1H), 2.89 (s, 2H). 13C NMR (100 MHz, acetone-d6) δ: 201.8, 152.7, 136.3, 134.6, 129.8, 126.4, 123.3, 84.2, 
75.9. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3403 (s, br), 2879 (w), 1720 (vs), 1608 (m), 1468 (w), 1320 (w), 1206 
(m), 1102 (m), 1063 (m), 982 (m), 753 (m) cm–1. HRMS (EI) calcd for C9H8O3 [M]+: 164.0468; found: 
164.0466. 
Diol I.320: 
 
To a solution of bromo-indanone I.319 (702.0 mg, 3.12 mmol, 1 equiv) in benzene (12.5 mL) was added 
1,8-diazabicyclo[5,4,0]-7-undecene (DBU) (1.40 mL, 9.36 mmol, 3.00 equiv) at 0 °C. After 1°h, diethyl 
ether (30 mL) was added. The organic layer was washed with saturated aqueous ammonium chloride 
solution (2 × 20 mL) and with saturated aqueous sodium chloride solution (20 mL). The washed solution 
was dried over magnesium sulfate, the dried solution was filtered and the filtrate was concentrated. The 
product was used in the next step without further purification.  
To a solution of the crude indenone in a mixture of acetone (10 mL), tert-butanol (4 mL) and water (4 mL) 
at 23 °C were added osmium tetroxide (4% in water 305 μL, 31.2 μmol, 0.01 equiv) and N-
methylmorpholine N-oxide (NMO) (481 μL, 4.68 mmol, 1.5 equiv). After 2 h, sodium thiosulfite (2 
spatula) and water (30 mL) were added. The layers were separated and the aqueous layer was extracted 
with ethyl acetate (3 × 20 mL). The combined organic layers were washed with saturated aqueous sodium 
chloride solution (30 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash chromatography on 
silica gel (5% acetone in dichloromethane) to provide I.320 (324 mg, 58%) as an amorphous white solid. 
TLC (5% acetone in dichloromethane): Rf = 0.33 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 7.79 (d, J 
= 7.7 Hz, 1H), 7.74–7.71 (m, 2H), 7.53 (ddd, J = 7.8, 4.5, 3.5 Hz, 1H), 4.91 (d, J = 4.6 Hz, 1H), 3.53–3.24 
(m, 2H), 1.43 (s, 2H). 13C NMR (100 MHz, CDCl3) δ: 205.4, 151.8, 136.3, 133.5, 130.3, 127.3, 124.8, 75.0, 
53.6, 23.1. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 3390 (br, m), 2973 (w), 1714 (vs), 1606 (s), 1468 (m), 1372 (m), 
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1293 (m), 1203 (s), 1046 (s), 972 (m), 900 (m), 732 (s) cm–1. HRMS (EI) calcd for C10H10O3 [M]+: 178.0624; 
found: 178.0619. 
Cyclic sulfate I.321: 
 
To a solution of diol I.320 (284 mg, 1.59 mmol, 1 equiv) in dichloromethane (8.5 mL) was added 
triethylamine (554 μL, 3.98 mmol, 2.50 equiv) and thionyl chloride (173 μL, 2.39 mmol, 1.50 equiv) at 
0 °C. After 2 h, dichloromethane (20 mL) was added and the organic layer was washed with saturated 
aqueous sodium chloride solution (30 mL). The washed solution was dried over sodium sulfate, the dried 
solution was filtered and the filtrate was concentrated. The product was used in the next step without 
further purification.  
To a solution of the crude sulfite in acetonitrile (7 mL) was added sodium periodate (680 mg, 3.18 mmol, 
2.00 equiv), ruthenium(III) chloride (16.5 mg, 79.5 μmol, 0.0500 equiv) and water (7 mL) at 23 °C. After 
30 min, diethyl ether (20 mL) was added. The layers were separated and the organic layer was washed with 
saturated aqueous sodium hydrogen carbonate solution (2 × 20 mL). The washed solution was dried over 
sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The crude product was 
purified by flash chromatography on silica gel (40% ethyl acetate in hexanes) to provide I.321 (286 mg, 
75%) as an amorphous white solid. 
TLC (40% ethyl acetate in hexanes): Rf = 0.38 (UV, CAM). 1H NMR (400 MHz, CDCl3) δ: 7.97 (ddt, J = 
7.8, 1.3, 0.6 Hz, 1H), 7.90 (td, J = 7.5, 1.2 Hz, 1H), 7.85–7.78 (m, 1H), 7.75 (td, J = 7.5, 1.1 Hz, 1H), 5.92 
(s, 1H), 1.90 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 193.8, 143.9, 137.8, 134.8, 133.1, 128.2, 126.0, 87.3, 
84.0, 19.0. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2360 (w), 1737 (vs), 1396 (s), 1213 (vs), 963 (s), 885 (m), 835 (m), 
738 (m) cm–1. HRMS (EI) calcd for C10H8O332S [M]+: 240.0087; found: 240.0089. 
1,4-Adduct I.323: 
 
To a suspension of zinc dust (488 mg, 7.46 mmol, 2.00 equiv) in acetonitrile (15 mL) was added 
triethylsilyl chloride (1.39 mL, 8.21 mmol, 2.20 equiv) at –20 °C. Ethyl dibromofluoroacetate (I.254) 
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(1.3 mL, 9.33 mmol, 2.50 equiv) was added dropwise. After 2 h, 2-cyclopenten-1-one (I.322) (306 mg, 
3.73 mmol, 1 equiv) was added at –20 °C. The solution was allowed to warm to 23 °C. After 18 h, 1 M 
aqueous hydrochloric acid solution (10 mL) was added. The aqueous layer was extracted with diethyl ether 
(3 × 10 mL). The combined organic layers were washed with saturated aqueous sodium hydrogen 
carbonate solution (20 mL) and saturated sodium chloride solution (20 mL). The washed solution was 
dried over magnesium sulfate, the dried solution was filtered and the filtrate was concentrated. The crude 
product was purified with flash column chromatography on silica gel (10% ethyl acetate in hexanes) to 
provide I.323 (486 mg, 49%) as a colorless oil. 
TLC (20% ethyl acetate in hexanes) Rf = 0.45 (CAM, KMnO4). 1H NMR (300 MHz, CDCl3) δ: 4.36 (qd, 
J = 7.2, 1.0 Hz, 2H), 3.33–3.07 (m, 1H), 2.55–2.03 (m, 6H), 1.36 (t, J = 7.1 Hz, 1H). 13C NMR (75 MHz, 
CDCl3) δ: 215.1, 165.6 (d, J = 27.1 Hz), 99.6 (d, J = 268.0 Hz), 63.6, 46.2 (d, J = 20.8 Hz), 39.9 (d, J = 2.2 
Hz), 38.3, 24.5 (d, J = 2.4 Hz), 14.0. 19F NMR (282 MHz, CDCl3) δ –127.69 (d, J = 24.1 Hz). IR 
(Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2981 (w), 1741 (m), 1463 (w), 1405 (w), 1262 (s), 1180 (s), 1131 (s), 1041 (s), 
899 (m), 869 (m) cm–1. 
Fluoro-cyclopropane I.324: 
 
To a solution of cyclopentanone I.323 (486 mg, 1.82 mmol, 1 equiv) in N,N-dimethylformamide (20 mL) 
was added diazabicyclo[5,4,0]-7-undecene (DBU) (2.72 mL, 18.2 mmol, 10.0 equiv) at 23 °C. After 1 h, 1 
M aqueous hydrochloric acid (50 mL) was added. The layers were separated and the aqueous layer was 
extracted with ethyl acetate (3 × 30 mL). The combined organic layers were washed with saturated 
aqueous sodium chloride solution (40 mL). The washed solution was dried over magnesium sulfate, the 
dried solution was filtered and the filtrate was concentrated. The crude product was purified by flash 
column chromatography on silica gel (20% ethyl acetate in hexanes) to provide I.324 (314 mg, 93%) as a 
colorless oil. 
TLC (20% ethyl acetate in hexanes) Rf = 0.38 (CAM, KMnO4). 1H NMR (600 MHz, CDCl3) δ: 4.29 (qd, 
J = 7.1, 1.5 Hz, 2H), 2.72 (td, J = 6.3, 1.9 Hz, 1H), 2.58 (d, J = 6.5 Hz, 1H), 2.51–2.40 (m, 1H), 2.36–2.27 
(m, 2H), 2.28–2.16 (m, 1H), 1.32 (t, J = 7.2 Hz, 3H). 13C NMR (150 MHz, CDCl3) δ: 209.1, 167.3 (d, J = 
25.3 Hz), 80.0 (d, J = 247.2 Hz), 62.7, 40.4 (d, J = 13.1 Hz), 35.7, 34.4 (d, J = 12.2 Hz), 19.7 (d, J = 4.6 
Hz), 14.3. 19F NMR (282 MHz, Chloroform-d) δ −210.9 (d, J = 3.2 Hz). IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 
2982 (w), 1729 (vs), 1372 (m), 1325 (s), 1272 (s), 1213 (vs), 1149 (m), 1096 (vs), 1013 (m), 954 (m) cm–1. 
HRMS (EI) calcd for C9H11FO3 [M]+: 186.0687; found: 186.0682. 
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Fluoro-cyclopropane I.325: 
 
To a solution of lithium bis(trimethylsilyl)amide (1 M in THF, 2.02 mL, 2.02 mmol, 1.20 equiv) in 
tetrahydrofuran (4 mL) was added dropwise a solution of cyclopropane I.324 (314 mg, 1.69 mmol, 
1 equiv) in tetrahydrofuran (16 mL) at –78 °C. After 1 h, trimethylsilyl chloride (323 μL, 2.53 mmol, 
1.50 equiv) was added dropwise at –78 °C. After 50 min, the solution was allowed to warm to 23 °C. After 
3.5 h, the solution was concentrated and hexanes (20 mL) was added. The mixture was filtered through a 
plug of Celite and the filtrate was concentrated. The crude product was used in the next step without 
further purification. 
To a solution of the crude enol ether in acetonitrile (16 mL) was added palladium(II) acetate (417 mg, 
1.86 mmol, 1.10 equiv) at 23°C. After 13 h, diethyl ether (20 mL) was added. The mixture was filtered 
through a plug of Celite and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (20% ethyl acetate in hexanes) to provide I.325 (179 mg, 58%) as colorless 
oil. 
TLC (20% ethyl acetate in hexanes): Rf = 0.23 (UV, KMnO4). 1H NMR (400 MHz, CD2Cl2) δ: 7.28 (dd, J 
= 5.6, 2.9 Hz, 1H), 6.01 (t, J = 5.3 Hz, 1H), 4.20 (qd, J = 7.1, 4.6 Hz, 2H), 3.18 (ddd, J = 14.5, 6.2, 2.9 Hz, 
1H), 2.71 (ddd, J = 17.4, 6.3, 0.9 Hz, 1H), 1.25 (t, J = 7.1 Hz, 3H). 13C NMR (100 MHz, CD2Cl2) δ: 199.3, 
164.3 (d, J = 25.6 Hz), 151.1, 136.1 (d, J = 7.0 Hz), 88.9 (d, J = 246.7 Hz), 63.0, 34.5 (d, J = 11.7 Hz), 33.9 
(d, J = 8.2 Hz).14.1. IR (Diamond-ATR, neat) 𝜈𝑚𝑎𝑥: 2986 (w), 1740 (vs), 1711 (vs), 1376 (m), 1304 (vs), 
1263 (s), 1179 (vs), 1151 (vs), 1126 (s), 1091 (m), 1015 (m), 809 (m) cm–1. HRMS (EI) calcd for C9H9FO3 
[M]+: 184.0530; found: 184.0528. 
Fluoronaphthol I.332: 
 
A solution of cyclopropane I.277 (6.0 mg, 0.016 mmol, 1 equiv) in sulfolane (0.2 mL) was heated to 
190 °C. After 0.5 h, water (5 mL) and diethyl ether (5 mL) were added and the layers were separated. The 
aqueous layer was extracted with diethyl ether (3 × 10 mL) and the combined organic layers were washed 
with saturated aqueous sodium chloride solution (20 mL). The washed solution was dried over magnesium 
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sulfate, the dried solution was filtered and the filtrate was concentrated. The crude product was purified by 
flash column chromatography (40% ethyl acetate in hexanes) to provide I.332 (2.6 mg, 43%) as a colorless 
oil. 
TLC (40% ethyl acetate in hexanes) Rf = 0.21 (UV, CAM). 1H NMR (400 MHz, CD2Cl2) δ: 8.16–8.12 (m, 
1H), 8.04–7.99 (m, 1H), 7.62–7.52 (m, 2H), 7.53–7.47 (m, 1H), 6.88 (d, J = 5.1 Hz, 1H), 3.86 (t, J = 4.9 
Hz, 2H), 3.79 (t, J = 4.9 Hz, 2H), 3.69–3.59 (m, 3H), 3.53–3.39 (m, 2H). 19F NMR (376 MHz, CD2Cl2) δ: 
−34.3 (d, J = 4.9 Hz). HRMS (EI) calcd for C15H13FNO3 [M−H]−: 274.08850; found: 274.08854. 
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7.3.2 1H, 13C and 19F NMR Spectra 
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7.3.3 X-Ray Crystallographic Data 
The single-crystal X-ray analyses were carried out by Dr. Peter Mayer in the analytic department. The X-
Ray structural analyses were performed on an Oxford Diffraction Xcalibur, Bruker D8Quest or Bruker 
D8Venture diffractometer using Mo-Kα radiation (λ = 0.71073 Å, graphite monochromator). The CrysAlisPro 
software was applied for the integration, scaling and multi-scan absorption correction of the data. The 
structures were solved by direct methods with SIR97 and refined by least-squares methods against F2 with 
SHELXL-97. All non-hydrogen atoms were refined anisotropically. The hydrogen atoms were placed in 
ideal geometry riding on their parent atoms. 
 
Table 15. Crystallographic data for cyclopropane I.257. 
net formula C25H19FO3 
Mr/g mol−1 386.415 
crystal size/mm 0.191 × 0.113 × 0.068 
T/K 173(2) 
radiation 'Mo Kα 
diffractometer 'Bruker D8Quest' 
crystal system monoclinic 
space group P21/n 
a/Å 14.6512(13) 
b/Å 9.1204(9) 
c/Å 15.5982(14) 
α/° 90 
β/° 111.692(2) 
γ/° 90 
V/Å3 1936.7(3) 
Z 4 
calc. density/g cm−3 1.3253(2) 
μ/mm−1 0.093 
absorption correction multi-scan 
transmission factor range 0.9194–0.9580 
refls. measured 28523 
Rint 0.0868 
mean σ(I)/I 0.0505 
θ range 2.64–25.39 
observed refls. 2289 
x, y (weighting scheme) 0.0456, 1.0359 
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hydrogen refinement constr 
refls in refinement 3546 
parameters 263 
restraints 0 
R(Fobs) 0.0485 
Rw(F2) 0.1195 
S 1.025 
shift/errormax 0.001 
max electron density/e Å−3 0.254 
min electron density/e Å−3 −0.236 
 
 
 
 
Table 16. Crystallographic data for I.299. 
net formula C13H11FO3 
Mr/g mol−1 234.22 
crystal size/mm 0.100 × 0.080 × 0.060 
T/K 100(2) 
radiation MoKα 
diffractometer 'Bruker D8Venture' 
crystal system triclinic 
space group 'P -1' 
a/Å 7.7116(5) 
b/Å 8.3039(5) 
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c/Å 9.4619(5) 
α/° 92.0946(18) 
β/° 103.2287(18) 
γ/° 110.7448(18) 
V/Å3 546.97(6) 
Z 2 
calc. density/g cm−3 1.422 
μ/mm−1 0.112 
absorption correction multi-scan 
transmission factor range 0.8876–0.9585 
refls. measured 9365 
Rint 0.0285 
mean σ(I)/I 0.0276 
θ range 2.924–26.38 
observed refls. 1804 
x, y (weighting scheme) 0.0637, 0.2950 
hydrogen refinement constr 
refls in refinement 2244 
parameters 155 
restraints 0 
R(Fobs) 0.0440 
Rw(F2) 0.1251 
S 1.044 
shift/errormax 0.001 
max electron density/e Å−3 0.442 
min electron density/e Å−3 −0.185 
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7.4  Supporting Information for Chapter 5.1 
 
 
 
 
 
Development of a β-C–H Bromination Approach Towards the 
Synthesis of Jerantinine E 
 
 
T. Huber, T. A. Preuhs, C. K. G. Gerlinger, T. Magauer, J. Org. Chem. 2017, 82, 7410–7419. 
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7.4.1 Experimental Procedures 
 
 
N-Benzyltetrahydrocarbazolone S1. To a solution of tetrahydrocarbazolone rac-13 (90 mg, 0.25 mmol, 1 
equiv) in N,N-dimethylformamide (1.2 mL) was added sodium hydride (15 mg, 0.37 mmol, 1.5 equiv, 60% 
dispersion in mineral oil) at 0 °C. After 30 min, benzyl bromide (51 mg, 0.30 mmol, 1.5 equiv) was added 
and the solution was allowed to warm to 23 °C. After 2 h, the solution was diluted with saturated aqueous 
ammonium chloride solution (10 mL) and ethyl acetate (10 mL). The layers were separated and the 
aqueous layer was extracted with ethyl acetate (3×10 mL). The combined organic layers were washed with 
saturated aqueous sodium chloride solution (10 mL) and the washed solution was dried over sodium 
sulfate. The dried solution was filtered and the filtrate was concentrated. The crude product was purified 
by flash column chromatography on silica gel (50% ethyl acetate in hexanes) to afford S1 as a white foam 
(100 mg, 89%). TLC (50% ethyl acetate in hexanes): Rf = 0.22 (UV, KMnO4). 1H NMR (400 MHz, 
CD2Cl2) δ 7.70 (s, 1H), 7.36–7.20 (m, 8H), 7.02–6.93 (m, 2H), 6.65 (s, 1H), 5.49 (d, J = 17.0 Hz, 1H), 5.29 
(d, J = 17.1 Hz, 1H), 4.48–4.38 (m, 2H), 3.89 (s, 3H), 3.73 (s, 4H), 3.72–3.68 (m, 1H), 3.61 (dd, J = 9.3, 6.4 
Hz, 1H), 3.41–3.30 (m, 1H), 2.66 (ddd, J = 18.3, 13.6, 5.4 Hz, 1H), 2.45–2.20 (m, 3H). 13C NMR (100 
MHz, CD2Cl2) δ 193.9, 150.8, 148.1, 147.7, 138.6, 137.2, 131.9, 129.4, 128.9, 128.2, 128.1, 126.5, 118.2, 
113.2, 103.7, 94.7, 73.7, 71.5, 56.7, 56.6, 47.9, 34.5, 33.5, 27.0. IR (Diamond-ATR, neat) ṽmax: 2935, 1728, 
1640, 1584, 1526, 1494, 1481, 1450, 1359, 1333, 1308, 1269, 1207, 1194, 1157, 1104, 1071 cm−1. HR-MS 
(ESI): calcd for (C29H30O4N)+ (M+H)+: 456.2175, found: 456.2164. 
 
Elimination Product S2. To a solution N-benzyltetrahydrocarbazolone S1 (17.5 mg, 38.4 µmol, 1 equiv) 
in tetrahydrofuran (0.3 mL) and tert-butanol (30 µL) was added potassium tert-butoxide (15.1 mg, 0.134 
mmol, 3.50 equiv) at 0 °C and the solution was allowed to warm to 23 °C. After 1 h, the solution was 
diluted with saturated aqueous ammonium chloride solution (5 mL) and ethyl acetate (5 mL). The layers 
were separated and the aqueous layer was extracted with ethyl acetate (3×5 mL). The combined organic 
layers were washed with saturated aqueous sodium chloride solution (10 mL) and the washed solution was 
dried over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude 
product was purified by flash column chromatography on silica gel (50% ethyl acetate in hexanes) to 
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afford S2 as a brown solid (8.5 mg, 64%). 1H NMR (400 MHz, CDCl3) δ 7.84 (s, 1H), 7.39–7.29 (m, 3H), 
7.13–7.07 (m, 2H), 6.64 (s, 1H), 5.51 (s, 2H), 5.34 (s, 1H), 5.13 (s, 1H), 4.00 (s, 3H), 3.82 (s, 3H), 2.86 (t, J 
= 6.4 Hz, 2H), 2.73 (t, J = 6.5 Hz, 2H).13C NMR (100 MHz, CDCl3) δ 194.5, 148.8, 147.6, 145.1, 136.5, 
135.1, 133.6, 129.3, 127.9, 125.8, 117.5, 114.3, 113.1, 103.4, 93.3, 56.5, 56.3, 48.7, 39.4, 35.5. IR (Diamond-
ATR, neat) ṽmax: 2945, 1646, 1559, 1497, 1480, 1448, 1360, 1270, 1194, 1141, 1095, 1027 cm−1. HR-MS 
(ESI): calcd for (C22H22O3N)+: 348.1600, found: 348.1591. 
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7.4.2 1H and 13C NMR Spectra 
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Figure S2. Key 1H-1H COSY and HMBC correlations of 46. 
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7.4.3 X-Ray Crystallographic Data 
CCDC 1547827 contains the supplementary crystallographic data for tetrahydrocarbazolone 33. These 
data can be obtained free of charge from The Cambridge Crystallographic Data Centre (CCDC) via 
www.ccdc.cam.ac.uk/data_request/cif. 
 
Table 17. Crystallographic data for tetrahydrocarbazolone 33. 
net formula C29H29NO5 
Mr/g mol−1 471.53 
crystal size/mm 0.100×0.050×0.030 
T/K 100(2) 
radiation Mo Kα 
diffractometer 'Bruker D8 Venture TXS' 
crystal system monoclinic 
space group 'P 1 21/c 1' 
a/Å 10.5106(2) 
b/Å 4.96800(10) 
c/Å 44.4015(9) 
α/° 90 
β/° 91.3250(10) 
γ/° 90 
V/Å3 2317.88(8) 
Z 4 
calc. density/g cm−3 1.351 
μ/mm−1 0.092 
absorption correction Multi-Scan 
transmission factor range 0.9211–0.9705 
refls. measured 22871 
Rint 0.0297 
mean σ(I)/I 0.0256 
θ range 3.331–26.372 
observed refls. 4074 
x, y (weighting scheme) 0.0343, 1.5990 
hydrogen refinement constr 
refls in refinement 4723 
parameters 319 
restraints 0 
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R(Fobs) 0.0395 
Rw(F2) 0.0946 
S 1.038 
shift/errormax 0.001 
max electron density/e Å−3 0.263 
min electron density/e Å−3 −0.209 
 
Figure S1. Molecular structure of tetrahydrocarbazolone 33. Displacement ellipsoids are drawn at the 
50% probability level. 
 
 
 
  
References 
283 
 
8 References 
 
1 K. Sugawara, M. Tsunakawa, M. Konishi, H. Kawaguchi, B. Krishnan, C. H. He, J. Clardy J. Org. Chem. 
1987, 52, 996–1001. 
2 a) M. R. Boyd, Y. F. Hallock, J. H. Cardellina II., K. P. Manfredi, J. W. Blunt, J. B. McMahon, R, W. 
Buckheit Jr., G. Bringmann, M. Schäffer, G. M. Cragg, D. W. Thomas, J. G. Jato, J. Med. Chem. 1994, 37, 
1740–1745. b) G. Bringmann, R. Götz, P. A. Keller, R. Walter, M. R. Boyd, F. Lang, A. Garcia, J. J. 
Walsh, I. Tellitu, K. V. Bhaskar, T. R. Kelly, J. Org. Chem. 1998, 63, 1090–1097. 
3 S. Adachi, K. Watanabe, Y. Iwata, S. Kameda, Y. Miyaoka, M. Onozuka, R. Mitsui, Y. Saikawa, M. 
Nakata, Angew. Chem. Int. Ed. 2013, 52, 2087–2091. 
4 a) F. A. Carey, R. J. Sundberg, Advanced Organic Chemistry, Part A: Structure and Mechanisms, 5th edn, Springer 
Science+Business Media, 2007, 771–831. b) A. Streitwieser, Jr., P. C. Mowery, R. G. Jesaitis, and A. Lewis, 
J. Am. Chem. Soc. 1970, 92, 6529–6533. 
5 D. A. Klumpp, in Arene Chemistry: Reaction Mechanisms and Methods for Aromatic Compounds (Ed.: J. Mortier), 
John Wiley & Sons, Inc, Hoboken, NJ, 2015, 1–21. 
6 E. Ador, J. Crafts, Ber. Dtsch. Chem. Ges. 1877, 10, 2173–2176. 
7 F. Ospina, W. Hidalgo, M. Cano, B. Schneider, F. Otálvaro, J. Org. Chem. 2016, 81, 1256–1262. 
8 F. Terrier, in Modern Nucleophilic Aromatic Substitution, Wiley-VCH Verlag GmbH & Co. KGaA, 
Weinheim, 2013, 1–94. 
9 R. Aissaoui, A. Nourry, A. Coquel, T. T. H. Dao, A. Derdour, J.-J. Helesbeux, O. Duval, A.-S. Castanet, 
J. Mortier, J. Org. Chem. 2011, 77, 718–724. 
10 T. Hattori, M. Suzuki, N. Tomita, A. Takeda, S. Miyano, J. Chem. Soc., Perkin Trans. 1 1997, 1117–1123. 
11 F. R. Leroux, J. Mortier, in Arene Chemistry: Reaction Mechanisms and Methods for Aromatic Compounds (Ed.: J. 
Mortier), John Wiley & Sons, Inc., Hoboken, New Jersey, 2015, 741–776. 
12 J. Clayden, C. S. Frampton, C. McCarthy, N. Westlund, Tetrahedron 1999, 55, 14161–14184. 
13 a) G. C. Clososki, C. J. Rohbogner, P. Knochel, Angew. Chem. Int. Ed. 2007, 46, 7681–7684. b) S. H. 
Wunderlich, C. J. Rohbogner, A. Unsinn, P. Knochel, Org. Process Res. Dev. 2010, 14, 339–345. 
14 a) T. W. Lyons, M. S. Sanford, Chem. Rev. 2010, 110, 1147–1169. b) X. Chen, K. M. Engle, D.-H. Wang, 
J.-Q. Yu, Angew. Chem. Int. Ed. 2009, 48, 5094–5115. 
15 a) L. C. Campeau, K. Fagnou, Chem. Commun. 2006, 1253–1264. b) J. J. Neumann, S. Rakshit, T. Dröge, 
S. Würtz, F. Glorius, Chem. Eur. J. 2011, 17, 7298–7303. 
16 a) I. V. Seregin, V. Gevorgyan, Chem. Soc. Rev. 2007, 36, 1173–1193. b) L. Ackermann, R. Vicente, A. R. 
Kapdi, Angew. Chem. Int. Ed. 2009, 48, 9792–9826. 
17 A. M. Wagner, A. J. Hickman, M. S. Sanford, J. Am. Chem. Soc. 2013, 135, 15710–15713. 
 
References 
284 
 
 
18 K. D. Collins, R. Honeker, S. Vásquez-Céspedes, D.-T. D. Tang, F. Glorius, Chem. Sci. 2015, 6, 1816–
1824. 
19 S. Danishefsky, T. Kitahara, J. Am. Chem. Soc. 1974, 96, 7807–7808. 
20 J. Banville, P. Brassard, J. Chem. Soc., Perkin Trans. 1 1976, 1852–1856. 
21 B. M. O’Keefe, D. M. Mans, D. E. Kaelin, Jr., S. F. Martin, Tetrahedron 2011, 67, 6524–6538. 
22 a) J. L. Charlton, M. M. Alauddin, Tetrahedron 1987, 43, 2873–2889. b) J. L. Segura, N. Martin, Chem. Rev. 
1999, 99, 3199–3246. c) R. W. Van De Water, T. R. R. Pettus, Tetrahedron 2002, 58, 5367–5405. 
23 K. Yamamoto, M. F. Hentemann, J. G. Allen, S. J. Danishefsky, Chem. Eur. J. 2003, 9, 3242–3252. 
24 N. Asao, K. Takahashi, S. Lee, T. Kasahara, Y. Yamamoto, J. Am. Chem. Soc. 2002, 124, 12650–12651. 
25 N. Asao, T. Nogami, S. Lee, Y. Yamamoto, J. Am. Chem. Soc. 2003, 125, 10921–10925. 
26 Y. He, X. Zhang, X. Fan, Chem. Commun. 2014, 50, 5641–5643. 
27 J. M. Hammann, T. A. Unzner, T. Magauer, Chem. Eur. J. 2014, 20, 6733–6738. 
28 C. B. de Koning, A. L. Rousseaub, W. A. L. van Otterlo, Tetrahedron 2003, 59, 7–36. 
29 H. W. Moore, O. H. W. Decker, Chem. Rev. 1986, 86, 821–830. 
30 A. H. Schmidt, G. Kircher, S. Maus, H. Bach, J. Org. Chem. 1996, 61, 2085–2094. 
31 R. Tiedemann, P. Turnbull, H. W. Moore, J. Org. Chem. 1999, 64, 4030–4041. 
32 a) T. Matsumoto, T. Hamura, M. Miyamoto, K. Suzuki, Tetrahedron Lett. 1998, 39, 4853–4856. b) T. 
Hamura, M. Miyamoto, T. Matsumoto, K. Suzuki, Org. Lett. 2002, 4, 229–232. c) T. Hamura, M. 
Miyamoto, K. Imura, T. Matsumoto, K. Suzuki, Org. Lett. 2002, 4, 1675–1678.  
33 a) T. Hosoya, T. Hasegawa, Y. Kuriyama, T. Matsumoto, K. Suzuki, Synlett 1995, 177–179. b) T. 
Hosoya, T. Hasegawa, Y. Kuriyama, K. Suzuki, K. Tetrahedron Lett. 1995, 36, 3377–3380. c) T. Hosoya, T. 
Hamura, Y. Kuriyama, T. Matsumoto, K. Suzuki, Synlett 2000, 520–522. 
34 T. Hamura, T. Suzuki, T. Matsumoto, K. Suzuki, Angew. Chem. Int. Ed. 2006, 45, 6294–6296. 
35 a) Y. Nishii, Y. Tanabe, Tetrahedron Lett. 1995, 36, 8803–8806. b) Y. Tanabe, S. Seko, Y. Nishii, T. 
Yoshida, N. Utsumi, G. Suzukamo, J. Chem. Soc., Perkin Trans. 1 1996, 2157–2165. c) Y. Nishii, T. Yoshida, 
Y. Tanabe, Tetrahedron. Lett. 1997, 38, 7195–7198. 
36 J. Chang, X. Song, W. Huang, D. Zhu, M. Wang, Chem. Commun. 2015, 51, 15362–15365. 
37 A. C. Glass, B. B. Morris, L. N. Zakharov, S.-Y. Liu, Org. Lett. 2008, 10, 4855–4857. 
38 A. C. Glass, S. Klonoski, L. N. Zakharovy, S.-Y. Liu, Chem. Commun. 2011, 47, 286–288. 
39 K. H. Dötz, Angew. Chem. Int. Ed. 1975, 14, 644–645. 
40 a) A. Minatti, K. H. Dötz, Topics Organomet Chem 2004, 13, 123–156. b) R. A. Fernandes, S. V. Mulay, J. 
Org. Chem. 2010, 75, 7029–7032. c) R. A. Fernandes, A. B. Ingle, V. P. Chavan, Org. Biomol. Chem. 2012, 10, 
4462–4466. d) S. V. Mulay, A. Bhowmik, R. A. Fernandes, Eur. J. Org. Chem. 2015, 4931–4938. e) T. 
Hirose, Y. Kojima, H. Matsui, H. Hanaki, M. Iwatsuki, K. Shiomi, S. Ōmura, T. Sunazuka, J. Antibiot. 
 
References 
285 
 
 
2017, 70, 574–581. f) X. Xie, M. C. Kozlowski, Org. Lett. 2001, 3, 2661–2663. g) S. R. Pulley, B. Czakó, 
Tetrahedron Lett. 2004, 45, 5511–5514. 
41 R. A. Fernandes, V. P. Chavan, S. V. Mulay, A. Manchoju, J. Org. Chem. 2012, 77, 10455–10460. 
42 Y. Sato, T. Tamura, A. Kinbara, M. Mori, Adv. Synth. Catal. 2007, 349, 647–661. 
43 a) K.-S. Huang, E.-C. Wang, Tetrahedron Lett. 2001, 42, 6155–6157. b) W. A. L. van Otterlo, E. L. Ngidi, 
E. M. Coyanis, C. B. de Koning, Tetrahedron Lett. 2003, 44, 311–313. 
44 a) R. R. Jones, R. G. Bergmann, J. Am. Chem. Soc. 1972, 94, 660–661. b) R. G. Bergmann, Acc. Chem. Res. 
1973, 6, 25–31. 
45 Selected reviews: a) A. Basak, S. Mandal, S. S. Bag, Chem. Rev. 2003, 103, 4077–4094. b) D. M. Bowles, 
G. J. Palmer, C. A. Landis, J. L. Scott, J. E. Anthony, Tetrahedron 2001, 57, 3753–3760. c) K. K. Wang, 
Chem. Rev. 1996, 96, 207–222. 
46 a) A. G. Myers, E. Y. Kuo, N. S. Finney, J. Am. Chem. Soc. 1989, 111, 8057–8059. b) K. Saito, T. 
Watanabe, K. Takahashi, Chem. Lett. 1989, 2099–2102. 
47 a) J. W. Grissom, T. L. Calkins, Tetrahedron Lett. 1992, 33, 2315–2318. b) J. W. Grissom, G. U. 
Gunawardena, D. Klingberg, D. H. Huang, Tetrahedron 1996, 52, 6453–6518. 
48 Y. Wang, M. G. Finn, J. Am. Chem. Soc. 1995, 117, 8045–8046. 
49 F. M. Hauser, R. P. Rhee, J. Org. Chem. 1978, 43, 178–180. 
50 G. A. Kraus, H. Sugimoto, Tetrahedron Lett. 1978, 2263–2266. 
51 a) A. S. Mitchell, R. A. Russell, Tetrahedron 1995, 51, 5207–5236. b) D. Mal, P. Pahari, Chem. Rev. 2007, 
107, 1892–1918. c) K. Rathwell, M. A. Brimble, Synthesis 2007, 643–662. 
52 F. M. Hauser, S. Chakrapani, W. P. Ellenberger, J. Org. Chem. 1991, 56, 5248–5250. 
53 a) N. Ueberschaar, Z. Xu, K. Scherlach, M. Metsä-Ketelä, T. Bretschneider, H.-M. Dahse, H. Görls, C. 
Hertweck, J. Am. Chem. Soc. 2013, 135, 17408–17416. b) N. Ueberschaar, H.-M. Dahse, T. Bretschneider, 
C. Hertweck, Angew. Chem. Int. Ed. 2013, 52, 6185–6189. 
54 D. Mal, A. K. Jana, P. Mitra, K. Ghosh, J. Org. Chem. 2011, 76, 3392–3398. 
55 a) G. E. Evans, F. J. Leeper, J. A. Murphy, J. Staunton, J. Chem. Soc., Chem. Comm. 1979, 205–206. b) J. 
Staunton, F. J. Leeper, J. Chem. Soc., Perkin Trans. 1 1984, 1053–1059. 
56 J. H. Dodd, J. E. Starrett, S. M. Weinreb, J. Am. Chem. Soc. 1984, 106, 1811–1812. 
57 C. D. Donner, N. P. H. Tan, Tetrahedron 2009, 65, 4007–4012.  
58 D. O’Hagan, Chem. Soc. Rev. 2008, 37, 308–319.  
59 K. Müller, C. Faeh, F. Diederich, Science 2007, 317, 1881–1886. 
60 L. R. Murphy, T. L. Meek, A. L. Allred, L. C. Allen, J. Phys. Chem. A 2000, 104, 5867–5871. 
61 A. Bondi, J. Phys. Chem. 1964, 68, 441–451. 
62 S. J. Blanksby, G. B. Ellison, Acc. Chem. Res. 2003, 36, 255–263. 
 
References 
286 
 
 
63 F. H, Allen, O. Kennard, D. g. Watson, L. Brammer, A. G. Orpen, E. Taylor, J. Chem. Soc. Perkin Trans. 
2 1987, S1–S19. 
64 B. E. Smart, J. Fluorine Chem. 2001, 109, 3–11. 
65 M.Schlosser, Angew. Chem. Int. Ed. 1998, 37, 1496–1513. 
66 K. B. Wiberg, M. A. Murcko, K. E. Laidig, P. J. MacDougall, J. Phys. Chem. 1990, 94, 6956–6959. 
67 N. C. Craig, A. Chen, K. H. Suh, S. Klee, G. C. Mellau, B. P. Winnewisser, M. Winnewisser, J. Am. 
Chem. Soc. 1997, 119, 4789–4790. 
68 P. R. Rablen, R. W. Hoffmann, D. A. Hrovat, W. T. Borden, J. Chem. Soc., Perkin Trans. 2 1999, 1719–
1726. 
69 a) T. Furuya, A. S. Kamlet, T. Ritter, Nature 2011, 473, 470–477. b) D. O’Hagan, C. Schaffrath, S. L. 
Cobb, J. T. G. Hamilton, C. D. Murphy, Nature 2002, 416, 279.  
70 W. R. Dolbier Jr., J. Fluorine Chem. 2005, 126, 157–163.  
71 C. D. Cadicamo, J. Courtieu, H. Deng, A. Meddour, D. O'Hagan, ChemBioChem 2004, 5, 685–690. 
72 A. Harsanyi, G. Sandford, Green Chem. 2015, 17, 2081–2086. 
73 a) W. J. Middleton, J. Org. Chem. 1975, 40, 574–578; (DAST). b) G. S. Lal, G. P. Pez, R. J. Pesaresi, F. M. 
Prozonic, H. Cheng, J. Org. Chem., 1999, 64, 7048–7054; (Deoxofluor). c) T. Umemoto, R. P. Singh, Y. Xu, 
N. Saito, J. Am. Chem. Soc. 2010, 132, 18199–18205; (Fluolead). d) W. J. Middleton, U.S. Patent 3 940 402, 
1976; (TASF). e) A. L’Heureux, F. Beaulieu, C. Bennett, D. R. Bill, S. Clayton, F. LaFlamme, M. 
Mirmehrabi, S. Tadayon, D. Tovell, M. Couturier, J. Org. Chem. 2010, 75, 3401–3411; (XtalFluor-E, 
XtalFluor-M). f) M. K. Nielsen, C. R. Ugaz, W. Li, A. G. Doyle, J. Am. Chem. Soc. 2015, 137, 9571–9574; 
(PyFluor). g) B. Bennua-Skalmowski, H. Vorbrüggen, Tetrahedron Lett. 1995, 36, 2611–2614; (PBSF). h) N. 
N. Yarovenko, M. A. Raksha, Zh. Obshch. Khim. 1959, 29, 2159–2163; (Yarovenko’s reagent). i) A. 
Takaoka, H. Iwakiri, N. Ishikawa, Bull. Chem. Soc. Jpn. 1979, 52, 3377–3380; (Ishikawa’s reagent). j) H. 
Hayashi, H. Sonoda, K. Fukumura, T. Nagatac, Chem. Commun. 2002, 1618–1619; (DFI). k) P. Tang, W. 
Wang, T. Ritter, J. Am. Chem. Soc. 2011, 133, 11482–11484; (PhenoFluor). 
74 G. S. Lal, G. P. Pez, R. G. Syvret, Chem. Rev. 1996, 96, 1737–1755. 
75 R. E. Banks, S. N. Mohialdinkhaffaf, G. S. Lal, I. Sharif, R. G. Syvret, J. Chem. Soc., Chem. Commun. 1992, 
595–596. 
76 T. Umemoto, G. Tomizawa, J. Org. Chem. 1995, 60, 6563–6570. 
77 K. L. Hull, W. Q. Anani, M. S. Sanford, J. Am. Chem. Soc. 2006, 128, 7134–7135. 
78 a) F. A. Davis, W. Han, C. K. Murphy, J. Org. Chem. 1995, 60, 4730–4737.  
79 a) E. Differding, R. W. Lang, Tetrahedron Lett. 1988, 29, 6087–6090. b) F. A. Davis, P. Zhou, C. K. 
Murphy, Tetrahedron Lett. 1993, 34, 3971–3974. c) Y. Takeuchi, T. Suzuki, A. Satoh, T. Shiragami, N. 
Shibata, J. Org. Chem. 1999, 64, 5708–5711. d)  
80 T. Liang, C. N. Neumann, T. Ritter, Angew. Chem. Int. Ed. 2013, 52, 8214–8264. 
 
References 
287 
 
 
81 a) G. Balz, G. Schiemann, Chem. Ber. 1927, 60, 1186–1190. b) O. Wallach, Justus Liebigs Ann. Chem. 1888, 
243, 219–244. 
82 H. B. Gottlieb, J. Am. Chem. Soc. 1936, 58, 532–533. 
83 a) H. Sun, S. G. DiMagno, Angew. Chem. Int. Ed. 2006, 45, 2720–2725. b) S. D. Schimler, S. J. Ryan, D. 
C. Bland, J. E. Anderson, M. S. Sanford, J. Org. Chem. 2015, 80, 12137–12145. 
84 S. Yamada, A. Gavryushin, P. Knochel, Angew. Chem. Int. Ed. 2010, 49, 2215–2218. 
85 T. Fujimoto, T. Ritter, Org.Lett. 2015, 17, 544–547. 
86 a) D. A. Watson, M. Su, G. Teverovskiy, Y. Zhang, J. García-Fortanet, T. Kinzel, S. L. Buchwald, Science 
2009, 325, 1161–1164. b) A. R. Mazzotti, M. G. Campbell, P. Tang, J. M. Murphy, T. Ritter, J. Am. Chem. 
Soc. 2013, 135, 14012–14015. 
87 a) J. M. Brown, V. Gouverneur, Angew. Chem. Int. Ed. 2009, 48, 8610–8614 b) M. G. Campbell, T. Ritter, 
Chem. Rev. 2015, 115, 612–633. 
88 a) R. P. Singh, J. M. Shreeve, Synthesis 2002, 2561–2578. b) T. Furuya, C. A. Kuttruff, T. Ritter, Curr. 
Opin. Drug Discovery Dev. 2008, 11, 803–819. 
89 L. Hintermann, A. Togni, Angew. Chem. Int. Ed. 2000, 39, 4359–4362. 
90 D. H. Paull, M. T. Scerba, E. Alden-Danforth, L. R. Widger, T. Lectka, J. Am. Chem. Soc. 2008, 130, 
17260–17261. 
91 a) N. Shibata, E. Suzuki, T. Asahi, M. Shiro, J. Am. Chem. Soc. 2001, 123, 7001–7009. b) T. Fukuzumi, N. 
Shibata, M. Sugiura, S. Nakamura, T. Toru, J. Fluorine Chem. 2006, 127, 548–551. c) P. Kwiatkowski, T. D. 
Beeson, J. C. Conrad, D. W. C. MacMillan, J. Am. Chem. Soc. 2011, 133, 1738–1741. 
92 a) X. Yang, R. J. Phipps, F. D. Toste, J. Am. Chem. Soc. 2014, 136, 5225–5228. b) R. J. Phipps, F. D. 
Toste, J. Am. Chem. Soc. 2013, 135, 1268–1271. 
93 a) M. Marigo, D. Fielenbach, A. Braunton, A. Kjærsgaard, K. A. Jørgensen, Angew. Chem. Int. Ed. 2005, 
44, 3703–3706. b) T. D. Beeson, D. W. C. MacMillan, J. Am. Chem. Soc. 2005, 127, 8826–8828. 
94 a) B. Greedy, J.-M. Paris, T. Vidal, V. Gouverneur, Angew. Chem. Int. Ed. 2003, 42, 3291–3294. b) S. 
Purser, B. Odell, T. D. W. Claridge, P. R. Moore, V. Gouverneur, Chem. Eur. J. 2006, 12, 9176–9185. c) 
Y.-h. Lam, C. Bobbio, I. R. Cooper, V. Gouverneur, Angew. Chem. Int. Ed. 2007, 46, 5106–5110. d) T. 
Ishimaru, N. Shibata, T. Horikawa, N. Yasuda, S. Nakamura, T. Toru, M. Shiro, Angew. Chem. Int. Ed. 
2008, 47, 4157–4161. e) G. T. Giuffredi, S. Purser, M. Sawicki, A. L. Thompson, V. Gouverneur, 
Tetrahedron: Asymmetry 2009, 20, 910–920. 
95 B. Greedy, V. Gouverneur, Chem. Commun. 2001, 233–234. 
96 a) C. Hollingworth, A. Hazari, M. N. Hopkinson, M. Tredwell, E. Benedetto, M. Huiban, A. D. Gee, J. 
M. Brown, V. Gouverneur, Angew. Chem. Int. Ed. 2011, 50, 2613–2617. b) A. Hazari, V. Gouverneur, J. M. 
Brown, Angew. Chem. Int. Ed. 2009, 48, 1296–1299. c) M. H. Katcher, A. G. Doyle, J. Am. Chem. Soc. 2010, 
132, 17402–17404. 
 
References 
288 
 
 
97 C. Sandford, R. Rasappan, V. K. Aggarwal, J. Am. Chem. Soc. 2015, 137, 10100–10103. 
98 a) C. A. Ramsden, M. M. Shaw, Tetrahedron Lett. 2009, 50, 3321–3324. b) F. Yin, Z. Wang, Z. Li, C. Li, J. 
Am. Chem. Soc. 2012, 134, 10401–10404. c) S. Ventre, F. R. Petronijevic, D. W. C. MacMillan, J. Am. Chem. 
Soc. 2015, 137, 5654–5657. 
99 a) D. O’Hagan, J. Fluorine Chem. 2010, 131, 1071–1081. b) J. Wang, M. Sánchez-Roselló, J. L. Aceńa, 
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